<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Biochim Biophys Sin (Shanghai)</journal-id><journal-id journal-id-type="iso-abbrev">Acta Biochim Biophys Sin (Shanghai)</journal-id><journal-id journal-id-type="pmc-domain-id">708</journal-id><journal-id journal-id-type="pmc-domain">abbs</journal-id><journal-id journal-id-type="publisher-id">ABBS</journal-id><journal-title-group><journal-title>Acta Biochimica et Biophysica Sinica</journal-title></journal-title-group><issn pub-type="ppub">1672-9145</issn><issn pub-type="epub">1745-7270</issn><publisher><publisher-name>Acta Biochimica et Biophysica Sinica Editorial Office</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9828688</article-id><article-id pub-id-type="pmcid-ver">PMC9828688.1</article-id><article-id pub-id-type="pmcaid">9828688</article-id><article-id pub-id-type="pmcaiid">9828688</article-id><article-id pub-id-type="pmid">35607958</article-id><article-id pub-id-type="doi">10.3724/abbs.2022012</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Biochemical mechanism underlying the pathogenesis of diabetic retinopathy and other diabetic complications in humans: the methanol-formaldehyde-formic acid hypothesis</article-title><subtitle>Pathogenesis of diabetic complications</subtitle></title-group><contrib-group><contrib contrib-type="author"><name specific-use="en" name-style="western"><surname>Zhu</surname><given-names initials="BT">Bao Ting</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn1" ref-type="corresp">*</xref></contrib><aff id="aff1">
<label>1</label>
<institution content-type="orgname">Shenzhen Key Laboratory of Steroid Drug Discovery and Development</institution>
<institution content-type="orgname">School of Medicine</institution>
<institution content-type="orgname">The Chinese University of Hong Kong</institution>
<addr-line><named-content content-type="city">Shenzhen</named-content><named-content content-type="zipcode">518172</named-content></addr-line>
<country>China</country>
</aff><aff id="aff2">
<label>2</label>
<institution content-type="orgname">Department of Pharmacology</institution>
<institution content-type="orgname">Toxicology and Therapeutics</institution>
<institution content-type="orgname">School of Medicine</institution>
<institution content-type="orgname">University of Kansas Medical Center</institution>
<institution content-type="orgname">Kansas City</institution>
<addr-line><named-content content-type="city">KS</named-content><named-content content-type="zipcode">66160</named-content></addr-line>
<country>USA</country>
</aff></contrib-group><author-notes><corresp id="fn1">Correspondence address. Tel: +86-755-84273851; E-mail: BTZhu@CUHK.edu.cn</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>3</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2022</year></pub-date><volume content-type="Vol.">54</volume><issue content-type="No.">4</issue><issue-id pub-id-type="pmc-issue-id">425793</issue-id><fpage>415</fpage><lpage>451</lpage><history><date date-type="received"><day>8</day><month>10</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>11</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>03</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>10</day><month>02</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-09 21:25:42.197"><day>09</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2021.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>
<open-access><p>This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/).</p></open-access>
</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="1672-9145-2022-54-4-415.pdf"/><abstract><p>Hyperglycemia in diabetic patients is associated with abnormally-elevated cellular glucose levels. It is hypothesized that increased cellular glucose will lead to increased formation of endogenous methanol and/or formaldehyde, both of which are then metabolically converted to formic acid. These one-carbon metabolites are known to be present naturally in humans, and their levels are increased under diabetic conditions. Mechanistically, while formaldehyde is a cross-linking agent capable of causing extensive cytotoxicity, formic acid is an inhibitor of mitochondrial cytochrome oxidase, capable of inducing histotoxic hypoxia, ATP deficiency and cytotoxicity. Chronic increase in the production and accumulation of these toxic one-carbon metabolites in diabetic patients can drive the pathogenesis of ocular as well as other diabetic complications. This hypothesis is supported by a large body of experimental and clinical observations scattered in the literature. For instance, methanol is known to have organ- and species-selective toxicities, including the characteristic ocular lesions commonly seen in humans and non-human primates, but not in rodents. Similarly, some of the diabetic complications (such as ocular lesions) also have a characteristic species-selective pattern, closely resembling methanol intoxication. Moreover, while alcohol consumption or combined use of folic acid plus vitamin B
<sub>6/12</sub> is beneficial for mitigating acute methanol toxicity in humans, their use also improves the outcomes of diabetic complications. In addition, there is also a large body of evidence from biochemical and cellular studies. Together, there is considerable experimental support for the proposed hypothesis that increased metabolic formation of toxic one-carbon metabolites in diabetic patients contributes importantly to the development of various clinical complications.
</p></abstract><kwd-group kwd-group-type="inspec"><kwd>hyperglycemia</kwd><kwd>one-carbon metabolites</kwd><kwd>diabetes mellitus</kwd><kwd>pathogenic mechanism</kwd></kwd-group><funding-group><award-group><funding-source>the grants from the University of Kansas Medical Center</funding-source><award-id>to</award-id><award-id>B.T.Z.</award-id></award-group><award-group><funding-source>the Shenzhen Peacock Plan</funding-source><award-id>No.</award-id><award-id>KQTD2016053117035204</award-id></award-group><award-group><funding-source>the Shenzhen Bay Laboratory</funding-source><award-id>No.</award-id><award-id>SZB2019062801007</award-id></award-group><award-group><funding-source>and the National Science Foundation of China</funding-source><award-id>No.</award-id><award-id>81630096</award-id></award-group><funding-statement>This work was supported in part by the grants from the University of Kansas Medical Center (to B.T.Z.), the Shenzhen Peacock Plan (No. KQTD2016053117035204), the Shenzhen Bay Laboratory (No. SZB2019062801007), and the National Science Foundation of China (No. 81630096).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>Citation</meta-name><meta-value>BT Zhu.Biochemical mechanism underlying the pathogenesis of diabetic retinopathy and other diabetic complications in humans: the methanol-formaldehyde-formic acid hypothesis. Acta Biochim Biophys Sin, 2022, 54, 415-451,
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3724/abbs.2022012">https://doi.org/10.3724/abbs.2022012</uri>
</meta-value></custom-meta><custom-meta><meta-name>Crossmark</meta-name><meta-value>2022/3/2 14:23:30</meta-value></custom-meta><custom-meta><meta-name>AuthorMark</meta-name><meta-value>Zhu</meta-value></custom-meta><custom-meta><meta-name>AuthorMarkCite</meta-name><meta-value>BT Zhu.</meta-value></custom-meta><custom-meta xml:lang="article-title"><meta-name>article-title</meta-name><meta-value>Biochemical mechanism underlying the pathogenesis of diabetic retinopathy and other diabetic complications in humans: the methanol-formaldehyde-formic acid hypothesis</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title id="SEC1">Introduction</title><p>Diabetes mellitus (DM), one of the world&#8217;s oldest diseases [
<xref rid="REF1" ref-type="bibr">1</xref>,
<xref rid="REF2" ref-type="bibr">2</xref>], has become a major epidemic of this century
<xref rid="REF3" ref-type="bibr">[3]</xref>. Its incidence continues to increase rapidly worldwide
<xref rid="REF4" ref-type="bibr">[4]</xref>. The International Diabetes Federation estimated that there were 382 million people aged between 20 and 79&#8197;years with DM in 2013, and this number is expected to increase to 592 million by 2035
<xref rid="REF5" ref-type="bibr">[5]</xref>. Common complications associated with long-standing DM include microangiopathy, retinopathy, nephropathy, neuropathy and myocardiopathy
<xref rid="REF6" ref-type="bibr">[6]</xref>. The complications occurring at late stages of DM are among the major causes of morbidity and mortality worldwide. Understanding the mechanistic basis of these clinical complications has been a subject of intense research for decades. Most of the available experimental and clinical evidence suggests that diabetic complications are the consequence of metabolic derangements, mainly hyperglycemia. In support of this general concept, studies have shown that when the kidneys from non-DM donors were transplanted into DM recipients, they developed characteristic lesions of diabetic nephropathy within 2&#8211;5&#8197;years after transplantation [
<xref rid="REF7" ref-type="bibr">7</xref>,
<xref rid="REF8" ref-type="bibr">8</xref>]; conversely, kidneys with characteristic lesions of diabetic nephropathy showed a reversal of the lesions after transplantation into normal recipients [
<xref rid="REF9" ref-type="bibr">9</xref>,
<xref rid="REF10" ref-type="bibr">10</xref>]. Many clinical studies have also shown that the progression of diabetic nephropathy can be delayed through better hyperglycemic control
<xref rid="REF11" ref-type="bibr">[11]</xref>.
</p><p>A number of mechanisms linking hyperglycemia to diabetic complications have been explored in the past. For instance, one of the well-known mechanisms is based on elevated glycation of various proteins as a pathogenic basis for certain diabetic complications [
<xref rid="REF12" ref-type="bibr">12</xref>&#8211;
<xref rid="REF14" ref-type="bibr">14</xref>]. It is known that glucose can form chemically-reversible glycation products with the amino groups of proteins without the aid of enzymes (a chemical reaction called Schiff base formation), and the intermediary products may rearrange to form more stable Amadori-type early glycation products. It is postulated that the early glycation products from collagens and other long-lived proteins in interstitial tissues and blood vessel walls can undergo a series of chemical rearrangements to form irreversible advanced glycation end products (AGEs), which might accumulate over a long period of time in the vessel walls. AGEs have a number of chemical and biological properties which are potentially pathogenic. Increased nonenzymatic glycation of proteins has long been suggested to be a pathogenic mechanism for certain diabetic complications, including microangiopathy, atherosclerosis, and nephropathy (reviewed in [
<xref rid="REF12" ref-type="bibr">12</xref>&#8211;
<xref rid="REF14" ref-type="bibr">14</xref>]). In addition, the levels of glycated hemoglobin HbA1c in the blood are widely used nowadays as an indicator in DM management
<xref rid="REF15" ref-type="bibr">[15]</xref>.
</p><p>In addition to increased formation of AGEs, a number of other metabolic pathways have also been suggested to be involved in the pathogenesis of diabetic complications
<xref rid="REF16" ref-type="bibr">[16]</xref>. These pathways include increased glucose flux through the aldose reductase pathway
<xref rid="REF17" ref-type="bibr">[17]</xref>, increased flux through the hexosamine pathway [
<xref rid="REF18" ref-type="bibr">18</xref>,
<xref rid="REF19" ref-type="bibr">19</xref>], and activation of the protein kinase C isoforms
<xref rid="REF20" ref-type="bibr">[20]</xref>. While all these mechanistic hypotheses offer partial explanations for some of the pathogenic complications associated with advanced DM, their relative clinical importance is still unclear. For instance, a number of specific inhibitors of the above-mentioned metabolic pathways have been developed in the past, but their clinical effectiveness was not as expected [
<xref rid="REF21" ref-type="bibr">21</xref>&#8211;
<xref rid="REF23" ref-type="bibr">23</xref>]. In addition, there were also many clinical and experimental observations that could not be adequately explained by the existing mechanisms. For instance, the experimental rodent models of DM usually develop very severe hyperglycemia but they fail to develop the more severe forms of diabetic complications commonly seen in humans.
</p><p>In this communication, a new hypothesis is proposed, which suggests that the pathogenesis of many DM-associated complications likely is contributed, at least in part, by the increased metabolic formation of methanol and/or its metabolites formaldehyde and formic acid inside the human body, particularly in those tissues and/or cells that have very high levels of cellular glucose, and these toxic one-carbon metabolites then drive the pathogenic processes associated with many human diabetic complications.</p></sec><sec><title id="SEC2">A General Hypothesis</title><p>A key component of the proposed hypothesis is that hyperglycemia-associated increase in cellular glucose levels in DM patients would lead to increased metabolic formation of endogenous methanol and/or formaldehyde, both of which are further metabolically converted to formic acid (
<xref rid="FIG1" ref-type="fig">Figure 1</xref>). Although the exact metabolic pathways as well as the enzymes involved are not clear at present, there is clear evidence showing that methanol, formaldehyde and formic acid are endogenously-formed metabolites present in humans, and that increased levels of these toxic one-carbon metabolites are present in DM patients (discussed in detail in later sections).
<fig position="float" id="FIG1" orientation="landscape"><caption><title>
<xref rid="FIG1" ref-type="fig">Figure1</xref>
</title><p>Proposed metabolic formation and biotransformation of the toxic one-carbon metabolites (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., methanol, formaldehyde and formic acid) in the body as well as their cytotoxicity
</p><p>Chronic increase in cellular glucose levels would lead to increased metabolic formation of endogenous methanol and/or formaldehyde, both of which are further metabolically converted to formic acid. The enzymes involved in the metabolic conversion of glucose into methanol and/or formaldehyde are not clear at present. Some of the presently-known enymes involved in the endogenous formation of methanol and formaldehyde as well as their further metabolic biotransformation are shown in green (refer to Metabolic biotransformation of methanol for description). While methanol per se has very weak cytotoxicity, its metabolites (formaldehyde and formic acid) are highly cytotoxic. Formaldehyde can cause cytotoxicity by covalently modifying (cross-linking) many nitrogen-containing macromolecules (e.g., DNA, RNA, proteins), and formic acid can directly inhibit the cytochrome oxidase complex of the mitochondrial respiratory chain, thereby reducing cellular ATP production and simultaneously causing cellular ROS (e.g., mitochondrial superoxide) accumulation. Hence, formaldehyde and formic acid can jointly contribute to the development of strong cytotoxicity. Abbreviations: ADH1 and ADH3: alcohol dehydrogenase 1 and 3, respectively; ALDH1 and ALDH2: aldehyde dehydrogenase 1 and 2, respectively; JHDM: JmjC domain-containing histone demethylases; LSD1: lysine-specific demethylase 1; SSAO: semicarbazide-sensitive amine oxidases; THF: tetrahydrofolate; CYP2E1: cytochrome P450 2E1.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ABBS-2021-527-t1.jpg"/></fig>
</p><p>Mechanistically, while methanol
<italic toggle="yes">per se</italic> has very weak cytotoxicity, its metabolites formaldehyde and formic acid are highly cytotoxic. Although formaldehyde usually does not accumulate in the body to high levels, it can covalently modify many nitrogen-containing compounds,
<italic toggle="yes">e</italic>.
<italic toggle="yes">g</italic>., DNA, RNA, proteins and amino acids. For proteins, formaldehyde can react with their amine groups to form Schiff bases and cross-link proteins by forming methylene bridges between the amine groups (
<xref rid="FIG2" ref-type="fig">Figure 2</xref>) [
<xref rid="REF24" ref-type="bibr">24</xref>,
<xref rid="REF25" ref-type="bibr">25</xref>]. It is hypothesized that the ability of formaldehyde to covalently cross-link intracellular as well as extracellular components (mostly macromolecules) may contribute critically to the thickening of the basement membrane structures in certain tissues or organs that have high levels of blood supply or perfusion, such as the capillaries of the eye and brain and the glomeruli of the kidney in DM patients.
<fig position="float" id="FIG2" orientation="landscape"><caption><title>
<xref rid="FIG2" ref-type="fig">Figure2</xref>
</title><p>Chemical reactions underlying the cross-linking of molecules by formaldehyde in the body</p><p>Formaldehyde can cause covalent cross-linking of molecules (usually macromolecules) in the body in two major chemical steps. First, formaldehyde reacts with a strong nucleophile contained in a biomolecule, such as a lysine &#1013;-amino group. This reaction forms a methylol intermediate that subsequently will lose a water molecule to form a Schiff base (an imine). Second, the Schiff base reacts with another nucleophile, possibly an amine group contained in a protein or a nucleotide in the DNA to generate a cross-linked product. The protein-DNA cross-linked product as shown is only one of the possible products. This figure is modified after Hoffman et al. [24].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ABBS-2021-527-t2.jpg"/></fig>
</p><p>For formic acid, it can quite readily accumulate in humans and non-human primates to high levels [
<xref rid="REF26" ref-type="bibr">26</xref>&#8211;
<xref rid="REF30" ref-type="bibr">30</xref>], and can cause cytotoxicity by directly inhibiting the cytochrome oxidase complex of the mitochondrial respiratory chain [
<xref rid="REF31" ref-type="bibr">31</xref>,
<xref rid="REF32" ref-type="bibr">32</xref>], thereby reducing the cellular ATP production. Depending on the levels of formic acid being formed and present inside a cell, the degree of inhibition of the mitochondrial oxidative phosphorylation would vary considerably. In severe cases, high levels of formic acid are expected to cause histotoxic hypoxia (which is commonly seen during acute methanol poisoning) and drastic reduction in cellular ATP production. In addition, formic acid can cause metabolic acidosis and alter intracellular calcium homeostasis, both of which also contribute to its cytotoxicity.
</p><p>It is readily understood that a relatively mild inhibition of the mitochondrial oxidative phosphorylation by endogenously-formed formic acid would result in activation of the anerobic glycolysis, which requires no oxygen for glucose metabolism for ATP production and serves as an alternative compensatory metabolic pathway. However, glycolysis is not efficient, producing far fewer ATP molecules compared to oxidative phosphorylation. Therefore, at early stages of DM, it is expected that the DM patients would suffer a relatively mild state of energy shortage in many tissues or cells, especially in those cells which have a high requirement for oxygen and energy supply.</p><p>However, when DM progresses and the hyperglycemia-associated formic acid production and accumulation reach higher levels, formic acid would pose a stronger inhibition of the mitochondrial respiratory chain, which would also result in elevated mitochondrial superoxide accumulation. High levels of superoxide would indirectly lead to inhibition of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity
<xref rid="REF33" ref-type="bibr">[33]</xref>, thereby suppressing the anerobic glycolytic pathway of glucose metabolism, further aggravating the situation of cellular energy shortage. In the meanwhile, the upstream glucose metabolites are forced to be diverted into other metabolic pathways, such as the polyol pathway and the hexosamine pathway, resulting in increased formation of AGEs and over-activation of protein kinase C (PKC), all of which would contribute to the pathogenesis of diabetic complications
<xref rid="REF34" ref-type="bibr">[34]</xref>.
</p><p>According to the proposed methanol-formaldehyde-formic acid (MFF) hypothesis, therefore, the mitochondrial energy production in many tissues and cells of DM patients would be impaired to varying degrees, depending on the length of exposure to the elevated levels of formic acid (together with its highly-toxic metabolic precursor formaldehyde). It is believed that formic acid-induced cellular ATP shortage or deficiency is an important causative factor that drives the processes of many DM-associated lesions and complications in humans. Further, it is suggested that tissues and organs with a high level of oxygen and energy requirement (
<italic toggle="yes">e</italic>.
<italic toggle="yes">g</italic>., optic neurons and their nerve fibers, brain, heart and kidney) would be particularly sensitive and vulnerabale to formic acid-induced histotoxic hypoxia, which is usually accompanied by varying degrees of cellular oxidative damage and even cell death.
</p><p>The MFF hypothesis is supported by a large number of scattered observations from both clinical and experimental studies. For instance, methanol is known to have characteristic organ- and species-selective toxicities, including the characteristic ocular lesions (including blindness), which are commonly seen in humans and non-human primates, but this ocular toxicity is not seen in rodents. Interestingly, some of the diabetic complications (such as ocular lesions) also have a characteristic species-selective pattern, closely resembling what is seen in methanol toxicity. Moreover, alcohol and folic acid (together with vitamin B
<sub>6/12</sub>) are commonly used clinically to alleviate acute methanol toxicity; interestingly, long-term moderate alcohol consumption or joint use of folic acid and vitamin B
<sub>6/12</sub> is also associated with an improved outcome in diabetic complications. A comparison of the pathological characteristics of the ocular changes in methanol toxicity
<italic toggle="yes">vs</italic>. in advanced DM also reveals a high degree of similarity, which clearly suggests a shared role of formic acid in these two pathogenic processes. In addition, as discussed later, there is a large body of experimental evidence from clinical, animal and cellular/biochemical studies that jointly offer strong support for the proposed MFF-based pathogenic mechanism.
</p><p>Provided below is a detailed discussion of each aspect of the proposed MFF hypothesis along with a critical analysis of the available supporting evidence, most of which is scattered in the literature in bits and pieces. In addition, efforts are made trying to apply the proposed MFF hypothesis to offer a tentative explanation for some of the well-known pathophysiological and pathogenic processes associated with human diabetic complications.</p></sec><sec><title id="SEC3">Sources of Methanol and Its Metabolites in Humans</title><p>Many years ago, a small amount of methanol was unexpectedly detected by chromatography in the breath of normal, healthy human subjects [
<xref rid="REF35" ref-type="bibr">35</xref>&#8211;
<xref rid="REF37" ref-type="bibr">37</xref>]. This finding was confirmed later by mass spectrometry showing that methanol was indeed present in the exhaled breath of healthy volunteers [
<xref rid="REF38" ref-type="bibr">38</xref>&#8211;
<xref rid="REF41" ref-type="bibr">41</xref>]. Later, it was also observed that when individuals drank wine or distilled spirits with very low or undetectable methanol content, their endogenous methanol levels still increased sharply [
<xref rid="REF36" ref-type="bibr">36</xref>,
<xref rid="REF42" ref-type="bibr">42</xref>]. Similarly, the blood formaldehyde levels also rose significantly after ethanol ingestion, but with some delay
<xref rid="REF42" ref-type="bibr">[42]</xref>. These observations indicated the existence of an endogenous source of metabolically-formed methanol, and inhibition of the catalytic activity of liver aldehyde dehydrogenase (ADH) by ethanol was postulated to be responsible for the increased accumulation of metabolically-formed methanol in the body. Interestingly, it is of note that earlier studies reported that an average person also had endogenously-formed ethanol in their blood
<xref rid="REF43" ref-type="bibr">[43]</xref> and breath [
<xref rid="REF40" ref-type="bibr">40</xref>,
<xref rid="REF41" ref-type="bibr">41</xref>].
</p><p>Based on the Mayo Clinic Laboratories in the U.S., the normal range of formic acid in the plasma (test definition: FORAC; determined by gas chromatography/mass spectrometry) is 1&#8211;9&#8197;&#956;g/mL (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., 21.7&#8211;195&#8197;&#956;M), and during pregnancy, its normal range is 0.5&#8211;44&#8197;&#956;g/mL (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., 10.8&#8211;956.5&#8197;&#956;M).
</p><p>Provided below is a brief discussion of the exogenous and endogenous sources of methanol and its metabolites formaldehyde and formic acid.</p><sec><title id="SEC3.1">Exogenous sources of methanol and its metabolites in humans</title><p>Certain food (
<italic toggle="yes">e</italic>.
<italic toggle="yes">g</italic>., fresh fruits, vegetables and fermented beverages) is an important exogenous source of methanol present in humans [
<xref rid="REF44" ref-type="bibr">44</xref>,
<xref rid="REF45" ref-type="bibr">45</xref>]. Alcoholic beverages might contain methanol as a contaminant and thus would directly increase methanol levels in individuals after ingestion. Aspartame, a dietary sweetener, can be partially converted into methanol (about 10%) inside the human body [
<xref rid="REF46" ref-type="bibr">46</xref>&#8211;
<xref rid="REF48" ref-type="bibr">48</xref>].
</p></sec><sec><title id="SEC3.2">Production of methanol and its metabolites by known endogenous metabolic pathways</title><sec><title id="SEC3.2.1">Semicarbazide-sensitive amine oxidases (SSAOs)</title><p>SSAOs represent a group of copper-containing amine oxidases that are inhibited by semicarbazide [
<xref rid="REF49" ref-type="bibr">49</xref>&#8211;
<xref rid="REF52" ref-type="bibr">52</xref>]. The SSAOs-mediated oxidative deamination of methylamine produces formaldehyde together with ammonia and hydrogen peroxide [
<xref rid="REF50" ref-type="bibr">50</xref>,
<xref rid="REF52" ref-type="bibr">52</xref>]. In mammals, SSAOs is present in a membrane-associated form or in a soluble form in circulation
<xref rid="REF49" ref-type="bibr">[49]</xref>.
</p><p>Notably, an increased enzymatic activity of SSAOs has been observed in DM, and it has been suggested that inhibition of SSAOs is of therapeutic benefits in DM
<xref rid="REF53" ref-type="bibr">[53]</xref>. In addition, participation of the brain SSAOs in formaldehyde production has been shown in a mouse model of Alzheimer&#8217;s disease [
<xref rid="REF54" ref-type="bibr">54</xref>,
<xref rid="REF55" ref-type="bibr">55</xref>].
</p></sec><sec><title id="SEC3.2.2">Protein carboxymethylase and demethylases</title><p>
<italic toggle="yes">s</italic>-Adenosyl-
<italic toggle="yes">l</italic>-methionine (AdoMet) is a universal endogenous methyl donor and a limiting factor in various methylation reactions, including protein carboxymethylation
<xref rid="REF56" ref-type="bibr">[56]</xref>. Protein carboxymethylase is highly expressed in certain tissues of mammals [
<xref rid="REF57" ref-type="bibr">57</xref>,
<xref rid="REF58" ref-type="bibr">58</xref>]. It has been reported that the AdoMet-dependent protein carboxymethylation can result in the formation of methanol, formaldehyde and formic acid in tissue homogenates prepared from rat brain striatum
<xref rid="REF56" ref-type="bibr">[56]</xref>.
</p><p>Earlier studies also reported that formaldehyde could be formed as a by-product of the reactions catalyzed by the lysine-specific demethylase 1 and the JmjC domain-containing histone demethylases [
<xref rid="REF59" ref-type="bibr">59</xref>&#8211;
<xref rid="REF62" ref-type="bibr">62</xref>].
</p></sec></sec><sec><title id="SEC3.3">Methanol production through fermentation by gut microbiota</title><p>It was suggested earlier that methanol might be produced through microbial fermentation of undigested carbohydrates and fibers from vegetables and fruits in the intestines of animals and humans [
<xref rid="REF35" ref-type="bibr">35</xref>,
<xref rid="REF63" ref-type="bibr">63</xref>&#8211;
<xref rid="REF67" ref-type="bibr">67</xref>]. This would be an important source of endogenously-produced methanol in humans, which also provides an explanation for the suggestion that the gut microbiota might be a potential risk factor for type 2 DM and its complications. More studies are needed in the future to characeterize which groups of gut microbiome are involved in producing methanol and other toxic one-carbon metabolites, and how to effectively reduce their production through beneficial manipulation of the human gut microbiome composition.
</p></sec><sec><title id="SEC3.4">Other potential sources of endogenous methanol and its metabolites</title><p>It is hypothesized that abnormally-elevated cellular glucose levels in DM patients would lead to increased metabolic formation of methanol and its toxic one-carbon metabolites formaldehyde and formic acid. Although the exact metabolic pathways and enzymes involved in converting excess glucose to methanol and/or its metabolites are not clear at present, there was unequivocal clinical evidence showing that markedly-elevated levels of methanol and formaldehyde were detected in the exhaled breath of advanced DM patients [
<xref rid="REF35" ref-type="bibr">35</xref>,
<xref rid="REF40" ref-type="bibr">40</xref>,
<xref rid="REF68" ref-type="bibr">68</xref>,
<xref rid="REF69" ref-type="bibr">69</xref>].
</p><p>As mentioned earlier, the plasma levels of formic acid in a &#8220;normal, healthy&#8221; pregnant woman can reach as high as approximately 1&#8197;mM, which is a rather high concentration. Based on recent experiments in our laboratory (unpublished data), long-term exposure to sodium formate (a salt form of formic acid) at this concentration can pose a small but detectable reduction of cell viability in some of the cell lines tested. It is speculated that the marked increase in plasma formic acid levels in some pregnant women might be due to the possibility that some of them may actually acquire a mild form of gestational DM, which could be an important potential cause for the sharp rise in blood formic acid levels. It will be of interest to experimentally examine this possibility in the future.</p></sec><sec><title id="SEC3.5">Section summary</title><p>It is known that methanol and formaldehyde are naturally-occurring compounds in normal, healthy human subjects
<xref rid="REF42" ref-type="bibr">[42]</xref>. A few endogenous metabolic processes and enzymes are known to produce methanol and formaldehyde. Anerobic fermentation by gut bacteria might be another important source of endogenous methanol. Lastly, it is hypothesized that hyperglycemia would lead to abnormally-elevated cellular glucose levels and subsequently an increased metabolic conversion of glucose into methanol and/or its toxic one-carbon metabolites. The exact metabolic pathways and enzymes involved in their formation are not clear at present.
</p></sec></sec><sec><title id="SEC4">Methanol Metabolism in Humans and Experimental Animals</title><p>Methanol itself has a rather low cytotoxicity
<xref rid="REF70" ref-type="bibr">[70]</xref>. For example, animal cells in culture can tolerate high concentrations of methanol [
<xref rid="REF71" ref-type="bibr">71</xref>,
<xref rid="REF72" ref-type="bibr">72</xref>]. The toxic effects of methanol are mostly produced by its metabolites formaldehyde and formic acid. Hence, differences in the rate of metabolic conversion of methanol to formaldehyde and formic acid would be important determinants of methanol toxicity. Provided below is a brief discussion of the different metabolic pathways and enzymes involved in biotransformation of methanol in humans and animal models as well as their major differences.
</p><sec><title id="SEC4.1">Metabolic biotransformation of methanol</title><sec><title id="SEC4.1.1">Conversion of methanol to formaldehyde</title><p>In humans, oxidation of methanol to formaldehyde is primarily catalyzed by two metabolic pathways. The first pathway involves ADH1, catalyzing up to 90% of methanol (and ethanol) in the human liver [
<xref rid="REF73" ref-type="bibr">73</xref>&#8211;
<xref rid="REF76" ref-type="bibr">76</xref>]. As ADH1 has a strong preference for ethanol over methanol as substrate, this makes ethanol a powerful competitive inhibitor of this enzyme. Another pathway involves CYP2E1 (and probably also CYP1A2) [
<xref rid="REF77" ref-type="bibr">77</xref>&#8211;
<xref rid="REF82" ref-type="bibr">82</xref>], which accounts for approximately 9% of methanol oxidation to formaldehyde in the human liver. Non-human primates share similar metabolic pathways of methanol oxidation as humans.
</p><p>Different from humans and non-human primates, ADH1 contributes minimally to methanol oxidation in rodents
<xref rid="REF83" ref-type="bibr">[83]</xref>, but the catalase-peroxidase system plays a far more important role in methanol oxidation to formaldehyde in rodents [
<xref rid="REF83" ref-type="bibr">83</xref>&#8211;
<xref rid="REF88" ref-type="bibr">88</xref>]. Humans and non-human primates do not oxidize methanol through the catalase-dependent system
<xref rid="REF89" ref-type="bibr">[89]</xref>, because of the low availability of peroxides
<xref rid="REF90" ref-type="bibr">[90]</xref>.
</p><p>It is of note that while formaldehyde is primarily produced through enzymatic oxidation of methanol, other enzymatic reactions can also directly produce formaldehyde in humans (already discussed in section &#8220;Production of methanol and its metabolites by known endogenous metabolic pathways&#8221;).</p></sec><sec><title id="SEC4.1.2">Conversion of formaldehyde to formic acid</title><p>Metabolic conversion of formaldehyde to formic acid is catalyzed by multiple enzymes [
<xref rid="REF91" ref-type="bibr">91</xref>&#8211;
<xref rid="REF93" ref-type="bibr">93</xref>]. Glutathione-dependent formaldehyde dehydrogenase (ADH3) is considered the major pathway for formaldehyde metabolism in both humans and rodents
<xref rid="REF94" ref-type="bibr">[94]</xref>. Other pathways that can also contribute to the oxidation of formaldehyde to formic acid include the cytosolic and mitochondrial aldehyde dehydrogenases (ALDH1 and ALDH2, respectively) [
<xref rid="REF76" ref-type="bibr">76</xref>,
<xref rid="REF94" ref-type="bibr">94</xref>&#8211;
<xref rid="REF98" ref-type="bibr">98</xref>].
</p><p>Owing to the multiple metabolic pathways involved in formaldehyde metabolism, formaldehyde usually would be rapidly metabolized in humans. An earlier investigation of a single human case of formaldehyde poisoning revealed that it was indeed so
<xref rid="REF99" ref-type="bibr">[99]</xref>.
</p></sec><sec><title id="SEC4.1.3">Conversion of formic acid to carbon dioxide</title><p>In humans and rodents, formic acid is further oxidized to carbon dioxide catalyzed by the tetrahydrofolate (THF)-dependent pathway, which detoxifies formic acid. Specifically, formic acid is first converted into 10-formyl-THF by formyl-THF synthetase, which is then further converted into carbon dioxide and water by 10-formyl-THF reductase
<xref rid="REF100" ref-type="bibr">[100]</xref>. In addition, rodents also use catalase to oxidize formic acid to carbon dioxide and water
<xref rid="REF101" ref-type="bibr">[101]</xref>, but this metabolic process does not occur in humans.
</p><p>It is of note that in humans and non-human primates, the hepatic THF level is only half of that in rats
<xref rid="REF100" ref-type="bibr">[100]</xref>, and the 10-formyl-THF dehydrogenase activity is only 20&#8211;25% of that in rats
<xref rid="REF102" ref-type="bibr">[102]</xref>. The combination of the low hepatic THF level and the low hepatic 10-formyl-THF dehydrogenase activity in humans and non-human primates jointly accounts for the very slow metabolic oxidation of formic acid, leading to formic acid accumulation
<xref rid="REF103" ref-type="bibr">[103]</xref>. Experimental studies in non-human primates showed that the THF-dependent oxidation of formic acid became saturated when methanol doses exceeded 300&#8197;mg/kg body weight
<xref rid="REF104" ref-type="bibr">[104]</xref>. In contrast, the THF-dependent pathway was not capacity-limited in rodents, and formic acid essentially did not accumulate in rodents even after methanol overdose
<xref rid="REF105" ref-type="bibr">[105]</xref>.
</p></sec></sec><sec><title id="SEC4.2">Accumulation of formaldehyde and formic acid in the body</title><p>Because formaldehyde is rapidly oxidized to formic acid or forms covalent adducts with many molecules in the body (including both small and large molecules) [
<xref rid="REF24" ref-type="bibr">24</xref>,
<xref rid="REF25" ref-type="bibr">25</xref>,
<xref rid="REF106" ref-type="bibr">106</xref>&#8211;
<xref rid="REF108" ref-type="bibr">108</xref>], it would not readily accumulate to high levels in body fluids or tissues
<xref rid="REF93" ref-type="bibr">[93]</xref>. Studies using monkeys revealed that even after intravenous infusion of formaldehyde, its apparent clearance from the blood occurred very rapidly
<xref rid="REF109" ref-type="bibr">[109]</xref>. In healthy human individuals, the formaldehyde concentration in the blood was reported to be at relatively low levels (0.01&#8211;0.08&#8197;mM) under physiological conditions, but the levels could significantly increase during ageing (over 65&#8197;years old) and under pathological conditions [
<xref rid="REF110" ref-type="bibr">110</xref>&#8211;
<xref rid="REF113" ref-type="bibr">113</xref>].
</p><p>In contrast, formic acid can readily accumulate in humans and non-human primates to far higher levels following administration of methanol [
<xref rid="REF26" ref-type="bibr">26</xref>&#8211;
<xref rid="REF30" ref-type="bibr">30</xref>]. For instance, an earlier study reported that when formate (the salt form of formic acid) was infused into monkeys, its accumulation in blood lasted 10&#8197;h, and after that, its blood level was still at 10&#8211;30&#8197;mM [
<xref rid="REF30" ref-type="bibr">30</xref>,
<xref rid="REF114" ref-type="bibr">114</xref>]. In another study, when the plasma pharmacokinetics of formic acid in monkeys, mice and rabbits were compared, it was found that formic acid accumulation in primates within the first 6&#8197;h was 43-fold and 5-fold higher than that in mice and rabbits, respectively [
<xref rid="REF115" ref-type="bibr">115</xref>,
<xref rid="REF116" ref-type="bibr">116</xref>].
</p></sec><sec><title id="SEC4.3">Section summary</title><p>Formaldehyde only has a very short half-life and usually does not accumulate to high levels in humans and animals. In comparison, formic acid can more readily accumulate in humans and non-human primates. Rodents have very different metabolic pathways for methanol and its toxic metabolites (formaldehyde and formic acid) from humans and non-human primates, and as a result, formic acid accumulation usually does not occur in rodents, unless under special conditions in which the metabolic disposition of methanol and its metabolites is selectively inhibited
<xref rid="REF117" ref-type="bibr">[117]</xref>.
</p></sec></sec><sec><title id="SEC5">General Toxicity and Mechanism of Action of One-Carbon Metabolites</title><sec><title id="SEC5.1">Methanol</title><p>The clinical presentation of methanol poisoning varies considerably from patient to patient. Methanol initially has a similar narcotic effect as ethanol, followed by a latent period of 6&#8211;24&#8197;h, depending on the absorbed amount
<xref rid="REF118" ref-type="bibr">[118]</xref>. This latent period (mostly asymptomatic) corresponds to the time required for the metabolism of methanol to formaldehyde and formic acid and the subsequent accumulation of formic acid in the body. Following this period, the patients may have a wide range of clinical symptoms and manifestations [
<xref rid="REF118" ref-type="bibr">118</xref>&#8211;
<xref rid="REF120" ref-type="bibr">120</xref>], depending on the severity of methanol-associated damage in various vital organs/tissues in the body, which commonly involve the eye, brain, kidney, heart, and other organs.
</p><p>One of the characteristics of methanol or formic acid intoxication is the development of metabolic acidosis [
<xref rid="REF26" ref-type="bibr">26</xref>&#8211;
<xref rid="REF28" ref-type="bibr">28</xref>,
<xref rid="REF118" ref-type="bibr">118</xref>]. Mechanistically, acidosis is thought to be partly caused by anerobic metabolism (likely also includes ketogenesis) which produces large amount of lactic acid (and ketone bodies), but not by the direct release of protons from formic acid [
<xref rid="REF26" ref-type="bibr">26</xref>&#8211;
<xref rid="REF28" ref-type="bibr">28</xref>,
<xref rid="REF118" ref-type="bibr">118</xref>].
</p><p>Some of the organs or tissues (such as the neuroretina, brain, kidney and heart) are more sensitive to the toxicity of methanol and its toxic metabolites. A brief discussion of the general toxicity of methanol (along with its metabolites) in these organs of humans and animals is provided below.</p><sec><title id="SEC5.1.1">Eye</title><p>It is widely accepted that the ocular lesion in methanol poisoning essentially represents a toxic optic neuropathy, which is accompanied with varying degrees of retinal edema. Moreover, the ocular toxicity associated with methanol poisoning is caused by formic acid but not by methanol or acidosis
<xref rid="REF30" ref-type="bibr">[30]</xref>. Humans and non-human primates are uniquely sensitive to the ocular toxicity of formic acid because of their limited capacity to oxidize and thus detoxify formic acid. A detailed discussion and comparison of the ocular lesions of methanol (and formic acid) in human subjects and other species is provided later; so it is only briefly mentioned here.
</p></sec><sec><title id="SEC5.1.2">Brain</title><p>In addition to the eye, methanol poisoning also causes extensive pathological changes in the brain [
<xref rid="REF30" ref-type="bibr">30</xref>,
<xref rid="REF121" ref-type="bibr">121</xref>&#8211;
<xref rid="REF123" ref-type="bibr">123</xref>]. Based on clinical MRI and CT imaging analyses [
<xref rid="REF124" ref-type="bibr">124</xref>&#8211;
<xref rid="REF131" ref-type="bibr">131</xref>], the common brain damage in methanol-intoxicated patients includes lesions of the putamen, globus pallidus and brainstem, hemorrhage in various parts of the brain, and calcium deposits in white matter with a primary subcortical localization. Consistent with findings from clinical imaging studies, post-mortem pathological analysis of brains from methanol-intoxicated patients showed similar findings
<xref rid="REF132" ref-type="bibr">[132]</xref>. The lesions include cerebral edema and hemorrhage in many parts of the brain, hemorrhagic necrosis in the thalamus, putamen, globus pallidus, cerebral cortex, and areas around the basal ganglia
<xref rid="REF132" ref-type="bibr">[132]</xref>.
</p><p>It is of note that the observed brain lesions are usually nonspecific, and may occur under other conditions of severe brain hypoxia (or ischemia), thus suggesting that histotoxic hypoxia plays a critical role in methanol intoxication-associated brain damage (this subject will be discussed in more detail later). Consistent with the pathological findings of lesions in the basal ganglia in methanol-intoxicated patients, there were survivors who later indeed developed Parkinsonism.</p><p>It is interesting that the basal ganglia is one of the brain regions that is particularly sensitive to the toxic effect of methanol. Mechanistically, it is postulated that neurons in this region contain very high levels of the neurotransmitter dopamine and thus are associated with a high basal level of intrinsic oxidative stress due to dopamine&#8217;s well-known chemical property to undergo facile auto-oxidation and redox cycling. This preexisting condition would make these neurons particularly sensitive to methanol&#8217;s toxicity as mitochondrial inhibition by formic acid or formaldehyde (toxic metabolites of methanol) would further increase mitochondrial ROS production and accumulation, which would aggravate ATP depletion, mitochondrial oxidative stress and damage, and ultimately neuronal death.</p><p>Animal studies showed that alterations in brain specimens from rabbits exposed to formic acid
<xref rid="REF122" ref-type="bibr">[122]</xref> were far less grave than changes seen in monkeys
<xref rid="REF30" ref-type="bibr">[30]</xref>, which was consistent with the different rates of metabolic disposition of formic acid in these two animal species (discussed in section "Methanol Metabolism in Humans and Experimental Animals&#8221;). The observed calcium deposits in the cerebral hemispheres and hippocampus of rabbits were in good agreement with the intracerebral calcifications which is commonly associated with renal tubular acidosis
<xref rid="REF133" ref-type="bibr">[133]</xref>.
</p></sec><sec><title id="SEC5.1.3">Kidney</title><p>The kidney, due to its high oxygen requirement for cellular functions, is often on the verge of hypoxia even under normal conditions [
<xref rid="REF134" ref-type="bibr">134</xref>,
<xref rid="REF135" ref-type="bibr">135</xref>]. Renal mitochondrial respiration and cellular calcium content are severely altered under ischemic or hypoxic conditions
<xref rid="REF136" ref-type="bibr">[136]</xref>. Therefore, it is expected that the kidney would be highly susceptible to methanol poisoning. Indeed, acute kidney injury had been widely reported after methanol poisoning [
<xref rid="REF123" ref-type="bibr">123</xref>,
<xref rid="REF131" ref-type="bibr">131</xref>&#8211;
<xref rid="REF139" ref-type="bibr">139</xref>]. According to Verhelst&#8217;s study
<xref rid="REF139" ref-type="bibr">[139]</xref>, the causes of methanol-induced nephrotoxicity was largely due to a combination of both direct factors, such as high blood levels of methanol and formic acid, and indirect factors, such as hemolysis and myoglobinuria
<xref rid="REF139" ref-type="bibr">[139]</xref>. Histopathological evaluation of the kidneys from patients of acute methanol intoxication suggested an initial hydropic changes in the proximal tubular epithelial cells, without significant lesions in the glomeruli [
<xref rid="REF138" ref-type="bibr">138</xref>,
<xref rid="REF139" ref-type="bibr">139</xref>].
</p><p>The mechanisms of methanol nephrotoxicity are multifactorial. The most important direct factor is the cytotoxic effect of formic acid on proximal tubular epithelial cells. There is a significant correlation between formic acid levels and the development of acute renal injury in the proximal tubules
<xref rid="REF139" ref-type="bibr">[139]</xref>. Because methanol and its metabolites are small water-soluble molecules and can be readily filtered through glomeruli, the clinical observations are consistent with the fact that the renal proximal tubules have a very high level of exposure to methanol and its toxic metabolites. Since formic acid is an inhibitor of mitochondrial cytochrome oxidase (discussed in detail later), it would inhibit mitochondrial respiration and ATP synthesis, resulting in hypoxia and injury in renal proximal tubular epithelial cells. In addition, the influx of calcium into cells is another contributing factor in methanol (formic acid)-induced cytotoxicity in renal tubular epithelial cells
<xref rid="REF32" ref-type="bibr">[32]</xref>. Earlier studies reported that formate increased the intracellular levels of sodium chloride in the proximal tubule [
<xref rid="REF140" ref-type="bibr">140</xref>,
<xref rid="REF141" ref-type="bibr">141</xref>]. Similarly, in a rat model of renal proximal tubule microperfusion model, infusion of formate led to increased proximal tubular cell volume (likely due to swelling) [
<xref rid="REF141" ref-type="bibr">141</xref>,
<xref rid="REF142" ref-type="bibr">142</xref>]. It is likely that all these changes are the direct result of formic acid-induced ATP deficiency in renal tubular cells.
</p><p>It is known that formic acid in the kidney can interfere with parathyroid hormone (PTH)-controlled Ca
<sup>2+</sup> reabsorption in proximal tubules
<xref rid="REF143" ref-type="bibr">[143]</xref>, which is an ATP-dependent active transport process. Consistent with this observation, a linear relationship between the urinary calcium levels and the formic acid concentrations in the air has been observed in workers chronically exposed to either methanol or formic acid
<xref rid="REF143" ref-type="bibr">[143]</xref>.
</p><p>Earlier studies have shown that the kidneys of rats and rabbits are far less sensitive to the toxicity of formaldehyde and formic acid (toxic metabolites of methanol) [
<xref rid="REF122" ref-type="bibr">122</xref>,
<xref rid="REF144" ref-type="bibr">144</xref>]. Major pathological changes observed in their kidneys mostly included swelling (with occasional focal degeneration) in proximal tubular epithelial cells
<xref rid="REF144" ref-type="bibr">[144]</xref>.
</p></sec><sec><title id="SEC5.1.4">Heart</title><p>Cardiac muscle cells have a very high demand for oxygen and energy supply. In adult rabbits injected intravenously with buffered formic acid once daily for 5 days, the maximum concentrations of formic acid in the brain, kidney and heart are similar to the
<italic toggle="yes">IC</italic>
<sub>50</sub> values for inhibiting the cytochrome oxidase activity
<italic toggle="yes">in vitro</italic>
<xref rid="REF122" ref-type="bibr">[122]</xref>. Histological analysis clearly demonstrated hypoxic changes at the cellular levels in cardiac muscle cells in these animals, along with formation of calcium aggregates. The formic acid-induced acidosis exacerbates spontaneous sarcoplasmic reticulum Ca
<sup>2+</sup> release in the myocardium, which is also potentially arrhythmogenic
<xref rid="REF145" ref-type="bibr">[145]</xref>.
</p></sec></sec><sec><title id="SEC5.2">Formaldehyde</title><p>Formaldehyde is the simplest aldehyde and highly reactive. It can undergo hydration and form hemiacetals with alcohols or thiohemiacetals with thiols. It can also covalently cross-link many nitrogen-containing compounds (
<italic toggle="yes">e</italic>.
<italic toggle="yes">g</italic>., DNA, RNA, proteins and amino acids) [
<xref rid="REF24" ref-type="bibr">24</xref>,
<xref rid="REF25" ref-type="bibr">25</xref>,
<xref rid="REF106" ref-type="bibr">106</xref>,
<xref rid="REF107" ref-type="bibr">107</xref>]. In case of proteins, formaldehyde can react with amines to form Schiff bases and cross-link proteins by forming methylene bridges between the two amine groups [
<xref rid="REF24" ref-type="bibr">24</xref>,
<xref rid="REF25" ref-type="bibr">25</xref>,
<xref rid="REF146" ref-type="bibr">146</xref>]. Due to the extensive protein cross-linking ability of formaldehyde, formalin (a water solution containing 40% formaldehyde) is widely used for tissue and cell preservation and fixation in medicine and biological research
<xref rid="REF147" ref-type="bibr">[147]</xref>.
</p><p>Formaldehyde is highly toxic in humans when intoxicated. For instance, ingestion of formalin as a result of accidental, homicidal or suicidal attempts can rapidly cause deleterious effects in every part of the body, such as causing gastrointestinal hemorrhage, cardiovascular collapse, unconsciousness or convulsions, severe metabolic acidosis, acute respiratory distress syndrome, and others [
<xref rid="REF148" ref-type="bibr">148</xref>,
<xref rid="REF149" ref-type="bibr">149</xref>]. Similar toxic effects in different systems and organs have also been observed in animal models
<xref rid="REF150" ref-type="bibr">[150]</xref>.
</p><p>In cultured cells, formaldehyde is highly cytotoxic
<xref rid="REF151" ref-type="bibr">[151]</xref>. The cytotoxicity of formaldehyde appears to be associated with its ability to form adducts with DNA and proteins
<xref rid="REF152" ref-type="bibr">[152]</xref>. At the subcellular levels, formaldehyde reduces mitochondrial membrane potential and inhibits mitochondrial respiration, which is accompanied by mitochondrial ROS accumulation
<xref rid="REF94" ref-type="bibr">[94]</xref>. Formaldehyde can also induce lipid peroxidation and cell death
<xref rid="REF94" ref-type="bibr">[94]</xref>. In addition, exposure of cultured brain cells to high levels of formaldehyde causes intracellular GSH depletion and extracellular GSH accumulation [
<xref rid="REF153" ref-type="bibr">153</xref>,
<xref rid="REF154" ref-type="bibr">154</xref>]. As GSH is involved in many important cellular functions like protection against reactive oxygen species (ROS) and metabolic detoxification of chemically-reactive endobiotics and xenobiotics [
<xref rid="REF155" ref-type="bibr">155</xref>,
<xref rid="REF156" ref-type="bibr">156</xref>], GSH depletion is an important cause for severe oxidative stress, which usually occurs after prolonged exposure to elevated levels of formaldehyde
<xref rid="REF154" ref-type="bibr">[154]</xref>.
</p><p>Because formaldehyde can chemically react with many molecules (small and large) in the body plus it is rapidly metabolized, generally this chemical does not accumulate to high levels in tissues or circulation. Nevertheless, it has also been noted that the tissue levels of formaldehyde can still vary considerably depending on the tissues and under different (patho)physiological conditions. Therefore, it has been speculated that the endogenously-formed formaldehyde might be involved in certain (patho)physiological processes. For instance, a number of studies have reported that there was a direct correlation between chronically-elevated formaldehyde levels in the brain and memory impairment in animal models [
<xref rid="REF54" ref-type="bibr">54</xref>,
<xref rid="REF55" ref-type="bibr">55</xref>,
<xref rid="REF62" ref-type="bibr">62</xref>,
<xref rid="REF112" ref-type="bibr">112</xref>,
<xref rid="REF113" ref-type="bibr">113</xref>,
<xref rid="REF157" ref-type="bibr">157</xref>,
<xref rid="REF158" ref-type="bibr">158</xref>]. A similar correlation has been observed between brain formaldehyde levels and neurodegeneration in humans [
<xref rid="REF55" ref-type="bibr">55</xref>,
<xref rid="REF110" ref-type="bibr">110</xref>,
<xref rid="REF113" ref-type="bibr">113</xref>,
<xref rid="REF159" ref-type="bibr">159</xref>,
<xref rid="REF160" ref-type="bibr">160</xref>]. Interestingly, increased expression/activity of the formaldehyde-generating enzymes has also been observed in human DM [
<xref rid="REF161" ref-type="bibr">161</xref>&#8211;
<xref rid="REF163" ref-type="bibr">163</xref>]. These studies suggest that increases in endogenous metabolic formation of formaldehyde may contribute to the pathogenesis of certain degenerative conditions in humans.
</p><p>Lastly, it is of note that because of its ability to covalently modify DNA, formaldehyde is believed to be mutagenic
<xref rid="REF164" ref-type="bibr">[164]</xref> and also potentially carcinogenic [
<xref rid="REF165" ref-type="bibr">165</xref>,
<xref rid="REF166" ref-type="bibr">166</xref>]. Human epidemiological studies have also indicated that there is sufficient evidence for the carcinogenicity of formaldehyde in humans [
<xref rid="REF167" ref-type="bibr">167</xref>&#8211;
<xref rid="REF170" ref-type="bibr">170</xref>].
</p></sec><sec><title id="SEC5.3">Formic acid</title><sec><title id="SEC5.3.1">General toxicity</title><p>Different from formaldehyde, formic acid can more readily accumulate in humans and non-human primates following methanol poisoning [
<xref rid="REF26" ref-type="bibr">26</xref>,
<xref rid="REF30" ref-type="bibr">30</xref>]. In methanol poisoning, formic acid accumulation in the body is believed to be largely responsible for the acute toxic effects such as metabolic acidosis, serious visual impairment (including blindness), damage to vital organs in the body (such as brain, kidney and heart), and even death [
<xref rid="REF82" ref-type="bibr">82</xref>,
<xref rid="REF83" ref-type="bibr">83</xref>]. The toxicity of formic acid was mostly investigated in connection with methanol studies; in fact, there were very few studies specifically studying the toxic effects of formic acid itself.
</p><p>As discussed earlier, methanol poisoning is characterized by a severe metabolic acidosis, and acidosis is thought to be partly caused by anerobic metabolism (likely also includes ketogenesis) which produces large amount of lactic acid (and ketone bodies) [
<xref rid="REF26" ref-type="bibr">26</xref>&#8211;
<xref rid="REF28" ref-type="bibr">28</xref>,
<xref rid="REF118" ref-type="bibr">118</xref>].
</p><p>Acute and severe formic acid intoxication usually has a high mortality rate
<xref rid="REF171" ref-type="bibr">[171]</xref>. Clinical features include the gastrointestinal tract (ulceration of the oral and pharyngeal mucosa), abdominal pain (accompanied by hematemesis and dysphagia), and inhalation pneumonitis which may proceed to respiratory infection and ultimately respiratory failure. The changes in the cardiovascular system are usually nonspecific, frequently accompanied by profound vascular hypotension, hematuria and acute renal failure. Renal biopsy indicated toxic, tubular necrosis. Patients usually succumb to severe vascular hypotension and respiratory arrest, acute renal failure and gastrointestinal hemorrhage.
</p></sec><sec><title id="SEC5.3.2">Mechanism of cytotoxicity</title><p>Based on earlier studies, it has been suggested that the mitochondrial cytochrome oxidase is an important target of formic acid cytotoxicity [
<xref rid="REF31" ref-type="bibr">31</xref>,
<xref rid="REF32" ref-type="bibr">32</xref>,
<xref rid="REF172" ref-type="bibr">172</xref>]. The cytochrome oxidase is a terminal member of the eukaryotic mitochondrial electron transport chain and an integral protein complex of the inner mitochondrial membrane. This enzyme is involved in the four-electron reduction process of the oxygen molecule resulting in the formation of ATP and water. It was reported earlier that formic acid can inhibit the activity of cytochrome oxidase by binding at the sixth coordination position of its ferric heme iron
<xref rid="REF173" ref-type="bibr">[173]</xref>, resulting in inhibition of the cytochrome oxidase complex of the mitochondrial respiratory chain [
<xref rid="REF31" ref-type="bibr">31</xref>,
<xref rid="REF173" ref-type="bibr">173</xref>]. The estimated
<italic toggle="yes">K</italic>
<sub>i</sub> for the inhibition of the cytochrome oxidase activity by formate is around 1&#8211;5&#8197;mM
<xref rid="REF31" ref-type="bibr">[31]</xref>. This concentration of formic acid is readily achievable in liver and other organs under certain pathogenic conditions. This inhibition by formic acid would reduce cellular ATP synthesis [
<xref rid="REF31" ref-type="bibr">31</xref>,
<xref rid="REF32" ref-type="bibr">32</xref>,
<xref rid="REF174" ref-type="bibr">174</xref>], which might be accompanied by increased anerobic glycolysis and potentially lactic acid accumulation. Glycolysis is not efficient, producing far fewer ATP molecules compared to oxidative phosphorylation.
</p><p>Inhibition of the mitochondrial respiratory chain by formic acid would also cause mitochondrial superoxide accumulation, which may result in lipid peroxidation, mitochondrial damage and even oxidative cell death [
<xref rid="REF175" ref-type="bibr">175</xref>&#8211;
<xref rid="REF177" ref-type="bibr">177</xref>]. In partial support of the involvement of ROS in methanol cytotoxicity, increased lipid peroxidation products have been detected in different tissues and urine samples from methanol intoxication animal models [
<xref rid="REF178" ref-type="bibr">178</xref>,
<xref rid="REF179" ref-type="bibr">179</xref>].
</p><p>Here it is of note that accumulation of mitochondrial superoxide could lead to inhibition of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity
<xref rid="REF33" ref-type="bibr">[33]</xref> and thereby suppress the anerobic glycolytic pathway of glucose metabolism, further aggravating the situation of cellular energy shortage. In the meanwhile, the upstream glucose metabolites might be forced to enter other metabolic pathways, such as the polyol pathway and the hexosamine pathway.
</p><p>From a mechanistic point of view, formic acid-induced hypoxia and cytotoxic effect
<xref rid="REF180" ref-type="bibr">[180]</xref> are somewhat similar to the toxic effect of cyanide, albeit with a far milder cytotoxic effect [
<xref rid="REF180" ref-type="bibr">180</xref>&#8211;
<xref rid="REF182" ref-type="bibr">182</xref>]. Based on this mechanistic understanding, it is understood that those organs which have a high rate of oxygen consumption (such as the neuroretina, brain, kidney and heart) would be highly sensitive to the toxicity of formic acid (and formaldehyde); a brief discussion of the toxicity in these organs has already been provided in earlier section &#8220;Methanol&#8221;.
</p><p>Lastly, it is of note that formic acid may alter cellular calcium levels through induction of cellular hypoxia [
<xref rid="REF122" ref-type="bibr">122</xref>,
<xref rid="REF183" ref-type="bibr">183</xref>&#8211;
<xref rid="REF185" ref-type="bibr">185</xref>]. Calcium accumulation in ischemic and hypoxic conditions has been reported earlier in renal cortex [
<xref rid="REF136" ref-type="bibr">136</xref>,
<xref rid="REF186" ref-type="bibr">186</xref>] and cardiomyocytes
<xref rid="REF177" ref-type="bibr">[177]</xref>. An increase in free cytosolic calcium can activate calcium-dependent phospholipases, resulting in the breakdown of cell membranes and accumulation of free fatty acids and lysophospholipids which are toxic to cells
<xref rid="REF177" ref-type="bibr">[177]</xref>. It has been suggested that mitochondrial calcium overload may also contribute to mitochondrial dysfunction
<xref rid="REF177" ref-type="bibr">[177]</xref>.
</p></sec></sec><sec><title id="SEC5.4">Section summary</title><p>The toxicity of methanol mostly comes from its oxidative metabolites, formaldehyde and formic acid
<xref rid="REF62" ref-type="bibr">[62]</xref>. Following methanol intoxication, formic acid would accumulate, and is largely responsible for methanol&#8217;s toxic effects, including the induction of metabolic acidosis, ocular impairment (including blindness), damage to vital organs in the body, and even death. There is a clear correlation between the
<italic toggle="yes">in vivo</italic> concentrations of formic acid (but not methanol) and various complications
<xref rid="REF187" ref-type="bibr">[187]</xref>.
</p><p>While humans and non-human primates are highly sensitive to the toxicities of methanol and formic acid, rodents are highly resistant to their toxicities [
<xref rid="REF119" ref-type="bibr">119</xref>,
<xref rid="REF120" ref-type="bibr">120</xref>]. The species difference in methanol toxicity is directly associated with the different levels of accumulation of formic acid in the body [
<xref rid="REF26" ref-type="bibr">26</xref>&#8211;
<xref rid="REF30" ref-type="bibr">30</xref>], which is determined by the different pathways involved in the metabolic activation and disposition of methanol [
<xref rid="REF114" ref-type="bibr">114</xref>,
<xref rid="REF188" ref-type="bibr">188</xref>,
<xref rid="REF189" ref-type="bibr">189</xref>].
</p><p>Mechanistically, formic acid can cause cytotoxicity by directly inhibiting the cytochrome oxidase complex of the mitochondrial respiratory chain, which eventually results in hypoxia and decreased ATP production in tissues or cells that have a high requirement for oxygen and energy supply.</p><p>Lastly, it is of note that because formic acid is a weak acid (p
<italic toggle="yes">K</italic>
<sub>a</sub> &#8201;=&#8201;3.78), a pH drop of 0.3 would mean a doubling of the undissociated formic acid level. Since it is the undissociated formic acid that can cross the plasma membrane, a decrease in cellular pH theoretically would mean a stronger inhibition of cytochrome oxidase by formic acid. Therefore, the induction of acidosis by formic acid may further aggravate the inhibition of mitochondrial cytochrome oxidase.
</p></sec></sec><sec><title id="SEC6">Ocular Lesions of Methanol (and Formic Acid) in Humans and Experimental Animals</title><p>A comparison of the ocular lesions seen in humans and laboratory animal models following exposure to methanol or formic acid is provided below.</p><sec><title id="SEC6.1">Methanol poisoning-induced ocular lesions in humans</title><p>In general, humans are very sensitive to methanol&#8217;s ocular toxicity; even a very low dose of pure methanol ingestion may cause blindness in human subjects [
<xref rid="REF117" ref-type="bibr">117</xref>,
<xref rid="REF190" ref-type="bibr">190</xref>]. An early study suggested that the ocular lesion in acute methanol poisoning is mostly produced by its metabolite formic acid
<xref rid="REF30" ref-type="bibr">[30]</xref>.
</p><p>The clinical symptoms of acute methanol ocular toxicity in humans range from blurred vision to &#8220;snowfield vision&#8221; or total blindness in severe cases [
<xref rid="REF104" ref-type="bibr">104</xref>,
<xref rid="REF191" ref-type="bibr">191</xref>,
<xref rid="REF192" ref-type="bibr">192</xref>]. On visual field testing, central scotoma, hyperemia, pallor of the optic disc, papilledema, and an afferent papillary defect may be present. Electroretinography usually shows a diminished &#946;-wave [
<xref rid="REF193" ref-type="bibr">193</xref>&#8211;
<xref rid="REF195" ref-type="bibr">195</xref>], a marker of bipolar cell dysfunction. Additionally, optical coherence tomography, which is similar to ultrasound but uses reflected light waves to image translucent tissues, often shows peripapillary nerve fiber swelling and intraretinal fluid accumulation
<xref rid="REF195" ref-type="bibr">[195]</xref>.
</p><p>Consistent with the clinical observations, pathological analysis also revealed that the ocular lesions in methanol-intoxicated patients essentially represent a toxic optic neuropathy, with retinal edema as an accompanying change [
<xref rid="REF30" ref-type="bibr">30</xref>,
<xref rid="REF191" ref-type="bibr">191</xref>,
<xref rid="REF196" ref-type="bibr">196</xref>&#8211;
<xref rid="REF203" ref-type="bibr">203</xref>]. In fatal cases, the optic nerve shows central necrosis in the distal (orbital) portion while the central optic tracts remain intact. Therefore, it is generally accepted that methanol poisoning causes eye impairments mostly through destruction of the optic nerves.
</p><p>It has been noted that the retinal pigmented epithelial and optic nerve cells are uniquely susceptible to methanol toxicity [
<xref rid="REF194" ref-type="bibr">194</xref>,
<xref rid="REF204" ref-type="bibr">204</xref>,
<xref rid="REF205" ref-type="bibr">205</xref>]. The changes in the retinal ganglion cells was thought to be the result of retrograde degeneration of optic nerve axons, while myelin change in the retrolaminal part of the nerve was also observed [
<xref rid="REF196" ref-type="bibr">196</xref>&#8211;
<xref rid="REF203" ref-type="bibr">203</xref>].
</p><p>An earlier study of methanol intoxication reported that the optic nerve has an axonal necrosis in the center part of the nerve, with a sharp border where they met the normally appearing axons in the periphery
<xref rid="REF206" ref-type="bibr">[206]</xref>. The selective bilateral damage of the orbital part of the optic nerve is interesting. It is apparent that the differential blood supply is an important factor. The orbital part is supplied by the pial plexus, with branches from the ophthalmic artery extending perpendicularly into the nerve, providing a generous perfusion of the optic nerve at the periphery
<xref rid="REF207" ref-type="bibr">[207]</xref>. This may explain why the central part of the nerve is more vulnerable [
<xref rid="REF208" ref-type="bibr">208</xref>,
<xref rid="REF209" ref-type="bibr">209</xref>]. Notably, similar changes had also been reported earlier for a case of bilateral ischemic optic neuropathy
<xref rid="REF210" ref-type="bibr">[210]</xref>.
</p><p>Similarly, earlier studies of chronic methanol vapor exposure among workers also revealed that the major changes included varying degrees of injury to the optic nerve [
<xref rid="REF211" ref-type="bibr">211</xref>,
<xref rid="REF212" ref-type="bibr">212</xref>].
</p></sec><sec><title id="SEC6.2">Methanol (and formic acid)-induced ocular lesions in experimental animals</title><sec><title id="SEC6.2.1">Ocular lesions in non-human primates</title><p>Administration of methanol in monkeys could induce nearly identical ocular changes as seen in humans, which included optic nerve lesions and pupillary reflex changes, with optic disc edema or hyperedema as accompanying changes [
<xref rid="REF30" ref-type="bibr">30</xref>,
<xref rid="REF213" ref-type="bibr">213</xref>]. Notably, the axonal necrosis was mostly seen in the central part of the optic nerve
<xref rid="REF214" ref-type="bibr">[214]</xref>. Electron microscopic examination found lesions in the optic nerve heads, retrolaminar optic nerve and intraorbital optic nerve, consisting of swelling and clustering of the mitochondria, disruption of the neurotubules, formation of vesicles, and swelling of glial cells.
</p><p>The ocular toxicity of intravenously-infused formic acid had also been studied in monkeys. Marked optic disc edema was observed 24&#8211;48&#8197;h after formic acid administration. Loss of pupillary reflexes occurred in most animals within 48&#8197;h. The symptoms produced by formic acid in monkeys were similar to the clinical features observed in monkeys with methanol administration
<xref rid="REF30" ref-type="bibr">[30]</xref>. As expected, it was observed that the onset of ocular toxicity occurred more rapidly in monkeys with formic acid administration than with methanol administration because the metabolic conversion of methanol to formic acid and the subsequent accumulation of the latter would take some time.
</p></sec><sec><title id="SEC6.2.2">Ocular lesions in rodents and rabbits</title><p>A number of studies have reported that methanol-intoxicated rodents would not develop the same kind of clinical symptoms that are commonly seen in humans and non-human primates. Poon
<italic toggle="yes">et al</italic>. [
<xref rid="REF215" ref-type="bibr">215</xref>,
<xref rid="REF216" ref-type="bibr">216</xref>] have investigated the toxic effect of methanol in rats that were exposed to vapors of methanol (300, 2500 and 3000&#8197;ppm) for 6&#8197;h&#8197;a&#8197;day, 5 days per week for 4 weeks. No eye disturbance was observed in these animals. A similar experiment had also been conducted in CD rats
<xref rid="REF217" ref-type="bibr">[217]</xref>, and there were no treatment- or dose-related effects observed during ophthalmoscopic and histopathological examinations in all animals. Functional and morphological studies of methanol-intoxicated rats revealed that formic acid acts as a mitochondrial toxicant in the retina and optic nerve
<xref rid="REF204" ref-type="bibr">[204]</xref>.
</p><p>Like rodents, most studies found that rabbits were similarly insensitive to the ocular toxicity induced by methanol or formic acid
<xref rid="REF218" ref-type="bibr">[218]</xref>. It was reported that the rabbits after exposure to methanol vapors for 6&#8197;months only developed rather mild ocular toxicity, including ultrastructural changes in the photoreceptor cells and M&#252;ller cells
<xref rid="REF218" ref-type="bibr">[218]</xref>.
</p><p>Here it is of note that an earlier study demonstrated that the retinal and optic nerve toxicity of methanol could be readily and equally demonstrated in rats when their folate-dependent oxidation of formic acid was selectively inhibited by nitrous oxide
<xref rid="REF117" ref-type="bibr">[117]</xref>. Under this experimental condition, methanol-intoxicated rats developed nearly the same degree of visual toxicity along with formic acid accumulation. Moreover, the temporal relationship between methanol administration and the development of ocular toxicity and formic acid accumulation in rats
<xref rid="REF117" ref-type="bibr">[117]</xref> was remarkably similar to what was seen in human methanol intoxication
<xref rid="REF32" ref-type="bibr">[32]</xref>. These results clearly demonstrated that the drastically-different sensitivity between humans (and non-human primates) and rodents to methanol and formic acid toxicity is principally due to the differences in their metabolic disposition of formic acid.
</p></sec></sec><sec><title id="SEC6.3">Mechanisms of methanol (and formic acid)-induced ocular lesions</title><p>An earlier study showed that formic acid
<italic toggle="yes">per se</italic>
could directly cause damage to the optic nerve and disc, in the absence of acidosis
<xref rid="REF30" ref-type="bibr">[30]</xref>. Moreover, the ocular effects of methanol poisoning were also similarly associated with formic acid-induced damage to the optic nerve and disc
<xref rid="REF32" ref-type="bibr">[32]</xref>.
</p><p>It has been suggested earlier that formic acid has an apparent affinity for the retrolaminar optic nerve and optic disc, which would partially account for its preferential retinal toxicity in susceptible species (
<italic toggle="yes">e</italic>.
<italic toggle="yes">g</italic>., humans and non-human primates). Mechanistically, as discussed earlier, formic acid can inhibit cytochrome oxidase in the mitochondria, which would result in decreased ATP production. Cellular ATP deficiency would impair the normal physiological functions of the optic nerve (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., the transmission of the action potentials along the nerve), which subsequently may produce severe damage to optic nerve fibers and neurons.
</p><p>Lastly, it is of note that formaldehyde is a cross-linking agent, and its carbonyl atom is a strong electrophilic site, making it react facilely with nucleophilic sites in proteins and DNA. Although formaldehyde usually does not accumulate to high levels in the body, its exceptional chemical reactivity may still contribute significantly to certain aspects of the methanol toxicity, including ocular lesions.</p></sec><sec><title id="SEC6.4">Section summary</title><p>Based on most observations, it is generally accepted that the ocular lesion in methanol poisoning essentially represents a toxic optic neuropathy, with retinal edema as an accompanying change. Moreover, the ocular toxicity associated with methanol poisoning is caused by formic acid but not by methanol or acidosis
<xref rid="REF30" ref-type="bibr">[30]</xref>. As expected, formic acid acts as a strong mitochondrial toxicant in the retina and optic nerves
<xref rid="REF204" ref-type="bibr">[204]</xref>.
</p><p>Humans and non-human primates are uniquely sensitive to the ocular and neurotoxicity of formic acid because they have a limited capacity to oxidize and thus detoxify formic acid. By contrast, rodents (such as rats and mice) are highly resistant to methanol and formic acid toxicity (including the ocular lesions), which is purely due to their exceptional ability to oxidize formic acid to carbon dioxide.</p></sec></sec><sec><title id="SEC7">Diabetic Ocular Lesions in Humans and Experimental Animals</title><sec><title id="SEC7.1">Clinical pathology of diabetic ocular lesions in humans</title><p>Nearly all type 1 DM patients and approximately 80% of insulin-dependent type 2 DM patients will have retinopathy 20&#8197;years after the disease diagnosis [
<xref rid="REF219" ref-type="bibr">219</xref>,
<xref rid="REF220" ref-type="bibr">220</xref>]. Diabetic retinopathy often includes altered vascular permeability, capillary microaneurysms, capillary degeneration, and excessive formation of new blood vessels (neovascularization). The neuroretina is also dysfunctional with neuronal cell death, which alters retinal electrophysiology as well as visual functions.
</p><p>Diabetic retinopathy is traditionally classified into two main clinical forms: proliferative diabetic retinopathy (PDR) and NPDR (non-PDR). In the early stages, hyperglycemia can lead to thickening of the basement membrane and intramural pericyte death, which jointly contribute to changes in the integrity of blood vessels within the retina and alter the blood-retinal barrier and vascular permeability
<xref rid="REF221" ref-type="bibr">[221]</xref>. In this initial stage of NPDR, people usually do not notice significant visual impairment. Degeneration or occlusion of the retinal capillaries is strongly associated with a worsening prognosis
<xref rid="REF222" ref-type="bibr">[222]</xref> and often followed by the release of angiogenic factors including those related to hypoxia. This progresses the disease into the proliferative phase where neovascularization and accumulation of fluid within the retina, which is commonly referred to as &#8220;macula edema&#8221;, contribute to visual impairment. In more severe cases, retinal bleeding associated with distorting of the retinal architecture is often seen and this change can lead to retinal detachment
<xref rid="REF221" ref-type="bibr">[221]</xref>.
</p><p>The prevalence of the sight-threatening forms of retinopathy is typified by PDR and DME (diabetic macular edema)
<xref rid="REF223" ref-type="bibr">[223]</xref>. In addition to diabetic retinopathy, another sight-threatening ocular lesion that is associated with DM is cataract.
</p></sec><sec><title id="SEC7.2">A new hypothesis on the pathogenic mechanism of human diabetic retinopathy</title><p>Traditionally, the understanding of the etiology and pathogenesis of diabetic retinopathy focuses on vascular dysfunction and loss of perfusion, which are hallmarks of diabetic retinopathy. However, it is still far from certain whether these changes are the fundamental causes that drive the cascade of diabetic retinopathy or there might be other more fundamental changes that we do not quite understand at present. It should be noted that there are clear clinical indications that the neuroretinal functions are compromised in DM patients, well before the onset of overt microvascular changes
<xref rid="REF224" ref-type="bibr">[224]</xref>. For instance, electrophysiological study of DM patients has revealed alterations in the neuroretina, including diminished color vision
<xref rid="REF225" ref-type="bibr">[225]</xref>, reduced contrast sensitivity
<xref rid="REF226" ref-type="bibr">[226]</xref>, and abnormal electroretinogram before the onset of overt retinopathy
<xref rid="REF227" ref-type="bibr">[227]</xref>. In agreement with these clinical observations, a number of studies using DM animal models as well as human subjects have also reported the early loss of inner retinal neurons and neuronal projections [
<xref rid="REF228" ref-type="bibr">228</xref>,
<xref rid="REF229" ref-type="bibr">229</xref>], degeneration of the pigment epithelium
<xref rid="REF230" ref-type="bibr">[230]</xref>, and dysfunction of M&#252;ller cells and astrocytes [
<xref rid="REF224" ref-type="bibr">224</xref>,
<xref rid="REF231" ref-type="bibr">231</xref>&#8211;
<xref rid="REF236" ref-type="bibr">236</xref>].
</p><p>Here, a new mechanistic hypothesis for the pathogenesis of diabetic retinopathy is proposed. This hypothesis is based on the premise that there is an increased metabolic formation and accumulation of formic acid (along with formaldehyde) in DM patients. The retina, in particular the neuroretina, probably requires the highest level of oxygen and energy supply among all the tissues in the human body, exceeding even that of the brain [
<xref rid="REF237" ref-type="bibr">237</xref>&#8211;
<xref rid="REF241" ref-type="bibr">241</xref>]. As such, the retina is richly vascularized for blood supply. It is hypothesized that hyperglycemia-associated increase in formic acid and formaldehyde levels in different retinal cells, in particular neuroretinal cells, can inhibit mitochondrial respiration, resulting in a state of hypoxia and reduced ATP synthesis [
<xref rid="REF31" ref-type="bibr">31</xref>,
<xref rid="REF173" ref-type="bibr">173</xref>,
<xref rid="REF178" ref-type="bibr">178</xref>]. This reduction in mitochondrial respiration may subsequently lead to increased anerobic glycolysis as a compensation. However, glycolysis is not efficient, producing far fewer ATP molecules compared to oxidative phosphorylation.
</p><p>As already mentioned earlier, inhibition of the mitochondrial respiration may lead to accumulation of the mitochondrial superoxide, which would lead to inhibition of the GAPDH activity
<xref rid="REF33" ref-type="bibr">[33]</xref> and thereby suppress the anerobic glycolysis, likely further aggravating the situation of cellular energy shortage. In the meanwhile, the upstream glucose metabolites might be forced to enter other metabolic pathways, such as the polyol pathway and the hexosamine pathway. Therefore, it is expected that at late stages of DM, the patients are usually associated with a state of severe energy deficiency in many tissues, especially in those tissues that normally have a very high demand for oxygen and energy supply (such as the neuroretina).
</p><p>In addition, the formic acid-induced mitochondrial superoxide accumulation may further cause mitochondrial damage and even oxidative cell death [
<xref rid="REF175" ref-type="bibr">175</xref>&#8211;
<xref rid="REF177" ref-type="bibr">177</xref>]. On the other hand, formaldehyde may contribute to mitochondrial damage and cell death in DM patients by causing extensive cross-linking of the mitochondrial and cellular proteins, in addition to its conversion to formic acid. In support of the proposed mechanistic explanation, mitochondrial dysfunction (such as dysregulation of the mitochondrial uncoupling proteins) [
<xref rid="REF242" ref-type="bibr">242</xref>&#8211;
<xref rid="REF245" ref-type="bibr">245</xref>] has been detected at the sites of diabetic complications, and these pathogenic changes are removed by overexpression of the manganese superoxide dismutase
<xref rid="REF246" ref-type="bibr">[246]</xref>, which effectively helps to remove mitochondrial superoxide.
</p><p>Based on the proposed MFF hypothesis, a tentative explanation of some of the biochemical, histopathological and clinical changes of diabetic retinopathy commonly seen in DM patients and/or animal models is provided below.</p><sec><title id="SEC7.2.1">Hypoxic neuroretinal degeneration is a critical early change in diabetic retinopathy</title><p>As discussed in &#8220;Ocular Lesions of Methanol (and Formic Acid) in Humans and Experimental Animals&#8221;, formic acid can preferentially induce hypoxic lesions (even death) in optical nerve and disc. According to the proposed MFF hypothesis, it is speculated that accumulation of formic acid in advanced DM patients would first result in hypoxia in the neuroretina, as this tissue has a very high demand for oxygen and energy supply. There are many earlier studies offering support for this suggestion. For instance, studies have shown that abnormalities in neuroretinal dysfunction were readily seen in DM patients in the absence of overt microvascular abnormalities [
<xref rid="REF247" ref-type="bibr">247</xref>&#8211;
<xref rid="REF251" ref-type="bibr">251</xref>]. Furthermore, apoptosis of retinal ganglion cells (RGCs) and reactive gliosis, which are hallmarks of retinal neurodegeneration, were also detected in diabetic donors without the appearance of microcirculatory abnormalities [
<xref rid="REF252" ref-type="bibr">252</xref>&#8211;
<xref rid="REF254" ref-type="bibr">254</xref>]. This loss of neuroretinal cells, which reduces the thickness of the retinal neuropile, was observed in DM patients with minimal or no diabetic retinopathy by using scanning laser polarimetry or optical coherence tomography (OCT)
<xref rid="REF255" ref-type="bibr">[255]</xref>.
</p></sec><sec><title id="SEC7.2.2">Pathogenic changes in retinal vasculature</title><p>As discussed above, neuroretinal degeneration is an early event in diabetic retinopathy, occurring before the onset of microvascular changes, including changes in retinal blood flow, thickening of the capillary basement membrane, breakdown of the blood-retinal barrier, and the impairment of neurovascular coupling [
<xref rid="REF247" ref-type="bibr">247</xref>,
<xref rid="REF256" ref-type="bibr">256</xref>&#8211;
<xref rid="REF258" ref-type="bibr">258</xref>]. Therefore, it is hypothesized that the neuroretinal degeneration caused by glucose-derived toxic one-carbon metabolites may drive the retinal vascular changes. A brief discussion of the supporting evidence is provided below.
</p><sec><title id="SEC7.2.2.1">Thickening of the capillary basement membrane.</title><p>One of the early histopathological changes observed in DM patients is the thickening of the capillary basement membrane (BM)
<xref rid="REF36" ref-type="bibr">[36]</xref>. Mechanistically, it has long been suspected that accumulation of AGEs is an important cause for the cross-linking of various proteins in vascular BM [
<xref rid="REF259" ref-type="bibr">259</xref>&#8211;
<xref rid="REF262" ref-type="bibr">262</xref>]. In my personal view, the relative importance of AGE accumulation in the thickening of the capillary BM might be smaller than usually thought, because in the rodent DM models, the blood glucose levels are usually far higher than those seen in human DM, and yet DM rodents rarely develop the same level of capillary changes (including BM thickening).
</p><p>Based on the proposed MFF hypothesis, the production of formaldehyde, which is a cross-linking agent, may contribute, in addition to AGEs, to the thickening of the capillary BM. The extensive cross-linking of capillary BM proteins by formaldehyde is expected to lead to increased synthesis of these components (
<italic toggle="yes">e</italic>.
<italic toggle="yes">g</italic>., collagen IV, fibronectin and laminin) and reduced degradation by catabolic enzymes [
<xref rid="REF263" ref-type="bibr">263</xref>,
<xref rid="REF264" ref-type="bibr">264</xref>]. Indeed, earlier studies [
<xref rid="REF259" ref-type="bibr">259</xref>&#8211;
<xref rid="REF264" ref-type="bibr">264</xref>] have found that the synthesis of collagen IV, fibronectin and laminin in capillary BM is increased in DM whereas their degradation by catabolic enzymes is reduced. Such matrix modifications may cause impaired endothelial-pericyte communication and inappropriate interaction between these cells with constituent BM proteins [
<xref rid="REF199" ref-type="bibr">199</xref>,
<xref rid="REF259" ref-type="bibr">259</xref>,
<xref rid="REF265" ref-type="bibr">265</xref>&#8211;
<xref rid="REF267" ref-type="bibr">267</xref>].
</p></sec><sec><title id="SEC7.2.2.2">Alteration of retinal blood flow.</title><p>It is known that the retinal vasculature lacks autonomic innervation, and regulation of blood flow to the retinal neuropile largely depends on local signaling mechanisms, carried out by M&#252;ller cells (discussed later), in a process commonly referred to as &#8220;neurovascular coupling&#8221;. It is hypothesized that due to formic acid-induced hypoxia in diabetic neuroretina and nerve fibers, which, through the functional neurovascular coupling mechanism, would lead to activation of the M&#252;ller cells, and the activated M&#252;ller cells then release substances that cause dilation of the retinal blood vessels to improve the blood flow and oxygen supply to the neuroretina.</p><p>Consistent with this suggestion, it was noted, as early as in the 1930s, that the retinal blood flow was indeed markedly altered in DM patients
<xref rid="REF268" ref-type="bibr">[268]</xref>. Additional studies have also noted that the caliber of retinal vessels was consistently increased in DM patients [
<xref rid="REF269" ref-type="bibr">269</xref>,
<xref rid="REF270" ref-type="bibr">270</xref>]. As DM progresses, the degree of retinal arteriole dilation and blood flow would increase in proportion to the severity of retinopathy
<xref rid="REF271" ref-type="bibr">[271]</xref>. Understandably, these changes only represent a temporary fix to the existing problems, and if hyperglycemia is not improved, the heightened retinal vasodilation and increased blood flow likely would hasten the future progression of diabetic retinopathy [
<xref rid="REF272" ref-type="bibr">272</xref>&#8211;
<xref rid="REF274" ref-type="bibr">274</xref>].
</p><p>In late stages of diabetic retinopathy, retinal capillary non-perfusion is the result of focal degeneration of the neuroretina (discussed in more detail in the next section). Retinal capillary non-perfusion, coupled with the existing mitochondrial respiratory inhibition by formic acid and formaldehyde, would lead to severe retinal ischemia and hypoxia, which would further heighten neovascularization, likely as a desperate last resort to improve the situation. As a result, neovascularization, accumulation of fluid within the retina, and associated vitreous hemorrhage, which are characteristic of the proliferative stage of diabetic retinopathy, would jointly worsen diabetic ocular impairments
<xref rid="REF6" ref-type="bibr">[6]</xref>. Here it is of note that the conditions of fluid accumulation within the retina and the associated vitreous hemorrhage are expected to be more severe in DM patients with hypertension, as clinical studies have consistently shown that high blood pressure is associated with a worsening outcome
<xref rid="REF275" ref-type="bibr">[275]</xref>.
</p><p>Lastly, it is of interest to point out that some of the presently-available treatment options for diabetic retinopathy also offer support for the proposed pathogenic mechanism of diabetic retinopathy. For instance, panretinal photocoagulation is commonly used as a treatment for PDR and DME [
<xref rid="REF276" ref-type="bibr">276</xref>,
<xref rid="REF277" ref-type="bibr">277</xref>]. The procedure involves creating thermal burns in the peripheral retina leading to tissue coagulation. In this way, the blood and oxygen requirement by the large peripheral areas of the neuroretina will be essentially removed, and as a result, the relative oxygen and energy supply to the remaining neuroretinal tissue (which is the central part of the retina with highest visual activities) would be significantly improved, and so are the clinical symptoms
<xref rid="REF278" ref-type="bibr">[278]</xref>.
</p></sec><sec><title id="SEC7.2.2.3">Capillary degeneration and microaneurysms.</title><p>Capillary degeneration is another important feature of diabetic retinopathy, with the appearance of acellular capillaries which are usually non-perfused naked BM tubes
<xref rid="REF279" ref-type="bibr">[279]</xref>. Severe capillary closures are often linked with cotton wool spots in the neural retina and also the occurrence of intraretinal microvascular abnormalities (IRMAs) [
<xref rid="REF280" ref-type="bibr">280</xref>,
<xref rid="REF281" ref-type="bibr">281</xref>]. The large-caliber vessels in IRMAs traverse hypoxic retina with direct communication between pre-capillary arterioles and post-capillary venules and probably represent shunt vessels in a desperate attempt to re-vascularize the hypoxic neuropile [
<xref rid="REF282" ref-type="bibr">282</xref>,
<xref rid="REF283" ref-type="bibr">283</xref>].
</p><p>Microaneurysms represent another hallmark lesion of diabetic retinopathy. Clinically, many microaneurysms are sclerosed and non-perfused, whereas others can be observed as fully or partially perfused during fluorescein angiography [
<xref rid="REF280" ref-type="bibr">280</xref>,
<xref rid="REF284" ref-type="bibr">284</xref>]. Microaneurysms occur largely on the arteriolar side of the circulation where they often occur immediately upstream of large areas of capillary acellularity
<xref rid="REF279" ref-type="bibr">[279]</xref>.
</p><p>It is hypothesized that the above-described retinal vascular degenerations in DM are the secondary changes to neuroretinal degeneration which is caused by chronic retinal accumulation of formic acid (and formaldehyde) and subsequent hypoxia and ATP deficiency. When neurons in certain parts of the retina degenerate, they would no longer be able to activate the nearby M&#252;ller cells to release growth factors to stimulate retinal angiogenesis. As a result, the capillary pericytes in certain regions of the retina would no longer regenerate and may not even survive for too long in the absence of proper growth factors. It is understandable that the calibers of these acellular capillaries might enlarge due to the weak vessel wall structure (in the absence of capillary pericytes) plus the action of vascular static pressure.</p><p>In support of the above explanation, it has been reported that one of the earliest features of microaneurysms in human diabetic retina is the loss of pericytes
<xref rid="REF285" ref-type="bibr">[285]</xref> and vascular smooth muscle cells [
<xref rid="REF286" ref-type="bibr">286</xref>,
<xref rid="REF287" ref-type="bibr">287</xref>]. In addition, endothelial cells also become dysfunctional, with exhausted replicative potential [
<xref rid="REF288" ref-type="bibr">288</xref>,
<xref rid="REF289" ref-type="bibr">289</xref>]. Retinal pericytes and smooth muscle cells are known to be heavily reliant on certain growth factors for regeneration and survival [
<xref rid="REF290" ref-type="bibr">290</xref>,
<xref rid="REF291" ref-type="bibr">291</xref>]. In DM, there is a selective depletion of these growth factors
<xref rid="REF292" ref-type="bibr">[292]</xref> (as a direct result of neuroretinal degeneration), which then leads to acellular capillary formation
<xref rid="REF282" ref-type="bibr">[282]</xref>.
</p></sec></sec><sec><title id="SEC7.2.3">Dysregulation of M&#252;ller cell functions</title><p>M&#252;ller cells, the principal glial cell type found in the retina, span the entire width of the retina and have contact with almost every cell type in the retina
<xref rid="REF283" ref-type="bibr">[283]</xref>. The M&#252;ller cells perform many important physiological functions in the retina, including recycling of neurotransmitters, retinoic acids and certain ions (such as potassium); regulation of the retinal nutrient supply, energy metabolism and blood flow; and maintenance of the blood-retinal-barrier
<xref rid="REF283" ref-type="bibr">[283]</xref>.
</p><p>It is known that M&#252;ller cells live primarily from glycolysis
<xref rid="REF293" ref-type="bibr">[293]</xref>. In so doing, M&#252;ller cells can spare oxygen for retinal neurons and other cell types that use oxidative phosphorylation for ATP production. Also because of this unique property, it is expected that M&#252;ller cells would be less sensitive to the toxicity of formic acid and formaldehyde.
</p><p>It is hypothesized that retinal accumulation of formic acid (along with formaldehyde) is the main cause for neuroretinal degeneration, which subsequently leads to M&#252;ller cell activation. The growth factors, cytokines and chemokines released from activated M&#252;ller cells serve as important biomediators between neuroretinal degeneration and retinal microangiopathy. As briefly discussed below, this speculation is supported by some experimental observations.</p><p>First, one of the most important functions of M&#252;ller cells is to serve as a mediator of the &#8220;neurovascular coupling&#8221; to regulate retinal blood flow and nutrient supplies, through the release of biomediators that control the constriction and dilation of the retinal blood vessels [
<xref rid="REF294" ref-type="bibr">294</xref>,
<xref rid="REF295" ref-type="bibr">295</xref>]. It is hypothesized that due to formic acid (and formaldehyde)-induced hypoxia and ATP deficiency in diabetic neuroretina and nerve fibers, M&#252;ller cells are activated, which then release biomediators to dilate retinal blood vessels as a feedback regulation to improve blood flow to the neuroretina.
</p><p>Second, another important function of M&#252;ller cells is their contribution to maintaining the integrity of the blood-retinal-barrier [
<xref rid="REF296" ref-type="bibr">296</xref>&#8211;
<xref rid="REF298" ref-type="bibr">298</xref>], through secretion of factors such as pigment epithelium-derived factor and thrombospondin-1 which increase the tightness of the endothelial barrier [
<xref rid="REF299" ref-type="bibr">299</xref>,
<xref rid="REF300" ref-type="bibr">300</xref>]. When the retinal blood vessels dilate and blood flow increase as a result of M&#252;ller cell activation caused by the hypoxic neuroretina, a potential side effect is the reduced integrity of the blood retinal barrier. Accordingly, it is speculated that the activated M&#252;ller cells would attempt to increase the secretion of relevant regulatory factors that would help improve the tightness of the endothelial barrier [
<xref rid="REF299" ref-type="bibr">299</xref>,
<xref rid="REF300" ref-type="bibr">300</xref>].
</p><p>Third, many studies have shown that M&#252;ller cells become activated in DM [
<xref rid="REF231" ref-type="bibr">231</xref>,
<xref rid="REF233" ref-type="bibr">233</xref>,
<xref rid="REF301" ref-type="bibr">301</xref>&#8211;
<xref rid="REF304" ref-type="bibr">304</xref>]. One of the best-known indicators of M&#252;ller cell activation in diabetic retinopathy is the increased expression of glial fibrillary acidic protein (GFAP) [
<xref rid="REF302" ref-type="bibr">302</xref>,
<xref rid="REF305" ref-type="bibr">305</xref>,
<xref rid="REF306" ref-type="bibr">306</xref>]. Under healthy conditions, M&#252;ller cells generally do not express GFAP [
<xref rid="REF307" ref-type="bibr">307</xref>,
<xref rid="REF308" ref-type="bibr">308</xref>]. Studies have shown that high levels of glucose can induce M&#252;ller cell activation to release growth factors, cytokines and chemokines [
<xref rid="REF308" ref-type="bibr">308</xref>&#8211;
<xref rid="REF314" ref-type="bibr">314</xref>].
</p><p>While many studies have focused on the detrimental effects of M&#252;ller cell-derived VEGF on the microvasculature in the diabetic retina [
<xref rid="REF307" ref-type="bibr">307</xref>,
<xref rid="REF315" ref-type="bibr">315</xref>&#8211;
<xref rid="REF317" ref-type="bibr">317</xref>]), it should be noted that the real intent of the growth factor production and release by M&#252;ller cells likely is to protect the neuroretina from chronic hypoxia and ATP deficiency caused by hyperglycemia-associated formic acid/formaldehyde accumulation. This notion is supported by a study in mice which carry a disrupted VEGF receptor 2 specifically in M&#252;ller cells. Loss of this receptor was found to reduce the M&#252;ller cell density, decrease the scotopic and photopic electroretinography amplitudes, and accelerate the loss of photoreceptors and neuroretinal cells in the retina
<xref rid="REF318" ref-type="bibr">[318]</xref>.
</p><p>Besides growth factors, M&#252;ller cells also release a number of cytokines and chemokines under hyperglycemic conditions, such as interleukin-1&#946; [
<xref rid="REF308" ref-type="bibr">308</xref>,
<xref rid="REF313" ref-type="bibr">313</xref>,
<xref rid="REF319" ref-type="bibr">319</xref>&#8211;
<xref rid="REF322" ref-type="bibr">322</xref>]. Vascular endothelial cells are susceptible to interleukin-1&#946; and rapidly progress to cell death in response to this pro-inflammatory cytokine
<xref rid="REF323" ref-type="bibr">[323]</xref>, along with the formation of acellular capillaries
<xref rid="REF324" ref-type="bibr">[324]</xref>. Besides interleukin-1&#946;, M&#252;ller cells also produce other pro-inflammatory cytokines such as tumor necrosis factor-&#945; and interleukin-6 [
<xref rid="REF325" ref-type="bibr">325</xref>&#8211;
<xref rid="REF329" ref-type="bibr">329</xref>]. Interleukin-6 has detrimental effects associated with vascular dysfunction [
<xref rid="REF330" ref-type="bibr">330</xref>&#8211;
<xref rid="REF332" ref-type="bibr">332</xref>]. It is speculated that the release of cytokines and chemokines by M&#252;ller cells under hyperglycemic conditions is the result of severe neuroretinal degeneration caused by formic acid accumulation. It is expected that following neuroretinal degeneration, the retinal vessels would regress, and eventually the population of M&#252;ller cells would also reduce.
</p><p>In summary, it was widely considered in the past that during the development of diabetic retinopathy, &#8220;dysregulation&#8221; of M&#252;ller cell function is a primary cause for retinal dysfunction through production of pro-angiogenic factors leading to neovascularization and eventually the creation of a chronic inflammatory retinal environment, which results in cell death. In light of the proposed MFF hypothesis, it is suggested that M&#252;ller cells are a key player that maintains a healthy retinal environment. Once this microenvironment is disrupted by accumulation of formic acid and formaldehyde in DM patients which subsequently causes histotoxic hypoxia and ATP deficiency in retinal neurons and nerve fibers, M&#252;ller cells would become activated to counter-regulate in an attempt to &#8220;repair&#8221; the disrupted retinal environment. While M&#252;ller cell-released growth factors and cytokines are closely associated with vascular dysfunction and angiogenesis, this is only part of the picture. Based on the new MFF hypothesis, it is postulated that the release of the regulatory factors (in particular growth factors) by M&#252;ller cells is intended to alleviate hyperglycemia-associated damage to the retinal neurons and nerve fibers, and these factors are only turned into self-damaging components in diabetic retinopathy when the initial causative factors (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., hyperglycemia-associated, formic acid-induced neuroretinal hypoxia and ATP deficiency) are not effectively corrected. When the M&#252;ller cell-derived pro-inflammatory cytokines/chemokines are released, it signals that the pathogenic process is reaching a late phase where severe retinal neurodegeneration has already occurred.
</p></sec><sec><title id="SEC7.2.4">Reconciliation with other pathogenic mechanisms of diabetic retinopathy</title><p>In the past, a number of independent hypotheses have been proposed to explain the role of the increased polyol pathway flux, the increased hexosamine pathway flux, the increased formation of AGEs, and the over-activation of protein kinase C in the pathogenesis of diabetic retinopathy
<xref rid="REF333" ref-type="bibr">[333]</xref>. These mechanisms should not be viewed as independent phenomena. Based on the proposed MFF hypothesis, it appears that they are the result of hyperglycemia-associated, formic acid/formaldehyde-mediated inhibition of the mitochondrial electron transport chain, which is associated with accumulation of mitochondrial ROS such as superoxide. Superoxide can indirectly cause inhibition of the glycolytic enzyme GAPDH (glyceraldehyde phosphate dehydrogenase)
<xref rid="REF33" ref-type="bibr">[33]</xref>, thereby diverting upstream glucose metabolites from glycolysis into other metabolic pathways mentioned above.
</p><p>The contribution of these metabolic derangements to the pathogenesis of diabetic retinal lesions (as well as other diabetic complications) has been discussed in many earlier papers. While a detailed discussion of these pathways is beyond the scope of this paper, a summary of selected major metabolic pathways is provided in
<xref rid="TBL1" ref-type="table">Table 1</xref> and
<xref rid="FIG3" ref-type="fig">Figure 3</xref> for ease of reference.
<fig position="float" id="FIG3" orientation="landscape"><caption><title>
<xref rid="FIG3" ref-type="fig">Figure3</xref>
</title><p>Effect of hyperglycemia-associated accumulation of toxic one-carbon metabolites on glucose metabolic pathways in DM</p><p>It is hypothesized that hyperglycemia would result in increased cellular glucose levels in DM patients, and this increase would further lead to increased metabolic formation of toxic one-carbon metabolites (methanol, formaldehyde and formic acid). Accumulation of formic acid (along with formaldehyde) would strongly inhibit mitochondrial respiration and superoxide production. High levels of superoxide would indirectly lead to inhibition of GAPDH, thereby suppressing anerobic glycolysis. As a result, the upstream glucose metabolites are forced to be diverted into other metabolic pathways, such as the polyol pathway, the hexosamine pathway, the PKC pathway, and the AGE pathway. It has been well documented that activation of these metabolic pathways contributes to the development of diabetic complications. Abbreviations: AR: aldose reductase; SDH: sorbitol dehydorgenase; GFAT: glutamine fructose-6-phosphate amidotransferase; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; NF-&#954;B: nuclear factor kappa B; PARP: poly(ADP-ribose) polymerase; DHAP: dihydroxyacetone-3-phosphate; DAG: diacylglycerols; PKC: protein kinase C; AGE: advanced glycation endproducts; RAGE: receptor of AGE; ROS: reactive oxygen species; UDPGlcNAc: UDP-N-acetylglucosamine.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ABBS-2021-527-t3.jpg"/></fig>
<table-wrap position="float" content-type="table" id="TBL1" orientation="landscape" xml:base="8.03pt"><caption><p>
<bold>
<xref rid="TBL1" ref-type="table">Table1</xref>
</bold>Summary of glucose metabolic pathways that are activated by hyperglycemia [
<xref rid="REF34" ref-type="bibr">34</xref>,
<xref rid="REF334" ref-type="bibr">334</xref>] (
<xref rid="FIG3" ref-type="fig">Figure 3</xref>)
</p></caption><table frame="hsides" rules="groups" cellpadding="0.5" cellspacing="0" width="100%"><colgroup span="1"><col width="50*" span="1"/><col width="81*" span="1"/></colgroup><thead><tr><td rowspan="1" colspan="1">
<p>Pathway</p>
</td><td rowspan="1" colspan="1">
<p>Characteristic changes</p>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<p>The polyol pathway</p>
</td><td rowspan="1" colspan="1">
<p>Aldose reductase (AR) reduces glucose to sorbitol, and sorbitol dehydrogenase (SDH) oxidizes sorbitol to fructose. Both enzymes are abundantly expressed in tissues that are prone to develop diabetic complications. Hyperglycemia activates the AR pathway partly by mass action. It is expected that increased flux through the AR pathway could increase the intracellular sorbitol, a relative intracellular hypertonic state, and this change may result in a compensatory efflux of other osmolytes such as myoinositol and taurine. In addition, the consumption of NADPH during AR-mediated glucose reduction to sorbitol would reduce cellular NADPH content, this change would suppress the regeneration of GSH, thereby contributing to heightened oxidative stress.</p>
</td></tr><tr><td rowspan="1" colspan="1">
<p>The hexosamine pathway</p>
</td><td rowspan="1" colspan="1">
<p>Fructose-6-phosphate is a metabolic intermediate of glycolysis. When glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is inhibited, some fructose-6-phosphate is shunted from the glycolytic pathway to the hexosamine pathway where it is converted to glucosamine-6-phosphate by glutamine fructose-6-phosphate amidotransferase (GFAT). Glucosamine-6-phosphate is then converted to uridine diphosphate-
<italic toggle="yes">N</italic>-acetyl glucosamine (UDP-GlcNAc), a molecule that attaches to the serine and threonine residues of transcription factors. In addition, hyperglycemic conditions can also directly activate the conversion of glucose-6-phosphate to fructose-6-phosphate, which creates additional flux through the hexosamine pathway, ultimately resulting in excess GlcNAc and abnormal modification of gene expression.
</p>
</td></tr><tr><td rowspan="1" colspan="1">
<p>The PKC pathway</p>
</td><td rowspan="1" colspan="1">
<p>Accumulation of glyceraldehydes-3-phosphate due to inhibition of GAPDH in hyperglycemic condition would lead to elevated level of dihydroxyacetone-3-phosphate (DHAP). DHAP is subsequently reduced to &#945;-glycerol-3-phosphate which in turn combines with fatty acids to drive the
<italic toggle="yes">de novo</italic> synthesis of diaclyglycerol (DAG), which in turn activates protein kinase C (PKC). Increased production of PKC &#946; has been implicated in overexpression of the angiogenic protein vascular endothelial growth factor (VEGF), plasminogen activator inhibitor-1 (PAI-1), nuclear factor kappa B (NF-&#954;B), transforming growth factor-&#946; (TGF-&#946;) and may contribute to the pathogenesis of some diabetic complications. Overexpression of PKC isoforms may also be involved in the induction of insulin resistance. Elevated activities of the PKC pathway may also stimulate ROS-generating enzymes such as NADPH oxidases and lipooxygenses which all together exacerbate cellular oxidative environment.
</p>
</td></tr><tr><td rowspan="1" colspan="1">
<p>The AGE pathway</p>
</td><td rowspan="1" colspan="1">
<p>Non-enzymatic reactions between the reducing sugars or oxaldehydes and proteins/lipids would result in the formation of the advanced glycation endproducts (AGEs). Three main pathways are responsible for the formation of reactive dicarbonyls (AGE precursors): 1) oxidation of glucose to form glyoxal; 2) degradation of the Amadori products (fructose-lysine adducts); and 3) aberrant metabolism of glycolytic intermediates to methylglyoxal. Extracellular protein AGEs such as those formed with plasma and matrix proteins may interfere with cellular adhesion and activate the receptor for AGEs (RAGE). AGE-RAGE interaction may lead to activation of the transcription factor NF-&#954;B. Also, activation of the RAGE in some tissues may induce oxidative stress through the NADPH oxidase activity.</p>
</td></tr></tbody></table></table-wrap>
</p><p>It is of note that a number of pharmacological inhibitors have been designed and tested for their potential beneficial effects in alleviating diabetic complications. For instance, elevated aldose reductase activity is linked to the early-onset severe diabetic retinopathy
<xref rid="REF333" ref-type="bibr">[333]</xref>, and pharmacological inhibition of the aldose reductase activity ameliorates the pathogenic process in certain animal models [
<xref rid="REF334" ref-type="bibr">334,</xref>
<xref rid="REF335" ref-type="bibr">335</xref>]. However, clinical trials with aldose reductase inhibitors have shown little or no effect in preventing human diabetic retinopathy. Ruboxistaurin, an oral protein kinase C-&#946; inhibitor, was shown to ameliorate retinal microvascular abnormalities in animal models
<xref rid="REF336" ref-type="bibr">[336]</xref>, but it did not prevent diabetic retinopathy progression in human subjects with moderately severe to very severe NPDR
<xref rid="REF337" ref-type="bibr">[337]</xref>. Lastly, inhibition of AGE formation, blockade of the AGE-RAGE interaction, and attenuation of the downstream signaling pathways were postulated to be of benefit in preventing diabetic retinopathy. However, aminoguanidine, the first AGE inhibitor tested in diabetic patients, was suspended due to its adverse effects
<xref rid="REF338" ref-type="bibr">[338]</xref>.
</p><p>It is important to note that the above-described inhibitors, while they are partially effective in certain animal models, are generally without significant benefits in DM patients. One of the main reasons for the discrepancy may lie in the fact that formic acid (along with formaldehyde) only plays a very minor role in the pathogenesis of diabetic complications in the commonly-used animal models of DM as opposed to their proposed pathogenic role in DM patients. Since these inhibitors likely would not significantly reduce formic acid and formaldehyde accumulation and their neuroretinal toxicity in DM patients, it is thus not surprising that they are without significant benefits in humans. On the other hand, the observed discrepancy as mentioned above also indirectly reflects the potential importance of formic acid (along with formaldehyde) in the pathogenesis of diabetic retinopathy in humans.</p></sec></sec><sec><title id="SEC7.3">Pathology of diabetic ocular lesions in animal models</title><sec><title id="SEC7.3.1">Diabetic ocular lesions in non-human primates</title><p>Studies have reported that monkeys treated with a single dose of streptozotocin (STZ) develop DM, and ischemic/hypoxic retinopathy with cotton-wool spots and hyper-fluorescent spots developed after 10&#8197;years [
<xref rid="REF339" ref-type="bibr">339</xref>,
<xref rid="REF340" ref-type="bibr">340</xref>]. In another study, monkeys were found to develop insulin dependency and hyperglycemia following pancreatectomy, and the blood-retinal barrier leakage was observed within 1&#8197;year following the onset of hyperglycemia. However, these monkeys still did not develop proliferative diabetic retinopathy (PDR) 10&#8197;years later
<xref rid="REF341" ref-type="bibr">[341]</xref>.
</p></sec><sec><title id="SEC7.3.2">Diabetic ocular lesions in rodents</title><p>In general, the rodent models of DM would only develop early stages of diabetic retinopathy, such as degeneration of retinal capillaries, but preretinal (intravitreal) neovascularization and degeneration of retinal neurons were not observed in diabetic rats and mice [
<xref rid="REF6" ref-type="bibr">6</xref>,
<xref rid="REF228" ref-type="bibr">228</xref>,
<xref rid="REF342" ref-type="bibr">342</xref>]. Moreover, the rodent models did not develop measurable visual impairment or blindness due to DM.
</p><p>For instance, in STZ-induced DM rats, their blood glucose levels were increased to ~700 mg/dL in 4 weeks, but these animals would not develop severe ocular impairment (including blindness)
<xref rid="REF343" ref-type="bibr">[343]</xref>. An earlier study
<xref rid="REF344" ref-type="bibr">[344]</xref> compared the ocular lesions in alloxan-induced diabetic rats or in rats fed a 30% or 50% galactose diet for 1.5&#8211;2&#8197;years. It was concluded that both DM rat models only developed microvascular lesions that are consistent with relatively earlier stages of diabetic retinopathy. Similar observations were also made in many other studies [
<xref rid="REF339" ref-type="bibr">339</xref>,
<xref rid="REF345" ref-type="bibr">345</xref>-
<xref rid="REF347" ref-type="bibr">347</xref>].
</p><p>While the inability to develop late-stage diabetic retinopathy in DM rodent models might be due to the short life span of rodents relative to humans, another important reason might be associated with the low sensitivity of rodents to formic acid/formaldehyde-induced ocular toxicity.</p></sec></sec><sec><title id="SEC7.4">Section summary</title><p>According to the proposed MFF hypothesis, energy production in the neuroretinal cells under DM conditions would be reduced, initially resulting from an inhibition of mitochondrial respiration by formic acid (along with formaldehyde); this change may lead to activation of the anerobic glycolysis [
<xref rid="REF34" ref-type="bibr">34</xref>,
<xref rid="REF348" ref-type="bibr">348</xref>], which produces far fewer ATP molecules compared to oxidative phosphorylation. However, when DM progresses, elevated mitochondrial superoxide production may lead to suppression of the anerobic glycolysis through inhibition of GAPDH
<xref rid="REF33" ref-type="bibr">[33]</xref>, further aggravating cellular energy shortage. It is expected that at late stages of DM, formic acid (and formaldehyde)-induced mitochondrial dysfunction and damage, coupled with severe energy deficiency in the neuroretina, would jointly drive the pathogenic processes of diabetic retinopathy.
</p><p>As discussed in earlier sections, rodents are highly resistant to the ocular toxicity of methanol and formic acid whereas humans (and non-human primates) are highly sensitive to their toxicity. Interestingly, the severe diabetic ocular lesions that are seen in DM patients (and non-human primates) are seldom seen in rodent models. These intriguing similarities, along with many other observations discussed above, offer support for the proposed hypothesis that the hyperglycemia-associated formation and accumulation of methanol and/or its toxic one-carbon metabolites in ocular tissues of diabetic human subjects may contribute importantly to the development of diabetic retinopathy.</p></sec></sec><sec><title id="SEC8">Mechanisms Underlying the Pathogenesis of Other Diabetic Complications</title><p>Besides retinopathy, there are also several other well-known diabetic complications, such as microangiopathy/angiopathy, nephropathy, neuropathy, myocardiopathy, and others
<xref rid="REF6" ref-type="bibr">[6]</xref>. In addition, insulin resistance is a common clinical manifestation of type 2 DM. Traditionally, microvascular complications were thought to be an important underlying cause for many of the diabetic complications (except insulin resistance). As already discussed in earlier sections regarding retinopathy, the microvascular changes in the retina likely are the secondary changes in response to neuroretinal damage caused by formic acid (and formaldehyde), which may play a more important role in driving the pathogenic process of diabetic retinopathy. In addition to the neuroretina, the brain, kidney, heart and muscles are other organs or tissues in the body that also have a very high requirement for oxygen and energy supply, and accordingly, these organs are also expected to be highly susceptible to formic acid (and formaldehyde)-induced hypoxic damage. It is suggested that each of these diabetic complications might be viewed as a tissue-specific manifestation of a somewhat similar formic acid (and formaldehyde)-induced pathogenic process. Provided below is a discussion of the potential roles of formic acid and formaldehyde in the pathogenesis of diabetic complications in other vital organs, including the brain, kidney, and heart. In addition, a brief discussion of the potential contributing roles of formic acid and formaldehyde in the development of insulin resistance, diabetic ketoacidosis, cataract and cancer in DM patients is also provided.
</p><sec><title id="SEC8.1">Vascular complications</title><p>Hyperglycemia-associated vascular complications are usually grouped under &#8220;microvascular disease&#8221; (microangiopathy, due to damage to small blood vessels) and &#8220;macrovascular disease&#8221; (angiopathy, due to damage to arteries).</p><p>In diabetic microangiopathy, one of the most consistent morphological changes is the diffusive thickening of the capillary basement membrane [
<xref rid="REF349" ref-type="bibr">349</xref>,
<xref rid="REF350" ref-type="bibr">350</xref>]. The thickening is most evident in the capillaries of the retina, renal glomeruli and medulla, skeletal muscles, brain and skin, giving rise to characteristic diabetic microangiopathy in these organs or tissues. Notably, thickening of the basement membrane may also occur in some nonvascular structures such as renal tubules, Bowman&#8217;s capsules, peripheral nerves, and placentas. Biochemically, a number of characteristic changes in the basement membrane have been commonly observed in diabetic microangiopathy, which typically include increased levels and synthesis of collagen type IV plus decreases in proteoglycans.
</p><p>Diabetic macroangiopathy contributes to the pathogenesis of coronary heart disease, peripheral vascular disease, and cerebrovascular disease. Cardiovascular disease remains a major cause of morbidity and mortality worldwide [
<xref rid="REF351" ref-type="bibr">351</xref>,
<xref rid="REF352" ref-type="bibr">352</xref>].
</p><sec><title id="SEC8.1.1">Pathogenic explanation</title><p>Traditionally, it has been suggested that increased formation of AGEs under hyperglycemic conditions plays a critical role in the pathogenesis of DM-associated vascular changes [
<xref rid="REF13" ref-type="bibr">13</xref>,
<xref rid="REF14" ref-type="bibr">14</xref>]. However, it should be noted that while increased formation of AGEs contributes to chronic vascular damage in a given organ or tissue, the real extent of its contribution to the overall pathogenic process might be smaller than thought. In STZ-induced DM rodent models, for instance, the animals generally lack advanced clinical characteristics of microvascular complications although their blood glucose level is usually very high, far higher than what is commonly seen in human DM patients. This notion has also been noted in the preceding section regarding diabetic retinopathy.
</p><p>The vascular endothelial cells in the body are prone to suffer from hyperglycemia-associated cellular damage, because these cells lack the ability to effectively regulate the rate of glucose influx to prevent excessive accumulation of glucose inside the cells [
<xref rid="REF334" ref-type="bibr">334</xref>,
<xref rid="REF353" ref-type="bibr">353</xref>]. When the glucose concentration inside the vascular endothelial cells becomes too high, it may lead to increased formation and accumulation of formic acid and formaldehyde in these cells. While formaldehyde can cause direct damage to vascular endothelial cells through chemical cross-linking, it can also be readily converted to formic acid. Formic acid accumulation in these cells can induce hypoxic cytotoxicity, which is usually coupled with endothelial hyperplasia. It is hypothesized that the cytotoxic effects of formic acid and formaldehyde may jointly contribute to the damages to vascular endothelial cells seen in chronically hyperglycemic patients. Offering support for the above mechanistic explanation, studies have shown that diabetic microvascular abnormalities, including capillary basement membrane thickening and endothelial hyperplasia, are often associated with diminished oxygen tension and particularly hypoxia in vascular endothelial cells
<xref rid="REF354" ref-type="bibr">[354]</xref>.
</p></sec></sec><sec><title id="SEC8.2">Diabetic neuropathy</title><p>Over 50% of DM patients eventually develop neuropathy
<xref rid="REF355" ref-type="bibr">[355]</xref>. Diabetic neuropathy represents a complex group of clinical conditions which include lesions in the somatic and autonomic peripheral nervous systems, the spinal cord
<xref rid="REF356" ref-type="bibr">[356]</xref> and brain
<xref rid="REF357" ref-type="bibr">[357]</xref>. The most common DM neuropathy is the symmetric peripheral neuropathy affecting both motor and sensory nerves of the lower extremities. In advanced stages, diabetic neuropathy may result in nerve fiber deterioration which is characterized by altered sensitivities to vibrations and thermal thresholds and ultimately progresses to loss of sensory perception. Pathologically, it is characterized by Schwann cell injury, myelin degeneration, and axonal damage.
</p><p>Besides peripheral nerve injury, people with DM often also have neurocognitive changes that include declines in cognitive function together with impairment of psychomotor speed, cognitive flexibility, attention, visual perception, sexual function and others [
<xref rid="REF358" ref-type="bibr">358</xref>,
<xref rid="REF359" ref-type="bibr">359</xref>]. In addition to the neuro-functional changes, advanced DM patients usually also have pathological degenerative changes in the brain and other parts of the nervous system [
<xref rid="REF360" ref-type="bibr">360</xref>&#8211;
<xref rid="REF365" ref-type="bibr">365</xref>].
</p><sec><title id="SEC8.2.1">Pathogenic explanation</title><p>The exact cause and mechanism of diabetic neuropathy is still poorly understood. Traditionally, diabetic neuropathy was considered to be closely associated with microvascular abnormalities, such as capillary basement membrane thickening and vascular endothelial hyperplasia. This view, however, has been challenged by some investigators because there is evidence showing that diabetic neuropathy preferentially targets sensory and autonomic neurons over motor neurons, initially with little or no vascular involvement. For instance, the loss of epidermal and corneal innervation was observed in DM patients before overt vascular changes were detected [
<xref rid="REF366" ref-type="bibr">366</xref>&#8211;
<xref rid="REF370" ref-type="bibr">370</xref>].
</p><p>It is of note that diabetic neuropathy usually develops in an axon length-dependent manner,
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., it first develops in long peripheral nerve fibers, and then it progresses in a distal-to-proximal manner. This feature suggests that the neuronal damage is initiated in the distal axons, such as those at the finger or toe tips. The axons are known to contain a high density of mitochondria, which are required for neural functions (such as neurotransmission) by providing the necessary ATP. However, for long nerve fibers, it would be more difficult for the nerve terminals to effectively repair and recover from chemically-induced hypoxic damage, as they are farther away from the neuronal cell body and it would be more difficult to transport the required elements from the neuronal cell body to the nerve endings. Moreover, the distal parts of a long axon (such as those at the finger and toe tips) usually have very poor blood circulation and oxygen/nutrient supply compared to the proximal regions of an axon. It is, therefore, hypothesized that a combination of the above two factors would predispose the distal parts of a long axon (usually of a large neuron) particularly vulnerable to hyperglycemia-associated, formic acid (and formaldehyde)-induced inhibition of their mitochondrial respiration
<xref rid="REF371" ref-type="bibr">[371]</xref>, which may result in reduced ATP production, mitochondrial ROS accumulation, and mitochondrial dysfunction [
<xref rid="REF372" ref-type="bibr">372</xref>,
<xref rid="REF373" ref-type="bibr">373</xref>].
</p><p>Notably, the mitochondria-produced superoxide is normally removed by cellular detoxification agents such as superoxide dismutase, catalase, and glutathione
<xref rid="REF373" ref-type="bibr">[373]</xref>. Hyperglycemia-associated, formic acid-induced over-production of superoxide may lead to inhibition of the GAPDH activity and subsequently the glycolytic pathway, thus further aggravating cellular ATP deficiency. Moreover, suppression of the glycolytic pathway would result in accumulation of the upstream glycolytic intermediates, which would then activate other glucose metabolic pathways (
<xref rid="TBL1" ref-type="table">Table 1</xref> and
<xref rid="FIG3" ref-type="fig">Figure 3</xref>). These metabolic derangements would further aggravate hyperglycemia-associated neural injury.
</p><p>At late-stages of DM, it is expected that excessive superoxide production as a result of hyperglycemia-associated formic acid and formaldehyde accumulation eventually would overload the antioxidant capacity of neuronal cells and their nerve fibers, which would exacerbate mitochondrial dysfunction and cellular ATP deficiency. These changes, coupled with the naturally low blood flow to the distal regions of the nerve fibers, would damage the distal axons, and over time, it might induce the characteristic pathological process of the distal axons gradually dying back toward their neuronal cell bodies [
<xref rid="REF374" ref-type="bibr">374</xref>,
<xref rid="REF375" ref-type="bibr">375</xref>].
</p><p>It is of note that in DM rodent models, the animals only display rather mild complications in the nervous system, which mostly include segmental demyelination accompanied with axon and fiber loss
<xref rid="REF376" ref-type="bibr">[376]</xref>. A longer duration of DM appears to precipitate discernible nerve pathology in some diabetic rodent models [
<xref rid="REF377" ref-type="bibr">377</xref>-
<xref rid="REF380" ref-type="bibr">380</xref>], with partial loss of skin sensory fiber terminals [
<xref rid="REF359" ref-type="bibr">359</xref>,
<xref rid="REF360" ref-type="bibr">360</xref>] in addition to sensory loss. The relatively short life span of rodents and their physically-shorter axons compared to humans may be the partial reasons for the lack of severe degenerative neuropathy in DM rodent models. However, it should also be noted that the insensitivity of rodents to the toxicities of methanol and its toxic one-carbon metabolites may be another, pherhaps more important, underlying factor for the apparent lack of severe diabetic neuropathy in DM rodent models.
</p><p>Compared to astrocytes, neurons are more vulnerable to formic acid-mediated inhibition of mitochondrial respiration and ATP depletion because neurons are unable to increase glycolysis to supply ATP due to the lack of activity of the glycolysis-promoting enzyme 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase (isoform 3). In comparison, astrocytes, which are apt to utilize glycolytically-produced ATP to maintain their mitochondrial membrane potential, are expected to be more resistant to the damaging effect of formic acid in the mitochondria.</p><p>In addition to formic acid, it is postulated that increased tissue levels of formaldehyde in DM patients may also play an important role in mediating diabetic neuropathy. In partial support of this hypothesis, many earlier studies have shown that elevated levels of formaldehyde in certain brain regions is closely associated with neurodegeneration in animal models [
<xref rid="REF54" ref-type="bibr">54</xref>,
<xref rid="REF55" ref-type="bibr">55</xref>,
<xref rid="REF62" ref-type="bibr">62</xref>,
<xref rid="REF112" ref-type="bibr">112</xref>,
<xref rid="REF113" ref-type="bibr">113</xref>,
<xref rid="REF157" ref-type="bibr">157</xref>,
<xref rid="REF158" ref-type="bibr">158</xref>] as well as in human subjects [
<xref rid="REF55" ref-type="bibr">55</xref>,
<xref rid="REF110" ref-type="bibr">110</xref>,
<xref rid="REF159" ref-type="bibr">159</xref>,
<xref rid="REF160" ref-type="bibr">160</xref>]. Interestingly, there were also studies reporting an association of the increased expression/activity of the formaldehyde-generating enzymes with human DM [
<xref rid="REF101" ref-type="bibr">101</xref>,
<xref rid="REF162" ref-type="bibr">162</xref>,
<xref rid="REF163" ref-type="bibr">163</xref>,
<xref rid="REF381" ref-type="bibr">381</xref>,
<xref rid="REF382" ref-type="bibr">382</xref>].
</p><p>In summary, formic acid (along with formaldehyde)-induced production and accumulation of mitochondrial ROS may drive a feed-forward cycle in which oxidative stress impairs cellular antioxidative defense mechanisms, which then leads to progressive nerve fiber dysfunction, damage, and loss in diabetic neuropathy. At late stages of peripheral neuropathy, severe ATP deficiency would ensue, and this would lead to injuries to the peripheral nerve fibers, which is usually accompanied with axons dying back toward their cell bodies [
<xref rid="REF374" ref-type="bibr">374</xref>,
<xref rid="REF375" ref-type="bibr">375</xref>].
</p></sec></sec><sec><title id="SEC8.3">Diabetic nephropathy</title><p>The kidneys are among the most severely-damaged organs in advanced DM patients. Renal failure as a result of long-lasting diabetic nephropathy accounts for many DM-associated deaths in both juveniles and adults
<xref rid="REF383" ref-type="bibr">[383]</xref>. Diabetic nephropathy is characterized clinically by the development of proteinuria (mostly albuminuria) with a subsequent decline in glomerular filtration rate, which progresses over a long period of time, usually over 10&#8211;20&#8197;years. Importantly, diabetic kidney disease is also a major risk factor for the development of macrovascular complications such as heart attacks and strokes
<xref rid="REF384" ref-type="bibr">[384]</xref>.
</p><p>The pathogenesis of diabetic nephropathy is highly complex given the diversity of cell populations present in the kidney and the various physiological functions this organ performs. It is commonly accepted that hyperglycemia can induce certain cellular changes, which then lead to functional changes in various resident cells in the kidney, such as endothelial cells, podocytes, mesangial cells, cells of the tubular system and inflammatory cells, and these changes jointly contribute to the pathogenesis of diabetic nephropathy.</p><sec><title id="SEC8.3.1">Pathogenic explanation</title><p>The kidney is among the most highly-perfused organs in the body and yet it is still highly susceptible to ischemia or hypoxia
<xref rid="REF385" ref-type="bibr">[385]</xref> because the renal tubular cells are mitochondria-rich and have very high ATP requirement for normal functioning. In fact, it has been suggested that the kidney is nearly always on the verge of hypoxia even under normal conditions [
<xref rid="REF134" ref-type="bibr">134</xref>,
<xref rid="REF385" ref-type="bibr">385</xref>]. In line with this suggestion, the kidney is known to be highly susceptible to ischemia/hypoxia-induced acute and chronic injuries
<xref rid="REF385" ref-type="bibr">[385]</xref>. It is hypothesized that diabetic nephropathy (diabetic kidney disease) can be viewed as the renal manifestation of a similar hyperglycemia-associated, formic acid/formaldehyde-dominated pathogenic process. This general hypothesis is partially supported by earlier observations indicating that dysfunctional renal mitochondria are key pathological mediators of diabetic nephropathy
<xref rid="REF386" ref-type="bibr">[386]</xref>. Furthermore, some of the pathological characteristics of formic acid-induced kidney injuries closely resemble those of the diabetic nephropathy. A discussion of the proposed formaldehyde/formic acid-dominated changes in renal cellular and non-cellular structures as well as functions is provided below.
</p><sec><title id="SEC8.3.1.1">Changes in glomerular basement membrane and capillary functions.</title><p>The glomerular basement membrane (GBM), a thin (250&#8211;400&#8197;nm) meshwork of extracellular matrix proteins, is an integral part of the glomerular filtration barrier. GBM has a similar composition as other basement membranes
<xref rid="REF387" ref-type="bibr">[387]</xref>, which are synthesized jointly by podocytes and endothelial cells
<xref rid="REF388" ref-type="bibr">[388]</xref>. GBM is mostly situated between glomerular endothelial cells and podocytes as part of the peripheral capillary wall
<xref rid="REF389" ref-type="bibr">[389]</xref>, and serves as a size- and charge-selective filtration barrier for circulating proteins [
<xref rid="REF390" ref-type="bibr">390</xref>&#8211;
<xref rid="REF392" ref-type="bibr">392</xref>].
</p><p>One of the earliest and most characteristic glomerular changes in DM is the thickening of GBM [
<xref rid="REF393" ref-type="bibr">393</xref>,
<xref rid="REF394" ref-type="bibr">394</xref>], and more-pronounced changes are observed later when diabetic kidney disease becomes more evident
<xref rid="REF395" ref-type="bibr">[395]</xref>. It is hypothesized that the increased formation of formaldehyde in hyperglycemic patients would markedly increase the cross-linking of GBM proteins, in addition to the formation of AGEs. It is of note that GBM is the region in the body which has the highest perfusion rate and thus would have the highest exposure to all water-soluble small molecules in circulation, including glucose, formaldehyde and formic acid. Extensive cross-linking of GBM compositions by formaldehyde, in addition to covalent modifications by glucose, would contribute to GBM thickening (due to reduced degradation of the cross-linked protein components) as well as changes in GBM charge or architecture, both of which would contribute partially to the development of albuminuria in DM patients.
</p><p>It is known that the GBM plays a pivotal role in maintaining the glomerular tuft and filtration function. Abnormal thickening and stiffening of GBM as a result of extensive cross-linking of the GBM proteins by formaldehyde and the covalent modifications by sugar molecules are expected to reduce the distensibility of the pericapillary walls, thus facilitating glomerular injury through hemodynamic mechanisms
<xref rid="REF396" ref-type="bibr">[396]</xref>.
</p></sec><sec><title id="SEC8.3.1.2">Changes in glomerular cellular components.</title><p>It has been suggested that the early pathogenic changes in renal glomerular cells are critical for the subsequent development of kidney damage, such as glomerulosclerosis and nephron dropout. The renal glomerulus mostly consists of glomerular endothelial cells, podocytes and mesangial cells, and these three types of cells cooperate with each other to carry out effective glomerular filtration. Podocytes are a group of highly-specialized, terminally-differentiated cells that cover the urinary side of the GBM. Intercellular signaling between glomerular endothelial cells and podocytes has been well established
<xref rid="REF397" ref-type="bibr">[397]</xref>. These two groups of cells work jointly for the maintenance of GBM and its charge barrier as well as the shape and integrity of the glomerular capillaries
<xref rid="REF398" ref-type="bibr">[398]</xref>.
</p><p>In diabetic glomerulus, it is hypothesized that the glomerular endothelial cells and podocytes are each chronically exposed to elevated levels of formic acid and formaldehyde, and as a result, these cells are chronically under severe hypoxic conditions, which would compromise their regular functions. It is further hypothesized that chronic exposure to elevated levels of formic acid (and formaldehyde) may be partly responsible for the induction of a number of patho-adaptive changes in podocytes, such as reduced motility and hypertrophy [
<xref rid="REF399" ref-type="bibr">399</xref>&#8211;
<xref rid="REF401" ref-type="bibr">401</xref>]. These changes in podocytes are an important contributing factor in the development of diabetic nephropathy. In support of this suggestion, an earlier study showed that podocyte-specific injuries alone can induce DM-like phenotypes of glomerulosclerosis and tubulointerstitial fibrosis, even in the absence of hyperglycemia
<xref rid="REF402" ref-type="bibr">[402]</xref>.
</p><p>In addition to endothelial cells and podocytes, the mesangial cells are another major group of cells in the glomerulus. These cells are responsible for constructing and maintaining the architecture of the glomerular capillary network through production of the mesangial matrix. These cells also regulate the functions of podocytes to affect glomerular filtration
<xref rid="REF403" ref-type="bibr">[403]</xref>. It is hypothesized that in DM patients, chronic hyperglycemia would lead to chronic injury to mesangial cells through formation and accumulation of formic acid/formaldehyde in these cells, which would then lead to mesangiolysis (focal degeneration of mesangial cells and the mesangial matrix) and the development of abnormal glomerular capillary structures as well as compensatory mesangial expansion (an increase in the fractional volume of the glomerulus occupied by the mesangium). This hypothesis is partially supported by the following experimental observations: First, selective injury to mesangial cells can lead to enlarged glomerular capillary loops, including balloon-like glomeruli (formed by the fusion of glomerular capillaries), as commonly seen in diabetic nephropathy
<xref rid="REF404" ref-type="bibr">[404]</xref>. Second, mesangial cell injury can alter the functions of podocytes and affect glomerular filtration by inducing a change in the phosphorylation of slit diaphragm proteins
<xref rid="REF403" ref-type="bibr">[403]</xref>. Third, mesangial cell injury can stimulate compensatory cell growth of its own along with increased synthesis of mesangial matrix, jointly contributing to mesangial expansion [
<xref rid="REF405" ref-type="bibr">405</xref>,
<xref rid="REF406" ref-type="bibr">406</xref>].
</p></sec><sec><title id="SEC8.3.1.3">Glomerular hypertrophy and proximal tubular changes.</title><p>The early-stage diabetic kidney undergoes significant hypertrophy within the glomeruli, which is accompanied by thickening of GBM and mesangial expansion
<xref rid="REF407" ref-type="bibr">[407]</xref>. The main cellular constituents in glomerular mesangium are mesangial cells, which account for approximately 30&#8211;40% of the total cells in the glomerulus. Earlier studies showed that under hyperglycemic conditions, mesangial cells underwent proliferation and hypertrophy along with increased production of matrix proteins
<xref rid="REF408" ref-type="bibr">[408]</xref>. Mechanistically, it is hypothesized that mesangial hypertrophy in diabetic patients is mostly due to hyperglycemia-associated, formic acid/formaldehyde-induced hypoxic damage to glomerular mesangial cells, which causes focal mesangiolysis
<xref rid="REF409" ref-type="bibr">[409]</xref>, followed by compensatory over-growth of mesangial cells and increased production of extracellular matrix, leading to mesangial expansion
<bold>.</bold>
</p><p>It is of note that mesangial expansion would reduce the total glomerular capillary surface area and consequently, reduce glomerular filtration
<xref rid="REF410" ref-type="bibr">[410]</xref>. When glomerular filtration is significantly compromised as a result of mesangial expansion, it is expected that compensatory intra-glomerular hypertension (and sometimes systemic hypertension as well) may ensue in some DM patients, which may hasten the progression toward the late-stage diabetic nephropathy depending on the severity of the compensatory hypertension. In partial support of this notion, some studies have indicated that there was a clear link between mesangial matrix expansion and the progression toward glomerulosclerosis [
<xref rid="REF393" ref-type="bibr">393</xref>,
<xref rid="REF394" ref-type="bibr">394</xref>,
<xref rid="REF411" ref-type="bibr">411</xref>,
<xref rid="REF412" ref-type="bibr">412</xref>].
</p><p>In addition to the glomeruli, the renal tubules are also adversely affected by DM. It is known that DM can cause significant growth and enlargement of renal proximal tubules at relatively early stages of diabetic nephropathy [
<xref rid="REF413" ref-type="bibr">413</xref>,
<xref rid="REF414" ref-type="bibr">414</xref>]. The following two reasons may jointly contribute to the pathogenic change. First, it is known that the proximal tubular cells have a very high metabolic rate and energy requirement imposed by the active reabsorption of a number of glomerular filtrates at this site. Coupled with the metabolic needs, the proximal tubular cells also contain a high density of mitochondria for the oxidative phosphorylation of glucose for ATP synthesis. However, the cortical region of the kidney has a relatively limited oxygen delivery due to the high density of peritubular capillaries. These factors jointly make the proximal tubular cells particularly vulnerable to hypoxia caused by formic acid (along with formaldehyde), which would cause varying degrees of ATP deficiency in these cells. Second, the proximal tubules are actively involved in ATP-dependent reabsorption of a number of filtrates. For instance, it is known that a fraction (10&#8211;15%) of calcium transport which is regulated by parathyroid hormone (PTH) and calcitonin is carried out by an ATP-dependent active transport system. An earlier study showed that this active transport system could be readily inhibited by formic acid in proximal tubules
<xref rid="REF143" ref-type="bibr">[143]</xref>. Based on this information, it is, therefore, hypothesized that the hyperglycemia-associated, formic acid-induced ATP deficiency in proximal tubular cells would cause significant functional inadequacy in the active reabsorption of glomerular filtrates at this site. This functional inadequacy would then lead to compensatory proliferation of the proximal tubular epithelial cells through feedback regulations.
</p><p>As the tubules grow, it is very likely that more of the glomerular filtrates (including sodium and glucose) are reabsorbed in a passive, energy-independent manner, and consequently, sodium delivery to the
<italic toggle="yes">macula densa</italic> is reduced and tubule-glomerular feedback is activated
<xref rid="REF415" ref-type="bibr">[415]</xref>, which would lead to increased intra-glomerular pressure and hyperfiltration to increase the glomerular filtration rate (GFR)
<xref rid="REF415" ref-type="bibr">[415]</xref>. These compensatory changes usually occur at relatively early stages of diabetic nephropathy. As DM advances, chronic renal exposure to elevated levels of formic acid and formaldehyde is expected to cause progressive and cumulative injuries to tubular epithelial cells, even cell death. These changes eventually would result in atrophic or dilated tubules, and in some cases, disappearance of tubules
<xref rid="REF416" ref-type="bibr">[416]</xref>. These tubular dysfunctions would contribute to the worsening of albuminuria
<xref rid="REF417" ref-type="bibr">[417]</xref>. In addition, these pathogenic tubular changes are usually accompanied by progressive tubulointerstitial fibrosis, which is considered the &#8216;final common pathway&#8217; for loss of renal function in diabetic kidney disease
<xref rid="REF418" ref-type="bibr">[418]</xref>.
</p><p>In partial support of the above explanation, it is of interest to note that an earlier study
<xref rid="REF419" ref-type="bibr">[419]</xref> showed that when rats were chronically administered with trichloroethanol (a major metabolite of trichloroethylene), the animals excreted large amounts of formic acid in their urine. These animals developed kidney lesions that shared characteristic changes of diabetic nephropathy, such as protein excretion, hypoxic tubular damage along with compensatory tubular epithelial over-growth, and focal formation of abnormal tubules
<xref rid="REF419" ref-type="bibr">[419]</xref>. The pathological similarities between trichloroethanol-induced kidney damage and diabetic nephropathy offer further support for the proposed MFF hypothesis on the pathogenesis of diabetic nephropathy.
</p><p>In addition to renal proximal tubules, other renal tubular cells are also affected, to varying degrees, in DM patients. It is expected that the degree and extent of pathogenic changes in other tubular cells would be jointly determined by a number of factors, such as the levels of the intracellular formic acid and formaldehyde, the cellular mitochondrial density and the level of cellular demand for oxygen and energy supplies.</p></sec><sec><title id="SEC8.3.1.4">Renal functional changes.</title><p>Changes in hemodynamics, associated with intraglomerular and/or systemic blood pressure increase, have been reported to occur early in DM and are characterized by glomerular hyperfiltration. Glomerular hyperfiltration was widely viewed as a significant contributing factor to the damage to glomeruli and preglomerular vessels
<xref rid="REF420" ref-type="bibr">[420]</xref>. It is hypothesized that these hemodynamic changes take place largely in response to accumulation of formic acid (along with formaldehyde) in renal tubular cells, which causes hypoxia and ATP deficiency in these cells. As a result, through feedback regulations of hemodynamic changes, the intra-glomerular pressure and sometimes systematic blood pressure would be increased. It is assumed that these compensatory changes in pressure likely are intended to improve the hypoxic conditions of many renal cells (tubular cells in particular). Providing partial support for this suggestion, there were clinical data suggesting that DM individuals who maintained normal glomerular filtration or hyperfiltration are often better protected against the progression to end-stage diabetic kidney disease
<xref rid="REF421" ref-type="bibr">[421]</xref>. However, it should also be noted that the increase in the glomerular filtration pressure could also become detrimental if it is abnormally elevated to too high levels.
</p><p>Proteinuria, with the protein albumin as a major component, often is a clinical manifestation of the disruption of the integrity of the glomerular filtration barrier, which jointly involves pathological changes in the structure and function of GBM and the functions of glomerular epithelial cells and podocytes. In addition, degenerative changes of the renal tubules also contribute importantly to the worsening of proteinuria in late-stage diabetic nephropathy.</p></sec><sec><title id="SEC8.3.1.5">Involvement of inflammatory cells.</title><p>It is hypothesized that the flux of inflammatory cells into the diabetic kidney is mostly due to formic acid/formaldehyde-induced renal hypoxic damage and cell death. These inflammatory responses are generally believed to serve as an important mediator of late-stage diabetic nephropathy [
<xref rid="REF422" ref-type="bibr">422</xref>,
<xref rid="REF423" ref-type="bibr">423</xref>]. In partial support of this general concept, animal studies have shown that inhibition of leukocyte recruitment and accumulation in diabetic kidney can help slow down the progressive renal damage [
<xref rid="REF424" ref-type="bibr">424</xref>,
<xref rid="REF425" ref-type="bibr">425</xref>], including alleviating albuminuria.
</p></sec><sec><title id="SEC8.3.1.6">Observations made in diabetic rodent models.</title><p>Results from animal studies have also offered some support for the mechanistic explanation based on the MFF hypothesis. In the most widely-used rodent DM models induced by multiple low-dose STZ injections, animals displayed a range of early functional and structural changes reminiscent of human diabetic nephropathy [
<xref rid="REF426" ref-type="bibr">426</xref>,
<xref rid="REF427" ref-type="bibr">427</xref>]. These included kidney hypertrophy, elevations in glomerular filtration, progressive leeching of albumin (albuminuria) and proteins into the urine, and ultrastructural changes such as GBM thickening and mesangial expansion. However, the STZ-induced DM in rodents usually did not progress to more advanced renal disease commonly seen in humans which is characterized by a loss of glomerular filtration, overt proteinuria, and advanced structural lesions [
<xref rid="REF426" ref-type="bibr">426</xref>,
<xref rid="REF427" ref-type="bibr">427</xref>]. This may be partly attributed to the fact that rodents are generally insensitive to the toxicities of metabolically-formed endogenous methanol and its toxic one-carbon metabolites as these chemicals would not readily accumulate in rodents.
</p><p>In summary, diabetic nephropathy can be viewed as the renal manifestation of a similar hyperglycemia-associated, formic acid/formaldehyde-dominated pathogenic process. It is hypothesized that the formic acid/formaldehyde-induced chronic renal hypoxia and ATP deficiency would induce a number of compensatory, but ultimately maladaptive, changes in the kidney [
<xref rid="REF428" ref-type="bibr">428</xref>&#8211;
<xref rid="REF430" ref-type="bibr">430</xref>], eventually leading to the pathogenesis of diabetic nephropathy. In partial support of the proposed pathogenic explanation of diabetic nephropathy, it should be noted that earlier studies have already shown that the kidneys are vulnerable to formic acid-induced damage [
<xref rid="REF31" ref-type="bibr">31</xref>,
<xref rid="REF122" ref-type="bibr">122</xref>,
<xref rid="REF431" ref-type="bibr">431</xref>,
<xref rid="REF432" ref-type="bibr">432</xref>]. Pathological analysis revealed that the renal proximal tubular cells of rats underwent hypoxic edematous degeneration after the animals were exposed to formaldehyde or formic acid
<xref rid="REF144" ref-type="bibr">[144]</xref>. These changes are characteristic of severe hypoxia and ATP deficiency, and are also similar to tubular cell injuries commonly seen in diabetic nephropathy.
</p><p>Here it is of note that while poor glycemic control
<xref rid="REF433" ref-type="bibr">[433]</xref> and hypertension
<xref rid="REF434" ref-type="bibr">[434]</xref> frequently precede overt diabetic nephropathy, there are also a subset of patients who develop nephropathy despite good glycemic control
<xref rid="REF435" ref-type="bibr">[435]</xref> and normal blood pressure. This discrepancy underscores the relative importance of other pathogenic factors. Based on the proposed MFF hypothesis, it is likely that the endogenous formation and accumulation of formic acid and formaldehyde in DM patients is a more important determinant in diabetic kidney disease, which, sometimes, may overwrite the influence of other modulating factors, such as glycemic control and blood pressure management.
</p></sec></sec></sec><sec><title id="SEC8.4">Diabetic cardiomyopathy</title><p>Diabetic cardiomyopathy often refers to hyperglycemia-associated direct damage to the myocardium in DM patients in the absence of hypertension and coronary artery disease [
<xref rid="REF436" ref-type="bibr">436</xref>,
<xref rid="REF437" ref-type="bibr">437</xref>]. A direct damaging effect of DM to the heart was first proposed in 1972 according to postmortem findings of heart failure in DM patients free of coronary artery disease or other known cardiac risk factors
<xref rid="REF437" ref-type="bibr">[437]</xref>. Additional studies reporting similar findings offered strong additional support for the existence of a specific cardiomyopathy with origins in diabetic heart muscle cells [
<xref rid="REF438" ref-type="bibr">438</xref>,
<xref rid="REF439" ref-type="bibr">439</xref>].
</p><p>Clinically, cardiomyopathy is characterized by diastolic dysfunction
<xref rid="REF440" ref-type="bibr">[440]</xref>, which is an apparent inability of the heart muscle to undergo adequate relaxation and then refilling during the diastolic part of a normal cardiac contract&#8211;relaxation cycle. Diastolic dysfunction actually is a common clinical manifestation, observed in up to 40&#8211;60% of all heart failure cases [
<xref rid="REF441" ref-type="bibr">441</xref>-
<xref rid="REF443" ref-type="bibr">443</xref>], with diabetic individuals over-represented
<xref rid="REF444" ref-type="bibr">[444]</xref>.
</p><sec><title id="SEC8.4.1">Pathogenic explanation</title><p>The pathogenic mechanism of diabetic cardiomyopathy is still not quite understood. It has been suggested that diastolic dysfunction may be the result of a number of pathological processes, including stiffening of the myocardium, hypertrophy of cardiac muscle, and neuronal abnormalities
<xref rid="REF433" ref-type="bibr">[433]</xref>. At the cellular level, it has been postulated that oxidative stress of cardiomyocytes is an important pathogenic factor [
<xref rid="REF445" ref-type="bibr">445</xref>,
<xref rid="REF446" ref-type="bibr">446</xref>]. According to the MFF hypothesis, it is suggested that DM-associated hyperglycemia will lead to elevated levels of formic acid in circulation as well as in cardiomyocytes, which then impairs cadiomyocyte energy metabolism and eventually leads to cardiac ATP deficiency and dysfunction. It is understood that under normal conditions, cardiac muscle cells prefer to use fatty acids over glucose as the energy source (although they can also use glucose for ATP production)
<xref rid="REF446" ref-type="bibr">[446]</xref>. Elevated levels of formic acid in cardiomyocytes will cause the same inhibition of the mitochondrial ATP synthesis as in other cells. Because of the unique physiological functions the heart performs, the cardiac muscle cells are equipped with a very high density of mitochondria and require high levels of oxygen and energy supply nearly all the time. It is postulated that the impaired mitochondrial ATP production in diabetic cardiomyocytes due to the presence of elevated levels of formic acid would lead to chronic ATP deficiency, which is believed to be an important cause for diastolic dysfunction in DM patients. In addition, the formic acid-induced severe hypoxia in cardiomyocytes is expected to increase cellular ROS levels (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., oxidative stress) and calcium levels
<xref rid="REF183" ref-type="bibr">[183]</xref>, both of which would also contribute to the development of diastolic dysfunction.
</p><p>Aldehyde dehydrogenase 2 (ALDH2) is a non-cytochrome P450 mitochondrial aldehyde oxidizing enzyme, and is best known for its role in the metabolism of aldehydes, including formaldehyde (
<xref rid="FIG1" ref-type="fig">Figure 1</xref>). Surprisingly, earlier studies have shown that ALDH2-deficiency rendered the mice highly susceptible to develop STZ-induced diastolic dysfunction
<xref rid="REF447" ref-type="bibr">[447]</xref>. These animals showed a characteristic reduced energy reserve (phosphocreatine/adenosine triphosphate ratio)
<xref rid="REF447" ref-type="bibr">[447]</xref>. It is hypothesized that the reduced ATP reserve is due to the fact that deficiency of mitochondrial ALDH2 would slow down the metabolic conversion of formaldehyde to formic acid inside the mitochondria, thus faciliating mitochondrial accumulation of formaldehyde. Formaldehyde usually has a far shorter half-life and does not accumulate inside the cells or cellular organelles such as the mitochondria, but when it does accumulate, formaldehyde would be far more cytotoxic than formic acid because of its cross-linking ability, which can covalently damage various mitochondrial and cellular proteins and also cause increased stiffening of cardiac muscle cells. In addition, formaldehyde can be readily converted to formic acid. It is expected that the elevated levels of formaldehyde (a part of it is formed inside the mitochondria) and formic acid (formed mostly in the cytosolic compartment) may jointly pose an inhibition of the mitochondrial ATP synthesis, contributing to the pathogenesis of diastolic dysfunction. Here it is of note that patients with ALDH2 mutations were also reported to be associated with more severe diastolic dysfunction
<xref rid="REF448" ref-type="bibr">[448]</xref>. Taken together, these results suggest that ATP deficiency in cardiomyocytes resulting from formic acid/formaldehyde-induced inhibition of the mitochondrial oxidative phosphorylation is an important cause for diastolic dysfunction in DM patients.
</p><p>Lastly, it is of note that, in addition to formic acid/formaldehyde-induced ATP deficiency in diabetic cardiomyocytes, diastolic dysfunction is also known to be associated with the stiffening of the cardiomyocytes. It is hypothesized that the hyperglycemia-associated formation of formaldehyde in DM patients, which can cause extensive cross-linking of proteins inside and outside cardiac muscle cells, might cause stiffening of the cardiac muscle fibers and thus partially contribute to the development of diastolic dysfunction in DM patients, in particular in those patients with ALDH2 mutations. In this context, it is of note that there are ~560 million East Asians who carry a common ALDH2-deficient variant (which causes the well-known alcohol flushing syndrome); it will be of interest to determine whether diabetic patients carrying an ALDH2-deficient variant are more susceptible to develop diastolic dysfunction.</p></sec></sec><sec><title id="SEC8.5">Insulin resistance</title><p>One of the most important functions of insulin in the body is to regulate blood glucose levels through stimulation of glucose uptake into major storage organs or tissues, such as the liver, skeletal muscle and fat. The main regulator of insulin secretion is the plasma glucose levels. Under normal conditions, higher plasma levels of glucose, whether from exogenous (dietary) or endogenous (through hepatic glucose production) sources, would usually stimulate more insulin secretion, assuming that the insulin-producing islet &#946; cells are functionally preserved. However, the ability of insulin to stimulate glucose uptake may vary widely under different conditions. In DM (in particular type 2 DM), the patients often experience a markedly reduced sensitivity to insulin&#8217;s actions, which is commonly referred to as &#8220;insulin resistance&#8221;
<xref rid="REF449" ref-type="bibr">[449]</xref>. From a mechanistic point of view, the degree of insulin resistance is closely associated with the severity of type 2 DM. Provided below is a brief explanation of the pathogenic processes leading to the development of insulin resistance, with a focus on the potential roles of the toxic one-carbon metabolites.
</p><sec><title id="SEC8.5.1">Pathogenic explanation</title><p>The major insulin-responsive tissues related to glucose metabolism are the liver, skeletal muscle and fat tissue. In a healthy individual under fasting conditions, the basal insulin levels are usually low, and the muscle uptake of glucose from the blood would be at a basal minimal level. Through feedback regulations (such as the release of glucagon), the adipose tissue would be activated to provide free fatty acids via lipolysis for hepatic glucose production, which helps maintain euglycemia and provide feul for important glucose-consuming cell types, such as neurons, red blood cells and renal medullary cells
<xref rid="REF450" ref-type="bibr">[450]</xref>. In comparison, when the plasma insulin level is elevated (such as shortly after a meal), the adipocyte lipolysis and hepatic glucose production are suppressed, whereas muscle glucose uptake and lipogenesis are stimulated. These effects of insulin are partly achieved by suppressing gluconeogenesis and glycogen breakdown in the liver and by activating the activity of the glucose transporter-4 in the muscle.
</p><p>From a more systemic point of views, the development of insulin resistance and type 2 DM is caused by the following two closely-related pathogenic processes. First, the combination of the daily excessive calorie intake (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., eating too much food, in particular carbohydrates and fats) and a lack of adequate physical activities (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., energy expenditures) constitutes the initial main cause for the development of insulin resistance and type 2 DM. When a healthy individual has an excessive calorie intake during a meal, it is certain that a higher plasma insulin level would be needed in order to exert a stronger stimulation of the liver, muscle and adipose tissues to uptake more sugar molecules into these storage sites. If this type of excessive calorie intake is only an occasional event, it is believed that the body could quite readily and effectively deal with the situation with no major long-term negative consequences. However, if an initially-healthy individual always has a daily calorie intake that exceeds (or far exceeds) the actual needs of the body, then it is expected that the islet &#946; cells would always need to secrete more insulin after each meal in order to stimulate the storage sites (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., the liver, muscle and adipose tissues) to uptake more sugar molecules. It is not difficult to understand that if this situation continues day after day for some time, not long the body would no longer have too much additional storage capacity left to handle the excess sugar molecules that are taken up into the circulation after each meal. Under this situation, the much-elevated plasma glucose levels might cause a stronger stimulation of the islet &#946; cells, and more insulin molecules might be released into the circulation. However, due to the limited (or lack of) storage capacity left in the storage sites (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., the liver, muscle and adipose tissues), even when much higher levels of insulin are present, these tissues may still not be able to respond to insulin&#8217;s stimulation with the same sensitivity and intensity as they did initially, thus gradually manifesting the characteristics of insulin resistance. If this vicious circle of excessive calorie intake&#8211;hyperglycemia&#8211;hyperinsulinemia continues, understandably not long the excess sugar molecules present in circulation may not have any good place to go in the body, except being filtered out by the renal glomeruli and passively released into urine for disposal, which would be a characteristic clinical manifestation of type 2 DM. Therefore, the occurrence of type 2 DM is almost always intimately coupled with the development of insulin resistance.
</p><p>In addition to the excessive calorie intake coupled with low energy expenditures, it is hypothesized that the increased formation of formic acid and formaldehyde is another important contributing factor in the development of insulin resistance. According to the MFF hypothesis, hyperglycemia in diabetic patients is associated with increases in cellular glucose levels, which would lead to increased formation of endogenous methanol and/or formaldehyde, both of which are then metabolically converted to formic acid. Formic acid and formaldehyde are inhibitors of mitochondrial cytochrome oxidase, capable of inducing histotoxic hypoxia. Mitochondrial inhibition by formic acid and formaldehyde would lead to reduced cellular ATP levels, and as such, the cells (in particular brain cells) would falsely &#8220;sense&#8221; a lack of cellular fuel (glucose) supply. Therefore, through feedback regulations (although the mechanism is still not completely clear), the body likely would stimulate the release of counter-regulatory hormones (such as glucagon and catecholamines) and increase hepatic gluconeogenesis and simultaneously suppress the insulin-stimulated glucose uptake by the liver, muscle and adipose tissues. These effects would jointly lead to higher blood glucose levels, thereby promoting the situation of insulin resistance.</p><p>In addition, the inhibition of the mitochondrial respiration by formic acid and formaldehyde in pancreatic islet &#946; cells would result in a reduction in the ATP/ADP ratio, which is expected to decrease the sensitivity of islet &#946; cells to postprandial glucose surge-induced insulin secretion. This effect would cause further increases in plasma glucose levels, accompanied by a reduced rate of insulin release by the islet &#946; cells. The change in sensitivity of islet &#946; cells to glucose may also partially explain the marked reduction in insulin secretion when type 2 DM progresses to late stages. The above explanation is supported by studies showing that there is a severe inability of islet &#946; cells to compensate for the reduced insulin activity in insulin-resistant DM patients
<xref rid="REF451" ref-type="bibr">[451]</xref>.
</p><p>As discussed earlier, excess daily intake of carbohydrates is an important causal factor for the development of insulin resistance and type 2 DM. Similarly, it is also readily understood that obesity is a strong risk factor for type 2 DM because it is expected that a higher percentage of the obese individuals will have an excessive daily calorie intake compared to the normal-weight individuals. Now let&#8217;s look at a more complex hypothetical scenario here: Assume that two initially-healthy normal adult males (with the same starting body weight and age) are being placed on the same carbohydrate-rich meal plan which provides excessive daily calorie that far exceeds what the body actually needs to maintain its normal functions. Also, we assume that these two individuals will keep the same daily physical activities (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., the same level of energy expenditure). After one year, one person becomes obese (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., gained a lot of weight), whereas the other person remains lean-looking (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., with very little weight gain). Undoubtedly, if these two individuals continue with their daily excessive calorie intake, both would, sooner or later, develop insulin resistance and type 2 DM. Theoretically, it is expected that the obese individual likely would have a significantly slower initial progression of his diabetic conditions compared to the lean-looking individual. The main reason is because the fat tissue in the obese person has a far greater storage capacity (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., &#8220;the cushion effect&#8221;) for the excess carbohydrates that are being absorbed and present in circulation after every meal. In comparison, under the same conditions, the lean-looking person is expected to develop DM more quickly, and the disease conditions would be more severe as most of the excess glucose molecules would have no place to go except staying in the circulation and being filtered through the glomeruli and removed from the body through urine. Also, it is expected that a higher fraction of the excess free glucose molecules would be enzymatically converted into the toxic one-carbon metabolites in the body, thereby accelerating the development of insulin resistance as well as various diabetic complications.
</p><p>During the development of insulin resistance, the sensitivity to insulin&#8217;s action may vary considerably in different insulin-responsive organs in a DM patient. For example, if there is an increased insulin resistance in skeletal muscle, greater insulin concentrations will be needed to induce muscle glucose uptake. As such, it would result in relative hyperinsulinemia to which all other tissues and organs in the body will also be exposed, and some of the metabolic/signaling pathways regulated by insulin but are not related to glucose homeostasis would be activated in excess, which may have pathogenic consequences. For example, exposure of certain brain regions to elevated insulin levels results in increased sympathetic discharge, usually manifesting in the form of elevated blood pressure [
<xref rid="REF452" ref-type="bibr">452</xref>,
<xref rid="REF453" ref-type="bibr">453</xref>]. Similarly, in the liver, elevated insulin levels, would excessively activate the insulin-responsive lipogenesis pathway (which is still sensitive to insulin), resulting in increased production of VLDL and reduced production HDL and manifesting as increased plasma triglycerides and reduced HDL-cholesterol levels [
<xref rid="REF454" ref-type="bibr">454</xref>,
<xref rid="REF455" ref-type="bibr">455</xref>].
</p><p>It is generally accepted that diabetic patients with significant insulin resistance would be predisposed to the development of a cluster of abnormalities, including varying degrees of glucose intolerance, increased plasma triglyceride levels and decreased high-density lipoprotein cholesterol levels, elevated blood pressure, hyperuricemia, and others. The cluster of changes associated with insulin resistance is usually referred to as syndrome X, which is closely associated with increased risk of coronary heart disease
<xref rid="REF456" ref-type="bibr">[456]</xref>.
</p><p>The non-nutritive sweeteners (such as aspartame) which have zero-to-negligible caloric load have been suggested for clinical use in the obese and diabetic individuals to aid in controlling their carbohydrate intake and blood glucose levels. However, a number of clinical studies have led to the suggestion that the intake of the non-nutritive sweeteners, aspartame in particular, may actually cause impaired blood glucose tolerance in DM patients, often accompanied by increased risk of weight gain rather than weight loss [
<xref rid="REF457" ref-type="bibr">457</xref>,
<xref rid="REF458" ref-type="bibr">458</xref>]. This intriguing clinical finding is actually not surprising in the light of the proposed MFF hypothesis. It is known that aspartame can be partially converted into methanol (about 10%) in humans [
<xref rid="REF46" ref-type="bibr">46</xref>&#8211;
<xref rid="REF48" ref-type="bibr">48</xref>,
<xref rid="REF459" ref-type="bibr">459</xref>]. Therefore, long-term intake of aspartame would significantly increase the formation of methanol together with formaldehyde and formic acid in the body
<xref rid="REF460" ref-type="bibr">[460]</xref>. Increased levels of these toxic one-carbon metabolites would worsen the situation of hyperglycemia and insulin resistance. Regarding the potential mechanism underlying the increased risk for weight gain in patients chronically receiving aspartame, it is likely due to an increased appetite stemming from the reduced intracellular fuel source and especially ATP levels.
</p><p>Lastly, it should also be noted that metformin, the most commonly-prescribed first-line therapy for type 2 DM worldwide, was reported to decrease hepatic glucose output and increase the body&#8217;s sensitivity to insulin
<xref rid="REF461" ref-type="bibr">[461]</xref>. It is speculated that some of the beneficial effects of metformin in DM may be related to its ability to reduce the endogenous formation and/or accumulation of the toxic one-carbon metabolites. This intriguing possibility merits experimental testing in the future.
</p></sec></sec><sec><title id="SEC8.6">Diabetic ketoacidosis</title><p>Diabetic ketoacidosis is one of the most serious and potentially life-threatening complications of DM. Diabetic ketoacidosis often results from a severe deficiency of insulin associated with increased secretion of counter-regulatory hormones, such as glucagon, epinephrine, cortisol, and growth hormone. Provided below is a discussion of the pathophysiology of diabetic ketoacidosis with a focus on the potential contribution of formic acid/formaldehyde-induced metabolic changes.</p><sec><title id="SEC8.6.1">Pathogenic explanation</title><p>When glucose is available intracellularly, many types of cells in the body would prefer to use glucose for ATP synthesis, but these cells can also switch to the use of ketones for ATP synthesis during starvation, extensive exercise, or low insulin states. Therefore, under conditions of cellular glucose deficiency, most of the ketone bodies which are produced in liver are transported to extrahepatic tissues (such as the brain, heart and skeletal muscle) for catabolism in their mitochondria to form acetyl-CoA, which then goes into the Kreb&#8217;s cycle for terminal mitochondrial oxidation and ATP production [
<xref rid="REF462" ref-type="bibr">462</xref>&#8211;
<xref rid="REF465" ref-type="bibr">465</xref>].
</p><p>As aforementioned, diabetic ketoacidosis is triggered by a severe deficiency of insulin plus heightened activity of counter-regulatory hormones. One of the most important functions of insulin is to stimulate the influx of glucose into various cells for use (
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., metabolic processing) and storage, and during insulin deficiency, many cells in the body would strongly sense a lack of cellular fuel (glucose) for ATP synthesis. As a result, the vital organs of the body (such as the brain and heart) likely would, through feedback regulations, activate the secretion of counter-regulatory hormones, especially glucagon and epinephrine. These hormones would lead to strong fat mobilization,
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., activation of the hormone-sensitive lipase in adipose tissue followed by breakdown of triglycerides into glycerol and free fatty acids. In the liver, free fatty acids are catabolized into ketone bodies
<xref rid="REF466" ref-type="bibr">[466]</xref>, a process predominantly stimulated by glucagon. Ketogenesis mostly occurs in the mitochondria of liver cells which produces two main ketone bodies: acetoacetate and 3&#946;-hydroxybutyrate from acetyl-CoA. Both chemicals are short-chain four carbon carboxylic acids with high water solubility and can serve as an energy source for tissues such as the brain, kidney, heart, and skeletal muscle [
<xref rid="REF467" ref-type="bibr">467</xref>,
<xref rid="REF468" ref-type="bibr">468</xref>]. Acetoacetate and 3&#946;-hydroxybutyrate are released from the liver in their protonated form, which may cause a reduction in blood pH,
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., acidosis.
</p><p>It is hypothesized that diabetic ketoacidosis might have an underlying cause which is the increased formation and accumulation of endogenous methanol and its metabolites under ketotic conditions. Increased levels of formic acid (and formaldehyde) would inhibit the oxidative metabolism of ketone bodies inside the mitochondria for ATP synthesis in various organs and tissues in the body. As a result, the ketone bodies would not be utilized efficiently in catabolism for ATP production, and thus would accumulate in the body, and the state of severe ATP deficiency in many organs and tissues would persist. ATP deficiency would then lead to a vicious cycle of feedback regulations, resulting in even stronger fat mobilization and heightened ketogenesis in the liver, and ultimately more severe ketoacidosis.</p><p>The above mechanistic explanation is somewhat consistent with the following two indirect observations: First, an earlier clinical study reported that a patient with type 1 DM would be more readily to develop severe metabolic ketoacidosis if the patient is also intoxicated with methanol
<xref rid="REF469" ref-type="bibr">[469]</xref>. Second, it is known that in STZ-induced DM rodent models, the animals usually develop more severe conditions of hyperglycemia plus insulin deficiency, and yet they usually do not develop the same degree of diabetic ketoacidosis. The reason likely is because rodents generally are insensitive to the toxicities of methanol and its metabolites as these chemicals are rapidly metabolized and do not accumulate in rodents.
</p><p>In addition to increased fat mobilization which results in ketogenesis and ketoacidosis, insulin deficiency (plus the presence of high levels of counter-regulatory hormones) would also lead to increased hepatic gluconeogenesis and glycogenolysis plus impaired glucose utilization by peripheral tissues. The joint consequence of these metabolic derangements would be a rapid and dangerous surge in blood glucose levels. Hyperglycemia would then lead to glycosuria and osmotic diuresis, subsequently resulting in severe dehydration, hypovolemia and reduction in glomerular filtration, and eventually impeding further glucose excretion
<xref rid="REF470" ref-type="bibr">[470]</xref>.
</p><p>It is of note that there are also cases of ketoacidosis occurring in DM patients without severe hyperglycemia [
<xref rid="REF471" ref-type="bibr">471</xref>&#8211;
<xref rid="REF473" ref-type="bibr">473</xref>], commonly referred to as &#8220;euglycemic ketoacidosis&#8221;. In euglycemic ketoacidosis, insulin deficiency and insulin resistance are often milder, thereby limiting the drastic surge in blood glucose levels. Therefore, glucose over-production is lesser than in regular hyperglycemic ketoacidosis. It should be noted, however, while euglycemic ketoacidosis often only displays moderate hyperglycemia, it usually has very severe ketonemia and acidosis. It is speculated that the formic acid levels in DM patients with euglycemic ketoacidosis might actually be higher than in other DM patients, and thus it would produce a stronger inhibition of the mitochondrial function, and ultimately a more severe state of cellular ATP deficiency. As a result, some of the vital organs in the body (such as the brain) would have a stronger &#8220;false sense&#8221; of cellular fuel (glucose) deficiency, and thus would, through feedback regulations, more powerfully stimulate the secretion of counter-regulatory hormones, resulting in excessive lipolysis and ketogenesis, and ultimately more severe ketoacidosis, which often becomes life-threatening if the underlying causes for severe cellular ATP deficiency in vital organs of the body persist or get worse.
</p></sec></sec><sec><title id="SEC8.7">Cataract</title><p>Besides diabetic retinopathy, cataract formation,
<italic toggle="yes">i</italic>.
<italic toggle="yes">e</italic>., the opacification of the eye lens, is another leading cause of human blindness worldwide, accounting for 47.8% of all causes of blindness [
<xref rid="REF474" ref-type="bibr">474</xref>,
<xref rid="REF475" ref-type="bibr">475</xref>]. While age is an important risk factor for cataract formation, DM is also recognized as a significant risk factor [
<xref rid="REF475" ref-type="bibr">475</xref>,
<xref rid="REF476" ref-type="bibr">476</xref>]. A number of studies have shown that glycemic control can significantly improve cataract outcome [
<xref rid="REF477" ref-type="bibr">477</xref>&#8211;
<xref rid="REF484" ref-type="bibr">484</xref>].
</p><p>Cataracts result from the deposition of aggregated proteins in the eye lens and damage to the plasma membrane of lens fiber cells, which cause clouding of the lens, light scattering, and obstruction of vision. It is known that ROS can induce damages in the lens cells, including oxidation of proteins, DNA damage, and/or lipid peroxidation, and these ROS-induced changes have been implicated in cataractogenesis [
<xref rid="REF482" ref-type="bibr">482</xref>&#8211;
<xref rid="REF484" ref-type="bibr">484</xref>].
</p><sec><title id="SEC8.7.1">Pathogenic explanation</title><p>It is known that more than 95% of oxygen produced during normal metabolism is generated by the electron transport chain in the inner mitochondrial membrane. Research has shown that dysfunctional mitochondria are the primary site of ROS production. Mitochondria are also a major target of ROS-induced cellular injury. It is hypothesized that the increased accumulation of formaldehyde and formic acid in eye lens of DM patients contributes significantly in the pathogenesis of cataract. The locally-formed formaldehyde would pose a more significant pathogenic effect, through cross-linking of the protein components in the eye lens. In addition, the hyperglycemia-associated formic acid accumulation in eye lens cells would increase mitochondrial superoxide production, and the elevated cellular superoxide level is known to cause perturbations in the polyol and oxidative stress pathways as well as in the unfolded protein response. These changes have been suggested earlier to be important contributing factors in the pathogenesis of cataract in advanced DM patients [
<xref rid="REF482" ref-type="bibr">482</xref>&#8211;
<xref rid="REF485" ref-type="bibr">485</xref>]. Consistent with the suggested role of ROS in cataract formation, animal and human studies have each shown that supplementation with antioxidants targeting the mitochondrial superoxide is beneficial for the prevention and treatment of cataract.
</p></sec></sec><sec><title id="SEC8.8">DM and cancer risk</title><p>The association between DM and cancer has recently received considerable attention partly due to the alarming increase in the prevalence of type 2 DM. Many studies have shown that individuals with DM are at a greater risk of developing and dying from multiple types of cancers [
<xref rid="REF486" ref-type="bibr">486</xref>&#8211;
<xref rid="REF492" ref-type="bibr">492</xref>]. Mechanistically, a number of potential links between DM and cancer have been proposed. Attention in recent years has been placed on addressing the potential roles of the insulin receptor-mediated signaling, gut microbiomes and AGEs in the pathogenesis of cancer.
</p><p>Formaldehyde is a strong cross-linking agent, and is known to cause covalent DNA modifications (described earlier). Formaldehyde is also a known mutagen and carcinogen [
<xref rid="REF164" ref-type="bibr">164</xref>&#8211;
<xref rid="REF166" ref-type="bibr">166</xref>]. Human epidemiological studies have indicated that there is sufficient evidence for the carcinogenicity of formaldehyde in humans [
<xref rid="REF167" ref-type="bibr">167</xref>&#8211;
<xref rid="REF170" ref-type="bibr">170</xref>]. According to the proposed MFF hypothesis, it is postulated that covalent modifications of DNA by formaldehyde may be an important causal factor that increases the risk and formation of different types of cancers in DM patients.
</p></sec></sec><sec><title id="SEC9">Comparison of the Clinical Treatments for Methanol Toxicity and Diabetic Complications</title><p>As briefly discussed below, some of the commonly-used treatments that help mitigate methanol toxicity in humans are also of benefit for improving diabetic complications.</p><sec><title id="SEC9.1">Folate can help reduce both methanol/formic acid toxicity and diabetic complications</title><sec><title id="SEC9.1.1">Methanol and formic acid intoxication</title><p>Folic acid is a necessary cofactor for enzyme-mediated conversion of formic acid to carbon dioxide
<xref rid="REF493" ref-type="bibr">[493]</xref>. During methanol poisoning, folate (a salt form of folic acid) is usually given to methanol-intoxicated patients to enhance the metabolic conversion of formic acid to carbon dioxide and water. Results from animal experiments and clinical case reports all suggest that administration of folate or its derivatives (such as folinic acid, a reduced form of folate) is therapeutically beneficial in mitigating methanol toxicity [
<xref rid="REF494" ref-type="bibr">494</xref>&#8211;
<xref rid="REF499" ref-type="bibr">499</xref>]. On the other hand, folate-deficient rats are more susceptible than normal rats to methanol toxicity
<xref rid="REF189" ref-type="bibr">[189]</xref>.
</p><p>Folate administration can also help mitigate the toxicity of formic acid. For instance, in a clinical case, a 36-year-old female intentionally ingested about 250&#8197;mL Ataka cleaning fluid (a 44% formic acid solution), which was estimated to contain 110&#8197;g of formic acid. Folinic acid therapy was initiated at 1&#8197;mg/kg every 4&#8197;h for the first 24&#8197;h. Serial analysis of formic acid concentrations showed low levels of formic acid during folinic acid treatment but a sharp rise in formic acid concentration was observed when folinic acid therapy was discontinued
<xref rid="REF499" ref-type="bibr">[499]</xref>.
</p></sec><sec><title id="SEC9.1.2">Diabetic complications</title><p>Nutritional folate deficiency is known to accelerate the progression of DM complications, and the use of folate is beneficial for slowing down the progression of these complications. For instance, it was reported that combined supplementation of folate, B
<sub>6</sub> and B
<sub>12</sub> improved retinal edema and light sensitivity in individuals with diabetic retinopathy
<xref rid="REF500" ref-type="bibr">[500]</xref>. In another study, a six-month supplementation of vitamin B
<sub>6</sub> showed a decrease in retinal edema and an improvement in light sensitivity in diabetic patients with nonproliferative retinopathy
<xref rid="REF500" ref-type="bibr">[500]</xref>. On the other hand, vitamin B
<sub>12</sub> deficiency was found to be a potential risk factor for other diabetic complications
<xref rid="REF501" ref-type="bibr">[501]</xref>.
</p><p>Here it is of note that earlier clinical studies have shown that joint supplementation of vitamins B
<sub>6</sub>, B
<sub>9</sub> and B
<sub>12</sub> (in the absence of folate or folic acid) which was intended for the reduction of homocysteine levels exacerbated the decline of renal function in DM patients and increased the risk of vascular disease in patients with diabetic nephropathy
<xref rid="REF502" ref-type="bibr">[502]</xref>. Similar observations were also made in another clinical study
<xref rid="REF503" ref-type="bibr">[503]</xref>. It is speculated that the lack of a beneficial effect of vitamins B
<sub>6/9/12</sub> supplementation alone (in the absence of folate or folic acid) might be due to the possibility that some of these vitamins (most likely vitamin B
<sub>9</sub>) might be involved (likely serving as an enzyme cofactor) in the metabolic conversion of glucose into methanol and/or its toxic one-carbon metabolites in DM patients. It will be of interest to experimentally examine this intriguing possibility in the future.
</p></sec></sec><sec><title id="SEC9.2">Ethanol can help reduce methanol toxicity and diabetic complications</title><sec><title id="SEC9.2.1">Methanol poisoning</title><p>Ethanol has been recognized as an antidote for ethylene glycol poisoning since the 1960&#8217;s because ADH1 has a higher affinity for ethanol than for ethylene glycol and the presence of ethanol inhibits the conversion of ethylene glycol to its toxic aldehyde. Similarly, ADH1 has a much higher affinity (10 to 20-fold higher) for ethanol than for methanol
<xref rid="REF504" ref-type="bibr">[504]</xref>. Ethanol would competitively inhibit the metabolism of methanol to its toxic metabolite, formaldehyde, by occupying ADH1&#8217;s substrate-binding site. Therefore, it is readily understood that ethanol, like fomepizole (an ADH inhibitor), can help reduce methanol toxicity. In clinical practice, ethanol is commonly used as an inexpensive, readily-available antidote to delay methanol metabolism until methanol is mostly eliminated from the patient&#8217;s system either naturally or via dialysis [
<xref rid="REF505" ref-type="bibr">505</xref>,
<xref rid="REF506" ref-type="bibr">506</xref>].
</p></sec><sec><title id="SEC9.2.2">Diabetic complications</title><p>There is a large body of epidemiological evidence from cross-sectional studies which indicates that regular mild-to-moderate alcohol intake is associated with improvements in insulin sensitivity and diabetic complications. For instance, Knott
<italic toggle="yes">et al</italic>.
<xref rid="REF507" ref-type="bibr">[507]</xref> conducted a dose-response meta-analysis including 38 observational studies. Results showed that reductions in the risk of type 2 DM were observed at all levels (&lt;63&#8197;g/day) of alcohol intake, with a peak risk reduction seen at 10&#8211;14&#8197;g/day. Similarly, Li and colleagues conducted a meta-analysis of 26 studies on the association between alcohol consumption and the subsequent risk of type 2 DM
<xref rid="REF508" ref-type="bibr">[508]</xref>. A nonlinear relationship between alcohol consumption and the risk of type 2 DM was identified in all cohorts. Light and moderate alcohol consumptions were associated with a reduced risk of type 2 DM, while heavy alcohol consumption had little or no beneficial effect. The mechanism of this phenomenon is not completely understood. A possible explanation is based on the ability of ethanol to inhibit the metabolic conversion of endogenously-formed methanol to formaldehyde and formic acid. It is known that the hepatic ADH1 catalyzes the metabolism of methanol and ethanol to their respective aldehydes (see
<xref rid="FIG1" ref-type="fig">Figure 1</xref>; also discussed in &#8220;Metabolic biotransformation of methanol&#8221;). It is expected that moderate ethanol consumption can competitively inhibit the conversion of methanol to formaldehyde, thus slowing down the production of endogenous formaldehyde (and also formic acid) in the organs. However, when the alcohol level in the body becomes too high, it might adversely affect the biotransformation of formaldehyde and formic acid, favoring their accumulation in the body.
</p><p>In summary, while the use of folate, folic acid or folinic acid alone or in combination with vitamins B
<sub>6/12</sub> is beneficial for reducing the complications of human methanol or formic acid intoxication, their use is also similarly beneficial for reducing human diabetic complications. In a similar manner, while alcohol is commonly used as an effective antidote for acute methanol toxicity, clinical studies have shown that long-term moderate alcohol consumption is associated with improved outcomes of diabetic complications. These correlations provide partial support for the proposed hypothesis that increased metabolic formation of endogenous methanol and/or its toxic one-carbon metabolites in chronic DM patients may contribute importantly to the pathogenesis of diabetic complications.
</p></sec></sec></sec><sec><title id="SEC10">Concluding Remarks</title><p>A new hypothesis is proposed to explain the pathogenic mechanism of diabetic complications in humans. It is hypothesized that hyperglycemia-associated increase in cellular glucose levels in DM patients may lead to increased metabolic formation of endogenous methanol and/or formaldehyde, both of which are further metabolically converted into formic acid. Chronic increase in metabolic production and accumulation of formaldehyde and formic acid would jointly drive the pathogenic processes of ocular lesions as well as other complications in DM patients.</p><p>As discussed in detail in earlier sections, the proposed MFF hypothesis provides a plausible mechanistic explanation for the pathogenesis of many hyperglycemia-associated complications in humans. In addition, this hypothesis is consistent with many clinical and experimental observations. For instance, methanol is known to have organ- and species-selective toxicities, including the characteristic ocular lesions (including blindness) which are commonly seen in humans and non-human primates, but are not seen in rodents. Similarly, diabetic ocular lesions also have a similar characteristic organ- and species-selective pattern, closely resembling what is seen in methanol toxicity. Moreover, while alcohol consumption or combined use of folate and vitamin B
<sub>6/12</sub> is beneficial for reducing acute methanol/formic acid toxicity in humans, their long-term use is also associated with improved outcomes in human diabetic complications. The pathological and clinical similarities between human methanol toxicity and diabetic complications point to a shared role of these toxic one-carbon metabolites in the pathogenic processes.
</p><p>In addition to the clinical observations, there is also a large body of supporting evidence from biochemical and cellular studies. Many earlier studies have shown that the mitochondria are an important site of damage in DM patients [
<xref rid="REF509" ref-type="bibr">509</xref>&#8211;
<xref rid="REF515" ref-type="bibr">515</xref>]. However, the exact causes for mitochondrial dysfunction and damage are not clear. The proposed MFF hypothesis provides a mechanistic basis for the observed mitochondrial damage and dysfunction in DM patients, which is due to hyperglycemia-associated production and accumulation of the endogenous formaldehyde and formic acid. These toxic one-carbon metabolites would inhibit mitochondrial respiration and ATP synthesis, along with mitochondrial superoxide over-production.
</p><p>Superoxide, a by-product of electron transport, is continuously produced in mitochondria. Many earlier studies have suggested that accumulation of mitochondrial superoxide plays a critical role in the pathogenesis of diabetic complications [
<xref rid="REF16" ref-type="bibr">16</xref>,
<xref rid="REF246" ref-type="bibr">246</xref>,
<xref rid="REF516" ref-type="bibr">516</xref>,
<xref rid="REF517" ref-type="bibr">517</xref>]. In addition, there is evidence showing that accumulation of mitochondrial superoxide can subsequently lead to inhibition of GAPDH as well as activation of other pathological pathways, such as protein kinase C, the aldose reductase pathway, and formation of AGEs, all of which were believed to be important contributing factors in the development of diabetic complications [
<xref rid="REF246" ref-type="bibr">246</xref>,
<xref rid="REF518" ref-type="bibr">518</xref>].
</p><p>According to the proposed MFF hypothesis, hyperglycemia-associated formation and accumulation of formaldehyde and formic acid would impair energy production in many cells of DM patients. Therefore, it is expected that many tissues and cells in the late-stage DM patients would be in a state of severe energy deficiency, and this would be particularly so in those tissues and cells that normally require a very high level of oxygen and energy supply for maintaining their physiological functions. Indeed, abnormalities in ATP production have also been suggested in many earlier studies as an important contributor to the development of diabetic complications [
<xref rid="REF519" ref-type="bibr">519</xref>&#8211;
<xref rid="REF524" ref-type="bibr">524</xref>]. It is hypothesized that the eventual loss of cellular ATP production would be the principal cause for the wide-spread cell death and drastic functional decline often seen in patients with end-stage diabetic complications.
</p><p>Based on the proposed MFF hypothesis, it is proposed that the testing of blood levels of toxic one-carbon metabolites should also be routinely included for all diabetic patients as these biochemical parameters are more directly related to diabetic injuries to cells and tissues than the traditional parameters of hyperglycemia and H1bAc, and the levels of toxic one-carbon metabolites would also be more directly indicative of the pathogenic process of diabetic complications as well as their progression. It is proposed that the effective strategies for prevention and treatment of human diabetic complications should focus squarely on reducing abnormally-elevated glucose levels in the blood and inside the cells, and on reducing the endogenous production and accumulation of toxic one-carbon metabolites (mostly formaldehyde and formic acid). To achieve these goals, it is critically important to reduce the daily intake of total carbohydrates and fats and simultaneously increase the daily energy expenditure through increased physical activities. The combination of these two basic approaches is believed to be of fundamental importance in helping restore normal insulin sensitivity and glucose homeostasis, which subsequently will help curb and even revert the progression of various human diabetic complications. At present, there are no known drugs that can selectively target the enzymes involved in the endogenous metabolic conversion of excess glucose molecules to toxic one carbon metabolites. Should such selective agents become available some day in the future for clinical use, they may be of considerable benefit to help slow down the development and progression of diabetic complications. Nevertheless, at present, the joint use of folic acid (or folate) and vitamins B
<sub>6/12</sub> is highly recommended as an important part of drug treatment as they can help the human body to more effectively detoxify the toxic one-carbon metabolites. In addition, the use of effective antioxidants that can target cellular and mitochondrial superoxide production and accumulation may also be of some benefit (as part of the adjuvant therapy) to help slow down the progression of diabetic complications.
</p></sec></body><back><ack><p>The author wishes to thank Miss. Rosy R. Yu, an Administrative Assistant at The Chinese University of Hong Kong, Shenzhen (CUHKSZ), for her assistance with collecting the PDF copies of many papers cited in the reference list, and particularly for her effort in editing and compiling some of the literature information about the ocular toxicities of methanol and its metabolites and the pathology of diabetic ocular lesions. The author also wishes to express his indebtedness to many researchers whose equally-important research work had to be trimmed off the original reference list during revision and resubmission due to space constraint. Lastly, it is of note that the key concept of this hypothesis paper was first conceived in a very abbreviated draft while the author worked at the University of Kansas Medical Center (KUMC), and the full paper was developed later after he moved to his current institute (CUHKSZ). The author also wishes to thank Elizabeth Yan Zhang and Aaron Yun Chen, two graduate students working in the author&#8217;s laboratory at KUMC around 2008, for their assistance with seting up a GC/MS method to determine circulating and tissue levels of methanol.</p></ack><notes notes-type="COI-statement"><title>COMPETING INTERESTS</title><p>The author declares that he has no conflict of interest.</p></notes><ref-list><ref id="REF1"><label>1</label><element-citation publication-type="other" id="CITATION1"><article-title>Ahmed AM. History of diabetes mellitus.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.13140/RG.2.2.23284.17289">Saudi Med J</uri> 2002, 23: 373&#8211;378
</article-title><pub-id pub-id-type="pmid">11953758</pub-id></element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="other" id="CITATION2"><article-title>Dobson M. Nature of urine in diabetes.
<italic toggle="yes">Medical Observations Inquiries</italic> 1776, 5: 298&#8211;310
</article-title></element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="journal" id="CITATION3"><person-group person-group-type="author"><name name-style="western"><surname>Shaw</surname><given-names>JE</given-names></name><name name-style="western"><surname>Sicree</surname><given-names>RA</given-names></name><name name-style="western"><surname>Zimmet</surname><given-names>PZ</given-names></name></person-group><article-title>Global estimates of the prevalence of diabetes for 2010 and 2030</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.diabres.2009.10.007">Diabetes Res Clin Pract</uri></source><year>2030</year><volume>87</volume><fpage>4</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2009.10.007</pub-id><pub-id pub-id-type="pmid">19896746</pub-id></element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal" id="CITATION4"><person-group person-group-type="author"><name name-style="western"><surname>Danaei</surname><given-names>G</given-names></name><name name-style="western"><surname>Finucane</surname><given-names>MM</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Singh</surname><given-names>GM</given-names></name><name name-style="western"><surname>Cowan</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Paciorek</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Lin</surname><given-names>JK</given-names></name><etal>et al.</etal></person-group><article-title>National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0140-6736(11)60679-X">Lancet</uri></source><year>2011</year><volume>378</volume><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)60679-X</pub-id><pub-id pub-id-type="pmid">21705069</pub-id></element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="journal" id="CITATION5"><person-group person-group-type="author"><name name-style="western"><surname>Guariguata</surname><given-names>L</given-names></name><name name-style="western"><surname>Whiting</surname><given-names>DR</given-names></name><name name-style="western"><surname>Hambleton</surname><given-names>I</given-names></name><name name-style="western"><surname>Beagley</surname><given-names>J</given-names></name><name name-style="western"><surname>Linnenkamp</surname><given-names>U</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>JE</given-names></name></person-group><article-title>Global estimates of diabetes prevalence for 2013 and projections for 2035</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.diabres.2013.11.002">Diabetes Res Clin Pract</uri></source><year>2014</year><volume>103</volume><fpage>137</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2013.11.002</pub-id><pub-id pub-id-type="pmid">24630390</pub-id></element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal" id="CITATION6"><person-group person-group-type="author"><name name-style="western"><surname>Forbes</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>ME</given-names></name></person-group><article-title>Mechanisms of diabetic complications</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/physrev.00045.2011">Physiol Rev</uri></source><year>2013</year><volume>93</volume><fpage>137</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1152/physrev.00045.2011</pub-id><pub-id pub-id-type="pmid">23303908</pub-id></element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal" id="CITATION7"><person-group person-group-type="author"><name name-style="western"><surname>Mauer</surname><given-names>SM</given-names></name><name name-style="western"><surname>Steffes</surname><given-names>MW</given-names></name><name name-style="western"><surname>Connett</surname><given-names>J</given-names></name><name name-style="western"><surname>Najarian</surname><given-names>JS</given-names></name><name name-style="western"><surname>Sutherland</surname><given-names>DER</given-names></name><name name-style="western"><surname>Barbosa</surname><given-names>J</given-names></name></person-group><article-title>The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.32.10.948">Diabetes</uri></source><year>1983</year><volume>32</volume><fpage>948</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.2337/diab.32.10.948</pub-id><pub-id pub-id-type="pmid">6352379</pub-id></element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="journal" id="CITATION8"><person-group person-group-type="author"><name name-style="western"><surname>Osterby</surname><given-names>R</given-names></name><name name-style="western"><surname>Nyberg</surname><given-names>G</given-names></name><name name-style="western"><surname>Hedman</surname><given-names>L</given-names></name><name name-style="western"><surname>Karlberg</surname><given-names>I</given-names></name><name name-style="western"><surname>Persson</surname><given-names>H</given-names></name><name name-style="western"><surname>Svalander</surname><given-names>C</given-names></name></person-group><article-title>Kidney transplantation in type 1 (insulin-dependent) diabetic patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF00400997">Diabetologia</uri></source><year>1991</year><volume>34</volume><fpage>668</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1007/BF00400997</pub-id><pub-id pub-id-type="pmid">1955100</pub-id></element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal" id="CITATION9"><person-group person-group-type="author"><name name-style="western"><surname>Abouna</surname><given-names>GM</given-names></name><name name-style="western"><surname>Kremer</surname><given-names>GD</given-names></name><name name-style="western"><surname>Daddah</surname><given-names>SK</given-names></name><name name-style="western"><surname>Al-Adnani</surname><given-names>MS</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>SA</given-names></name><name name-style="western"><surname>Kusma</surname><given-names>G</given-names></name></person-group><article-title>Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/s0140-6736(83)91151-0">Lancet</uri></source><year>1983</year><volume>322</volume><fpage>1274</fpage><lpage>1276</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(83)91151-0</pub-id><pub-id pub-id-type="pmid">6139620</pub-id></element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="journal" id="CITATION10"><person-group person-group-type="author"><name name-style="western"><surname>Harada</surname><given-names>S</given-names></name><name name-style="western"><surname>Ushigome</surname><given-names>H</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>A</given-names></name><name name-style="western"><surname>Nakao</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>T</given-names></name><name name-style="western"><surname>Koshino</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Histological reversibility of diabetic nephropathy after kidney transplantation from diabetic donor to non-diabetic recipient</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/nep.12451">Nephrology</uri></source><year>2015</year><volume>20</volume><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1111/nep.12451</pub-id><pub-id pub-id-type="pmid">26031585</pub-id></element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="journal" id="CITATION11"><person-group person-group-type="author"><name name-style="western"><surname>MacIsaac</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Jerums</surname><given-names>G</given-names></name><name name-style="western"><surname>Ekinci</surname><given-names>EI</given-names></name></person-group><article-title>Glycemic control as primary prevention for diabetic kidney disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1053/j.ackd.2017.11.003">Adv Chronic Kidney Dis</uri></source><year>2018</year><volume>25</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1053/j.ackd.2017.11.003</pub-id><pub-id pub-id-type="pmid">29580578</pub-id></element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="other" id="CITATION12"><article-title>Thomas MC. Advanced glycation end products.
<italic toggle="yes">
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sciencedirect.com/topics/medicine-and-dentistry/advanced-glycation-end-product">Contrib Nephrol</uri>
</italic> 2011, 170: 66&#8211;74
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000324945</pub-id><pub-id pub-id-type="pmid">21659759</pub-id></element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal" id="CITATION13"><person-group person-group-type="author"><name name-style="western"><surname>Chilelli</surname><given-names>NC</given-names></name><name name-style="western"><surname>Burlina</surname><given-names>S</given-names></name><name name-style="western"><surname>Lapolla</surname><given-names>A</given-names></name></person-group><article-title>AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a &#8220;glycoxidation-centric&#8221; point of view</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.numecd.2013.04.004">Nutr Metab Cardiovasc Dis</uri></source><year>2013</year><volume>23</volume><fpage>913</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2013.04.004</pub-id><pub-id pub-id-type="pmid">23786818</pub-id></element-citation></ref><ref id="REF14"><label>14</label><element-citation publication-type="journal" id="CITATION14"><person-group person-group-type="author"><name name-style="western"><surname>Semba</surname><given-names>RD</given-names></name><name name-style="western"><surname>Nicklett</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Ferrucci</surname><given-names>L</given-names></name></person-group><article-title>Does accumulation of advanced glycation end products contribute to the aging phenotype?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/gerona/glq074">J Gerontol A Biol Sci Med Sci</uri></source><year>2010</year><volume>65A</volume><fpage>963</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1093/gerona/glq074</pub-id><pub-id pub-id-type="pmid">20478906</pub-id><pub-id pub-id-type="pmcid">PMC2920582</pub-id></element-citation></ref><ref id="REF15"><label>15</label><element-citation publication-type="journal" id="CITATION15"><person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>T</given-names></name></person-group><article-title>HbA1c for screening and diagnosis of diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s12020-012-9768-y">Endocrine</uri></source><year>2013</year><volume>43</volume><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1007/s12020-012-9768-y</pub-id><pub-id pub-id-type="pmid">22907625</pub-id></element-citation></ref><ref id="REF16"><label>16</label><element-citation publication-type="journal" id="CITATION16"><person-group person-group-type="author"><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>The pathobiology of diabetic complications: a unifying mechanism</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.54.6.1615">Diabetes</uri></source><year>2005</year><volume>54</volume><fpage>1615</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.2337/diabetes.54.6.1615</pub-id><pub-id pub-id-type="pmid">15919781</pub-id></element-citation></ref><ref id="REF17"><label>17</label><element-citation publication-type="journal" id="CITATION17"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>AYW</given-names></name><name name-style="western"><surname>Chung</surname><given-names>SK</given-names></name><name name-style="western"><surname>Chung</surname><given-names>SSM</given-names></name></person-group><article-title>Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1073/pnas.92.7.2780">Proc Natl Acad Sci U S A</uri></source><year>1995</year><volume>92</volume><fpage>2780</fpage><lpage>2784</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.7.2780</pub-id><pub-id pub-id-type="other">1995PNAS...92.2780L</pub-id><pub-id pub-id-type="pmid">7708723</pub-id><pub-id pub-id-type="pmcid">PMC42302</pub-id></element-citation></ref><ref id="REF18"><label>18</label><element-citation publication-type="journal" id="CITATION18"><person-group person-group-type="author"><name name-style="western"><surname>Sayeski</surname><given-names>PP</given-names></name><name name-style="western"><surname>Kudlow</surname><given-names>JE</given-names></name></person-group><article-title>Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-&#945; gene transcription</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1074/jbc.271.25.15237">J Biol Chem</uri></source><year>1996</year><volume>271</volume><fpage>15237</fpage><lpage>15243</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.25.15237</pub-id><pub-id pub-id-type="pmid">8663078</pub-id></element-citation></ref><ref id="REF19"><label>19</label><element-citation publication-type="journal" id="CITATION19"><person-group person-group-type="author"><name name-style="western"><surname>Kolm-Litty</surname><given-names>V</given-names></name><name name-style="western"><surname>Sauer</surname><given-names>U</given-names></name><name name-style="western"><surname>Nerlich</surname><given-names>A</given-names></name><name name-style="western"><surname>Lehmann</surname><given-names>R</given-names></name><name name-style="western"><surname>Schleicher</surname><given-names>ED</given-names></name></person-group><article-title>High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI119875">J Clin Invest</uri></source><year>1998</year><volume>101</volume><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1172/JCI119875</pub-id><pub-id pub-id-type="pmid">9421478</pub-id><pub-id pub-id-type="pmcid">PMC508552</pub-id></element-citation></ref><ref id="REF20"><label>20</label><element-citation publication-type="journal" id="CITATION20"><person-group person-group-type="author"><name name-style="western"><surname>Koya</surname><given-names>D</given-names></name><name name-style="western"><surname>King</surname><given-names>GL</given-names></name></person-group><article-title>Protein kinase C activation and the development of diabetic complications</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.47.6.859">Diabetes</uri></source><year>1998</year><volume>47</volume><fpage>859</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.2337/diabetes.47.6.859</pub-id><pub-id pub-id-type="pmid">9604860</pub-id></element-citation></ref><ref id="REF21"><label>21</label><element-citation publication-type="journal" id="CITATION21"><person-group person-group-type="author"><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>Advanced protein glycosylation in diabetes and aging</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1146/annurev.med.46.1.223">Annu Rev Med</uri></source><year>1995</year><volume>46</volume><fpage>223</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1146/annurev.med.46.1.223</pub-id><pub-id pub-id-type="pmid">7598459</pub-id></element-citation></ref><ref id="REF22"><label>22</label><element-citation publication-type="journal" id="CITATION22"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>L</given-names></name><name name-style="western"><surname>Raman</surname><given-names>KG</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ferran Jr.</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Chow</surname><given-names>WS</given-names></name><name name-style="western"><surname>Stern</surname><given-names>D</given-names></name><etal>et al.</etal></person-group><article-title>Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/2012">Nat Med</uri></source><year>1998</year><volume>4</volume><fpage>1025</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1038/2012</pub-id><pub-id pub-id-type="pmid">9734395</pub-id></element-citation></ref><ref id="REF23"><label>23</label><element-citation publication-type="journal" id="CITATION23"><person-group person-group-type="author"><name name-style="western"><surname>Sima</surname><given-names>AA</given-names></name><name name-style="western"><surname>Prashar</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>WX</given-names></name><name name-style="western"><surname>Chakrabarti</surname><given-names>S</given-names></name><name name-style="western"><surname>Greene</surname><given-names>DA</given-names></name></person-group><article-title>Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI114585">J Clin Invest</uri></source><year>1990</year><volume>85</volume><fpage>1410</fpage><lpage>1420</lpage><pub-id pub-id-type="doi">10.1172/JCI114585</pub-id><pub-id pub-id-type="pmid">2110189</pub-id><pub-id pub-id-type="pmcid">PMC296586</pub-id></element-citation></ref><ref id="REF24"><label>24</label><element-citation publication-type="journal" id="CITATION24"><person-group person-group-type="author"><name name-style="western"><surname>Hoffman</surname><given-names>EA</given-names></name><name name-style="western"><surname>Frey</surname><given-names>BL</given-names></name><name name-style="western"><surname>Smith</surname><given-names>LM</given-names></name><name name-style="western"><surname>Auble</surname><given-names>DT</given-names></name></person-group><article-title>Formaldehyde crosslinking: a tool for the study of chromatin complexes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1074/jbc.R115.651679">J Biol Chem</uri></source><year>2015</year><volume>290</volume><fpage>26404</fpage><lpage>26411</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.651679</pub-id><pub-id pub-id-type="pmid">26354429</pub-id><pub-id pub-id-type="pmcid">PMC4646298</pub-id></element-citation></ref><ref id="REF25"><label>25</label><element-citation publication-type="journal" id="CITATION25"><person-group person-group-type="author"><name name-style="western"><surname>Metz</surname><given-names>B</given-names></name><name name-style="western"><surname>Kersten</surname><given-names>GF</given-names></name><name name-style="western"><surname>Hoogerhout</surname><given-names>P</given-names></name><name name-style="western"><surname>Brugghe</surname><given-names>HF</given-names></name><name name-style="western"><surname>Timmermans</surname><given-names>HA</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>A</given-names></name><name name-style="western"><surname>Meiring</surname><given-names>H</given-names></name><etal>et al.</etal></person-group><article-title>Identification of formaldehyde-induced modifications in proteins: reactions with model peptides</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1074/jbc.M310752200">J Biol Chem</uri></source><year>2004</year><volume>279</volume><fpage>6235</fpage><lpage>6243</lpage><pub-id pub-id-type="doi">10.1074/jbc.M310752200</pub-id><pub-id pub-id-type="pmid">14638685</pub-id></element-citation></ref><ref id="REF26"><label>26</label><element-citation publication-type="journal" id="CITATION26"><person-group person-group-type="author"><name name-style="western"><surname>McMartin</surname><given-names>KE</given-names></name><name name-style="western"><surname>Ambre</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>Methanol poisoning in human subjects</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9343(80)90113-8">Am J Med</uri></source><year>1980</year><volume>68</volume><fpage>414</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(80)90113-8</pub-id><pub-id pub-id-type="pmid">7361809</pub-id></element-citation></ref><ref id="REF27"><label>27</label><element-citation publication-type="journal" id="CITATION27"><person-group person-group-type="author"><name name-style="western"><surname>Sejersted</surname><given-names>OM</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>D</given-names></name><name name-style="western"><surname>&#216;vreb&#248;</surname><given-names>S</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>H</given-names></name></person-group><article-title>Formate concentrations in plasma from patients poisoned with methanol</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.0954-6820.1983.tb03699.x">Acta Med Scand</uri></source><year>1983</year><volume>213</volume><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1111/j.0954-6820.1983.tb03699.x</pub-id><pub-id pub-id-type="pmid">6837328</pub-id></element-citation></ref><ref id="REF28"><label>28</label><element-citation publication-type="journal" id="CITATION28"><person-group person-group-type="author"><name name-style="western"><surname>McMartin</surname><given-names>KE</given-names></name><name name-style="western"><surname>Makar</surname><given-names>AB</given-names></name><name name-style="western"><surname>Martin</surname><given-names>GA</given-names></name><name name-style="western"><surname>Palese</surname><given-names>M</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>Methanol poisoning I. The role of formic acid in the development of metabolic acidosis in the monkey and the reversal by 4-methylpyrazole</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0006-2944(75)90171-4">Biochem Med</uri></source><year>1975</year><volume>13</volume><fpage>319</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/0006-2944(75)90171-4</pub-id><pub-id pub-id-type="pmid">2163</pub-id></element-citation></ref><ref id="REF29"><label>29</label><element-citation publication-type="journal" id="CITATION29"><person-group person-group-type="author"><name name-style="western"><surname>Clay</surname><given-names>KL</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>RC</given-names></name><name name-style="western"><surname>Watrins</surname><given-names>WD</given-names></name></person-group><article-title>Experimental methanol toxicity in the primate: analysis of metabolic acidosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0041-008X(75)90174-X">Toxicol Appl Pharmacol</uri></source><year>1975</year><volume>34</volume><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/0041-008X(75)90174-X</pub-id><pub-id pub-id-type="pmid">819</pub-id></element-citation></ref><ref id="REF30"><label>30</label><element-citation publication-type="journal" id="CITATION30"><person-group person-group-type="author"><name name-style="western"><surname>Martin-Amat</surname><given-names>G</given-names></name><name name-style="western"><surname>McMartin</surname><given-names>KE</given-names></name><name name-style="western"><surname>Hayreh</surname><given-names>SS</given-names></name><name name-style="western"><surname>Hayreh</surname><given-names>MS</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>Methanol poisoning: ocular toxicity produced by formate</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0041-008X(78)90040-6">Toxicol Appl Pharmacol</uri></source><year>1978</year><volume>45</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/0041-008X(78)90040-6</pub-id><pub-id pub-id-type="pmid">99844</pub-id></element-citation></ref><ref id="REF31"><label>31</label><element-citation publication-type="journal" id="CITATION31"><person-group person-group-type="author"><name name-style="western"><surname>Nicholls</surname><given-names>P</given-names></name></person-group><article-title>The effect of formate on cytochrome aa3 and on electron transport in the intact respiratory chain</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0005-2728(76)90218-8">Biochim Biophys Acta</uri></source><year>1976</year><volume>430</volume><fpage>13</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/0005-2728(76)90218-8</pub-id><pub-id pub-id-type="pmid">4141</pub-id></element-citation></ref><ref id="REF32"><label>32</label><element-citation publication-type="journal" id="CITATION32"><person-group person-group-type="author"><name name-style="western"><surname>Liesivuori</surname><given-names>J</given-names></name><name name-style="western"><surname>Savolainen</surname><given-names>H</given-names></name></person-group><article-title>Methanol and formic acid toxicity: biochemical mechanisms</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1600-0773.1991.tb01290.x">Pharmacol Toxicol</uri></source><year>1990</year><volume>69</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0773.1991.tb01290.x</pub-id><pub-id pub-id-type="pmid">1665561</pub-id></element-citation></ref><ref id="REF33"><label>33</label><element-citation publication-type="journal" id="CITATION33"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>X</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>T</given-names></name><name name-style="western"><surname>Edelstein</surname><given-names>D</given-names></name><name name-style="western"><surname>Rossetti</surname><given-names>L</given-names></name><name name-style="western"><surname>Zsengell&#233;r</surname><given-names>Z</given-names></name><name name-style="western"><surname>Szab&#243;</surname><given-names>C</given-names></name><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI18127">J Clin Invest</uri></source><year>2003</year><volume>112</volume><fpage>1049</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1172/JCI18127</pub-id><pub-id pub-id-type="pmid">14523042</pub-id><pub-id pub-id-type="pmcid">PMC198524</pub-id></element-citation></ref><ref id="REF34"><label>34</label><element-citation publication-type="journal" id="CITATION34"><person-group person-group-type="author"><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>Biochemistry and molecular cell biology of diabetic complications</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/414813a">Nature</uri></source><year>2001</year><volume>414</volume><fpage>813</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1038/414813a</pub-id><pub-id pub-id-type="other">2001Natur.414..813B</pub-id><pub-id pub-id-type="pmid">11742414</pub-id></element-citation></ref><ref id="REF35"><label>35</label><element-citation publication-type="journal" id="CITATION35"><person-group person-group-type="author"><name name-style="western"><surname>Eriksen</surname><given-names>SP</given-names></name><name name-style="western"><surname>Kulkarni</surname><given-names>AB</given-names></name></person-group><article-title>Methanol in normal human breath</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1126/science.141.3581.639">Science</uri></source><year>1963</year><volume>141</volume><fpage>639</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1126/science.141.3581.639</pub-id><pub-id pub-id-type="other">1963Sci...141..639E</pub-id><pub-id pub-id-type="pmid">17781761</pub-id></element-citation></ref><ref id="REF36"><label>36</label><element-citation publication-type="journal" id="CITATION36"><person-group person-group-type="author"><name name-style="western"><surname>Taucher</surname><given-names>J</given-names></name><name name-style="western"><surname>Lagg</surname><given-names>A</given-names></name><name name-style="western"><surname>Hansel</surname><given-names>A</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>W</given-names></name><name name-style="western"><surname>Lindinger</surname><given-names>W</given-names></name></person-group><article-title>Methanol in human breath</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1530-0277.1995.tb01593.x">Alcoholism Clin Exp Res</uri></source><year>1995</year><volume>19</volume><fpage>1147</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1111/j.1530-0277.1995.tb01593.x</pub-id><pub-id pub-id-type="pmid">8561283</pub-id></element-citation></ref><ref id="REF37"><label>37</label><element-citation publication-type="other" id="CITATION37"><article-title>Western OC, Ozburn EE. Methanol and formaldehyde in normal body tissues and fluids.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18129165/">US Nav Med Bull</uri> 1949, 49: 574
</article-title><pub-id pub-id-type="pmid">18129165</pub-id></element-citation></ref><ref id="REF38"><label>38</label><element-citation publication-type="journal" id="CITATION38"><person-group person-group-type="author"><name name-style="western"><surname>Enderby</surname><given-names>B</given-names></name><name name-style="western"><surname>Lenney</surname><given-names>W</given-names></name><name name-style="western"><surname>Brady</surname><given-names>M</given-names></name><name name-style="western"><surname>Emmett</surname><given-names>C</given-names></name><name name-style="western"><surname>&#352;pan&#283;l</surname><given-names>P</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D</given-names></name></person-group><article-title>Concentrations of some metabolites in the breath of healthy children aged 7&#8211;18 years measured using selected ion flow tube mass spectrometry (SIFT-MS)</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1088/1752-7155/3/3/036001">J Breath Res</uri></source><year>2009</year><volume>3</volume><fpage>036001</fpage><pub-id pub-id-type="doi">10.1088/1752-7155/3/3/036001</pub-id><pub-id pub-id-type="other">2009JBR.....3c6001E</pub-id><pub-id pub-id-type="pmid">21383465</pub-id></element-citation></ref><ref id="REF39"><label>39</label><element-citation publication-type="journal" id="CITATION39"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>JW</given-names></name></person-group><article-title>Analysis of respiratory exchange of methanol in the lung of the monkey using a physiological model</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/toxsci/53.2.185">Toxicol Sci</uri></source><year>2000</year><volume>53</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1093/toxsci/53.2.185</pub-id><pub-id pub-id-type="pmid">10696766</pub-id></element-citation></ref><ref id="REF40"><label>40</label><element-citation publication-type="journal" id="CITATION40"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>C</given-names></name><name name-style="western"><surname>Spanel</surname><given-names>P</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D</given-names></name></person-group><article-title>A longitudinal study of methanol in the exhaled breath of 30 healthy volunteers using selected ion flow tube mass spectrometry, SIFT-MS</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1088/0967-3334/27/7/007">Physiol Meas</uri></source><year>2006</year><volume>27</volume><fpage>637</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1088/0967-3334/27/7/007</pub-id><pub-id pub-id-type="other">2006PhyM...27..637T</pub-id><pub-id pub-id-type="pmid">16705261</pub-id></element-citation></ref><ref id="REF41"><label>41</label><element-citation publication-type="journal" id="CITATION41"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>C</given-names></name><name name-style="western"><surname>Parekh</surname><given-names>B</given-names></name><name name-style="western"><surname>Walton</surname><given-names>C</given-names></name><name name-style="western"><surname>&#352;pan&#283;l</surname><given-names>P</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D</given-names></name><name name-style="western"><surname>Evans</surname><given-names>M</given-names></name></person-group><article-title>An exploratory comparative study of volatile compounds in exhaled breath and emitted by skin using selected ion flow tube mass spectrometry</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/rcm.3402">Rapid Commun Mass Spectrom</uri></source><year>2008</year><volume>22</volume><fpage>526</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1002/rcm.3402</pub-id><pub-id pub-id-type="other">2008RCMS...22..526T</pub-id><pub-id pub-id-type="pmid">18215004</pub-id></element-citation></ref><ref id="REF42"><label>42</label><element-citation publication-type="journal" id="CITATION42"><person-group person-group-type="author"><name name-style="western"><surname>Shindyapina</surname><given-names>AV</given-names></name><name name-style="western"><surname>Petrunia</surname><given-names>IV</given-names></name><name name-style="western"><surname>Komarova</surname><given-names>TV</given-names></name><name name-style="western"><surname>Sheshukova</surname><given-names>EV</given-names></name><name name-style="western"><surname>Kosorukov</surname><given-names>VS</given-names></name><name name-style="western"><surname>Kiryanov</surname><given-names>GI</given-names></name><name name-style="western"><surname>Dorokhov</surname><given-names>YL</given-names></name></person-group><article-title>Dietary methanol regulates human gene activity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1371/journal.pone.0102837">PLoS ONE</uri></source><year>2014</year><volume>9</volume><fpage>e102837</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0102837</pub-id><pub-id pub-id-type="other">2014PLoSO...9j2837S</pub-id><pub-id pub-id-type="pmid">25033451</pub-id><pub-id pub-id-type="pmcid">PMC4102594</pub-id></element-citation></ref><ref id="REF43"><label>43</label><element-citation publication-type="other" id="CITATION43"><article-title>Ledochowski M, Amman A, Fuchs D. Breath gas analysis in patients with carbohydrate malabsorption syndrome. Iin: breath analysis for clinical diagnosis and therapeutic monitoring, eds A amann and D smith (Singapore: World Scientific), pp. 375&#8211;392, 2005</article-title></element-citation></ref><ref id="REF44"><label>44</label><element-citation publication-type="journal" id="CITATION44"><person-group person-group-type="author"><name name-style="western"><surname>Payasi</surname><given-names>A</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>NN</given-names></name><name name-style="western"><surname>Chaves</surname><given-names>ALS</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name></person-group><article-title>Biochemistry of fruit softening: an overview</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s12298-009-0012-z">Physiol Mol Biol Plants</uri></source><year>2009</year><volume>15</volume><fpage>103</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1007/s12298-009-0012-z</pub-id><pub-id pub-id-type="pmid">23572919</pub-id><pub-id pub-id-type="pmcid">PMC3550369</pub-id></element-citation></ref><ref id="REF45"><label>45</label><element-citation publication-type="journal" id="CITATION45"><person-group person-group-type="author"><name name-style="western"><surname>Prasanna</surname><given-names>V</given-names></name><name name-style="western"><surname>Prabha</surname><given-names>TN</given-names></name><name name-style="western"><surname>Tharanathan</surname><given-names>RN</given-names></name></person-group><article-title>Fruit ripening phenomena&#8212;an overview</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/10408390600976841">Crit Rev Food Sci Nutr</uri></source><year>2007</year><volume>47</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1080/10408390600976841</pub-id><pub-id pub-id-type="pmid">17364693</pub-id></element-citation></ref><ref id="REF46"><label>46</label><element-citation publication-type="journal" id="CITATION46"><person-group person-group-type="author"><name name-style="western"><surname>Humphries</surname><given-names>P</given-names></name><name name-style="western"><surname>Pretorius</surname><given-names>E</given-names></name><name name-style="western"><surname>Naud&#233;</surname><given-names>H</given-names></name></person-group><article-title>Direct and indirect cellular effects of aspartame on the brain</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/sj.ejcn.1602866">Eur J Clin Nutr</uri></source><year>2008</year><volume>62</volume><fpage>451</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602866</pub-id><pub-id pub-id-type="pmid">17684524</pub-id></element-citation></ref><ref id="REF47"><label>47</label><element-citation publication-type="other" id="CITATION47"><article-title>Oppermann JA. Aspartame metabolism in animals. Aspartame, physiology and biochemistry. Marcel Dekker Inc, pp. 141&#8211;159, 1984</article-title></element-citation></ref><ref id="REF48"><label>48</label><element-citation publication-type="other" id="CITATION48"><article-title>Stegink F. Aspartame: Physiology and biochemistry. CRC Press, 1984</article-title></element-citation></ref><ref id="REF49"><label>49</label><element-citation publication-type="journal" id="CITATION49"><person-group person-group-type="author"><name name-style="western"><surname>Jalkanen</surname><given-names>S</given-names></name></person-group><article-title>New EMBO member&#8217;s review: cell surface monoamine oxidases: enzymes in search of a function</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/emboj/20.15.3893">EMBO J</uri></source><year>2001</year><volume>20</volume><fpage>3893</fpage><lpage>3901</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.15.3893</pub-id><pub-id pub-id-type="pmid">11483492</pub-id><pub-id pub-id-type="pmcid">PMC149172</pub-id></element-citation></ref><ref id="REF50"><label>50</label><element-citation publication-type="journal" id="CITATION50"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>PH</given-names></name><name name-style="western"><surname>Wright</surname><given-names>S</given-names></name><name name-style="western"><surname>Fan</surname><given-names>EH</given-names></name><name name-style="western"><surname>Lun</surname><given-names>ZR</given-names></name><name name-style="western"><surname>Gubisne-Harberle</surname><given-names>D</given-names></name></person-group><article-title>Physiological and pathological implications of semicarbazide-sensitive amine oxidase</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S1570-9639(03)00101-8">Biochim Biophys Acta</uri></source><year>2003</year><volume>1647</volume><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/S1570-9639(03)00101-8</pub-id><pub-id pub-id-type="pmid">12686132</pub-id></element-citation></ref><ref id="REF51"><label>51</label><element-citation publication-type="journal" id="CITATION51"><person-group person-group-type="author"><name name-style="western"><surname>Kazachkov</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Babiy</surname><given-names>S</given-names></name><name name-style="western"><surname>Yu</surname><given-names>PH</given-names></name></person-group><article-title>Evidence for
<italic toggle="yes">in vivo</italic>
scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1124/jpet.107.124123">J Pharmacol Exp Ther</uri></source><year>2007</year><volume>322</volume><fpage>1201</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1124/jpet.107.124123</pub-id><pub-id pub-id-type="pmid">17596537</pub-id></element-citation></ref><ref id="REF52"><label>52</label><element-citation publication-type="journal" id="CITATION52"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>J</given-names></name></person-group><article-title>Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0161-813X(03)00117-7">Neurotoxicology</uri></source><year>2004</year><volume>25</volume><fpage>303</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/S0161-813X(03)00117-7</pub-id><pub-id pub-id-type="pmid">14697905</pub-id></element-citation></ref><ref id="REF53"><label>53</label><element-citation publication-type="journal" id="CITATION53"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>MY</given-names></name><name name-style="western"><surname>Saad</surname><given-names>S</given-names></name><name name-style="western"><surname>Wong</surname><given-names>MG</given-names></name><name name-style="western"><surname>Stangenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Jarolimek</surname><given-names>W</given-names></name><name name-style="western"><surname>Schilter</surname><given-names>H</given-names></name><name name-style="western"><surname>Zaky</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1371/journal.pone.0234617">PLoS ONE</uri></source><year>2020</year><volume>15</volume><fpage>e0234617</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0234617</pub-id><pub-id pub-id-type="other">2020PLoSO..1534617W</pub-id><pub-id pub-id-type="pmid">32555665</pub-id><pub-id pub-id-type="pmcid">PMC7302447</pub-id></element-citation></ref><ref id="REF54"><label>54</label><element-citation publication-type="journal" id="CITATION54"><person-group person-group-type="author"><name name-style="western"><surname>Qiang</surname><given-names>M</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>R</given-names></name><name name-style="western"><surname>Su</surname><given-names>T</given-names></name><name name-style="western"><surname>Wu</surname><given-names>BB</given-names></name><name name-style="western"><surname>Tong</surname><given-names>ZQ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>RQ</given-names></name></person-group><article-title>A novel mechanism for endogenous formaldehyde elevation in SAMP8 mouse</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3233/JAD-131595">J Alzheimer Dis</uri></source><year>2014</year><volume>40</volume><fpage>1039</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.3233/JAD-131595</pub-id><pub-id pub-id-type="pmid">24583407</pub-id></element-citation></ref><ref id="REF55"><label>55</label><element-citation publication-type="journal" id="CITATION55"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H</given-names></name><etal>et al.</etal></person-group><article-title>Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.neurobiolaging.2009.07.013">NeuroBiol Aging</uri></source><year>2011</year><volume>32</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.07.013</pub-id><pub-id pub-id-type="pmid">19879019</pub-id></element-citation></ref><ref id="REF56"><label>56</label><element-citation publication-type="journal" id="CITATION56"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>ES</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Hardman</surname><given-names>C</given-names></name><name name-style="western"><surname>Simm</surname><given-names>A</given-names></name><name name-style="western"><surname>Charlton</surname><given-names>C</given-names></name></person-group><article-title>Excessive
<italic toggle="yes">S-</italic>adenosyl-
<italic toggle="yes">L-</italic>methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: Possible role in
<italic toggle="yes">S</italic>-adenosyl-
<italic toggle="yes">L</italic>-methionine-induced Parkinson&#8217;s disease-like disorders
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.lfs.2008.09.020">Life Sci</uri></source><year>2008</year><volume>83</volume><fpage>821</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2008.09.020</pub-id><pub-id pub-id-type="pmid">18930743</pub-id><pub-id pub-id-type="pmcid">PMC2885904</pub-id></element-citation></ref><ref id="REF57"><label>57</label><element-citation publication-type="journal" id="CITATION57"><person-group person-group-type="author"><name name-style="western"><surname>Diliberto</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Humberto Viveros</surname><given-names>O</given-names></name><name name-style="western"><surname>Axelrod</surname><given-names>J</given-names></name></person-group><article-title>Subcellualr distribution of protein carboxymethylase and its endogenous substrates in the adrenal medulla: possible role in excitation-secretion coupling</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1073/pnas.73.11.4050">Proc Natl Acad Sci U S A</uri></source><year>1976</year><volume>73</volume><fpage>4050</fpage><lpage>4054</lpage><pub-id pub-id-type="doi">10.1073/pnas.73.11.4050</pub-id><pub-id pub-id-type="other">1976PNAS...73.4050D</pub-id><pub-id pub-id-type="pmid">1069292</pub-id><pub-id pub-id-type="pmcid">PMC431323</pub-id></element-citation></ref><ref id="REF58"><label>58</label><element-citation publication-type="journal" id="CITATION58"><person-group person-group-type="author"><name name-style="western"><surname>Diliberto</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Axelrod</surname><given-names>J</given-names></name></person-group><article-title>Regional and subcellular distribution of protein carboxymethylase in brain and other tissues</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1471-4159.1976.tb07001.x">J Neurochem</uri></source><year>1976</year><volume>26</volume><fpage>1159</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1976.tb07001.x</pub-id><pub-id pub-id-type="pmid">6627</pub-id></element-citation></ref><ref id="REF59"><label>59</label><element-citation publication-type="journal" id="CITATION59"><person-group person-group-type="author"><name name-style="western"><surname>Cloos</surname><given-names>PAC</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>J</given-names></name><name name-style="western"><surname>Agger</surname><given-names>K</given-names></name><name name-style="western"><surname>Helin</surname><given-names>K</given-names></name></person-group><article-title>Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1101/gad.1652908">Genes Dev</uri></source><year>2008</year><volume>22</volume><fpage>1115</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1101/gad.1652908</pub-id><pub-id pub-id-type="pmid">18451103</pub-id><pub-id pub-id-type="pmcid">PMC2732404</pub-id></element-citation></ref><ref id="REF60"><label>60</label><element-citation publication-type="journal" id="CITATION60"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>XH</given-names></name><name name-style="western"><surname>Pan</surname><given-names>H</given-names></name><name name-style="western"><surname>Mazur</surname><given-names>P</given-names></name></person-group><article-title>Permeation and toxicity of ethylene glycol and methanol in larvae of
<italic toggle="yes">Anopheles gambiae</italic>
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1242/jeb.00420">J Exp Biol</uri></source><year>2003</year><volume>206</volume><fpage>2221</fpage><lpage>2228</lpage><pub-id pub-id-type="doi">10.1242/jeb.00420</pub-id><pub-id pub-id-type="pmid">12771171</pub-id></element-citation></ref><ref id="REF61"><label>61</label><element-citation publication-type="journal" id="CITATION61"><person-group person-group-type="author"><name name-style="western"><surname>Tsukada</surname><given-names>YI</given-names></name><name name-style="western"><surname>Fang</surname><given-names>J</given-names></name><name name-style="western"><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name name-style="western"><surname>Warren</surname><given-names>ME</given-names></name><name name-style="western"><surname>Borchers</surname><given-names>CH</given-names></name><name name-style="western"><surname>Tempst</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Histone demethylation by a family of JmjC domain-containing proteins</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/nature04433">Nature</uri></source><year>2006</year><volume>439</volume><fpage>811</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1038/nature04433</pub-id><pub-id pub-id-type="other">2006Natur.439..811T</pub-id><pub-id pub-id-type="pmid">16362057</pub-id></element-citation></ref><ref id="REF62"><label>62</label><element-citation publication-type="journal" id="CITATION62"><person-group person-group-type="author"><name name-style="western"><surname>Tulpule</surname><given-names>K</given-names></name><name name-style="western"><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Formaldehyde in brain: an overlooked player in neurodegeneration?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/jnc.12356">J Neurochem</uri></source><year>2013</year><volume>127</volume><fpage>7</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1111/jnc.12356</pub-id><pub-id pub-id-type="pmid">23800365</pub-id></element-citation></ref><ref id="REF63"><label>63</label><element-citation publication-type="journal" id="CITATION63"><person-group person-group-type="author"><name name-style="western"><surname>Martens</surname><given-names>EC</given-names></name><name name-style="western"><surname>Lowe</surname><given-names>EC</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Pudlo</surname><given-names>NA</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>McNulty</surname><given-names>NP</given-names></name><name name-style="western"><surname>Abbott</surname><given-names>DW</given-names></name><etal>et al.</etal></person-group><article-title>Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1371/journal.pbio.1001221">PLoS Biol</uri></source><year>2011</year><volume>9</volume><fpage>e1001221</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1001221</pub-id><pub-id pub-id-type="pmid">22205877</pub-id><pub-id pub-id-type="pmcid">PMC3243724</pub-id></element-citation></ref><ref id="REF64"><label>64</label><element-citation publication-type="journal" id="CITATION64"><person-group person-group-type="author"><name name-style="western"><surname>Dorokhov</surname><given-names>YL</given-names></name><name name-style="western"><surname>Shindyapina</surname><given-names>AV</given-names></name><name name-style="western"><surname>Sheshukova</surname><given-names>EV</given-names></name><name name-style="western"><surname>Komarova</surname><given-names>TV</given-names></name></person-group><article-title>Metabolic methanol: molecular pathways and physiological roles</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/physrev.00034.2014">Physiol Rev</uri></source><year>2015</year><volume>95</volume><fpage>603</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1152/physrev.00034.2014</pub-id><pub-id pub-id-type="pmid">25834233</pub-id></element-citation></ref><ref id="REF65"><label>65</label><element-citation publication-type="journal" id="CITATION65"><person-group person-group-type="author"><name name-style="western"><surname>Toma</surname><given-names>K</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Iitani</surname><given-names>K</given-names></name><name name-style="western"><surname>Arakawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mitsubayashi</surname><given-names>K</given-names></name></person-group><article-title>Biochemical methanol gas sensor (MeOH Bio-Sniffer) for non-invasive assessment of intestinal flora from breath methanol</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3390/s21144897">Sensors</uri></source><year>2021</year><volume>21</volume><fpage>4897</fpage><pub-id pub-id-type="doi">10.3390/s21144897</pub-id><pub-id pub-id-type="other">2021Senso..21.4897T</pub-id><pub-id pub-id-type="pmid">34300636</pub-id><pub-id pub-id-type="pmcid">PMC8309873</pub-id></element-citation></ref><ref id="REF66"><label>66</label><element-citation publication-type="journal" id="CITATION66"><person-group person-group-type="author"><name name-style="western"><surname>Komarova</surname><given-names>TV</given-names></name><name name-style="western"><surname>Petrunia</surname><given-names>IV</given-names></name><name name-style="western"><surname>Shindyapina</surname><given-names>AV</given-names></name><name name-style="western"><surname>Silachev</surname><given-names>DN</given-names></name><name name-style="western"><surname>Sheshukova</surname><given-names>EV</given-names></name><name name-style="western"><surname>Kiryanov</surname><given-names>GI</given-names></name><name name-style="western"><surname>Dorokhov</surname><given-names>YL</given-names></name></person-group><article-title>Endogenous methanol regulates mammalian gene activity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1371/journal.pone.0090239">PLoS ONE</uri></source><year>2014</year><volume>9</volume><fpage>e90239</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0090239</pub-id><pub-id pub-id-type="other">2014PLoSO...990239K</pub-id><pub-id pub-id-type="pmid">24587296</pub-id><pub-id pub-id-type="pmcid">PMC3937363</pub-id></element-citation></ref><ref id="REF67"><label>67</label><element-citation publication-type="journal" id="CITATION67"><person-group person-group-type="author"><name name-style="western"><surname>Siragusa</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Cerda</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Baig</surname><given-names>MM</given-names></name><name name-style="western"><surname>Burgin</surname><given-names>CW</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>FL</given-names></name></person-group><article-title>Methanol production from the degradation of pectin by human colonic bacteria</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/ajcn/47.5.848">Am J Clin Nutr</uri></source><year>1988</year><volume>47</volume><fpage>848</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1093/ajcn/47.5.848</pub-id><pub-id pub-id-type="pmid">3364401</pub-id></element-citation></ref><ref id="REF68"><label>68</label><element-citation publication-type="journal" id="CITATION68"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>AW</given-names></name></person-group><article-title>Abnormally high concentrations of methanol in breath: a useful biochemical marker of recent heavy drinking</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/clinchem/32.6.1241a">Clin Chem</uri></source><year>1986</year><volume>32</volume><fpage>1241</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1093/clinchem/32.6.1241a</pub-id><pub-id pub-id-type="pmid">3708812</pub-id></element-citation></ref><ref id="REF69"><label>69</label><element-citation publication-type="journal" id="CITATION69"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>AW</given-names></name></person-group><article-title>Elimination half-life of methanol during hangover</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1600-0773.1987.tb01737.x">Pharmacol Toxicol</uri></source><year>1987</year><volume>60</volume><fpage>217</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0773.1987.tb01737.x</pub-id><pub-id pub-id-type="pmid">3588516</pub-id></element-citation></ref><ref id="REF70"><label>70</label><element-citation publication-type="journal" id="CITATION70"><person-group person-group-type="author"><name name-style="western"><surname>Kostic</surname><given-names>MA</given-names></name><name name-style="western"><surname>Dart</surname><given-names>RC</given-names></name></person-group><article-title>Rethinking the toxic methanol level</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1081/CLT-120025344">J Toxicol Clin Toxicol</uri></source><year>2003</year><volume>41</volume><fpage>793</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1081/CLT-120025344</pub-id><pub-id pub-id-type="pmid">14677789</pub-id></element-citation></ref><ref id="REF71"><label>71</label><element-citation publication-type="journal" id="CITATION71"><person-group person-group-type="author"><name name-style="western"><surname>Datta</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Namasivayam</surname><given-names>A</given-names></name></person-group><article-title>
<italic toggle="yes">In vitro</italic>
effect of methanol on folate-deficient rat hepatocytes
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0376-8716(03)00066-8">Drug Alcohol Depend</uri></source><year>2003</year><volume>71</volume><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/S0376-8716(03)00066-8</pub-id><pub-id pub-id-type="pmid">12821209</pub-id></element-citation></ref><ref id="REF72"><label>72</label><element-citation publication-type="journal" id="CITATION72"><person-group person-group-type="author"><name name-style="western"><surname>Nakao</surname><given-names>H</given-names></name><name name-style="western"><surname>Umebayashi</surname><given-names>C</given-names></name><name name-style="western"><surname>Nakata</surname><given-names>M</given-names></name><name name-style="western"><surname>Nishizaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Noda</surname><given-names>K</given-names></name><name name-style="western"><surname>Okano</surname><given-names>Y</given-names></name><name name-style="western"><surname>Oyama</surname><given-names>Y</given-names></name></person-group><article-title>Formaldehyde-induced shrinkage of rat thymocytes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1254/jphs.91.83">J Pharmacol Sci</uri></source><year>2003</year><volume>91</volume><fpage>83</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1254/jphs.91.83</pub-id><pub-id pub-id-type="pmid">12686735</pub-id></element-citation></ref><ref id="REF73"><label>73</label><element-citation publication-type="journal" id="CITATION73"><person-group person-group-type="author"><name name-style="western"><surname>Lutwak-Mann</surname><given-names>C</given-names></name></person-group><article-title>Alcohol dehydrogenase of animal tissues</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1042/bj0321364">Biochem J</uri></source><year>1938</year><volume>32</volume><fpage>1364</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1042/bj0321364</pub-id><pub-id pub-id-type="pmid">16746762</pub-id><pub-id pub-id-type="pmcid">PMC1264196</pub-id></element-citation></ref><ref id="REF74"><label>74</label><element-citation publication-type="journal" id="CITATION74"><person-group person-group-type="author"><name name-style="western"><surname>Cederbaum</surname><given-names>AI</given-names></name></person-group><article-title>Alcohol metabolism</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.cld.2012.08.002">Clin Liver Dis</uri></source><year>2012</year><volume>16</volume><fpage>667</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1016/j.cld.2012.08.002</pub-id><pub-id pub-id-type="pmid">23101976</pub-id><pub-id pub-id-type="pmcid">PMC3484320</pub-id></element-citation></ref><ref id="REF75"><label>75</label><element-citation publication-type="journal" id="CITATION75"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>C</given-names></name></person-group><article-title>Methanol metabolism and embryotoxicity in rat and mouse conceptuses: comparisons of alcohol dehydrogenase (ADH1), formaldehyde dehydrogenase (ADH3), and catalase</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0890-6238(03)00013-3">Reprod Toxicol</uri></source><year>2003</year><volume>17</volume><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/S0890-6238(03)00013-3</pub-id><pub-id pub-id-type="pmid">12759105</pub-id></element-citation></ref><ref id="REF76"><label>76</label><element-citation publication-type="journal" id="CITATION76"><person-group person-group-type="author"><name name-style="western"><surname>Wagner</surname><given-names>FW</given-names></name><name name-style="western"><surname>Burger</surname><given-names>AR</given-names></name><name name-style="western"><surname>Vallee</surname><given-names>BL</given-names></name></person-group><article-title>Kinetic properties of human liver alcohol dehydrogenase: oxidation of alcohols by class I isoenzymes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1021/bi00277a018">Biochemistry</uri></source><year>1983</year><volume>22</volume><fpage>1857</fpage><lpage>1863</lpage><pub-id pub-id-type="doi">10.1021/bi00277a018</pub-id><pub-id pub-id-type="pmid">6342669</pub-id></element-citation></ref><ref id="REF77"><label>77</label><element-citation publication-type="journal" id="CITATION77"><person-group person-group-type="author"><name name-style="western"><surname>Teschke</surname><given-names>R</given-names></name><name name-style="western"><surname>Hasumura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lieber</surname><given-names>CS</given-names></name></person-group><article-title>Hepatic microsomal ethanol-oxidizing system: solubilization, isolation, and characterization</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0003-9861(74)90492-5">Arch Biochem Biophys</uri></source><year>1974</year><volume>163</volume><fpage>404</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(74)90492-5</pub-id><pub-id pub-id-type="pmid">4152897</pub-id></element-citation></ref><ref id="REF78"><label>78</label><element-citation publication-type="journal" id="CITATION78"><person-group person-group-type="author"><name name-style="western"><surname>Kunitoh</surname><given-names>S</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>T</given-names></name><name name-style="western"><surname>Imaoka</surname><given-names>S</given-names></name><name name-style="western"><surname>Funae</surname><given-names>Y</given-names></name><name name-style="western"><surname>Monna</surname><given-names>Y</given-names></name></person-group><article-title>Contribution of cytochrome P450s to MEOS (microsomal ethanol-oxidizing system): a specific and sensitive assay of MEOS activity by HPLC with fluorescence labeling</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/alcalc/28.Supplement_1B.63">Alcohol Alcohol Suppl</uri></source><year>1993</year><volume>28</volume><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1093/alcalc/28.Supplement_1B.63</pub-id><pub-id pub-id-type="pmid">8003131</pub-id></element-citation></ref><ref id="REF79"><label>79</label><element-citation publication-type="journal" id="CITATION79"><person-group person-group-type="author"><name name-style="western"><surname>Caro</surname><given-names>AA</given-names></name><name name-style="western"><surname>Cederbaum</surname><given-names>AI</given-names></name></person-group><article-title>Oxidative stress, toxicology, and pharmacology of CYP2E1</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1146/annurev.pharmtox.44.101802.121704">Annu Rev Pharmacol Toxicol</uri></source><year>2004</year><volume>44</volume><fpage>27</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.44.101802.121704</pub-id><pub-id pub-id-type="pmid">14744237</pub-id></element-citation></ref><ref id="REF80"><label>80</label><element-citation publication-type="journal" id="CITATION80"><person-group person-group-type="author"><name name-style="western"><surname>Coon</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Koop</surname><given-names>DR</given-names></name></person-group><article-title>Alcohol-inducible cytochrome P-450 (P-450ALC)</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF00296940">Arch Toxicol</uri></source><year>1987</year><volume>60</volume><fpage>16</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/BF00296940</pub-id><pub-id pub-id-type="pmid">3304205</pub-id></element-citation></ref><ref id="REF81"><label>81</label><element-citation publication-type="journal" id="CITATION81"><person-group person-group-type="author"><name name-style="western"><surname>Lieber</surname><given-names>CS</given-names></name></person-group><article-title>The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1081/dmr-200033441">Drug Metab Rev</uri></source><year>2004</year><volume>36</volume><fpage>511</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1081/dmr-200033441</pub-id><pub-id pub-id-type="pmid">15554233</pub-id></element-citation></ref><ref id="REF82"><label>82</label><element-citation publication-type="journal" id="CITATION82"><person-group person-group-type="author"><name name-style="western"><surname>Wallage</surname><given-names>HR</given-names></name><name name-style="western"><surname>Watterson</surname><given-names>JH</given-names></name></person-group><article-title>Formic acid and methanol concentrations in death investigations</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/jat/32.3.241">J Anal Toxicol</uri></source><year>2008</year><volume>32</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1093/jat/32.3.241</pub-id><pub-id pub-id-type="pmid">18397576</pub-id></element-citation></ref><ref id="REF83"><label>83</label><element-citation publication-type="journal" id="CITATION83"><person-group person-group-type="author"><name name-style="western"><surname>Bradford</surname><given-names>BU</given-names></name><name name-style="western"><surname>Seed</surname><given-names>CB</given-names></name><name name-style="western"><surname>Handler</surname><given-names>JA</given-names></name><name name-style="western"><surname>Forman</surname><given-names>DT</given-names></name><name name-style="western"><surname>Thurman</surname><given-names>RG</given-names></name></person-group><article-title>Evidence that catalase is a major pathway of ethanol oxidation
<italic toggle="yes">in vivo</italic>: dose-response studies in deer mice using methanol as a selective substrate
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1006/abbi.1993.1269">Arch Biochem Biophys</uri></source><year>1993</year><volume>303</volume><fpage>172</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1006/abbi.1993.1269</pub-id><pub-id pub-id-type="pmid">8489262</pub-id></element-citation></ref><ref id="REF84"><label>84</label><element-citation publication-type="journal" id="CITATION84"><person-group person-group-type="author"><name name-style="western"><surname>Thurman</surname><given-names>R</given-names></name><name name-style="western"><surname>Handler</surname><given-names>J</given-names></name></person-group><article-title>New perspectives in catalase dependent ethanol metabolism</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/03602538909103570">Drug Metab Rev</uri></source><year>1989</year><volume>20</volume><fpage>679</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.3109/03602538909103570</pub-id><pub-id pub-id-type="pmid">2680403</pub-id></element-citation></ref><ref id="REF85"><label>85</label><element-citation publication-type="journal" id="CITATION85"><person-group person-group-type="author"><name name-style="western"><surname>Cederbaum</surname><given-names>AI</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>A</given-names></name></person-group><article-title>Role of catalase and hydroxyl radicals in the oxidation of methanol by rat liver microsomes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0006-2952(82)90179-4">Biochem Pharmacol</uri></source><year>1982</year><volume>31</volume><fpage>329</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(82)90179-4</pub-id><pub-id pub-id-type="pmid">6280725</pub-id></element-citation></ref><ref id="REF86"><label>86</label><element-citation publication-type="journal" id="CITATION86"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name><name name-style="western"><surname>Deitrich</surname><given-names>R</given-names></name></person-group><article-title>Putative role of brain acetaldehyde in ethanol addiction</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2174/1874473710801010003">CDAR</uri></source><year>2008</year><volume>1</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2174/1874473710801010003</pub-id><pub-id pub-id-type="pmcid">PMC2613359</pub-id><pub-id pub-id-type="pmid">19122804</pub-id></element-citation></ref><ref id="REF87"><label>87</label><element-citation publication-type="other" id="CITATION87"><article-title>Goodman JI, Tephly TR. Peroxidative oxidation of methanol in human liver: the role of hepatic microbody and soluble oxidases.
<italic toggle="yes">
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/31111">Res Commun Chem Pathol Pharmacol</uri>
</italic> 1970, 1: 441&#8211;450
</article-title><pub-id pub-id-type="pmid">4400173</pub-id></element-citation></ref><ref id="REF88"><label>88</label><element-citation publication-type="other" id="CITATION88"><article-title>Karinje KU, Ogata M. Methanol metabolism in acatalasemic mice.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/2129307/">Physiol Chem Phys Med NMR</uri> 1990, 22: 193&#8211;198
</article-title><pub-id pub-id-type="pmid">2129307</pub-id></element-citation></ref><ref id="REF89"><label>89</label><element-citation publication-type="journal" id="CITATION89"><person-group person-group-type="author"><name name-style="western"><surname>Mannering</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Harken</surname><given-names>DR</given-names></name><name name-style="western"><surname>Makar</surname><given-names>AB</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>WD</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>JI</given-names></name></person-group><article-title>Role of the intracellular distribution of hepatic catalase in the peroxidative oxidation of methanol</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1749-6632.1969.tb43114.x">Ann NY Acad Sci</uri></source><year>1969</year><volume>168</volume><fpage>265</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1969.tb43114.x</pub-id><pub-id pub-id-type="other">1969NYASA.168..265M</pub-id><pub-id pub-id-type="pmid">4988806</pub-id></element-citation></ref><ref id="REF90"><label>90</label><element-citation publication-type="journal" id="CITATION90"><person-group person-group-type="author"><name name-style="western"><surname>Oshino</surname><given-names>N</given-names></name><name name-style="western"><surname>Jamieson</surname><given-names>D</given-names></name><name name-style="western"><surname>Sugano</surname><given-names>T</given-names></name><name name-style="western"><surname>Chance</surname><given-names>B</given-names></name></person-group><article-title>Optical measurement of the catalase-hydrogen peroxide intermediate (Compound I) in the liver of anaesthetized rats and its implication to hydrogen peroxide production
<italic toggle="yes">in situ</italic>
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1042/bj1460067">Biochem J</uri></source><year>1975</year><volume>146</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1042/bj1460067</pub-id><pub-id pub-id-type="pmid">1147905</pub-id><pub-id pub-id-type="pmcid">PMC1165276</pub-id></element-citation></ref><ref id="REF91"><label>91</label><element-citation publication-type="journal" id="CITATION91"><person-group person-group-type="author"><name name-style="western"><surname>Uotila</surname><given-names>L</given-names></name><name name-style="western"><surname>Koivusalo</surname><given-names>M</given-names></name></person-group><article-title>Formaldehyde dehydrogenase from human liver</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0021-9258(19)81287-5">J Biol Chem</uri></source><year>1974</year><volume>249</volume><fpage>7653</fpage><lpage>7663</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)81287-5</pub-id><pub-id pub-id-type="pmid">4373474</pub-id></element-citation></ref><ref id="REF92"><label>92</label><element-citation publication-type="journal" id="CITATION92"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>C</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>M</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>JM</given-names></name></person-group><article-title>Glutathione depletion modulates methanol, formaldehyde and formate toxicity in cultured rat conceptuses</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1023/B:CBTO.0000029466.08607.86">Cell Biol Toxicol</uri></source><year>2004</year><volume>20</volume><fpage>133</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1023/B:CBTO.0000029466.08607.86</pub-id><pub-id pub-id-type="pmid">15250539</pub-id></element-citation></ref><ref id="REF93"><label>93</label><element-citation publication-type="journal" id="CITATION93"><person-group person-group-type="author"><name name-style="western"><surname>Staab</surname><given-names>CA</given-names></name><name name-style="western"><surname>Hellgren</surname><given-names>M</given-names></name><name name-style="western"><surname>H&#246;&#246;g</surname><given-names>JO</given-names></name></person-group><article-title>Medium- and short-chain dehydrogenase/reductase gene and protein families</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00018-008-8592-2">Cell Mol Life Sci</uri></source><year>2008</year><volume>65</volume><fpage>3950</fpage><lpage>3960</lpage><pub-id pub-id-type="doi">10.1007/s00018-008-8592-2</pub-id><pub-id pub-id-type="pmid">19011746</pub-id><pub-id pub-id-type="pmcid">PMC11131861</pub-id></element-citation></ref><ref id="REF94"><label>94</label><element-citation publication-type="journal" id="CITATION94"><person-group person-group-type="author"><name name-style="western"><surname>Teng</surname><given-names>S</given-names></name><name name-style="western"><surname>Beard</surname><given-names>K</given-names></name><name name-style="western"><surname>Pourahmad</surname><given-names>J</given-names></name><name name-style="western"><surname>Moridani</surname><given-names>M</given-names></name><name name-style="western"><surname>Easson</surname><given-names>E</given-names></name><name name-style="western"><surname>Poon</surname><given-names>R</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>PJ</given-names></name></person-group><article-title>The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0009-2797(00)00272-6">Chemico-Biol Interactions</uri></source><year>2001</year><volume>130-132</volume><fpage>285</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/S0009-2797(00)00272-6</pub-id><pub-id pub-id-type="pmid">11306052</pub-id></element-citation></ref><ref id="REF95"><label>95</label><element-citation publication-type="journal" id="CITATION95"><person-group person-group-type="author"><name name-style="western"><surname>Koivula</surname><given-names>T</given-names></name><name name-style="western"><surname>Koivusalo</surname><given-names>M</given-names></name></person-group><article-title>Partial purification and properties of a phenobarbital-induced aldehyde dehydrogenase of rat liver</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0005-2744(75)90202-8">Biochim Biophys Acta</uri></source><year>1975</year><volume>410</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/0005-2744(75)90202-8</pub-id><pub-id pub-id-type="pmid">66</pub-id></element-citation></ref><ref id="REF96"><label>96</label><element-citation publication-type="journal" id="CITATION96"><person-group person-group-type="author"><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>The toxicity of methanol</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0024-3205(91)90504-5">Life Sci</uri></source><year>1991</year><volume>48</volume><fpage>1031</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(91)90504-5</pub-id><pub-id pub-id-type="pmid">1997785</pub-id></element-citation></ref><ref id="REF97"><label>97</label><element-citation publication-type="journal" id="CITATION97"><person-group person-group-type="author"><name name-style="western"><surname>Vasiliou</surname><given-names>V</given-names></name><name name-style="western"><surname>Pappa</surname><given-names>A</given-names></name><name name-style="western"><surname>Estey</surname><given-names>T</given-names></name></person-group><article-title>Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1081/DMR-120034001">Drug Metab Rev</uri></source><year>2004</year><volume>36</volume><fpage>279</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1081/DMR-120034001</pub-id><pub-id pub-id-type="pmid">15237855</pub-id></element-citation></ref><ref id="REF98"><label>98</label><element-citation publication-type="journal" id="CITATION98"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>D</given-names></name><name name-style="western"><surname>de Visser</surname><given-names>SP</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>PK</given-names></name><name name-style="western"><surname>Derat</surname><given-names>E</given-names></name><name name-style="western"><surname>Shaik</surname><given-names>S</given-names></name></person-group><article-title>The intrinsic axial ligand effect on propene oxidation by horseradish peroxidase versus cytochrome P450 enzymes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00775-004-0622-4">J Biol Inorg Chem</uri></source><year>2005</year><volume>10</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1007/s00775-004-0622-4</pub-id><pub-id pub-id-type="pmid">15723206</pub-id></element-citation></ref><ref id="REF99"><label>99</label><element-citation publication-type="journal" id="CITATION99"><person-group person-group-type="author"><name name-style="western"><surname>Eells</surname><given-names>JT</given-names></name></person-group><article-title>Formaldehyde poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/jama.1981.03320110049029">JAMA</uri></source><year>1981</year><volume>246</volume><fpage>1237</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1001/jama.1981.03320110049029</pub-id><pub-id pub-id-type="pmid">7265415</pub-id></element-citation></ref><ref id="REF100"><label>100</label><element-citation publication-type="journal" id="CITATION100"><person-group person-group-type="author"><name name-style="western"><surname>Black</surname><given-names>KA</given-names></name><name name-style="western"><surname>Eells</surname><given-names>JT</given-names></name><name name-style="western"><surname>Noker</surname><given-names>PE</given-names></name><name name-style="western"><surname>Hawtrey</surname><given-names>CA</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>Role of hepatic tetrahydrofolate in the species difference in methanol toxicity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1073/pnas.82.11.3854">Proc Natl Acad Sci U S A</uri></source><year>1985</year><volume>82</volume><fpage>3854</fpage><lpage>3858</lpage><pub-id pub-id-type="doi">10.1073/pnas.82.11.3854</pub-id><pub-id pub-id-type="other">1985PNAS...82.3854B</pub-id><pub-id pub-id-type="pmid">3923481</pub-id><pub-id pub-id-type="pmcid">PMC397886</pub-id></element-citation></ref><ref id="REF101"><label>101</label><element-citation publication-type="journal" id="CITATION101"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>EN</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>RT</given-names></name></person-group><article-title>Acute toxicity of methanol in the folate-deficient acatalasemic mouse</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0300-483X(82)90105-6">Toxicology</uri></source><year>1982</year><volume>25</volume><fpage>271</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/0300-483X(82)90105-6</pub-id><pub-id pub-id-type="pmid">7157404</pub-id></element-citation></ref><ref id="REF102"><label>102</label><element-citation publication-type="other" id="CITATION102"><article-title>Johlin FC, Fortman CS, Nghiem DD, Tephly TR. Studies of the role of folk acid and folate-dependent enzymes in human methanol poisoning.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0160-5402(87)90058-1">Mol Pharmacol</uri> 1987, 31: 557&#8211;561
</article-title><pub-id pub-id-type="pmid">3574297</pub-id></element-citation></ref><ref id="REF103"><label>103</label><element-citation publication-type="journal" id="CITATION103"><person-group person-group-type="author"><name name-style="western"><surname>Makar</surname><given-names>AB</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name><name name-style="western"><surname>Sahin</surname><given-names>G</given-names></name><name name-style="western"><surname>Osweiler</surname><given-names>G</given-names></name></person-group><article-title>Formate metabolism in young swine</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0041-008X(90)90192-W">Toxicol Appl Pharmacol</uri></source><year>1990</year><volume>105</volume><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/0041-008X(90)90192-W</pub-id><pub-id pub-id-type="pmid">2219121</pub-id></element-citation></ref><ref id="REF104"><label>104</label><element-citation publication-type="journal" id="CITATION104"><person-group person-group-type="author"><name name-style="western"><surname>Kavet</surname><given-names>R</given-names></name><name name-style="western"><surname>Nauss</surname><given-names>KM</given-names></name></person-group><article-title>The toxicity of inhaled methanol vapors</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/10408449009089872">Crit Rev Toxicol</uri></source><year>1990</year><volume>21</volume><fpage>21</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.3109/10408449009089872</pub-id><pub-id pub-id-type="pmid">2264926</pub-id></element-citation></ref><ref id="REF105"><label>105</label><element-citation publication-type="journal" id="CITATION105"><person-group person-group-type="author"><name name-style="western"><surname>Medinsky</surname><given-names>MA</given-names></name><name name-style="western"><surname>Dorman</surname><given-names>DC</given-names></name></person-group><article-title>Recent developments in methanol toxicity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0378-4274(95)03515-X">Toxicol Lett</uri></source><year>1995</year><volume>82-83</volume><fpage>707</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/0378-4274(95)03515-X</pub-id><pub-id pub-id-type="pmid">8597130</pub-id></element-citation></ref><ref id="REF106"><label>106</label><element-citation publication-type="other" id="CITATION106"><article-title>Heminiki K. Urinary sulfur-containing metabolites after administration of ethanol, acetaldehyde and formaldehyde to rats.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0378-4274(82)90096-0">Toxicol Lett</uri> 1982, 11: 1&#8211;6
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-4274(82)90096-0</pub-id><pub-id pub-id-type="pmid">7089999</pub-id></element-citation></ref><ref id="REF107"><label>107</label><element-citation publication-type="journal" id="CITATION107"><person-group person-group-type="author"><name name-style="western"><surname>Mashford</surname><given-names>PM</given-names></name><name name-style="western"><surname>Jones</surname><given-names>AR</given-names></name></person-group><article-title>Formaldehyde metabolism by the rat: a re-appraisal</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/00498258209046785">Xenobiotica</uri></source><year>1982</year><volume>12</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.3109/00498258209046785</pub-id><pub-id pub-id-type="pmid">6806997</pub-id></element-citation></ref><ref id="REF108"><label>108</label><element-citation publication-type="journal" id="CITATION108"><person-group person-group-type="author"><name name-style="western"><surname>Shaham</surname><given-names>J</given-names></name><name name-style="western"><surname>Bomstein</surname><given-names>Y</given-names></name><name name-style="western"><surname>Meltzer</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>Z</given-names></name><name name-style="western"><surname>Palma</surname><given-names>E</given-names></name><name name-style="western"><surname>Ribak</surname><given-names>J</given-names></name></person-group><article-title>DNA-protein crosslinks, a biomarker of exposure to formaldehyde&#8212;
<italic toggle="yes">in vitro</italic> and
<italic toggle="yes">in vivo</italic> studies
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/carcin/17.1.121">Carcinogenesis</uri></source><year>1996</year><volume>17</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1093/carcin/17.1.121</pub-id><pub-id pub-id-type="pmid">8565120</pub-id></element-citation></ref><ref id="REF109"><label>109</label><element-citation publication-type="journal" id="CITATION109"><person-group person-group-type="author"><name name-style="western"><surname>McMartin</surname><given-names>KE</given-names></name><name name-style="western"><surname>Martin-Amat</surname><given-names>G</given-names></name><name name-style="western"><surname>Noker</surname><given-names>PE</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>Lack of a role for formaldehyde in methanol poisoning in the monkey</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0006-2952(79)90149-7">Biochem Pharmacol</uri></source><year>1979</year><volume>28</volume><fpage>645</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(79)90149-7</pub-id><pub-id pub-id-type="pmid">109089</pub-id></element-citation></ref><ref id="REF110"><label>110</label><element-citation publication-type="journal" id="CITATION110"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>RQ</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Miao</surname><given-names>JY</given-names></name></person-group><article-title>Formaldehyde stress</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s11427-010-4112-3">Sci China Life Sci</uri></source><year>2010</year><volume>53</volume><fpage>1399</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1007/s11427-010-4112-3</pub-id><pub-id pub-id-type="pmid">21181340</pub-id></element-citation></ref><ref id="REF111"><label>111</label><element-citation publication-type="journal" id="CITATION111"><person-group person-group-type="author"><name name-style="western"><surname>Heck</surname><given-names>HA</given-names></name><name name-style="western"><surname>Casanova</surname><given-names>M</given-names></name></person-group><article-title>The implausibility of leukemia induction by formaldehyde: a critical review of the biological evidence on distant-site toxicity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.yrtph.2004.05.001">Regulatory Toxicol Pharmacol</uri></source><year>2004</year><volume>40</volume><fpage>92</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.yrtph.2004.05.001</pub-id><pub-id pub-id-type="pmid">15450713</pub-id></element-citation></ref><ref id="REF112"><label>112</label><element-citation publication-type="journal" id="CITATION112"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Han</surname><given-names>C</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>Accumulated hippocampal formaldehyde induces age-dependent memory decline</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s11357-012-9388-8">Age</uri></source><year>2013</year><volume>35</volume><fpage>583</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1007/s11357-012-9388-8</pub-id><pub-id pub-id-type="pmid">22382760</pub-id><pub-id pub-id-type="pmcid">PMC3636394</pub-id></element-citation></ref><ref id="REF113"><label>113</label><element-citation publication-type="journal" id="CITATION113"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Han</surname><given-names>C</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H</given-names></name><name name-style="western"><surname>Qiang</surname><given-names>M</given-names></name><name name-style="western"><surname>Su</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Aging-associated excess formaldehyde leads to spatial memory deficits</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/srep01807">Sci Rep</uri></source><year>2013</year><volume>3</volume><fpage>1807</fpage><pub-id pub-id-type="doi">10.1038/srep01807</pub-id><pub-id pub-id-type="other">2013NatSR...3E1807T</pub-id><pub-id pub-id-type="pmid">23657727</pub-id><pub-id pub-id-type="pmcid">PMC3648839</pub-id></element-citation></ref><ref id="REF114"><label>114</label><element-citation publication-type="other" id="CITATION114"><article-title>McMartin KE, Martin-Amat G, Makar AB, Tephly TR. Methanol poisoning. V. Role of formate metabolism in the monkey.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/B978-0-12-691402-3.50045-7">J Pharmacol Exp Ther</uri> 1977, 201: 564&#8211;572
</article-title><pub-id pub-id-type="pmid">405471</pub-id></element-citation></ref><ref id="REF115"><label>115</label><element-citation publication-type="other" id="CITATION115"><article-title>Wells PG, McCallum GP, Miller L, Siu MT, Sweeting JN. Oxidative stress and species differences in the metabolism, developmental toxicity and carcinogenic potential of methanol and ethanol. In: THE TOXICOLOGY OF METHANOL, John J. Clary (editor), pp. 169&#8211;253, Wiley, Hoboken, USA, 2013</article-title></element-citation></ref><ref id="REF116"><label>116</label><element-citation publication-type="journal" id="CITATION116"><person-group person-group-type="author"><name name-style="western"><surname>Sweeting</surname><given-names>JN</given-names></name><name name-style="western"><surname>Siu</surname><given-names>M</given-names></name><name name-style="western"><surname>McCallum</surname><given-names>GP</given-names></name><name name-style="western"><surname>Miller</surname><given-names>L</given-names></name><name name-style="western"><surname>Wells</surname><given-names>PG</given-names></name></person-group><article-title>Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.taap.2010.05.009">Toxicol Appl Pharmacol</uri></source><year>2010</year><volume>247</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2010.05.009</pub-id><pub-id pub-id-type="pmid">20510256</pub-id></element-citation></ref><ref id="REF117"><label>117</label><element-citation publication-type="journal" id="CITATION117"><person-group person-group-type="author"><name name-style="western"><surname>Eells</surname><given-names>JT</given-names></name><name name-style="western"><surname>Salzman</surname><given-names>MM</given-names></name><name name-style="western"><surname>Lewandowski</surname><given-names>MF</given-names></name><name name-style="western"><surname>Murray</surname><given-names>TG</given-names></name></person-group><article-title>Formate-induced alterations in retinal function in methanol-intoxicated rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1006/taap.1996.0197">Toxicol Appl Pharmacol</uri></source><year>1996</year><volume>140</volume><fpage>58</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1006/taap.1996.0197</pub-id><pub-id pub-id-type="pmid">8806870</pub-id></element-citation></ref><ref id="REF118"><label>118</label><element-citation publication-type="other" id="CITATION118"><article-title>R&#246;e O. The metabolism and toxicity of methanol.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/13266515/">Pharmacol Rev</uri>1955, 7: 399&#8211;412
</article-title><pub-id pub-id-type="pmid">13266515</pub-id></element-citation></ref><ref id="REF119"><label>119</label><element-citation publication-type="journal" id="CITATION119"><person-group person-group-type="author"><name name-style="western"><surname>Kruse</surname><given-names>JA</given-names></name></person-group><article-title>Methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF01694340">Intensive Care Med</uri></source><year>1992</year><volume>18</volume><fpage>391</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1007/BF01694340</pub-id><pub-id pub-id-type="pmid">1469176</pub-id></element-citation></ref><ref id="REF120"><label>120</label><element-citation publication-type="journal" id="CITATION120"><person-group person-group-type="author"><name name-style="western"><surname>R&#246;e</surname><given-names>O</given-names></name><name name-style="western"><surname>Enoksson</surname><given-names>P</given-names></name></person-group><article-title>Species differences in methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/10408448209003368">Crit Rev Toxicol</uri></source><year>1982</year><volume>10</volume><fpage>275</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.3109/10408448209003368</pub-id><pub-id pub-id-type="pmid">6756793</pub-id></element-citation></ref><ref id="REF121"><label>121</label><element-citation publication-type="other" id="CITATION121"><article-title>Henze T, Scheidt P, Prange HW. Die Methanol-Intoxikation. Klinische, neuropathologische und computertomografische Befunde.
<italic toggle="yes">Nervenarzt</italic> 1986, 57: 658&#8211;661
</article-title><pub-id pub-id-type="pmid">3808134</pub-id></element-citation></ref><ref id="REF122"><label>122</label><element-citation publication-type="other" id="CITATION122"><article-title>Liesivuori J, Kosma VM, Naukkarinen A, Savolainen H. Kinetics and toxic effects of repeated intravenous dosage of formic acid in rabbits.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://europepmc.org/article/MED/3426949">Brit J Exp Pathol</uri> 1987, 68: 853&#8211;861
</article-title><pub-id pub-id-type="pmcid">PMC2013086</pub-id><pub-id pub-id-type="pmid">3426949</pub-id></element-citation></ref><ref id="REF123"><label>123</label><element-citation publication-type="journal" id="CITATION123"><person-group person-group-type="author"><name name-style="western"><surname>Vasquez-Rios</surname><given-names>G</given-names></name><name name-style="western"><surname>Alkhankan</surname><given-names>H</given-names></name><name name-style="western"><surname>Sawaya</surname><given-names>BP</given-names></name><name name-style="western"><surname>Neyra</surname><given-names>JA</given-names></name></person-group><article-title>Extensive brain infarction and acute kidney injury in a young adult with methanol intoxication: a case report and review of the literature</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.5414/CN109494">Clin Nephrol</uri></source><year>2018</year><volume>90</volume><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.5414/CN109494</pub-id><pub-id pub-id-type="pmid">29932410</pub-id></element-citation></ref><ref id="REF124"><label>124</label><element-citation publication-type="other" id="CITATION124"><article-title>Vaneckova M, Zakharov S, Klempir J, Ruzicka E, Bezdicek O, Brozova H, Diblik P, Miovsky M, Hubacek JA, Urban P, Ridzon P, Pelclova D, Burgetova A, Masek M, Kotikova K, Peterova K, Liskova I, Hamplova L, Seidl Z. Imaging findings after methanol intoxication (cohort of 46 patients).
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26921573/">Neuro Endocrinol Lett</uri> 2015, 36: 737-744
</article-title><pub-id pub-id-type="pmid">26921573</pub-id></element-citation></ref><ref id="REF125"><label>125</label><element-citation publication-type="journal" id="CITATION125"><person-group person-group-type="author"><name name-style="western"><surname>Zakharov</surname><given-names>S</given-names></name><name name-style="western"><surname>Kotikova</surname><given-names>K</given-names></name><name name-style="western"><surname>Vaneckova</surname><given-names>M</given-names></name><name name-style="western"><surname>Seidl</surname><given-names>Z</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>O</given-names></name><name name-style="western"><surname>Navratil</surname><given-names>T</given-names></name><name name-style="western"><surname>Caganova</surname><given-names>B</given-names></name><etal>et al.</etal></person-group><article-title>Acute methanol poisoning: prevalence and predisposing factors of haemorrhagic and non-haemorrhagic brain lesions</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/bcpt.12559">Basic Clin Pharmacol Toxicol</uri></source><year>2016</year><volume>119</volume><fpage>228</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1111/bcpt.12559</pub-id><pub-id pub-id-type="pmid">26806851</pub-id></element-citation></ref><ref id="REF126"><label>126</label><element-citation publication-type="other" id="CITATION126"><article-title>Anderson TJ, Shuaib A, Becker WJ. Neurologic sequelae of methanol poisoning.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://europepmc.org/article/MED/3567778">Can Med Assoc J</uri> 1987, 136: 1177&#8211;1179
</article-title><pub-id pub-id-type="pmcid">PMC1492183</pub-id><pub-id pub-id-type="pmid">3567778</pub-id></element-citation></ref><ref id="REF127"><label>127</label><element-citation publication-type="journal" id="CITATION127"><person-group person-group-type="author"><name name-style="western"><surname>Almansori</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>SN</given-names></name></person-group><article-title>CT findings in methanol intoxication</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1503/cmaj.060647">Can Med Assoc J</uri></source><year>2007</year><volume>176</volume><fpage>620</fpage><pub-id pub-id-type="doi">10.1503/cmaj.060647</pub-id><pub-id pub-id-type="pmcid">PMC1800341</pub-id><pub-id pub-id-type="pmid">17325325</pub-id></element-citation></ref><ref id="REF128"><label>128</label><element-citation publication-type="journal" id="CITATION128"><person-group person-group-type="author"><name name-style="western"><surname>Arora</surname><given-names>V</given-names></name><name name-style="western"><surname>Nijjar</surname><given-names>IBS</given-names></name><name name-style="western"><surname>Multani</surname><given-names>AS</given-names></name><name name-style="western"><surname>Singh</surname><given-names>JP</given-names></name><name name-style="western"><surname>Abrol</surname><given-names>R</given-names></name><name name-style="western"><surname>Chopra</surname><given-names>R</given-names></name><name name-style="western"><surname>Attri</surname><given-names>R</given-names></name></person-group><article-title>MRI findings in methanol intoxication: a report of two cases</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1259/bjr/40137535">BJR</uri></source><year>2007</year><volume>80</volume><fpage>e243</fpage><lpage>e246</lpage><pub-id pub-id-type="doi">10.1259/bjr/40137535</pub-id><pub-id pub-id-type="pmid">17959915</pub-id></element-citation></ref><ref id="REF129"><label>129</label><element-citation publication-type="other" id="CITATION129"><article-title>Dujardin M, Peeters E, Ernst C, Stadnik T. Bilateral putaminal necrosis due to methanol abuse.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17274589/">JBR-BTR</uri> 2006, 89: 315&#8211;317
</article-title><pub-id pub-id-type="pmid">17274589</pub-id></element-citation></ref><ref id="REF130"><label>130</label><element-citation publication-type="journal" id="CITATION130"><person-group person-group-type="author"><name name-style="western"><surname>Jarwani</surname><given-names>BS</given-names></name><name name-style="western"><surname>Motiani</surname><given-names>P</given-names></name><name name-style="western"><surname>Divetia</surname><given-names>R</given-names></name><name name-style="western"><surname>Thakkar</surname><given-names>G</given-names></name></person-group><article-title>Rare combination of bilateral putaminal necrosis, optic neuritis, and polyneuropathy in a case of acute methanol intoxication among patients met with hooch tragedy in Gujarat, India</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.4103/0974-2700.102413">J Emerg Trauma Shock</uri></source><year>2012</year><volume>5</volume><fpage>356</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.4103/0974-2700.102413</pub-id><pub-id pub-id-type="pmid">23248510</pub-id><pub-id pub-id-type="pmcid">PMC3519054</pub-id></element-citation></ref><ref id="REF131"><label>131</label><element-citation publication-type="journal" id="CITATION131"><person-group person-group-type="author"><name name-style="western"><surname>Sanaei-Zadeh</surname><given-names>H</given-names></name></person-group><article-title>Typical bilateral putaminal lesions of methanol intoxication</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.jemermed.2009.08.010">J Emergency Med</uri></source><year>2012</year><volume>42</volume><fpage>178</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.jemermed.2009.08.010</pub-id><pub-id pub-id-type="pmid">19782499</pub-id></element-citation></ref><ref id="REF132"><label>132</label><element-citation publication-type="journal" id="CITATION132"><person-group person-group-type="author"><name name-style="western"><surname>Karayel</surname><given-names>F</given-names></name><name name-style="western"><surname>Turan</surname><given-names>AA</given-names></name><name name-style="western"><surname>Sav</surname><given-names>A</given-names></name><name name-style="western"><surname>Pakis</surname><given-names>I</given-names></name><name name-style="western"><surname>Akyildiz</surname><given-names>EU</given-names></name><name name-style="western"><surname>Ersoy</surname><given-names>G</given-names></name></person-group><article-title>Methanol intoxication: pathological changes of central nervous system (17 cases)</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/PAF.0b013e3181c160d9">Am J Forensic Med Pathol</uri></source><year>2010</year><volume>31</volume><fpage>34</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1097/PAF.0b013e3181c160d9</pub-id><pub-id pub-id-type="pmid">20010293</pub-id></element-citation></ref><ref id="REF133"><label>133</label><element-citation publication-type="journal" id="CITATION133"><person-group person-group-type="author"><name name-style="western"><surname>Sly</surname><given-names>WS</given-names></name><name name-style="western"><surname>Whyte</surname><given-names>MP</given-names></name><name name-style="western"><surname>Sundaram</surname><given-names>V</given-names></name><name name-style="western"><surname>Tashian</surname><given-names>RE</given-names></name><name name-style="western"><surname>Hewett-Emmett</surname><given-names>D</given-names></name><name name-style="western"><surname>Guibaud</surname><given-names>P</given-names></name><name name-style="western"><surname>Vainsel</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1056/NEJM198507183130302">N Engl J Med</uri></source><year>1985</year><volume>313</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1056/NEJM198507183130302</pub-id><pub-id pub-id-type="pmid">3925334</pub-id></element-citation></ref><ref id="REF134"><label>134</label><element-citation publication-type="other" id="CITATION134"><article-title>Preuss HG, Baird K, Goldin H. Oxygen consumption and ammoniagenesis in isolated dog renal tubules.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/4419667/">J Lab Clin Med</uri> 1974, 83: 937&#8211;946
</article-title><pub-id pub-id-type="pmid">4419667</pub-id></element-citation></ref><ref id="REF135"><label>135</label><element-citation publication-type="journal" id="CITATION135"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>T</given-names></name><name name-style="western"><surname>Nangaku</surname><given-names>M</given-names></name></person-group><article-title>Angiogenesis and hypoxia in the kidney</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/nrneph.2013.35">Nat Rev Nephrol</uri></source><year>2013</year><volume>9</volume><fpage>211</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2013.35</pub-id><pub-id pub-id-type="pmid">23458926</pub-id></element-citation></ref><ref id="REF136"><label>136</label><element-citation publication-type="journal" id="CITATION136"><person-group person-group-type="author"><name name-style="western"><surname>Schieppati</surname><given-names>A</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>PD</given-names></name><name name-style="western"><surname>Burke</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Schrier</surname><given-names>RW</given-names></name></person-group><article-title>Effect of renal ischemia on cortical microsomal calcium accumulation</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajpcell.1985.249.5.C476">Am J Physiol</uri></source><year>1985</year><volume>249</volume><fpage>C476</fpage><lpage>C483</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1985.249.5.C476</pub-id><pub-id pub-id-type="pmid">4061632</pub-id></element-citation></ref><ref id="REF137"><label>137</label><element-citation publication-type="other" id="CITATION137"><article-title>Korchanov LS, Lebedev FM, Lizanets MN. Treatment of patients with acute kidney insufficiency caused by methyl alcohol poisoning.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/5457170/">Urol Nefrol</uri> 1970, 35: 66&#8211;67
</article-title><pub-id pub-id-type="pmid">5457170</pub-id></element-citation></ref><ref id="REF138"><label>138</label><element-citation publication-type="journal" id="CITATION138"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>ST</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YT</given-names></name><name name-style="western"><surname>Hou</surname><given-names>YC</given-names></name><name name-style="western"><surname>Wang</surname><given-names>IK</given-names></name><name name-style="western"><surname>Hong</surname><given-names>HH</given-names></name><name name-style="western"><surname>Weng</surname><given-names>CH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>WH</given-names></name><etal>et al.</etal></person-group><article-title>Acute kidney injury and the risk of mortality in patients with methanol intoxication</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1186/s12882-019-1404-0">BMC Nephrol</uri></source><year>2019</year><volume>20</volume><fpage>205</fpage><pub-id pub-id-type="doi">10.1186/s12882-019-1404-0</pub-id><pub-id pub-id-type="pmid">31170938</pub-id><pub-id pub-id-type="pmcid">PMC6554873</pub-id></element-citation></ref><ref id="REF139"><label>139</label><element-citation publication-type="journal" id="CITATION139"><person-group person-group-type="author"><name name-style="western"><surname>Verhelst</surname><given-names>D</given-names></name><name name-style="western"><surname>Moulin</surname><given-names>P</given-names></name><name name-style="western"><surname>Haufroid</surname><given-names>V</given-names></name><name name-style="western"><surname>Wittebole</surname><given-names>X</given-names></name><name name-style="western"><surname>Jadoul</surname><given-names>M</given-names></name><name name-style="western"><surname>Hantson</surname><given-names>P</given-names></name></person-group><article-title>Acute renal injury following methanol poisoning: analysis of a case series</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/10915810490506795">Int J Toxicol</uri></source><year>2004</year><volume>23</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1080/10915810490506795</pub-id><pub-id pub-id-type="pmid">15371171</pub-id></element-citation></ref><ref id="REF140"><label>140</label><element-citation publication-type="journal" id="CITATION140"><person-group person-group-type="author"><name name-style="western"><surname>Knauf</surname><given-names>F</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CL</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>RB</given-names></name><name name-style="western"><surname>Mentone</surname><given-names>SA</given-names></name><name name-style="western"><surname>Giebisch</surname><given-names>G</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>PS</given-names></name></person-group><article-title>Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1073/pnas.141241098">Proc Natl Acad Sci U S A</uri></source><year>2001</year><volume>98</volume><fpage>9425</fpage><lpage>9430</lpage><pub-id pub-id-type="doi">10.1073/pnas.141241098</pub-id><pub-id pub-id-type="other">2001PNAS...98.9425K</pub-id><pub-id pub-id-type="pmid">11459928</pub-id><pub-id pub-id-type="pmcid">PMC55437</pub-id></element-citation></ref><ref id="REF141"><label>141</label><element-citation publication-type="journal" id="CITATION141"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Giebisch</surname><given-names>G</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>PS</given-names></name></person-group><article-title>Effects of formate and oxalate on volume absorption in rat proximal tubule</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajprenal.1992.263.1.F37">Am J Physiol</uri></source><year>1992</year><volume>263</volume><fpage>F37</fpage><lpage>F42</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.1992.263.1.F37</pub-id><pub-id pub-id-type="pmid">1636743</pub-id></element-citation></ref><ref id="REF142"><label>142</label><element-citation publication-type="other" id="CITATION142"><article-title>Aronson PS, Giebisch G. Mechanisms of chloride transport in the proximal tubule.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajprenal.1997.273.2.F179">Am J Physiol</uri> 1997, 273(2 Pt 2): F179&#8211;F192
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.1997.273.2.F179</pub-id><pub-id pub-id-type="pmid">9277578</pub-id></element-citation></ref><ref id="REF143"><label>143</label><element-citation publication-type="journal" id="CITATION143"><person-group person-group-type="author"><name name-style="western"><surname>Liesivuori</surname><given-names>J</given-names></name><name name-style="western"><surname>Savolainen</surname><given-names>H</given-names></name></person-group><article-title>Effect of renal formic acid excretion on urinary calcium and ammonia concentrations</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF01737005">Klin Wochenschr</uri></source><year>1987</year><volume>65</volume><fpage>860</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1007/BF01737005</pub-id><pub-id pub-id-type="pmid">3669558</pub-id></element-citation></ref><ref id="REF144"><label>144</label><element-citation publication-type="journal" id="CITATION144"><person-group person-group-type="author"><name name-style="western"><surname>Zitting</surname><given-names>A</given-names></name><name name-style="western"><surname>Savolainen</surname><given-names>H</given-names></name><name name-style="western"><surname>Nickels</surname><given-names>J</given-names></name></person-group><article-title>Biochemical and toxicological effects of single and repeated exposures to polyacetal thermodegradation products</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0013-9351(82)90031-7">Environ Res</uri></source><year>1982</year><volume>29</volume><fpage>287</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/0013-9351(82)90031-7</pub-id><pub-id pub-id-type="pmid">7160348</pub-id></element-citation></ref><ref id="REF145"><label>145</label><element-citation publication-type="journal" id="CITATION145"><person-group person-group-type="author"><name name-style="western"><surname>Orchard</surname><given-names>CH</given-names></name><name name-style="western"><surname>Houser</surname><given-names>SR</given-names></name><name name-style="western"><surname>Kort</surname><given-names>AA</given-names></name><name name-style="western"><surname>Bahinski</surname><given-names>A</given-names></name><name name-style="western"><surname>Capogrossi</surname><given-names>MC</given-names></name><name name-style="western"><surname>Lakatta</surname><given-names>EG</given-names></name></person-group><article-title>Acidosis facilitates spontaneous sarcoplasmic reticulum Ca
<sup>2+</sup> release in rat myocardium
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1085/jgp.90.1.145">J Gen Physiol</uri></source><year>1987</year><volume>90</volume><fpage>145</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1085/jgp.90.1.145</pub-id><pub-id pub-id-type="pmid">3625165</pub-id><pub-id pub-id-type="pmcid">PMC2228866</pub-id></element-citation></ref><ref id="REF146"><label>146</label><element-citation publication-type="journal" id="CITATION146"><person-group person-group-type="author"><name name-style="western"><surname>Metz</surname><given-names>B</given-names></name><name name-style="western"><surname>Kersten</surname><given-names>GFA</given-names></name><name name-style="western"><surname>Baart</surname><given-names>GJE</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>A</given-names></name><name name-style="western"><surname>Meiring</surname><given-names>H</given-names></name><name name-style="western"><surname>ten Hove</surname><given-names>J</given-names></name><name name-style="western"><surname>van Steenbergen</surname><given-names>MJ</given-names></name><etal>et al.</etal></person-group><article-title>Identification of formaldehyde-induced modifications in proteins:&#8201; reactions with insulin</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1021/bc050340f">Bioconjug Chem</uri></source><year>2006</year><volume>17</volume><fpage>815</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1021/bc050340f</pub-id><pub-id pub-id-type="pmid">16704222</pub-id></element-citation></ref><ref id="REF147"><label>147</label><element-citation publication-type="journal" id="CITATION147"><person-group person-group-type="author"><name name-style="western"><surname>Kiernan</surname><given-names>JA</given-names></name></person-group><article-title>Formaldehyde, formalin, paraformaldehyde and glutaraldehyde: what they are and what they do</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1017/S1551929500057060">Microsc Today</uri></source><year>2000</year><volume>8</volume><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1017/S1551929500057060</pub-id></element-citation></ref><ref id="REF148"><label>148</label><element-citation publication-type="journal" id="CITATION148"><person-group person-group-type="author"><name name-style="western"><surname>Pandey</surname><given-names>CK</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>A</given-names></name><name name-style="western"><surname>Baronia</surname><given-names>A</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name></person-group><article-title>Toxicity of ingested formalin and its management</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1191/096032700678815954">Hum Exp Toxicol</uri></source><year>2000</year><volume>19</volume><fpage>360</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1191/096032700678815954</pub-id><pub-id pub-id-type="pmid">10962510</pub-id></element-citation></ref><ref id="REF149"><label>149</label><element-citation publication-type="journal" id="CITATION149"><person-group person-group-type="author"><name name-style="western"><surname>Beeregowda</surname><given-names>YC</given-names></name><name name-style="western"><surname>Srihari</surname><given-names>A</given-names></name><name name-style="western"><surname>Pradan</surname><given-names>SK</given-names></name><name name-style="western"><surname>Susheela</surname><given-names>P</given-names></name><name name-style="western"><surname>Manjunatha</surname><given-names>YC</given-names></name></person-group><article-title>Homicidal acute formalin poisoning in an infant from a rural sericulture family presenting with multisystem failure</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/PEC.0b013e31828ebfef">Pediatr Emerge Care</uri></source><year>2013</year><volume>29</volume><fpage>653</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1097/PEC.0b013e31828ebfef</pub-id><pub-id pub-id-type="pmid">23640147</pub-id></element-citation></ref><ref id="REF150"><label>150</label><element-citation publication-type="journal" id="CITATION150"><person-group person-group-type="author"><name name-style="western"><surname>Beall</surname><given-names>JR</given-names></name><name name-style="western"><surname>Ulsamer</surname><given-names>AG</given-names></name></person-group><article-title>Formaldehyde and hepatotoxicity: a review</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/15287398409530560">J Toxicol Environ Health</uri></source><year>1984</year><volume>14</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1080/15287398409530560</pub-id><pub-id pub-id-type="pmid">6389892</pub-id></element-citation></ref><ref id="REF151"><label>151</label><element-citation publication-type="journal" id="CITATION151"><person-group person-group-type="author"><name name-style="western"><surname>Szende</surname><given-names>B</given-names></name><name name-style="western"><surname>Tyih&#225;k</surname><given-names>E</given-names></name></person-group><article-title>Effect of formaldehyde on cell proliferation and death</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1042/CBI20100532">Cell Biol Int</uri></source><year>2010</year><volume>34</volume><fpage>1273</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1042/CBI20100532</pub-id><pub-id pub-id-type="pmid">21067524</pub-id></element-citation></ref><ref id="REF152"><label>152</label><element-citation publication-type="journal" id="CITATION152"><person-group person-group-type="author"><name name-style="western"><surname>Tyihak</surname><given-names>E</given-names></name><name name-style="western"><surname>Trezl</surname><given-names>L</given-names></name><name name-style="western"><surname>Szende</surname><given-names>B</given-names></name></person-group><article-title>Formaldehyde cycle and the phases of stress syndrome</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1749-6632.1998.tb09001.x">Ann NY Acad Sci</uri></source><year>1998</year><volume>851</volume><fpage>259</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1998.tb09001.x</pub-id><pub-id pub-id-type="other">1998NYASA.851..259T</pub-id></element-citation></ref><ref id="REF153"><label>153</label><element-citation publication-type="journal" id="CITATION153"><person-group person-group-type="author"><name name-style="western"><surname>Tulpule</surname><given-names>K</given-names></name><name name-style="western"><surname>Hohnholt</surname><given-names>MC</given-names></name><name name-style="western"><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Formaldehyde metabolism and formaldehyde-induced stimulation of lactate production and glutathione export in cultured neurons</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/jnc.12170">J Neurochem</uri></source><year>2013</year><volume>125</volume><fpage>260</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1111/jnc.12170</pub-id><pub-id pub-id-type="pmid">23356791</pub-id></element-citation></ref><ref id="REF154"><label>154</label><element-citation publication-type="journal" id="CITATION154"><person-group person-group-type="author"><name name-style="western"><surname>Songur</surname><given-names>A</given-names></name><name name-style="western"><surname>Sarsilmaz</surname><given-names>M</given-names></name><name name-style="western"><surname>Ozen</surname><given-names>O</given-names></name><name name-style="western"><surname>Sahin</surname><given-names>S</given-names></name><name name-style="western"><surname>Koken</surname><given-names>R</given-names></name><name name-style="western"><surname>Zararsiz</surname><given-names>I</given-names></name><name name-style="western"><surname>Ilhan</surname><given-names>N</given-names></name></person-group><article-title>The effects of inhaled formaldehyde on oxidant and antioxidant systems of rat cerebellum during the postnatal development process</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/15376510701555288">Toxicol Mech Methods</uri></source><year>2008</year><volume>18</volume><fpage>569</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1080/15376510701555288</pub-id><pub-id pub-id-type="pmid">20020855</pub-id></element-citation></ref><ref id="REF155"><label>155</label><element-citation publication-type="journal" id="CITATION155"><person-group person-group-type="author"><name name-style="western"><surname>Lushchak</surname><given-names>VI</given-names></name></person-group><article-title>Glutathione homeostasis and functions: potential targets for medical interventions</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1155/2012/736837">J Amino Acids</uri></source><year>2012</year><volume>2012</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1155/2012/736837</pub-id><pub-id pub-id-type="pmid">22500213</pub-id><pub-id pub-id-type="pmcid">PMC3303626</pub-id></element-citation></ref><ref id="REF156"><label>156</label><element-citation publication-type="other" id="CITATION156"><article-title>Schmidt MM, Dringen R. GSH synthesis and metabolism. In: Gruetter R and Choi IY eds. Advances in Neurobiology.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/978-1-4614-1788-0_36">Neural MetabolismIn Vivo</uri> New York: Springer 2012, 1029&#8211;1050
</article-title></element-citation></ref><ref id="REF157"><label>157</label><element-citation publication-type="other" id="CITATION157"><article-title>Songur A, Ozen OA, Sarsilmaz M. The toxic effects of formaldehyde on the nervous system.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/978-1-4419-1352-4_3">Rev Environ Contamination Toxicol</uri> 2010, 203: 105&#8211;118
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4419-1352-4_3</pub-id><pub-id pub-id-type="pmid">19957118</pub-id></element-citation></ref><ref id="REF158"><label>158</label><element-citation publication-type="journal" id="CITATION158"><person-group person-group-type="author"><name name-style="western"><surname>Pallas</surname><given-names>M</given-names></name><name name-style="western"><surname>Camins</surname><given-names>A</given-names></name><name name-style="western"><surname>Smith</surname><given-names>MA</given-names></name><name name-style="western"><surname>Perry</surname><given-names>G</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Casadesus</surname><given-names>G</given-names></name></person-group><article-title>From aging to Alzheimer&#8217;s disease: unveiling &#8220;the switch&#8221; with the senescence-accelerated mouse model (SAMP8)</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3233/jad-2008-15408">J Alzheimer Dis</uri></source><year>2008</year><volume>15</volume><fpage>615</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.3233/jad-2008-15408</pub-id><pub-id pub-id-type="pmid">19096160</pub-id></element-citation></ref><ref id="REF159"><label>159</label><element-citation publication-type="journal" id="CITATION159"><person-group person-group-type="author"><name name-style="western"><surname>del Mar Hernandez</surname><given-names>M</given-names></name><name name-style="western"><surname>Esteban</surname><given-names>M</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>P</given-names></name><name name-style="western"><surname>Boada</surname><given-names>M</given-names></name><name name-style="western"><surname>Unzeta</surname><given-names>M</given-names></name></person-group><article-title>Human plasma semicarbazide sensitive amine oxidase (SSAO), &#946;-amyloid protein and aging</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.neulet.2005.04.074">Neurosci Lett</uri></source><year>2005</year><volume>384</volume><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2005.04.074</pub-id><pub-id pub-id-type="pmid">15894424</pub-id></element-citation></ref><ref id="REF160"><label>160</label><element-citation publication-type="journal" id="CITATION160"><person-group person-group-type="author"><name name-style="western"><surname>Unzeta</surname><given-names>M</given-names></name><name name-style="western"><surname>Sol&#233;</surname><given-names>M</given-names></name><name name-style="western"><surname>Boada</surname><given-names>M</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>M</given-names></name></person-group><article-title>Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer&#8217;s disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00702-007-0701-0">J Neural Transm</uri></source><year>2007</year><volume>114</volume><fpage>857</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1007/s00702-007-0701-0</pub-id><pub-id pub-id-type="pmid">17393059</pub-id></element-citation></ref><ref id="REF161"><label>161</label><element-citation publication-type="journal" id="CITATION161"><person-group person-group-type="author"><name name-style="western"><surname>M&#233;sz&#225;ros</surname><given-names>Z</given-names></name><name name-style="western"><surname>Szombathy</surname><given-names>T</given-names></name><name name-style="western"><surname>Raimondi</surname><given-names>L</given-names></name><name name-style="western"><surname>Kar&#225;di</surname><given-names>I</given-names></name><name name-style="western"><surname>Romics</surname><given-names>L</given-names></name><name name-style="western"><surname>Magyar</surname><given-names>K</given-names></name></person-group><article-title>Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0026-0495(99)90019-7">Metabolism</uri></source><year>1999</year><volume>48</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/S0026-0495(99)90019-7</pub-id><pub-id pub-id-type="pmid">9920154</pub-id></element-citation></ref><ref id="REF162"><label>162</label><element-citation publication-type="journal" id="CITATION162"><person-group person-group-type="author"><name name-style="western"><surname>Gr&#246;nvall-Nordquist</surname><given-names>JLE</given-names></name><name name-style="western"><surname>B&#228;cklund</surname><given-names>LB</given-names></name><name name-style="western"><surname>Garpenstrand</surname><given-names>H</given-names></name><name name-style="western"><surname>Ekblom</surname><given-names>J</given-names></name><name name-style="western"><surname>Landin</surname><given-names>B</given-names></name><name name-style="western"><surname>Yu</surname><given-names>PH</given-names></name><name name-style="western"><surname>Oreland</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in type 2 diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S1056-8727(01)00151-9">J Diabetes Complications</uri></source><year>2001</year><volume>15</volume><fpage>250</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/S1056-8727(01)00151-9</pub-id><pub-id pub-id-type="pmid">11522499</pub-id></element-citation></ref><ref id="REF163"><label>163</label><element-citation publication-type="journal" id="CITATION163"><person-group person-group-type="author"><name name-style="western"><surname>Obata</surname><given-names>T</given-names></name></person-group><article-title>Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.lfs.2006.01.017">Life Sci</uri></source><year>2006</year><volume>79</volume><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2006.01.017</pub-id><pub-id pub-id-type="pmid">16487546</pub-id></element-citation></ref><ref id="REF164"><label>164</label><element-citation publication-type="journal" id="CITATION164"><person-group person-group-type="author"><name name-style="western"><surname>Ragan</surname><given-names>DL</given-names></name><name name-style="western"><surname>Boreiko</surname><given-names>CJ</given-names></name></person-group><article-title>Initiation of solC3H10T12 cell transformation by formaldehyde</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0304-3835(81)90061-6">Cancer Lett</uri></source><year>1981</year><volume>13</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/0304-3835(81)90061-6</pub-id><pub-id pub-id-type="pmid">7306959</pub-id></element-citation></ref><ref id="REF165"><label>165</label><element-citation publication-type="other" id="CITATION165"><article-title>Swenberg JA, Kerns WD, Mitchell RI, Gralla EJ, Pavkov KL. Induction of squamous cell carcinomas of the rat nasal cavity by inhalation to formaldehyde vapor.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7427950/">Cancer Res</uri> 1980, 40: 3398&#8211;3402
</article-title><pub-id pub-id-type="pmid">7427950</pub-id></element-citation></ref><ref id="REF166"><label>166</label><element-citation publication-type="other" id="CITATION166"><article-title>Albert RE, Sellakumas AR, Laskia S, Nelson N, Snyder CA. Gaseous formaldehyde and hydrogen chloride induction of nasal cancer in the rat.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/jnci/68.4.597">J Natl Cancer Inst</uri> 1982, 68: 597&#8211;603
</article-title><pub-id pub-id-type="pmid">6951075</pub-id></element-citation></ref><ref id="REF167"><label>167</label><element-citation publication-type="other" id="CITATION167"><article-title>International Agency for Research on Cancer (IARC) IARC monographs on the evaluation of carcinogenic risks to humans. Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol, Vol. 88. Lyon: International Agency for Research on Cancer. 2006, 39&#8211;325</article-title><pub-id pub-id-type="pmcid">PMC4781641</pub-id><pub-id pub-id-type="pmid">17366697</pub-id></element-citation></ref><ref id="REF168"><label>168</label><element-citation publication-type="journal" id="CITATION168"><person-group person-group-type="author"><name name-style="western"><surname>Checkoway</surname><given-names>H</given-names></name><name name-style="western"><surname>Boffetta</surname><given-names>P</given-names></name><name name-style="western"><surname>Mundt</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Mundt</surname><given-names>KA</given-names></name></person-group><article-title>Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s10552-012-0055-2">Cancer Causes Control</uri></source><year>2012</year><volume>23</volume><fpage>1747</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.1007/s10552-012-0055-2</pub-id><pub-id pub-id-type="pmid">22983399</pub-id><pub-id pub-id-type="pmcid">PMC3465649</pub-id></element-citation></ref><ref id="REF169"><label>169</label><element-citation publication-type="journal" id="CITATION169"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lineker</surname><given-names>GA</given-names></name></person-group><article-title>A review and meta-analysis of formaldehyde exposure and leukemia</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.yrtph.2004.04.006">Regul Toxicol Pharmacol</uri></source><year>2004</year><volume>40</volume><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.yrtph.2004.04.006</pub-id><pub-id pub-id-type="pmid">15450712</pub-id></element-citation></ref><ref id="REF170"><label>170</label><element-citation publication-type="journal" id="CITATION170"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Steinmaus</surname><given-names>C</given-names></name><name name-style="western"><surname>Eastmond</surname><given-names>DA</given-names></name><name name-style="western"><surname>Xin</surname><given-names>XK</given-names></name><name name-style="western"><surname>Smith</surname><given-names>MT</given-names></name></person-group><article-title>Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.mrrev.2008.07.002">Mutat Res Rev Mutat Res</uri></source><year>2009</year><volume>681</volume><fpage>150</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.mrrev.2008.07.002</pub-id><pub-id pub-id-type="pmid">18674636</pub-id></element-citation></ref><ref id="REF171"><label>171</label><element-citation publication-type="other" id="CITATION171"><article-title>Malizia E, Reale C, Pietropaoli P, De Ritis GC (1977) Formic acid intoxications.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/302589/">Acta Pharmacol Toxicol (Copenh)</uri> 1977, 4(Suppl 2): 342&#8211;347
</article-title><pub-id pub-id-type="pmid">302589</pub-id></element-citation></ref><ref id="REF172"><label>172</label><element-citation publication-type="journal" id="CITATION172"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>KB</given-names></name></person-group><article-title>Mitochondria-mediated cell injury. Symposium overview</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1006/faat.1997.2320">Fundamental Appl Toxicol</uri></source><year>1997</year><volume>38</volume><fpage>23</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1006/faat.1997.2320</pub-id><pub-id pub-id-type="pmid">9268603</pub-id></element-citation></ref><ref id="REF173"><label>173</label><element-citation publication-type="journal" id="CITATION173"><person-group person-group-type="author"><name name-style="western"><surname>Keyhani</surname><given-names>J</given-names></name><name name-style="western"><surname>Keyhani</surname><given-names>E</given-names></name></person-group><article-title>EPR study of the effect of formate on cytochrome c oxidase</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0006-291X(80)91556-9">Biochem Biophys Res Commun</uri></source><year>1980</year><volume>92</volume><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(80)91556-9</pub-id><pub-id pub-id-type="pmid">6243938</pub-id></element-citation></ref><ref id="REF174"><label>174</label><element-citation publication-type="journal" id="CITATION174"><person-group person-group-type="author"><name name-style="western"><surname>Dorman</surname><given-names>DC</given-names></name><name name-style="western"><surname>Bolon</surname><given-names>B</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>KT</given-names></name></person-group><article-title>The toxic effects of formate in dissociated primary mouse neural cell cultures</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1006/taap.1993.1195">Toxicol Appl Pharmacol</uri></source><year>1993</year><volume>122</volume><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1006/taap.1993.1195</pub-id><pub-id pub-id-type="pmid">8212008</pub-id></element-citation></ref><ref id="REF175"><label>175</label><element-citation publication-type="journal" id="CITATION175"><person-group person-group-type="author"><name name-style="western"><surname>Bralet</surname><given-names>J</given-names></name><name name-style="western"><surname>Bouvier</surname><given-names>C</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>L</given-names></name><name name-style="western"><surname>Boquillon</surname><given-names>M</given-names></name></person-group><article-title>Effect of acidosis on lipid peroxidation in brain slices</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0006-8993(91)90703-X">Brain Res</uri></source><year>1991</year><volume>539</volume><fpage>175</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(91)90703-X</pub-id><pub-id pub-id-type="pmid">2015500</pub-id></element-citation></ref><ref id="REF176"><label>176</label><element-citation publication-type="journal" id="CITATION176"><person-group person-group-type="author"><name name-style="western"><surname>Chacon</surname><given-names>E</given-names></name></person-group><article-title>Mitochondrial regulation of superoxide by Ca
<sup>2+</sup>: an alternate mechanism for the cardiotoxicity of doxorubicin
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0041-008X(91)90336-D">Toxicol Appl Pharmacol</uri></source><year>1991</year><volume>107</volume><fpage>117</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/0041-008X(91)90336-D</pub-id><pub-id pub-id-type="pmid">1702908</pub-id></element-citation></ref><ref id="REF177"><label>177</label><element-citation publication-type="journal" id="CITATION177"><person-group person-group-type="author"><name name-style="western"><surname>Cheung</surname><given-names>JY</given-names></name><name name-style="western"><surname>Leaf</surname><given-names>A</given-names></name><name name-style="western"><surname>Bonventre</surname><given-names>JV</given-names></name></person-group><article-title>Mitochondrial function and intracellular calcium in anoxic cardiac myocytes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajpcell.1986.250.1.C18">Am J Physiol</uri></source><year>1986</year><volume>250</volume><fpage>C18</fpage><lpage>C25</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1986.250.1.C18</pub-id><pub-id pub-id-type="pmid">2417494</pub-id></element-citation></ref><ref id="REF178"><label>178</label><element-citation publication-type="journal" id="CITATION178"><person-group person-group-type="author"><name name-style="western"><surname>Skrzydlewska</surname><given-names>E</given-names></name><name name-style="western"><surname>Farbiszewski</surname><given-names>R</given-names></name></person-group><article-title>Trolox-derivative antioxidant protects against methanol-induced damage</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1472-8206.1997.tb00209.x">Fundamental Clin Pharmacol</uri></source><year>1997</year><volume>11</volume><fpage>460</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1111/j.1472-8206.1997.tb00209.x</pub-id><pub-id pub-id-type="pmid">9342600</pub-id></element-citation></ref><ref id="REF179"><label>179</label><element-citation publication-type="journal" id="CITATION179"><person-group person-group-type="author"><name name-style="western"><surname>Farbiszewski</surname><given-names>ESR</given-names></name></person-group><article-title>Lipid peroxidation and antioxidant status in the liver, erythrocytes, and serum of rats after methanol intoxication</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/009841098159088">J Toxicol Environ Health Part A</uri></source><year>1998</year><volume>53</volume><fpage>637</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1080/009841098159088</pub-id><pub-id pub-id-type="pmid">9572161</pub-id></element-citation></ref><ref id="REF180"><label>180</label><element-citation publication-type="other" id="CITATION180"><article-title>Erecinska M, Wilson DF. Inhibitors of cytochrome c oxidase.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi:10.1016/0163-7258(80)90057-1">Pharmacol Ther</uri> 1980, 8: 1&#8211;20
</article-title></element-citation></ref><ref id="REF181"><label>181</label><element-citation publication-type="journal" id="CITATION181"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>JD</given-names></name><name name-style="western"><surname>Meisenheimer</surname><given-names>TL</given-names></name><name name-style="western"><surname>Isom</surname><given-names>GE</given-names></name></person-group><article-title>Cyanide-induced neurotoxicity: role of neuronal calcium</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0041-008X(86)90251-6">Toxicol Appl Pharmacol</uri></source><year>1986</year><volume>84</volume><fpage>464</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/0041-008X(86)90251-6</pub-id><pub-id pub-id-type="pmid">3726869</pub-id></element-citation></ref><ref id="REF182"><label>182</label><element-citation publication-type="journal" id="CITATION182"><person-group person-group-type="author"><name name-style="western"><surname>Maduh</surname><given-names>EU</given-names></name><name name-style="western"><surname>Borowitz</surname><given-names>JL</given-names></name><name name-style="western"><surname>Isom</surname><given-names>GE</given-names></name></person-group><article-title>Cyanide-induced alteration of cytosolic pH: involvement of cellular hydrogen ion handling processes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0041-008X(90)90240-U">Toxicol Appl Pharmacol</uri></source><year>1990</year><volume>106</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/0041-008X(90)90240-U</pub-id><pub-id pub-id-type="pmid">2256111</pub-id></element-citation></ref><ref id="REF183"><label>183</label><element-citation publication-type="journal" id="CITATION183"><person-group person-group-type="author"><name name-style="western"><surname>Iijima</surname><given-names>T</given-names></name><name name-style="western"><surname>Ciani</surname><given-names>S</given-names></name><name name-style="western"><surname>Hagiwara</surname><given-names>S</given-names></name></person-group><article-title>Effects of the external pH on Ca channels: experimental studies and theoretical considerations using a two-site, two-ion model</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1073/pnas.83.3.654">Proc Natl Acad Sci U S A</uri></source><year>1986</year><volume>83</volume><fpage>654</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1073/pnas.83.3.654</pub-id><pub-id pub-id-type="other">1986PNAS...83..654I</pub-id><pub-id pub-id-type="pmid">2418439</pub-id><pub-id pub-id-type="pmcid">PMC322922</pub-id></element-citation></ref><ref id="REF184"><label>184</label><element-citation publication-type="other" id="CITATION184"><article-title>Farber JL, Chien KR, Mittnacht S Jr. Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.0000/PMID7008623">Am J Pathol</uri> 1981, 102: 271&#8211;281
</article-title><pub-id pub-id-type="pmcid">PMC1903688</pub-id><pub-id pub-id-type="pmid">7008623</pub-id></element-citation></ref><ref id="REF185"><label>185</label><element-citation publication-type="journal" id="CITATION185"><person-group person-group-type="author"><name name-style="western"><surname>Dienel</surname><given-names>GA</given-names></name></person-group><article-title>Regional accumulation of calcium in postischemic rat brain</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1471-4159.1984.tb12825.x">J Neurochem</uri></source><year>1984</year><volume>43</volume><fpage>913</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1984.tb12825.x</pub-id><pub-id pub-id-type="pmid">6470713</pub-id></element-citation></ref><ref id="REF186"><label>186</label><element-citation publication-type="journal" id="CITATION186"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>DP</given-names></name></person-group><article-title>Renal metabolism during normoxia, hypoxia, and ischemic injury</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1146/annurev.ph.48.030186.000341">Annu Rev Physiol</uri></source><year>1986</year><volume>48</volume><fpage>33</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1146/annurev.ph.48.030186.000341</pub-id><pub-id pub-id-type="pmid">3518618</pub-id></element-citation></ref><ref id="REF187"><label>187</label><element-citation publication-type="journal" id="CITATION187"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Daya</surname><given-names>MR</given-names></name><name name-style="western"><surname>Carrasquillo</surname><given-names>O</given-names></name><name name-style="western"><surname>Kales</surname><given-names>SN</given-names></name></person-group><article-title>Prognostic factors in patients with methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/15563659809028937">J Toxicol Clin Toxicol</uri></source><year>1998</year><volume>36</volume><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.3109/15563659809028937</pub-id><pub-id pub-id-type="pmid">9656972</pub-id></element-citation></ref><ref id="REF188"><label>188</label><element-citation publication-type="journal" id="CITATION188"><person-group person-group-type="author"><name name-style="western"><surname>Noker</surname><given-names>PE</given-names></name><name name-style="western"><surname>Eells</surname><given-names>JT</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>Methanol toxicity: treatment with folic acid and 5-formyl tetrahydrofolic acid</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1530-0277.1980.tb04835.x">Alcohol Clin Exp Res</uri></source><year>1980</year><volume>4</volume><fpage>378</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1111/j.1530-0277.1980.tb04835.x</pub-id><pub-id pub-id-type="pmid">7004236</pub-id></element-citation></ref><ref id="REF189"><label>189</label><element-citation publication-type="journal" id="CITATION189"><person-group person-group-type="author"><name name-style="western"><surname>Makar</surname><given-names>AB</given-names></name><name name-style="western"><surname>Tephly</surname><given-names>TR</given-names></name></person-group><article-title>Methanol poisoning in the folate-deficient rat</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/261715a0">Nature</uri></source><year>1976</year><volume>261</volume><fpage>715</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1038/261715a0</pub-id><pub-id pub-id-type="other">1976Natur.261..715M</pub-id><pub-id pub-id-type="pmid">6915</pub-id></element-citation></ref><ref id="REF190"><label>190</label><element-citation publication-type="journal" id="CITATION190"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>CS</given-names></name></person-group><article-title>Estimations of the lethal and exposure doses for representative methanol symptoms in humans</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1186/s40557-017-0197-5">Ann Occup Environ Med</uri></source><year>2017</year><volume>29</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/s40557-017-0197-5</pub-id><pub-id pub-id-type="pmid">29026612</pub-id><pub-id pub-id-type="pmcid">PMC5625597</pub-id></element-citation></ref><ref id="REF191"><label>191</label><element-citation publication-type="journal" id="CITATION191"><person-group person-group-type="author"><name name-style="western"><surname>Sharpe</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hostovsky</surname><given-names>M</given-names></name><name name-style="western"><surname>Bilbao</surname><given-names>JM</given-names></name><name name-style="western"><surname>Rewcastle</surname><given-names>NB</given-names></name></person-group><article-title>Methanol optic neuropathy: a histopathological study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1212/WNL.32.10.1093">Neurology</uri></source><year>1982</year><volume>32</volume><fpage>1093</fpage><pub-id pub-id-type="doi">10.1212/WNL.32.10.1093</pub-id><pub-id pub-id-type="pmid">6889696</pub-id></element-citation></ref><ref id="REF192"><label>192</label><element-citation publication-type="journal" id="CITATION192"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>EA</given-names></name><name name-style="western"><surname>Green</surname><given-names>AS</given-names></name></person-group><article-title>Methanol toxicity secondary to inhalant abuse in adult men</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/15563650802498781">Clin Toxicol</uri></source><year>2009</year><volume>47</volume><fpage>239</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1080/15563650802498781</pub-id><pub-id pub-id-type="pmid">19012086</pub-id></element-citation></ref><ref id="REF193"><label>193</label><element-citation publication-type="journal" id="CITATION193"><person-group person-group-type="author"><name name-style="western"><surname>Onder</surname><given-names>F</given-names></name><name name-style="western"><surname>Ilker</surname><given-names>S</given-names></name><name name-style="western"><surname>Kansu</surname><given-names>T</given-names></name><name name-style="western"><surname>Tatar</surname><given-names>T</given-names></name><name name-style="western"><surname>Kural</surname><given-names>G</given-names></name></person-group><article-title>Acute blindness and putaminal necrosis in methanol intoxication</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1023/A:1006173526927">Int Ophthalmol</uri></source><year>1999</year><volume>22</volume><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1023/A:1006173526927</pub-id><pub-id pub-id-type="pmid">10472766</pub-id></element-citation></ref><ref id="REF194"><label>194</label><element-citation publication-type="journal" id="CITATION194"><person-group person-group-type="author"><name name-style="western"><surname>Treichel</surname><given-names>JL</given-names></name><name name-style="western"><surname>Murray</surname><given-names>TG</given-names></name><name name-style="western"><surname>Lewandowski</surname><given-names>MF</given-names></name><name name-style="western"><surname>Stueven</surname><given-names>HA</given-names></name><name name-style="western"><surname>Eells</surname><given-names>JT</given-names></name><name name-style="western"><surname>Burke</surname><given-names>JM</given-names></name></person-group><article-title>Retinal toxicity in methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/00006982-200404000-00023">Retina</uri></source><year>2004</year><volume>24</volume><fpage>309</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1097/00006982-200404000-00023</pub-id><pub-id pub-id-type="pmid">15097899</pub-id></element-citation></ref><ref id="REF195"><label>195</label><element-citation publication-type="journal" id="CITATION195"><person-group person-group-type="author"><name name-style="western"><surname>Fujihara</surname><given-names>M</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kurimoto</surname><given-names>Y</given-names></name></person-group><article-title>Methanol-induced retinal toxicity patient examined by optical coherence tomography</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s10384-005-0311-z">Jpn J Ophthalmol</uri></source><year>2006</year><volume>50</volume><fpage>239</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1007/s10384-005-0311-z</pub-id><pub-id pub-id-type="pmid">16767379</pub-id></element-citation></ref><ref id="REF196"><label>196</label><element-citation publication-type="journal" id="CITATION196"><person-group person-group-type="author"><name name-style="western"><surname>Fink</surname><given-names>WH</given-names></name></person-group><article-title>The ocular pathology of methyl alcohol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0002-9394(43)91002-5">Am J Ophthalmol</uri></source><year>1943</year><volume>26</volume><fpage>802</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/S0002-9394(43)91002-5</pub-id><pub-id pub-id-type="pmcid">PMC1315061</pub-id><pub-id pub-id-type="pmid">16693297</pub-id></element-citation></ref><ref id="REF197"><label>197</label><element-citation publication-type="other" id="CITATION197"><article-title>Roe D. The ganglion cells of the retina in cases of methanol poisoning in human beings and experimental animals.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18878056/">Acta Ophthalmol (Kbh)</uri> 1948, 26: 169&#8211;182
</article-title><pub-id pub-id-type="pmid">18878056</pub-id></element-citation></ref><ref id="REF198"><label>198</label><element-citation publication-type="journal" id="CITATION198"><person-group person-group-type="author"><name name-style="western"><surname>Potts</surname><given-names>AM</given-names></name><name name-style="western"><surname>Praglin</surname><given-names>J</given-names></name><name name-style="western"><surname>Farkas</surname><given-names>I</given-names></name><name name-style="western"><surname>Orbison</surname><given-names>L</given-names></name><name name-style="western"><surname>Chickering</surname><given-names>D</given-names></name></person-group><article-title>Studies on the visual toxicity of methanol: VIII. Additional observations on methanol poisoning in the primate test object</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9394(55)91839-0">Am J Ophthalmol</uri></source><year>1955</year><volume>40</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(55)91839-0</pub-id><pub-id pub-id-type="pmid">13268554</pub-id></element-citation></ref><ref id="REF199"><label>199</label><element-citation publication-type="journal" id="CITATION199"><person-group person-group-type="author"><name name-style="western"><surname>Benton Jr.</surname><given-names>CD</given-names></name><name name-style="western"><surname>Phinizy Calhoun Jr.</surname><given-names>F</given-names></name></person-group><article-title>The ocular effects of methyl alcohol poisoning. Report of a catastrophe involving 320 persons</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9394(53)90002-6">Am J Ophthalmol</uri></source><year>1953</year><volume>36</volume><fpage>1677</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(53)90002-6</pub-id><pub-id pub-id-type="pmid">13104581</pub-id></element-citation></ref><ref id="REF200"><label>200</label><element-citation publication-type="other" id="CITATION200"><article-title>Fink WH. The ocular pathology of methyl alcohol poisoning.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1315061/">Am J Ophthalmol</uri> 1943, 26: 694&#8211;709
</article-title><pub-id pub-id-type="pmcid">PMC1315061</pub-id><pub-id pub-id-type="pmid">16693297</pub-id></element-citation></ref><ref id="REF201"><label>201</label><element-citation publication-type="other" id="CITATION201"><article-title>Menne FR. Acute methyl alcohol poisoning. A report of twenty-two instances with post mortem examinations.
<italic toggle="yes">Arch Pathol</italic> 1936, 26: 77&#8211;92
</article-title></element-citation></ref><ref id="REF202"><label>202</label><element-citation publication-type="other" id="CITATION202"><article-title>Lindenberg R, Walch FB, Sacks JG. Neuropathology of vision: an atlas. Philadelphia: Lea and Febiger 10: 118, 1973</article-title></element-citation></ref><ref id="REF203"><label>203</label><element-citation publication-type="journal" id="CITATION203"><person-group person-group-type="author"><name name-style="western"><surname>Liberski</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaluzny</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Koci&#281;cki</surname><given-names>J</given-names></name></person-group><article-title>Methanol-induced optic neuropathy: a still-present problem</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00204-021-03202-0">Arch Toxicol</uri></source><year>2022</year><volume>6</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1007/s00204-021-03202-0</pub-id><pub-id pub-id-type="pmid">34988610</pub-id><pub-id pub-id-type="pmcid">PMC8731680</pub-id></element-citation></ref><ref id="REF204"><label>204</label><element-citation publication-type="other" id="CITATION204"><article-title>Eells JT, Henry MM, Lewandowski MF, Seme MT, Murray TG. Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10894122/">Neurotoxicology</uri> 2000, 21: 321&#8211;330.
</article-title><pub-id pub-id-type="pmid">10894122</pub-id></element-citation></ref><ref id="REF205"><label>205</label><element-citation publication-type="journal" id="CITATION205"><person-group person-group-type="author"><name name-style="western"><surname>Treichel</surname><given-names>JL</given-names></name><name name-style="western"><surname>Henry</surname><given-names>MM</given-names></name><name name-style="western"><surname>Skumatz</surname><given-names>CMB</given-names></name><name name-style="western"><surname>Eells</surname><given-names>JT</given-names></name><name name-style="western"><surname>Burke</surname><given-names>JM</given-names></name></person-group><article-title>Formate, the toxic metabolite of methanol, in cultured ocular cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0161-813X(03)00059-7">Neurotoxicology</uri></source><year>2003</year><volume>24</volume><fpage>825</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1016/S0161-813X(03)00059-7</pub-id><pub-id pub-id-type="pmid">14637377</pub-id></element-citation></ref><ref id="REF206"><label>206</label><element-citation publication-type="journal" id="CITATION206"><person-group person-group-type="author"><name name-style="western"><surname>Naeser</surname><given-names>P</given-names></name></person-group><article-title>Optic nerve involvement in a case of methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bjo.72.10.778">Br J Ophthalmol</uri></source><year>1988</year><volume>72</volume><fpage>778</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1136/bjo.72.10.778</pub-id><pub-id pub-id-type="pmid">3191081</pub-id><pub-id pub-id-type="pmcid">PMC1041582</pub-id></element-citation></ref><ref id="REF207"><label>207</label><element-citation publication-type="journal" id="CITATION207"><person-group person-group-type="author"><name name-style="western"><surname>Lieberman</surname><given-names>MF</given-names></name><name name-style="western"><surname>Maumenee</surname><given-names>AE</given-names></name><name name-style="western"><surname>Green</surname><given-names>WR</given-names></name></person-group><article-title>Histologic studies of the vasculature of the anterior optic nerve</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9394(76)90489-X">Am J Ophthalmol</uri></source><year>1976</year><volume>82</volume><fpage>405</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(76)90489-X</pub-id><pub-id pub-id-type="pmid">961792</pub-id></element-citation></ref><ref id="REF208"><label>208</label><element-citation publication-type="journal" id="CITATION208"><person-group person-group-type="author"><name name-style="western"><surname>Francois</surname><given-names>J</given-names></name><name name-style="western"><surname>Neetens</surname><given-names>A</given-names></name></person-group><article-title>Central retinal artery and central optic nerve artery</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bjo.47.1.21">Br J Ophthalmol</uri></source><year>1963</year><volume>47</volume><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1136/bjo.47.1.21</pub-id><pub-id pub-id-type="pmid">18170852</pub-id><pub-id pub-id-type="pmcid">PMC505742</pub-id></element-citation></ref><ref id="REF209"><label>209</label><element-citation publication-type="journal" id="CITATION209"><person-group person-group-type="author"><name name-style="western"><surname>Goder</surname><given-names>G</given-names></name></person-group><article-title>The capillaries of the optic nerve</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9394(74)90532-7">Am J Ophthalmol</uri></source><year>1974</year><volume>77</volume><fpage>684</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(74)90532-7</pub-id><pub-id pub-id-type="pmid">4823779</pub-id></element-citation></ref><ref id="REF210"><label>210</label><element-citation publication-type="journal" id="CITATION210"><person-group person-group-type="author"><name name-style="western"><surname>Rootman</surname><given-names>J</given-names></name><name name-style="western"><surname>Butler</surname><given-names>D</given-names></name></person-group><article-title>Ischaemic optic neuropathy&#8212;a combined mechanism</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bjo.64.11.826">Br J Ophthalmol</uri></source><year>1980</year><volume>64</volume><fpage>826</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1136/bjo.64.11.826</pub-id><pub-id pub-id-type="pmid">7426554</pub-id><pub-id pub-id-type="pmcid">PMC1043827</pub-id></element-citation></ref><ref id="REF211"><label>211</label><element-citation publication-type="journal" id="CITATION211"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>C</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Shin</surname><given-names>K</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>J</given-names></name><name name-style="western"><surname>Jung-Choi</surname><given-names>K</given-names></name><name name-style="western"><surname>Lim</surname><given-names>K</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name></person-group><article-title>Toxic effects of methanol among illegally dispatched workers at aluminum CNC cutting process in small-scale, third-tier subcontractor factories of smartphone manufacturers in the Republic of Korea</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3390/ijerph15071332">Int J Environ Res Public Health</uri></source><year>2018</year><volume>15</volume><fpage>1332</fpage><pub-id pub-id-type="doi">10.3390/ijerph15071332</pub-id><pub-id pub-id-type="pmid">29941839</pub-id><pub-id pub-id-type="pmcid">PMC6068479</pub-id></element-citation></ref><ref id="REF212"><label>212</label><element-citation publication-type="journal" id="CITATION212"><person-group person-group-type="author"><name name-style="western"><surname>Frederick</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Schulte</surname><given-names>PA</given-names></name><name name-style="western"><surname>Apol</surname><given-names>A</given-names></name></person-group><article-title>Investigation and control of occupational hazards associated with the use of spirit duplicators</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/15298668491399361">Am Industrial Hyg Association J</uri></source><year>1984</year><volume>45</volume><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1080/15298668491399361</pub-id><pub-id pub-id-type="pmid">6702599</pub-id></element-citation></ref><ref id="REF213"><label>213</label><element-citation publication-type="journal" id="CITATION213"><person-group person-group-type="author"><name name-style="western"><surname>Baumbach</surname><given-names>GL</given-names></name></person-group><article-title>Methyl alcohol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archopht.1977.04450100161023">Arch Ophthalmol</uri></source><year>1977</year><volume>95</volume><fpage>1859</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.1001/archopht.1977.04450100161023</pub-id><pub-id pub-id-type="pmid">71893</pub-id></element-citation></ref><ref id="REF214"><label>214</label><element-citation publication-type="other" id="CITATION214"><article-title>Pick L, Bielschowsky M. Uber histologische Befunde im Auge und im centralen Nervensystem des Menschen bei akuter totlicher Vergiftung mit Methylalkohol.
<italic toggle="yes">Berl Klin Wochenschr</italic> 1912, 49: 888&#8211;893
</article-title></element-citation></ref><ref id="REF215"><label>215</label><element-citation publication-type="journal" id="CITATION215"><person-group person-group-type="author"><name name-style="western"><surname>Poon</surname><given-names>R</given-names></name><name name-style="western"><surname>Chu</surname><given-names>I</given-names></name><name name-style="western"><surname>Bjarnason</surname><given-names>S</given-names></name><name name-style="western"><surname>Potvin</surname><given-names>M</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>R</given-names></name><name name-style="western"><surname>Miller</surname><given-names>RB</given-names></name><name name-style="western"><surname>Valli</surname><given-names>VE</given-names></name></person-group><article-title>Inhalation toxicity study of methanol, toluene, and methanol/toluene mixtures in rats: effects of 28-day exposure</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1177/074823379401000310">Toxicol Ind Health</uri></source><year>1994</year><volume>10</volume><fpage>231</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1177/074823379401000310</pub-id><pub-id pub-id-type="pmid">7855870</pub-id></element-citation></ref><ref id="REF216"><label>216</label><element-citation publication-type="journal" id="CITATION216"><person-group person-group-type="author"><name name-style="western"><surname>Poon</surname><given-names>R</given-names></name><name name-style="western"><surname>Chu</surname><given-names>IH</given-names></name><name name-style="western"><surname>Bjarnason</surname><given-names>S</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>R</given-names></name><name name-style="western"><surname>Potvin</surname><given-names>M</given-names></name><name name-style="western"><surname>Miller</surname><given-names>RB</given-names></name><name name-style="western"><surname>Valli</surname><given-names>VE</given-names></name></person-group><article-title>Short-term inhalation toxicity of methanol, gasoline, and methanol/gasoline in the rat</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1177/074823379501100305">Toxicol Ind Health</uri></source><year>1995</year><volume>11</volume><fpage>343</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1177/074823379501100305</pub-id><pub-id pub-id-type="pmid">7482574</pub-id></element-citation></ref><ref id="REF217"><label>217</label><element-citation publication-type="journal" id="CITATION217"><person-group person-group-type="author"><name name-style="western"><surname>Andrews</surname><given-names>LS</given-names></name><name name-style="western"><surname>Clary</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Terrill</surname><given-names>JB</given-names></name><name name-style="western"><surname>Bolte</surname><given-names>HF</given-names></name></person-group><article-title>Subchronic inhalation toxicity of methanol</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/15287398709530965">J Toxicol Environ Health</uri></source><year>1987</year><volume>20</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1080/15287398709530965</pub-id><pub-id pub-id-type="pmid">3806698</pub-id></element-citation></ref><ref id="REF218"><label>218</label><element-citation publication-type="journal" id="CITATION218"><person-group person-group-type="author"><name name-style="western"><surname>Gilger</surname><given-names>AP</given-names></name><name name-style="western"><surname>Potts</surname><given-names>AM</given-names></name></person-group><article-title>Studies on the visual toxicity of methanol: V. The role of acidosis in experimental methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9394(55)90010-6">Am J Ophthalmol</uri></source><year>1955</year><volume>39</volume><fpage>63</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(55)90010-6</pub-id><pub-id pub-id-type="pmid">13228551</pub-id></element-citation></ref><ref id="REF219"><label>219</label><element-citation publication-type="journal" id="CITATION219"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>R</given-names></name><name name-style="western"><surname>Klein</surname><given-names>BEK</given-names></name><name name-style="western"><surname>Moss</surname><given-names>SE</given-names></name></person-group><article-title>The Wisconsin epidemiological study of diabetic retinopathy: a review</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/dmr.5610050703">Diabetes Metab Rev</uri></source><year>1989</year><volume>5</volume><fpage>559</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1002/dmr.5610050703</pub-id><pub-id pub-id-type="pmid">2689119</pub-id></element-citation></ref><ref id="REF220"><label>220</label><element-citation publication-type="journal" id="CITATION220"><person-group person-group-type="author"><name name-style="western"><surname>Romero-Aroca</surname><given-names>P</given-names></name><name name-style="western"><surname>Marc Baget-Bernaldiz</surname><given-names>P</given-names></name><name name-style="western"><surname>Angel Bautista-Perez</surname><given-names>P</given-names></name><name name-style="western"><surname>Teresa Basora-Gallisa</surname><given-names>P</given-names></name><name name-style="western"><surname>Josep Basora-Gallisa</surname><given-names>P</given-names></name><name name-style="western"><surname>Basora-Gallisa</surname><given-names>P</given-names></name></person-group><article-title>Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2147/OPTH.S14521">OPTH</uri></source><year>2010</year><volume>4</volume><fpage>1481</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S14521</pub-id><pub-id pub-id-type="pmcid">PMC3009995</pub-id><pub-id pub-id-type="pmid">21191444</pub-id></element-citation></ref><ref id="REF221"><label>221</label><element-citation publication-type="other" id="CITATION221"><article-title>Frank RN. Diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/14702427/">N Engl J Med</uri> 2004, 350: 48&#8211;58
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra021678</pub-id><pub-id pub-id-type="pmid">14702427</pub-id></element-citation></ref><ref id="REF222"><label>222</label><element-citation publication-type="other" id="CITATION222"><article-title>Bresnick GH, Engerman R, Davis MD, de Venecia G, Myers FL. Patterns of ischemia in diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/822560/">Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol</uri> 1976, 81: OP694&#8211;709.
</article-title><pub-id pub-id-type="pmid">822560</pub-id></element-citation></ref><ref id="REF223"><label>223</label><element-citation publication-type="journal" id="CITATION223"><person-group person-group-type="author"><name name-style="western"><surname>Yau</surname><given-names>JWY</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>SL</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>R</given-names></name><name name-style="western"><surname>Lamoureux</surname><given-names>EL</given-names></name><name name-style="western"><surname>Kowalski</surname><given-names>JW</given-names></name><name name-style="western"><surname>Bek</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SJ</given-names></name><etal>et al.</etal></person-group><article-title>Global prevalence and major risk factors of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc11-1909">Diabetes Care</uri></source><year>2012</year><volume>35</volume><fpage>556</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.2337/dc11-1909</pub-id><pub-id pub-id-type="pmid">22301125</pub-id><pub-id pub-id-type="pmcid">PMC3322721</pub-id></element-citation></ref><ref id="REF224"><label>224</label><element-citation publication-type="journal" id="CITATION224"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Le</surname><given-names>YZ</given-names></name></person-group><article-title>Functions of M&#252;ller cell-derived vascular endothelial growth factor in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.4239/wjd.v6.i5.726">World J Diabetes</uri></source><year>2015</year><volume>6</volume><fpage>726</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.4239/wjd.v6.i5.726</pub-id><pub-id pub-id-type="pmid">26069721</pub-id><pub-id pub-id-type="pmcid">PMC4458501</pub-id></element-citation></ref><ref id="REF225"><label>225</label><element-citation publication-type="journal" id="CITATION225"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>MS</given-names></name><name name-style="western"><surname>Gunkel</surname><given-names>RD</given-names></name><name name-style="western"><surname>Podgor</surname><given-names>MJ</given-names></name></person-group><article-title>Color vision defects in early diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archopht.1986.01050140079024">Arch Ophthalmol</uri></source><year>1986</year><volume>104</volume><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1001/archopht.1986.01050140079024</pub-id><pub-id pub-id-type="pmid">3484948</pub-id></element-citation></ref><ref id="REF226"><label>226</label><element-citation publication-type="journal" id="CITATION226"><person-group person-group-type="author"><name name-style="western"><surname>Sokol</surname><given-names>S</given-names></name><name name-style="western"><surname>Moskowitz</surname><given-names>A</given-names></name><name name-style="western"><surname>Skarf</surname><given-names>B</given-names></name><name name-style="western"><surname>Evans</surname><given-names>R</given-names></name><name name-style="western"><surname>Molitch</surname><given-names>M</given-names></name><name name-style="western"><surname>Senior</surname><given-names>B</given-names></name></person-group><article-title>Contrast sensitivity in diabetics with and without background retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archopht.1985.01050010055018">Arch Ophthalmol</uri></source><year>1985</year><volume>103</volume><fpage>51</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1001/archopht.1985.01050010055018</pub-id><pub-id pub-id-type="pmid">3977675</pub-id></element-citation></ref><ref id="REF227"><label>227</label><element-citation publication-type="journal" id="CITATION227"><person-group person-group-type="author"><name name-style="western"><surname>Yonemura</surname><given-names>D</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>T</given-names></name><name name-style="western"><surname>Tsuzuki</surname><given-names>K</given-names></name></person-group><article-title>Electroretinogram in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archopht.1962.00960030023005">Arch Ophthalmol</uri></source><year>1962</year><volume>68</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1001/archopht.1962.00960030023005</pub-id><pub-id pub-id-type="pmid">14009176</pub-id></element-citation></ref><ref id="REF228"><label>228</label><element-citation publication-type="journal" id="CITATION228"><person-group person-group-type="author"><name name-style="western"><surname>Barber</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Lieth</surname><given-names>E</given-names></name><name name-style="western"><surname>Khin</surname><given-names>SA</given-names></name><name name-style="western"><surname>Antonetti</surname><given-names>DA</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>AG</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>TW</given-names></name></person-group><article-title>Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI2425">J Clin Invest</uri></source><year>1998</year><volume>102</volume><fpage>783</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1172/JCI2425</pub-id><pub-id pub-id-type="pmid">9710447</pub-id><pub-id pub-id-type="pmcid">PMC508941</pub-id></element-citation></ref><ref id="REF229"><label>229</label><element-citation publication-type="journal" id="CITATION229"><person-group person-group-type="author"><name name-style="western"><surname>Gastinger</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Singh</surname><given-names>RSJ</given-names></name><name name-style="western"><surname>Barber</surname><given-names>AJ</given-names></name></person-group><article-title>Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and ins2
<sup>Akita</sup>-diabetic mouse retinas
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.05-1376">Invest Ophthalmol Vis Sci</uri></source><year>2006</year><volume>47</volume><fpage>3143</fpage><pub-id pub-id-type="doi">10.1167/iovs.05-1376</pub-id><pub-id pub-id-type="pmid">16799061</pub-id></element-citation></ref><ref id="REF230"><label>230</label><element-citation publication-type="journal" id="CITATION230"><person-group person-group-type="author"><name name-style="western"><surname>Bensaoula</surname><given-names>T</given-names></name><name name-style="western"><surname>Ottlecz</surname><given-names>A</given-names></name></person-group><article-title>Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1089/10807680152729266">J Ocular Pharmacol Ther</uri></source><year>2001</year><volume>17</volume><fpage>573</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1089/10807680152729266</pub-id><pub-id pub-id-type="pmid">11777181</pub-id></element-citation></ref><ref id="REF231"><label>231</label><element-citation publication-type="journal" id="CITATION231"><person-group person-group-type="author"><name name-style="western"><surname>Mizutani</surname><given-names>M</given-names></name><name name-style="western"><surname>Gerhardinger</surname><given-names>C</given-names></name><name name-style="western"><surname>Lorenzi</surname><given-names>M</given-names></name></person-group><article-title>M&#252;ller cell changes in human diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.47.3.445">Diabetes</uri></source><year>1998</year><volume>47</volume><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.2337/diabetes.47.3.445</pub-id><pub-id pub-id-type="pmid">9519752</pub-id></element-citation></ref><ref id="REF232"><label>232</label><element-citation publication-type="other" id="CITATION232"><article-title>Puro DG. Diabetes-induced dysfunction of retinal M&#252;ller cells.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12545700/">Trans Am Ophthalmol Soc</uri> 2002, 100: 339.
</article-title><pub-id pub-id-type="pmcid">PMC1358969</pub-id><pub-id pub-id-type="pmid">12545700</pub-id></element-citation></ref><ref id="REF233"><label>233</label><element-citation publication-type="other" id="CITATION233"><article-title>Rungger&#8211;Br&#228;ndle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10845624/">Invest Ophthalmol Vis Sci</uri> 2000, 41: 1971&#8211;1980.
</article-title><pub-id pub-id-type="pmid">10845624</pub-id></element-citation></ref><ref id="REF234"><label>234</label><element-citation publication-type="other" id="CITATION234"><article-title>Cohen SR, Gardner TW. Diabetic retinopathy and diabetic macular edema.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1159/000438970">Retinal Pharmacotherapeutics</uri> 2016, 55: 137&#8211;146.
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000438970</pub-id><pub-id pub-id-type="pmcid">PMC4775164</pub-id><pub-id pub-id-type="pmid">26501152</pub-id></element-citation></ref><ref id="REF235"><label>235</label><element-citation publication-type="other" id="CITATION235"><article-title>Midena E, Pilotto E. Emerging Insights into Pathogenesis.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1159/000459687">Dev Ophthalmol</uri>
<italic toggle="yes">2017</italic>, 60: 16-27.
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000459687</pub-id><pub-id pub-id-type="pmid">28427061</pub-id></element-citation></ref><ref id="REF236"><label>236</label><element-citation publication-type="journal" id="CITATION236"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name></person-group><article-title>Microglial activation in human diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archophthalmol.2007.65">Arch Ophthalmol</uri></source><year>2008</year><volume>126</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1001/archophthalmol.2007.65</pub-id><pub-id pub-id-type="pmid">18268214</pub-id></element-citation></ref><ref id="REF237"><label>237</label><element-citation publication-type="journal" id="CITATION237"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>B</given-names></name><name name-style="western"><surname>Saltzman</surname><given-names>HA</given-names></name></person-group><article-title>Retinal oxygen utilization measured by hyperbaric blackout</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archopht.1964.00970020794009">Arch Ophthalmol</uri></source><year>1964</year><volume>72</volume><fpage>792</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1001/archopht.1964.00970020794009</pub-id><pub-id pub-id-type="pmid">14205438</pub-id></element-citation></ref><ref id="REF238"><label>238</label><element-citation publication-type="journal" id="CITATION238"><person-group person-group-type="author"><name name-style="western"><surname>Ames 3d</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>YY</given-names></name><name name-style="western"><surname>Heher</surname><given-names>EC</given-names></name><name name-style="western"><surname>Kimble</surname><given-names>CR</given-names></name></person-group><article-title>Energy metabolism of rabbit retina as related to function: high cost of Na
<sup>+</sup> transport
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1523/JNEUROSCI.12-03-00840.1992">J Neurosci</uri></source><year>1992</year><volume>12</volume><fpage>840</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.12-03-00840.1992</pub-id><pub-id pub-id-type="pmid">1312136</pub-id><pub-id pub-id-type="pmcid">PMC6576058</pub-id></element-citation></ref><ref id="REF239"><label>239</label><element-citation publication-type="journal" id="CITATION239"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>DY</given-names></name><name name-style="western"><surname>Cringle</surname><given-names>SJ</given-names></name></person-group><article-title>Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S1350-9462(00)00027-6">Prog Retinal Eye Res</uri></source><year>2001</year><volume>20</volume><fpage>175</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/S1350-9462(00)00027-6</pub-id><pub-id pub-id-type="pmid">11173251</pub-id></element-citation></ref><ref id="REF240"><label>240</label><element-citation publication-type="journal" id="CITATION240"><person-group person-group-type="author"><name name-style="western"><surname>Wong-Riley</surname><given-names>MTT</given-names></name></person-group><article-title>Energy metabolism of the visual system</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2147/EB.S9078">Eye Brain</uri></source><year>2010</year><volume>2</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.2147/EB.S9078</pub-id><pub-id pub-id-type="pmid">23226947</pub-id><pub-id pub-id-type="pmcid">PMC3515641</pub-id></element-citation></ref><ref id="REF241"><label>241</label><element-citation publication-type="journal" id="CITATION241"><person-group person-group-type="author"><name name-style="western"><surname>Lechner</surname><given-names>J</given-names></name><name name-style="western"><surname>O&#8217;Leary</surname><given-names>OE</given-names></name><name name-style="western"><surname>Stitt</surname><given-names>AW</given-names></name></person-group><article-title>The pathology associated with diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.visres.2017.04.003">Vision Res</uri></source><year>2017</year><volume>139</volume><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.visres.2017.04.003</pub-id><pub-id pub-id-type="pmid">28412095</pub-id></element-citation></ref><ref id="REF242"><label>242</label><element-citation publication-type="journal" id="CITATION242"><person-group person-group-type="author"><name name-style="western"><surname>Hidaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Kakuma</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshimatsu</surname><given-names>H</given-names></name><name name-style="western"><surname>Sakino</surname><given-names>H</given-names></name><name name-style="western"><surname>Fukuchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Sakata</surname><given-names>T</given-names></name></person-group><article-title>Streptozotocin treatment upregulates uncoupling protein 3 expression in the rat heart</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.48.2.430">Diabetes</uri></source><year>1999</year><volume>48</volume><fpage>430</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.2337/diabetes.48.2.430</pub-id><pub-id pub-id-type="pmid">10334327</pub-id></element-citation></ref><ref id="REF243"><label>243</label><element-citation publication-type="journal" id="CITATION243"><person-group person-group-type="author"><name name-style="western"><surname>Persson</surname><given-names>MF</given-names></name><name name-style="western"><surname>Franz&#233;n</surname><given-names>S</given-names></name><name name-style="western"><surname>Catrina</surname><given-names>SB</given-names></name><name name-style="western"><surname>Dallner</surname><given-names>G</given-names></name><name name-style="western"><surname>Hansell</surname><given-names>P</given-names></name><name name-style="western"><surname>Brismar</surname><given-names>K</given-names></name><name name-style="western"><surname>Palm</surname><given-names>F</given-names></name></person-group><article-title>Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-012-2469-5">Diabetologia</uri></source><year>2012</year><volume>55</volume><fpage>1535</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1007/s00125-012-2469-5</pub-id><pub-id pub-id-type="pmid">22311417</pub-id></element-citation></ref><ref id="REF244"><label>244</label><element-citation publication-type="journal" id="CITATION244"><person-group person-group-type="author"><name name-style="western"><surname>Rudofsky Jr</surname><given-names>G</given-names></name><name name-style="western"><surname>Schroedter</surname><given-names>A</given-names></name><name name-style="western"><surname>Schlotterer</surname><given-names>A</given-names></name><name name-style="western"><surname>Voron&#8217;ko</surname><given-names>OE</given-names></name><name name-style="western"><surname>Schlimme</surname><given-names>M</given-names></name><name name-style="western"><surname>Tafel</surname><given-names>J</given-names></name><name name-style="western"><surname>Isermann</surname><given-names>BH</given-names></name><etal>et al.</etal></person-group><article-title>Functional polymorphisms of
<italic toggle="yes">UCP2</italic> and
<italic toggle="yes">UCP3</italic> are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diacare.29.01.06.dc05-0757">Diabetes Care</uri></source><year>2006</year><volume>29</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.2337/diacare.29.01.06.dc05-0757</pub-id><pub-id pub-id-type="pmid">16373902</pub-id></element-citation></ref><ref id="REF245"><label>245</label><element-citation publication-type="journal" id="CITATION245"><person-group person-group-type="author"><name name-style="western"><surname>Vincent</surname><given-names>AM</given-names></name><name name-style="western"><surname>Olzmann</surname><given-names>JA</given-names></name><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name><name name-style="western"><surname>Sivitz</surname><given-names>WI</given-names></name><name name-style="western"><surname>Russell</surname><given-names>JW</given-names></name></person-group><article-title>Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.53.3.726">Diabetes</uri></source><year>2004</year><volume>53</volume><fpage>726</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.2337/diabetes.53.3.726</pub-id><pub-id pub-id-type="pmid">14988258</pub-id></element-citation></ref><ref id="REF246"><label>246</label><element-citation publication-type="journal" id="CITATION246"><person-group person-group-type="author"><name name-style="western"><surname>Nishikawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Edelstein</surname><given-names>D</given-names></name><name name-style="western"><surname>Du</surname><given-names>XL</given-names></name><name name-style="western"><surname>Yamagishi</surname><given-names>S</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaneda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yorek</surname><given-names>MA</given-names></name><etal>et al.</etal></person-group><article-title>Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/35008121">Nature</uri></source><year>2000</year><volume>404</volume><fpage>787</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1038/35008121</pub-id><pub-id pub-id-type="other">2000Natur.404..787N</pub-id><pub-id pub-id-type="pmid">10783895</pub-id></element-citation></ref><ref id="REF247"><label>247</label><element-citation publication-type="journal" id="CITATION247"><person-group person-group-type="author"><name name-style="western"><surname>Sim&#243;</surname><given-names>R</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C</given-names></name></person-group><article-title>Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bjophthalmol-2012-302005">Br J Ophthalmol</uri></source><year>2012</year><volume>96</volume><fpage>1285</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2012-302005</pub-id><pub-id pub-id-type="pmid">22887976</pub-id></element-citation></ref><ref id="REF248"><label>248</label><element-citation publication-type="journal" id="CITATION248"><person-group person-group-type="author"><name name-style="western"><surname>Reis</surname><given-names>A</given-names></name><name name-style="western"><surname>Mateus</surname><given-names>C</given-names></name><name name-style="western"><surname>Melo</surname><given-names>P</given-names></name><name name-style="western"><surname>Figueira</surname><given-names>J</given-names></name><name name-style="western"><surname>Cunha-Vaz</surname><given-names>J</given-names></name><name name-style="western"><surname>Castelo-Branco</surname><given-names>M</given-names></name></person-group><article-title>Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db13-1673">Diabetes</uri></source><year>2014</year><volume>63</volume><fpage>3926</fpage><lpage>3937</lpage><pub-id pub-id-type="doi">10.2337/db13-1673</pub-id><pub-id pub-id-type="pmid">24947354</pub-id></element-citation></ref><ref id="REF249"><label>249</label><element-citation publication-type="journal" id="CITATION249"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>Y</given-names></name><name name-style="western"><surname>Schneck</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bearse Jr</surname><given-names>MA</given-names></name><name name-style="western"><surname>Barez</surname><given-names>S</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>CH</given-names></name><name name-style="western"><surname>Jewell</surname><given-names>NP</given-names></name><name name-style="western"><surname>Adams</surname><given-names>AJ</given-names></name></person-group><article-title>Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.04-0405">Invest Ophthalmol Vis Sci</uri></source><year>2004</year><volume>45</volume><fpage>4106</fpage><lpage>4112</lpage><pub-id pub-id-type="doi">10.1167/iovs.04-0405</pub-id><pub-id pub-id-type="pmid">15505062</pub-id></element-citation></ref><ref id="REF250"><label>250</label><element-citation publication-type="journal" id="CITATION250"><person-group person-group-type="author"><name name-style="western"><surname>Harrison</surname><given-names>WW</given-names></name><name name-style="western"><surname>Bearse Jr</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ng</surname><given-names>JS</given-names></name><name name-style="western"><surname>Jewell</surname><given-names>NP</given-names></name><name name-style="western"><surname>Barez</surname><given-names>S</given-names></name><name name-style="western"><surname>Burger</surname><given-names>D</given-names></name><name name-style="western"><surname>Schneck</surname><given-names>ME</given-names></name><etal>et al.</etal></person-group><article-title>Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.10-5931">Invest Ophthalmol Vis Sci</uri></source><year>2011</year><volume>52</volume><fpage>772</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1167/iovs.10-5931</pub-id><pub-id pub-id-type="pmid">20926810</pub-id><pub-id pub-id-type="pmcid">PMC3053106</pub-id></element-citation></ref><ref id="REF251"><label>251</label><element-citation publication-type="journal" id="CITATION251"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>JS</given-names></name><name name-style="western"><surname>Bearse Jr</surname><given-names>MA</given-names></name><name name-style="western"><surname>Schneck</surname><given-names>ME</given-names></name><name name-style="western"><surname>Barez</surname><given-names>S</given-names></name><name name-style="western"><surname>Adams</surname><given-names>AJ</given-names></name></person-group><article-title>Local diabetic retinopathy prediction by multifocal ERG delays over 3 years</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.07-1157">Invest Ophthalmol Vis Sci</uri></source><year>2008</year><volume>49</volume><fpage>1622</fpage><lpage>1628</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-1157</pub-id><pub-id pub-id-type="pmid">18385083</pub-id></element-citation></ref><ref id="REF252"><label>252</label><element-citation publication-type="journal" id="CITATION252"><person-group person-group-type="author"><name name-style="western"><surname>Carrasco</surname><given-names>E</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C</given-names></name><name name-style="western"><surname>Miralles</surname><given-names>A</given-names></name><name name-style="western"><surname>Huguet</surname><given-names>P</given-names></name><name name-style="western"><surname>Farr&#233;s</surname><given-names>J</given-names></name><name name-style="western"><surname>Sim&#243;</surname><given-names>R</given-names></name></person-group><article-title>Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc07-0332">Diabetes Care</uri></source><year>2007</year><volume>30</volume><fpage>2902</fpage><lpage>2908</lpage><pub-id pub-id-type="doi">10.2337/dc07-0332</pub-id><pub-id pub-id-type="pmid">17704349</pub-id></element-citation></ref><ref id="REF253"><label>253</label><element-citation publication-type="journal" id="CITATION253"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Ram&#237;rez</surname><given-names>M</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C</given-names></name><name name-style="western"><surname>Villarroel</surname><given-names>M</given-names></name><name name-style="western"><surname>Canals</surname><given-names>F</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>MA</given-names></name><name name-style="western"><surname>Fortuny</surname><given-names>R</given-names></name><name name-style="western"><surname>Masmiquel</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-009-1548-8">Diabetologia</uri></source><year>2009</year><volume>52</volume><fpage>2633</fpage><lpage>2641</lpage><pub-id pub-id-type="doi">10.1007/s00125-009-1548-8</pub-id><pub-id pub-id-type="pmid">19823802</pub-id></element-citation></ref><ref id="REF254"><label>254</label><element-citation publication-type="other" id="CITATION254"><article-title>Valverde AM, Miranda S, Garc&#237;a-Ram&#237;rez M, Gonz&#225;lez-Rodriguez A, Hern&#225;ndez C, Sim&#243; R. Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi10.1016/j.jdiacomp.2017.02.006">Mol Vis</uri> 2013, 19: 47&#8211;53.
</article-title><pub-id pub-id-type="pmcid">PMC3541044</pub-id><pub-id pub-id-type="pmid">23335850</pub-id></element-citation></ref><ref id="REF255"><label>255</label><element-citation publication-type="journal" id="CITATION255"><person-group person-group-type="author"><name name-style="western"><surname>Sim&#243;</surname><given-names>R</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C</given-names></name></person-group><article-title>Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.preteyeres.2015.04.003">Prog Retinal Eye Res</uri></source><year>2015</year><volume>48</volume><fpage>160</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2015.04.003</pub-id><pub-id pub-id-type="pmid">25936649</pub-id></element-citation></ref><ref id="REF256"><label>256</label><element-citation publication-type="other" id="CITATION256"><article-title>Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc06-0650">N Engl J Med</uri> 2012, 366: 1227&#8211;1239
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra1005073</pub-id><pub-id pub-id-type="pmid">22455417</pub-id></element-citation></ref><ref id="REF257"><label>257</label><element-citation publication-type="journal" id="CITATION257"><person-group person-group-type="author"><name name-style="western"><surname>Abcouwer</surname><given-names>SF</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>TW</given-names></name></person-group><article-title>Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/nyas.12412">Ann NY Acad Sci</uri></source><year>2014</year><volume>1311</volume><fpage>174</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1111/nyas.12412</pub-id><pub-id pub-id-type="other">2014NYASA1311..174A</pub-id><pub-id pub-id-type="pmid">24673341</pub-id><pub-id pub-id-type="pmcid">PMC4154702</pub-id></element-citation></ref><ref id="REF258"><label>258</label><element-citation publication-type="journal" id="CITATION258"><person-group person-group-type="author"><name name-style="western"><surname>Sim&#243;</surname><given-names>R</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C</given-names></name></person-group><article-title>Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.tem.2013.09.005">Trends Endocrinol Metab</uri></source><year>2014</year><volume>25</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2013.09.005</pub-id><pub-id pub-id-type="pmid">24183659</pub-id></element-citation></ref><ref id="REF259"><label>259</label><element-citation publication-type="journal" id="CITATION259"><person-group person-group-type="author"><name name-style="western"><surname>Stitt</surname><given-names>AW</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Canning</surname><given-names>P</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>O</given-names></name><name name-style="western"><surname>Cox</surname><given-names>O</given-names></name><name name-style="western"><surname>Frizzell</surname><given-names>N</given-names></name><name name-style="western"><surname>Thorpe</surname><given-names>SR</given-names></name><etal>et al.</etal></person-group><article-title>Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-004-1523-3">Diabetologia</uri></source><year>2004</year><volume>47</volume><fpage>1735</fpage><lpage>1746</lpage><pub-id pub-id-type="doi">10.1007/s00125-004-1523-3</pub-id><pub-id pub-id-type="pmid">15502926</pub-id></element-citation></ref><ref id="REF260"><label>260</label><element-citation publication-type="other" id="CITATION260"><article-title>Kalfa TA, Gerritsen ME, Carlson EC, Binstock AJ, Tsilibary EC. Altered proliferation of retinal microvascular cells on glycated matrix.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7591625/">Invest Ophthal mol Visual Sci</uri>1995, 36: 2358&#8211;2367.
</article-title><pub-id pub-id-type="pmid">7591625</pub-id></element-citation></ref><ref id="REF261"><label>261</label><element-citation publication-type="journal" id="CITATION261"><person-group person-group-type="author"><name name-style="western"><surname>Boyd-White</surname><given-names>J</given-names></name><name name-style="western"><surname>Williams Jr</surname><given-names>JC</given-names></name></person-group><article-title>Effect of cross-linking on matrix permeability: a model for AGE-modified basement membranes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.45.3.348">Diabetes</uri></source><year>1996</year><volume>45</volume><fpage>348</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.2337/diab.45.3.348</pub-id><pub-id pub-id-type="pmid">8593941</pub-id></element-citation></ref><ref id="REF262"><label>262</label><element-citation publication-type="journal" id="CITATION262"><person-group person-group-type="author"><name name-style="western"><surname>Mott</surname><given-names>JD</given-names></name><name name-style="western"><surname>Khalifah</surname><given-names>RG</given-names></name><name name-style="western"><surname>Nagase</surname><given-names>H</given-names></name><name name-style="western"><surname>Shield Iii</surname><given-names>CF</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>JK</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>BG</given-names></name></person-group><article-title>Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/ki.1997.455">Kidney Int</uri></source><year>1997</year><volume>52</volume><fpage>1302</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1038/ki.1997.455</pub-id><pub-id pub-id-type="pmid">9350653</pub-id></element-citation></ref><ref id="REF263"><label>263</label><element-citation publication-type="journal" id="CITATION263"><person-group person-group-type="author"><name name-style="western"><surname>Stitt</surname><given-names>AW</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>HR</given-names></name><name name-style="western"><surname>Gardiner</surname><given-names>TA</given-names></name><name name-style="western"><surname>Archer</surname><given-names>DB</given-names></name></person-group><article-title>Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bjo.78.2.133">Br J Ophthalmol</uri></source><year>1994</year><volume>78</volume><fpage>133</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1136/bjo.78.2.133</pub-id><pub-id pub-id-type="pmid">8123622</pub-id><pub-id pub-id-type="pmcid">PMC504717</pub-id></element-citation></ref><ref id="REF264"><label>264</label><element-citation publication-type="journal" id="CITATION264"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Maiello</surname><given-names>M</given-names></name><name name-style="western"><surname>Lorenzi</surname><given-names>M</given-names></name></person-group><article-title>Increased expression of basement membrane collagen in human diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI116979">J Clin Invest</uri></source><year>1994</year><volume>93</volume><fpage>438</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1172/JCI116979</pub-id><pub-id pub-id-type="pmid">8282817</pub-id><pub-id pub-id-type="pmcid">PMC293808</pub-id></element-citation></ref><ref id="REF265"><label>265</label><element-citation publication-type="journal" id="CITATION265"><person-group person-group-type="author"><name name-style="western"><surname>Beltramo</surname><given-names>E</given-names></name><name name-style="western"><surname>Pomero</surname><given-names>F</given-names></name><name name-style="western"><surname>Allione</surname><given-names>A</given-names></name><name name-style="western"><surname>D&#8217;Al&#249;</surname><given-names>F</given-names></name><name name-style="western"><surname>Ponte</surname><given-names>E</given-names></name><name name-style="western"><surname>Porta</surname><given-names>M</given-names></name></person-group><article-title>Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-001-0761-x">Diabetologia</uri></source><year>2002</year><volume>45</volume><fpage>416</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1007/s00125-001-0761-x</pub-id><pub-id pub-id-type="pmid">11914747</pub-id></element-citation></ref><ref id="REF266"><label>266</label><element-citation publication-type="journal" id="CITATION266"><person-group person-group-type="author"><name name-style="western"><surname>Padayatti</surname><given-names>PS</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Glomb</surname><given-names>MA</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>K</given-names></name><name name-style="western"><surname>Nagaraj</surname><given-names>RH</given-names></name></person-group><article-title>High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1076/ceyr.23.2.106.5472">Curr Eye Res</uri></source><year>2001</year><volume>23</volume><fpage>106</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1076/ceyr.23.2.106.5472</pub-id><pub-id pub-id-type="pmid">11840348</pub-id></element-citation></ref><ref id="REF267"><label>267</label><element-citation publication-type="journal" id="CITATION267"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Tonkiss</surname><given-names>J</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name></person-group><article-title>Aging increases retinal vascular lesions characteristic of early diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s10522-010-9263-x">Biogerontology</uri></source><year>2010</year><volume>11</volume><fpage>447</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1007/s10522-010-9263-x</pub-id><pub-id pub-id-type="pmid">20119717</pub-id></element-citation></ref><ref id="REF268"><label>268</label><element-citation publication-type="journal" id="CITATION268"><person-group person-group-type="author"><name name-style="western"><surname>Behl</surname><given-names>Y</given-names></name><name name-style="western"><surname>Krothapalli</surname><given-names>P</given-names></name><name name-style="western"><surname>Desta</surname><given-names>T</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Graves</surname><given-names>DT</given-names></name></person-group><article-title>FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db08-0537">Diabetes</uri></source><year>2009</year><volume>58</volume><fpage>917</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.2337/db08-0537</pub-id><pub-id pub-id-type="pmid">19168598</pub-id><pub-id pub-id-type="pmcid">PMC2661587</pub-id></element-citation></ref><ref id="REF269"><label>269</label><element-citation publication-type="journal" id="CITATION269"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>KH</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>J</given-names></name><name name-style="western"><surname>Han</surname><given-names>KH</given-names></name></person-group><article-title>Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1182/blood-2004-08-3178">Blood</uri></source><year>2005</year><volume>105</volume><fpage>1405</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-08-3178</pub-id><pub-id pub-id-type="pmid">15498848</pub-id></element-citation></ref><ref id="REF270"><label>270</label><element-citation publication-type="other" id="CITATION270"><article-title>The DAMAD Study Group. Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.38.4.491">Diabetes</uri> 1989, 38: 491&#8211;498.
</article-title><pub-id pub-id-type="pmid">2647556</pub-id></element-citation></ref><ref id="REF271"><label>271</label><element-citation publication-type="journal" id="CITATION271"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>A</given-names></name><name name-style="western"><surname>MacMahon</surname><given-names>S</given-names></name><name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></name><name name-style="western"><surname>Neal</surname><given-names>B</given-names></name><name name-style="western"><surname>Billot</surname><given-names>L</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>M</given-names></name><name name-style="western"><surname>Marre</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><collab>ADVANCE Collaborative Group</collab><article-title>Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1056/NEJMoa0802987">N Engl J Med</uri></source><year>2008</year><volume>358</volume><fpage>2560</fpage><lpage>2572</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0802987</pub-id><pub-id pub-id-type="pmid">18539916</pub-id></element-citation></ref><ref id="REF272"><label>272</label><element-citation publication-type="journal" id="CITATION272"><person-group person-group-type="author"><name name-style="western"><surname>Leite</surname><given-names>EB</given-names></name><name name-style="western"><surname>Mota</surname><given-names>MC</given-names></name><name name-style="western"><surname>de Abreu</surname><given-names>JRF</given-names></name><name name-style="western"><surname>Cunha-Vaz</surname><given-names>JG</given-names></name></person-group><article-title>Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF00154206">Int Ophthalmol</uri></source><year>1990</year><volume>14</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/BF00154206</pub-id><pub-id pub-id-type="pmid">2187006</pub-id></element-citation></ref><ref id="REF273"><label>273</label><element-citation publication-type="journal" id="CITATION273"><person-group person-group-type="author"><name name-style="western"><surname>Ribeiro</surname><given-names>ML</given-names></name><name name-style="western"><surname>Seres</surname><given-names>AI</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>AM</given-names></name><name name-style="western"><surname>Stur</surname><given-names>M</given-names></name><name name-style="western"><surname>Zourdani</surname><given-names>A</given-names></name><name name-style="western"><surname>Caillon</surname><given-names>P</given-names></name><name name-style="western"><surname>Cunha-Vaz</surname><given-names>JG</given-names></name></person-group><article-title>Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00417-006-0318-2">Graefes Arch Clin Exp Ophthalmol</uri></source><year>2006</year><volume>244</volume><fpage>1591</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.1007/s00417-006-0318-2</pub-id><pub-id pub-id-type="pmid">16763797</pub-id></element-citation></ref><ref id="REF274"><label>274</label><element-citation publication-type="journal" id="CITATION274"><person-group person-group-type="author"><name name-style="western"><surname>Joussen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Poulaki</surname><given-names>V</given-names></name><name name-style="western"><surname>Mitsiades</surname><given-names>N</given-names></name><name name-style="western"><surname>Kirchhof</surname><given-names>B</given-names></name><name name-style="western"><surname>Koizumi</surname><given-names>K</given-names></name><name name-style="western"><surname>D&#246;hmen</surname><given-names>S</given-names></name><name name-style="western"><surname>P. Adamis</surname><given-names>A</given-names></name></person-group><article-title>Nonsteroidal anti&#8208;inflammatory drugs prevent early diabetic retinopathy via TNF&#8208;&#945; suppression</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1096/fj.01-0707fje">FASEB J</uri></source><year>2002</year><volume>16</volume><fpage>438</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1096/fj.01-0707fje</pub-id><pub-id pub-id-type="pmid">11821258</pub-id></element-citation></ref><ref id="REF275"><label>275</label><element-citation publication-type="journal" id="CITATION275"><person-group person-group-type="author"><name name-style="western"><surname>Kohner</surname><given-names>EM</given-names></name><name name-style="western"><surname>Patel</surname><given-names>V</given-names></name><name name-style="western"><surname>Rassam</surname><given-names>SMB</given-names></name></person-group><article-title>Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.44.6.603">Diabetes</uri></source><year>1995</year><volume>44</volume><fpage>603</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.2337/diab.44.6.603</pub-id><pub-id pub-id-type="pmid">7789621</pub-id></element-citation></ref><ref id="REF276"><label>276</label><element-citation publication-type="other" id="CITATION276"><article-title>Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy, ETDRS report number 9.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0161-6420(13)38011-7">Ophthalmology</uri> 1991, 98: 766&#8211;785.
</article-title><pub-id pub-id-type="pmid">2062512</pub-id></element-citation></ref><ref id="REF277"><label>277</label><element-citation publication-type="other" id="CITATION277"><article-title>Arrigg PG, Cavallerano J. The role of vitrectomy for diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9844325/">J Am Optom Assoc</uri> 1998, 69: 733&#8211;740.
</article-title><pub-id pub-id-type="pmid">9844325</pub-id></element-citation></ref><ref id="REF278"><label>278</label><element-citation publication-type="journal" id="CITATION278"><person-group person-group-type="author"><name name-style="western"><surname>Reddy</surname><given-names>SV</given-names></name><name name-style="western"><surname>Husain</surname><given-names>D</given-names></name></person-group><article-title>Panretinal photocoagulation: a review of complications</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/08820538.2017.1353820">Semin Ophthalmol</uri></source><year>2018</year><volume>33</volume><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1080/08820538.2017.1353820</pub-id><pub-id pub-id-type="pmid">29172937</pub-id></element-citation></ref><ref id="REF279"><label>279</label><element-citation publication-type="journal" id="CITATION279"><person-group person-group-type="author"><name name-style="western"><surname>Gardiner</surname><given-names>TA</given-names></name><name name-style="western"><surname>Archer</surname><given-names>DB</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>TM</given-names></name><name name-style="western"><surname>Stitt</surname><given-names>AW</given-names></name></person-group><article-title>Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1080/10739680601072123">Microcirculation</uri></source><year>2007</year><volume>14</volume><fpage>25</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1080/10739680601072123</pub-id><pub-id pub-id-type="pmid">17365659</pub-id></element-citation></ref><ref id="REF280"><label>280</label><element-citation publication-type="journal" id="CITATION280"><person-group person-group-type="author"><name name-style="western"><surname>Kohner</surname><given-names>EM</given-names></name><name name-style="western"><surname>Dollery</surname><given-names>CT</given-names></name></person-group><article-title>Fluorescein angiography of the fundus in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/oxfordjournals.bmb.a070770">Br Med Bull</uri></source><year>1970</year><volume>26</volume><fpage>166</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.bmb.a070770</pub-id><pub-id pub-id-type="pmid">4911770</pub-id></element-citation></ref><ref id="REF281"><label>281</label><element-citation publication-type="journal" id="CITATION281"><person-group person-group-type="author"><name name-style="western"><surname>Bresnick</surname><given-names>GH</given-names></name></person-group><article-title>Clinicopathologic correlations in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archopht.1977.04450070113010">Arch Ophthalmol</uri></source><year>1977</year><volume>95</volume><fpage>1215</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1001/archopht.1977.04450070113010</pub-id><pub-id pub-id-type="pmid">880082</pub-id></element-citation></ref><ref id="REF282"><label>282</label><element-citation publication-type="journal" id="CITATION282"><person-group person-group-type="author"><name name-style="western"><surname>Hammes</surname><given-names>HP</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>Renner</surname><given-names>O</given-names></name><name name-style="western"><surname>Shani</surname><given-names>M</given-names></name><name name-style="western"><surname>Lundqvist</surname><given-names>A</given-names></name><name name-style="western"><surname>Betsholtz</surname><given-names>C</given-names></name><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Pericytes and the pathogenesis of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.51.10.3107">Diabetes</uri></source><year>2002</year><volume>51</volume><fpage>3107</fpage><lpage>3112</lpage><pub-id pub-id-type="doi">10.2337/diabetes.51.10.3107</pub-id><pub-id pub-id-type="pmid">12351455</pub-id></element-citation></ref><ref id="REF283"><label>283</label><element-citation publication-type="journal" id="CITATION283"><person-group person-group-type="author"><name name-style="western"><surname>Coughlin</surname><given-names>BA</given-names></name><name name-style="western"><surname>Feenstra</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>S</given-names></name></person-group><article-title>M&#252;ller cells and diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.visres.2017.03.013">Vision Res</uri></source><year>2017</year><volume>139</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.visres.2017.03.013</pub-id><pub-id pub-id-type="pmid">28866025</pub-id><pub-id pub-id-type="pmcid">PMC5794018</pub-id></element-citation></ref><ref id="REF284"><label>284</label><element-citation publication-type="journal" id="CITATION284"><person-group person-group-type="author"><name name-style="western"><surname>Kohner</surname><given-names>EM</given-names></name><name name-style="western"><surname>Henkind</surname><given-names>P</given-names></name></person-group><article-title>Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9394(70)92273-7">Am J Ophthalmol</uri></source><year>1970</year><volume>69</volume><fpage>403</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/0002-9394(70)92273-7</pub-id><pub-id pub-id-type="pmid">4907465</pub-id></element-citation></ref><ref id="REF285"><label>285</label><element-citation publication-type="other" id="CITATION285"><article-title>Li W, Yanoff M, Liu X, Ye X. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9642318/">Chin Med J (Engl)</uri> 1997, 110: 659&#8211;663
</article-title><pub-id pub-id-type="pmid">9642318</pub-id></element-citation></ref><ref id="REF286"><label>286</label><element-citation publication-type="journal" id="CITATION286"><person-group person-group-type="author"><name name-style="western"><surname>Gardiner</surname><given-names>TA</given-names></name><name name-style="western"><surname>Stitt</surname><given-names>AW</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>HR</given-names></name><name name-style="western"><surname>Archer</surname><given-names>DB</given-names></name></person-group><article-title>Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bjo.78.1.54">Br J Ophthalmol</uri></source><year>1994</year><volume>78</volume><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1136/bjo.78.1.54</pub-id><pub-id pub-id-type="pmid">8110701</pub-id><pub-id pub-id-type="pmcid">PMC504692</pub-id></element-citation></ref><ref id="REF287"><label>287</label><element-citation publication-type="journal" id="CITATION287"><person-group person-group-type="author"><name name-style="western"><surname>Mizutani</surname><given-names>M</given-names></name><name name-style="western"><surname>Kern</surname><given-names>TS</given-names></name><name name-style="western"><surname>Lorenzi</surname><given-names>M</given-names></name></person-group><article-title>Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI118746">J Clin Invest</uri></source><year>1996</year><volume>97</volume><fpage>2883</fpage><lpage>2890</lpage><pub-id pub-id-type="doi">10.1172/JCI118746</pub-id><pub-id pub-id-type="pmid">8675702</pub-id><pub-id pub-id-type="pmcid">PMC507384</pub-id></element-citation></ref><ref id="REF288"><label>288</label><element-citation publication-type="journal" id="CITATION288"><person-group person-group-type="author"><name name-style="western"><surname>Hayflick</surname><given-names>L</given-names></name></person-group><article-title>The limited
<italic toggle="yes">in vitro</italic> lifetime of human diploid cell strains
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0014-4827(65)90211-9">Exp Cell Res</uri></source><year>1965</year><volume>37</volume><fpage>614</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1016/0014-4827(65)90211-9</pub-id><pub-id pub-id-type="pmid">14315085</pub-id></element-citation></ref><ref id="REF289"><label>289</label><element-citation publication-type="journal" id="CITATION289"><person-group person-group-type="author"><name name-style="western"><surname>Linskens</surname><given-names>MHK</given-names></name><name name-style="western"><surname>Harley</surname><given-names>CB</given-names></name><name name-style="western"><surname>West</surname><given-names>MD</given-names></name><name name-style="western"><surname>Campisi</surname><given-names>J</given-names></name><name name-style="western"><surname>Hayflick</surname><given-names>L</given-names></name></person-group><article-title>Replicative senescence and cell death</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1126/science.7848496">Science</uri></source><year>1995</year><volume>267</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1126/science.7848496</pub-id><pub-id pub-id-type="other">1995Sci...267...17L</pub-id><pub-id pub-id-type="pmid">7848496</pub-id></element-citation></ref><ref id="REF290"><label>290</label><element-citation publication-type="other" id="CITATION290"><article-title>Fruttiger M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11818400/">Invest Ophthalmol Visual Sci</uri> 2002, 43: 522&#8211;527.
</article-title><pub-id pub-id-type="pmid">11818400</pub-id></element-citation></ref><ref id="REF291"><label>291</label><element-citation publication-type="journal" id="CITATION291"><person-group person-group-type="author"><name name-style="western"><surname>Hoffmann</surname><given-names>J</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hagen</surname><given-names>F</given-names></name><name name-style="western"><surname>Hillenbrand</surname><given-names>A</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>Erber</surname><given-names>R</given-names></name><name name-style="western"><surname>Vajkoczy</surname><given-names>P</given-names></name><etal>et al.</etal></person-group><article-title>Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries, determine vessel plasticity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1096/fj.04-2109fje">FASEB J</uri></source><year>2005</year><volume>19</volume><fpage>2035</fpage><lpage>2036</lpage><pub-id pub-id-type="doi">10.1096/fj.04-2109fje</pub-id><pub-id pub-id-type="pmid">16215210</pub-id></element-citation></ref><ref id="REF292"><label>292</label><element-citation publication-type="other" id="CITATION292"><article-title>Cox O, Stitt AW, Simpson DA, Gardiner TA. Sources of PDGF expression in murine retina and the effect of short-term diabetes.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.molvis.org/molvis/v9/a80/v9a80-cox.pdf">Mol Vision</uri> 2003, 10: 665&#8211;672.
</article-title><pub-id pub-id-type="pmid">14685146</pub-id></element-citation></ref><ref id="REF293"><label>293</label><element-citation publication-type="other" id="CITATION293"><article-title>Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal M&#252;ller cells.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766465/">Invest Ophthalmol VisSci</uri> 2000, 41: 3183&#8211;3190.
</article-title><pub-id pub-id-type="pmcid">PMC1766465</pub-id><pub-id pub-id-type="pmid">10967082</pub-id></element-citation></ref><ref id="REF294"><label>294</label><element-citation publication-type="journal" id="CITATION294"><person-group person-group-type="author"><name name-style="western"><surname>Metea</surname><given-names>MR</given-names></name></person-group><article-title>Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1523/JNEUROSCI.4048-05.2006">J Neurosci</uri></source><year>2006</year><volume>26</volume><fpage>2862</fpage><lpage>2870</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4048-05.2006</pub-id><pub-id pub-id-type="pmid">16540563</pub-id><pub-id pub-id-type="pmcid">PMC2270788</pub-id></element-citation></ref><ref id="REF295"><label>295</label><element-citation publication-type="journal" id="CITATION295"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>EA</given-names></name></person-group><article-title>Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1098/rstb.2014.0195">Phil Trans R Soc B</uri></source><year>2015</year><volume>370</volume><fpage>20140195</fpage><pub-id pub-id-type="doi">10.1098/rstb.2014.0195</pub-id><pub-id pub-id-type="pmid">26009774</pub-id><pub-id pub-id-type="pmcid">PMC4455764</pub-id></element-citation></ref><ref id="REF296"><label>296</label><element-citation publication-type="journal" id="CITATION296"><person-group person-group-type="author"><name name-style="western"><surname>Tout</surname><given-names>S</given-names></name><name name-style="western"><surname>Chan-Ling</surname><given-names>T</given-names></name><name name-style="western"><surname>Holl&#228;nder</surname><given-names>H</given-names></name><name name-style="western"><surname>Stone</surname><given-names>J</given-names></name></person-group><article-title>The role of m&#252;ller cells in the formation of the blood-retinal barrier</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0306-4522(93)90473-S">Neuroscience</uri></source><year>1993</year><volume>55</volume><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(93)90473-S</pub-id><pub-id pub-id-type="pmid">8350991</pub-id></element-citation></ref><ref id="REF297"><label>297</label><element-citation publication-type="other" id="CITATION297"><article-title>Abukawa H, Tomi M, Kiyokawa J, Hori S, Kondo T, Terasaki T, Hosoya K. Modulation of retinal capillary endothelial cells by M&#252;ller glial cell-derived factors.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19247458/">Mol Vis</uri> 2009, 15: 451&#8211;457.
</article-title><pub-id pub-id-type="pmcid">PMC2647974</pub-id><pub-id pub-id-type="pmid">19247458</pub-id></element-citation></ref><ref id="REF298"><label>298</label><element-citation publication-type="journal" id="CITATION298"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>W</given-names></name><name name-style="western"><surname>Fruttiger</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Chung</surname><given-names>SH</given-names></name><name name-style="western"><surname>Barnett</surname><given-names>NL</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>JK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Conditional M&#252;ller cell ablation causes independent neuronal and vascular pathologies in a novel transgenic model</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1523/JNEUROSCI.2841-12.2012">J Neurosci</uri></source><year>2012</year><volume>32</volume><fpage>15715</fpage><lpage>15727</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2841-12.2012</pub-id><pub-id pub-id-type="pmid">23136411</pub-id><pub-id pub-id-type="pmcid">PMC4014009</pub-id></element-citation></ref><ref id="REF299"><label>299</label><element-citation publication-type="journal" id="CITATION299"><person-group person-group-type="author"><name name-style="western"><surname>Eichler</surname><given-names>W</given-names></name><name name-style="western"><surname>Yafai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Keller</surname><given-names>T</given-names></name><name name-style="western"><surname>Wiedemann</surname><given-names>P</given-names></name><name name-style="western"><surname>Reichenbach</surname><given-names>A</given-names></name></person-group><article-title>PEDF derived from glial M&#252;ller cells: a possible regulator of retinal angiogenesis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.yexcr.2004.05.020">Exp Cell Res</uri></source><year>2004</year><volume>299</volume><fpage>68</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2004.05.020</pub-id><pub-id pub-id-type="pmid">15302574</pub-id></element-citation></ref><ref id="REF300"><label>300</label><element-citation publication-type="journal" id="CITATION300"><person-group person-group-type="author"><name name-style="western"><surname>Bringmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Pannicke</surname><given-names>T</given-names></name><name name-style="western"><surname>Grosche</surname><given-names>J</given-names></name><name name-style="western"><surname>Francke</surname><given-names>M</given-names></name><name name-style="western"><surname>Wiedemann</surname><given-names>P</given-names></name><name name-style="western"><surname>Skatchkov</surname><given-names>S</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>N</given-names></name><etal>et al.</etal></person-group><article-title>M&#252;ller cells in the healthy and diseased retina</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.preteyeres.2006.05.003">Prog Retinal Eye Res</uri></source><year>2006</year><volume>25</volume><fpage>397</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2006.05.003</pub-id><pub-id pub-id-type="pmid">16839797</pub-id></element-citation></ref><ref id="REF301"><label>301</label><element-citation publication-type="other" id="CITATION301"><article-title>Puro DG. Diabetes-induced dysfunction of retinal M&#252;ller cells.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12545700/">Trans Am Ophthalmol Soc</uri> 2002, 100: 339&#8211;352.
</article-title><pub-id pub-id-type="pmcid">PMC1358969</pub-id><pub-id pub-id-type="pmid">12545700</pub-id></element-citation></ref><ref id="REF302"><label>302</label><element-citation publication-type="journal" id="CITATION302"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>A</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group><article-title>PPP1CA/YAP/GS/Gln/mTORC1 pathway activates retinal M&#252;ller cells during diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.exer.2021.108703">Exp Eye Res</uri></source><year>2021</year><volume>210</volume><fpage>108703</fpage><pub-id pub-id-type="doi">10.1016/j.exer.2021.108703</pub-id><pub-id pub-id-type="pmid">34280391</pub-id></element-citation></ref><ref id="REF303"><label>303</label><element-citation publication-type="journal" id="CITATION303"><person-group person-group-type="author"><name name-style="western"><surname>Gerhardinger</surname><given-names>C</given-names></name><name name-style="western"><surname>Costa</surname><given-names>MB</given-names></name><name name-style="western"><surname>Coulombe</surname><given-names>MC</given-names></name><name name-style="western"><surname>Toth</surname><given-names>I</given-names></name><name name-style="western"><surname>Hoehn</surname><given-names>T</given-names></name><name name-style="western"><surname>Grosu</surname><given-names>P</given-names></name></person-group><article-title>Expression of acute-phase response proteins in retinal m&#252;ller cells in diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.04-0860">Invest Ophthalmol Vis Sci</uri></source><year>2005</year><volume>46</volume><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1167/iovs.04-0860</pub-id><pub-id pub-id-type="pmid">15623795</pub-id></element-citation></ref><ref id="REF304"><label>304</label><element-citation publication-type="other" id="CITATION304"><article-title>Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-posphate dehydrogenase: a role in high glucose-induced apoptosis in retinal M&#252;ller cells.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15111614/">Invest Ophthalmol Vis Sci</uri>2004, 45: 1553&#8211;1561.
</article-title><pub-id pub-id-type="pmid">15111614</pub-id></element-citation></ref><ref id="REF305"><label>305</label><element-citation publication-type="journal" id="CITATION305"><person-group person-group-type="author"><name name-style="western"><surname>Lieth</surname><given-names>E</given-names></name><name name-style="western"><surname>Barber</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name><name name-style="western"><surname>Dice</surname><given-names>C</given-names></name><name name-style="western"><surname>Ratz</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Tanase</surname><given-names>D</given-names></name><name name-style="western"><surname>Strother</surname><given-names>JM</given-names></name></person-group><article-title>Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.47.5.815">Diabetes</uri></source><year>1998</year><volume>47</volume><fpage>815</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.2337/diabetes.47.5.815</pub-id><pub-id pub-id-type="pmid">9588455</pub-id></element-citation></ref><ref id="REF306"><label>306</label><element-citation publication-type="other" id="CITATION306"><article-title>Rungger&#8211;Br&#228;ndle E, Dosso AA, Leuenberger PM. Glial Reactivity, an early feature of diabetic retinopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10845624/">Invest Ophthalmol Vis Sci</uri> 2000, 41: 1971&#8211;1980.
</article-title><pub-id pub-id-type="pmid">10845624</pub-id></element-citation></ref><ref id="REF307"><label>307</label><element-citation publication-type="journal" id="CITATION307"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>MH</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Le</surname><given-names>YZ</given-names></name></person-group><article-title>M&#252;ller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db09-1420">Diabetes</uri></source><year>2010</year><volume>59</volume><fpage>2297</fpage><lpage>2305</lpage><pub-id pub-id-type="doi">10.2337/db09-1420</pub-id><pub-id pub-id-type="pmid">20530741</pub-id><pub-id pub-id-type="pmcid">PMC2927953</pub-id></element-citation></ref><ref id="REF308"><label>308</label><element-citation publication-type="journal" id="CITATION308"><person-group person-group-type="author"><name name-style="western"><surname>Yego</surname><given-names>ECK</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>JA</given-names></name><name name-style="western"><surname>Sarthy</surname><given-names>V</given-names></name><name name-style="western"><surname>Busik</surname><given-names>JV</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>S</given-names></name></person-group><article-title>Differential regulation of high glucose&#8211;induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation in m&#252;ller cells by IL-1&#946; and IL-6</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.08-2082">Invest Ophthalmol Vis Sci</uri></source><year>2009</year><volume>50</volume><fpage>1920</fpage><lpage>1928</lpage><pub-id pub-id-type="doi">10.1167/iovs.08-2082</pub-id><pub-id pub-id-type="pmid">19060282</pub-id></element-citation></ref><ref id="REF309"><label>309</label><element-citation publication-type="journal" id="CITATION309"><person-group person-group-type="author"><name name-style="western"><surname>Mu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>XM</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Dong</surname><given-names>L</given-names></name><name name-style="western"><surname>Feng</surname><given-names>ZL</given-names></name></person-group><article-title>Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal M&#252;ller cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s11033-008-9428-8">Mol Biol Rep</uri></source><year>2009</year><volume>36</volume><fpage>2147</fpage><lpage>2151</lpage><pub-id pub-id-type="doi">10.1007/s11033-008-9428-8</pub-id><pub-id pub-id-type="pmid">19107574</pub-id></element-citation></ref><ref id="REF310"><label>310</label><element-citation publication-type="journal" id="CITATION310"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sarthy</surname><given-names>VP</given-names></name><name name-style="western"><surname>Kern</surname><given-names>TS</given-names></name></person-group><article-title>Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajpregu.00080.2003">Am J Physiol Regul Integr Comp Physiol</uri></source><year>2004</year><volume>287</volume><fpage>R735</fpage><lpage>R741</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00080.2003</pub-id><pub-id pub-id-type="pmid">15371279</pub-id></element-citation></ref><ref id="REF311"><label>311</label><element-citation publication-type="journal" id="CITATION311"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Su</surname><given-names>SB</given-names></name></person-group><article-title>Neuroinflammatory responses in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1186/s12974-015-0368-7">J Neuroinflammation</uri></source><year>2015</year><volume>12</volume><fpage>141</fpage><pub-id pub-id-type="doi">10.1186/s12974-015-0368-7</pub-id><pub-id pub-id-type="pmid">26245868</pub-id><pub-id pub-id-type="pmcid">PMC4527131</pub-id></element-citation></ref><ref id="REF312"><label>312</label><element-citation publication-type="journal" id="CITATION312"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>T</given-names></name><name name-style="western"><surname>Che</surname><given-names>D</given-names></name><name name-style="western"><surname>Lan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name><name name-style="western"><surname>Gong</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>CY</given-names></name><etal>et al.</etal></person-group><article-title>Mesenchymal marker expression is elevated in M&#252;ller cells exposed to high glucose and in animal models of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.18632/oncotarget.13945">Oncotarget</uri></source><year>2017</year><volume>8</volume><fpage>4582</fpage><lpage>4594</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.13945</pub-id><pub-id pub-id-type="pmid">27999189</pub-id><pub-id pub-id-type="pmcid">PMC5354856</pub-id></element-citation></ref><ref id="REF313"><label>313</label><element-citation publication-type="journal" id="CITATION313"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>J</given-names></name><name name-style="western"><surname>Hu</surname><given-names>LM</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mou</surname><given-names>L</given-names></name><name name-style="western"><surname>Xu</surname><given-names>G</given-names></name><etal>et al.</etal></person-group><article-title>EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2741/e234">Front Biosci</uri></source><year>2011</year><volume>E3</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.2741/e234</pub-id><pub-id pub-id-type="pmid">21196299</pub-id></element-citation></ref><ref id="REF314"><label>314</label><element-citation publication-type="journal" id="CITATION314"><person-group person-group-type="author"><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C</given-names></name><name name-style="western"><surname>Segura</surname><given-names>RM</given-names></name><name name-style="western"><surname>Fonollosa</surname><given-names>A</given-names></name><name name-style="western"><surname>Carrasco</surname><given-names>E</given-names></name><name name-style="western"><surname>Francisco</surname><given-names>G</given-names></name><name name-style="western"><surname>Sim&#243;</surname><given-names>R</given-names></name></person-group><article-title>Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1464-5491.2005.01538.x">Diabet Med</uri></source><year>2005</year><volume>22</volume><fpage>719</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2005.01538.x</pub-id><pub-id pub-id-type="pmid">15910622</pub-id></element-citation></ref><ref id="REF315"><label>315</label><element-citation publication-type="journal" id="CITATION315"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Le</surname><given-names>YZ</given-names></name></person-group><article-title>M&#252;ller cell-derived VEGF is a significant contributor to retinal neovascularization</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/path.2611">J Pathol</uri></source><year>2009</year><volume>219</volume><fpage>446</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1002/path.2611</pub-id><pub-id pub-id-type="pmid">19768732</pub-id></element-citation></ref><ref id="REF316"><label>316</label><element-citation publication-type="journal" id="CITATION316"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jin</surname><given-names>J</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>KK</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Le</surname><given-names>YZ</given-names></name><etal>et al.</etal></person-group><article-title>Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal M&#252;ller cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-011-2081-0">Diabetologia</uri></source><year>2011</year><volume>54</volume><fpage>1554</fpage><lpage>1566</lpage><pub-id pub-id-type="doi">10.1007/s00125-011-2081-0</pub-id><pub-id pub-id-type="pmid">21360191</pub-id><pub-id pub-id-type="pmcid">PMC6592825</pub-id></element-citation></ref><ref id="REF317"><label>317</label><element-citation publication-type="journal" id="CITATION317"><person-group person-group-type="author"><name name-style="western"><surname>Vellanki</surname><given-names>S</given-names></name><name name-style="western"><surname>Ferrigno</surname><given-names>A</given-names></name><name name-style="western"><surname>Alanis</surname><given-names>Y</given-names></name><name name-style="western"><surname>Betts-Obregon</surname><given-names>BS</given-names></name><name name-style="western"><surname>Tsin</surname><given-names>AT</given-names></name></person-group><article-title>High glucose and glucose deprivation modulate M&#252;ller cell viability and VEGF secretion</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.19070/2332-290X-1600037">Int J Ophthalmol Eye Sci</uri></source><year>2016</year><fpage>178</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.19070/2332-290X-1600037</pub-id><pub-id pub-id-type="pmid">27347496</pub-id><pub-id pub-id-type="pmcid">PMC4917289</pub-id></element-citation></ref><ref id="REF318"><label>318</label><element-citation publication-type="journal" id="CITATION318"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>S</given-names></name><name name-style="western"><surname>Dong</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Sherry</surname><given-names>DM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>You</surname><given-names>Z</given-names></name><name name-style="western"><surname>Haigh</surname><given-names>JJ</given-names></name><etal>et al.</etal></person-group><article-title>M&#252;ller glia are a major cellular source of survival signals for retinal neurons in diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db15-0180">Diabetes</uri></source><year>2015</year><volume>64</volume><fpage>3554</fpage><lpage>3563</lpage><pub-id pub-id-type="doi">10.2337/db15-0180</pub-id><pub-id pub-id-type="pmid">26068541</pub-id><pub-id pub-id-type="pmcid">PMC4587642</pub-id></element-citation></ref><ref id="REF319"><label>319</label><element-citation publication-type="journal" id="CITATION319"><person-group person-group-type="author"><name name-style="western"><surname>Natoli</surname><given-names>R</given-names></name><name name-style="western"><surname>Fernando</surname><given-names>N</given-names></name><name name-style="western"><surname>Madigan</surname><given-names>M</given-names></name><name name-style="western"><surname>Chu-Tan</surname><given-names>JA</given-names></name><name name-style="western"><surname>Valter</surname><given-names>K</given-names></name><name name-style="western"><surname>Provis</surname><given-names>J</given-names></name><name name-style="western"><surname>Rutar</surname><given-names>M</given-names></name></person-group><article-title>Microglia-derived IL-1&#946; promotes chemokine expression by M&#252;ller cells and RPE in focal retinal degeneration</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1186/s13024-017-0175-y">Mol Neurodegener</uri></source><year>2017</year><volume>12</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s13024-017-0175-y</pub-id><pub-id pub-id-type="pmid">28438165</pub-id><pub-id pub-id-type="pmcid">PMC5404662</pub-id></element-citation></ref><ref id="REF320"><label>320</label><element-citation publication-type="journal" id="CITATION320"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Biarn&#233;s Costa</surname><given-names>M</given-names></name><name name-style="western"><surname>Gerhardinger</surname><given-names>C</given-names></name></person-group><article-title>IL-1&#946; is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1&#946; autostimulation</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1371/journal.pone.0036949">PLoS ONE</uri></source><year>2012</year><volume>7</volume><fpage>e36949</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0036949</pub-id><pub-id pub-id-type="other">2012PLoSO...736949L</pub-id><pub-id pub-id-type="pmid">22615852</pub-id><pub-id pub-id-type="pmcid">PMC3353989</pub-id></element-citation></ref><ref id="REF321"><label>321</label><element-citation publication-type="journal" id="CITATION321"><person-group person-group-type="author"><name name-style="western"><surname>Mohr</surname><given-names>S</given-names></name></person-group><article-title>Potential new strategies to prevent the development of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1517/13543784.13.3.189">Expert Opin Investig Drugs</uri></source><year>2004</year><volume>13</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1517/13543784.13.3.189</pub-id><pub-id pub-id-type="pmid">15013939</pub-id></element-citation></ref><ref id="REF322"><label>322</label><element-citation publication-type="journal" id="CITATION322"><person-group person-group-type="author"><name name-style="western"><surname>Demircan</surname><given-names>N</given-names></name><name name-style="western"><surname>Safran</surname><given-names>BG</given-names></name><name name-style="western"><surname>Soylu</surname><given-names>M</given-names></name><name name-style="western"><surname>Ozcan</surname><given-names>AA</given-names></name><name name-style="western"><surname>Sizmaz</surname><given-names>S</given-names></name></person-group><article-title>Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/sj.eye.6702138">Eye</uri></source><year>2006</year><volume>20</volume><fpage>1366</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1038/sj.eye.6702138</pub-id><pub-id pub-id-type="pmid">16284605</pub-id></element-citation></ref><ref id="REF323"><label>323</label><element-citation publication-type="journal" id="CITATION323"><person-group person-group-type="author"><name name-style="western"><surname>Busik</surname><given-names>JV</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>S</given-names></name><name name-style="western"><surname>Grant</surname><given-names>MB</given-names></name></person-group><article-title>Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db07-1520">Diabetes</uri></source><year>2008</year><volume>57</volume><fpage>1952</fpage><lpage>1965</lpage><pub-id pub-id-type="doi">10.2337/db07-1520</pub-id><pub-id pub-id-type="pmid">18420487</pub-id><pub-id pub-id-type="pmcid">PMC2453610</pub-id></element-citation></ref><ref id="REF324"><label>324</label><element-citation publication-type="journal" id="CITATION324"><person-group person-group-type="author"><name name-style="western"><surname>Tilton</surname><given-names>RG</given-names></name><name name-style="western"><surname>Faller</surname><given-names>AM</given-names></name><name name-style="western"><surname>Burkhardt</surname><given-names>JK</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>PL</given-names></name><name name-style="western"><surname>Kilo</surname><given-names>C</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>JR</given-names></name></person-group><article-title>Pericyte degeneration and acellular capillaries are increased in the feet of human diabetic patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF00703132">Diabetologia</uri></source><year>1985</year><volume>28</volume><fpage>895</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1007/BF00703132</pub-id><pub-id pub-id-type="pmid">4092858</pub-id></element-citation></ref><ref id="REF325"><label>325</label><element-citation publication-type="journal" id="CITATION325"><person-group person-group-type="author"><name name-style="western"><surname>Krady</surname><given-names>JK</given-names></name><name name-style="western"><surname>Basu</surname><given-names>A</given-names></name><name name-style="western"><surname>Allen</surname><given-names>CM</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>LaNoue</surname><given-names>KF</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>TW</given-names></name><name name-style="western"><surname>Levison</surname><given-names>SW</given-names></name></person-group><article-title>Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.54.5.1559">Diabetes</uri></source><year>2005</year><volume>54</volume><fpage>1559</fpage><lpage>1565</lpage><pub-id pub-id-type="doi">10.2337/diabetes.54.5.1559</pub-id><pub-id pub-id-type="pmid">15855346</pub-id></element-citation></ref><ref id="REF326"><label>326</label><element-citation publication-type="journal" id="CITATION326"><person-group person-group-type="author"><name name-style="western"><surname>Schmalen</surname><given-names>A</given-names></name><name name-style="western"><surname>Lorenz</surname><given-names>L</given-names></name><name name-style="western"><surname>Grosche</surname><given-names>A</given-names></name><name name-style="western"><surname>Pauly</surname><given-names>D</given-names></name><name name-style="western"><surname>Deeg</surname><given-names>CA</given-names></name><name name-style="western"><surname>Hauck</surname><given-names>SM</given-names></name></person-group><article-title>Proteomic phenotyping of stimulated M&#252;ller cells uncovers profound pro-inflammatory signaling and antigen-presenting capacity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fphar.2021.771571">Front Pharmacol</uri></source><year>2021</year><volume>12</volume><fpage>771571</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.771571</pub-id><pub-id pub-id-type="pmid">34776983</pub-id><pub-id pub-id-type="pmcid">PMC8585775</pub-id></element-citation></ref><ref id="REF327"><label>327</label><element-citation publication-type="journal" id="CITATION327"><person-group person-group-type="author"><name name-style="western"><surname>Feenstra</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Yego</surname><given-names>EC</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>S</given-names></name></person-group><article-title>Modes of retinal cell death in diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.4172/2155-9570.1000298">J Clin Exp Ophthalmol</uri></source><year>2013</year><volume>04</volume><fpage>298</fpage><pub-id pub-id-type="doi">10.4172/2155-9570.1000298</pub-id><pub-id pub-id-type="pmid">24672740</pub-id><pub-id pub-id-type="pmcid">PMC3963519</pub-id></element-citation></ref><ref id="REF328"><label>328</label><element-citation publication-type="journal" id="CITATION328"><person-group person-group-type="author"><name name-style="western"><surname>Trueblood</surname><given-names>KE</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>S</given-names></name><name name-style="western"><surname>Dubyak</surname><given-names>GR</given-names></name></person-group><article-title>Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal M&#252;ller cell line rMC-1</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajpcell.00265.2011">Am J Physiol Cell Physiol</uri></source><year>2011</year><volume>301</volume><fpage>C1213</fpage><lpage>C1223</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00265.2011</pub-id><pub-id pub-id-type="pmid">21832250</pub-id><pub-id pub-id-type="pmcid">PMC3213916</pub-id></element-citation></ref><ref id="REF329"><label>329</label><element-citation publication-type="journal" id="CITATION329"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>S</given-names></name><name name-style="western"><surname>Sotozono</surname><given-names>C</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>T</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>S</given-names></name></person-group><article-title>Interleukin-6 (IL-6) production by cytokine-stimulated human M&#252;ller cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1076/ceyr.22.5.341.5498">Curr Eye Res</uri></source><year>2001</year><volume>22</volume><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1076/ceyr.22.5.341.5498</pub-id><pub-id pub-id-type="pmid">11600934</pub-id></element-citation></ref><ref id="REF330"><label>330</label><element-citation publication-type="journal" id="CITATION330"><person-group person-group-type="author"><name name-style="western"><surname>Barnes</surname><given-names>TC</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>ME</given-names></name><name name-style="western"><surname>Moots</surname><given-names>RJ</given-names></name></person-group><article-title>The many faces of interleukin-6: The role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1155/2011/721608">Int J Rheumatol</uri></source><year>2011</year><volume>2011</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1155/2011/721608</pub-id><pub-id pub-id-type="pmid">21941555</pub-id><pub-id pub-id-type="pmcid">PMC3176444</pub-id></element-citation></ref><ref id="REF331"><label>331</label><element-citation publication-type="journal" id="CITATION331"><person-group person-group-type="author"><name name-style="western"><surname>Neurath</surname><given-names>MF</given-names></name><name name-style="western"><surname>Finotto</surname><given-names>S</given-names></name></person-group><article-title>IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.cytogfr.2011.02.003">Cytokine Growth Factor Rev</uri></source><year>2011</year><volume>22</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2011.02.003</pub-id><pub-id pub-id-type="pmid">21377916</pub-id></element-citation></ref><ref id="REF332"><label>332</label><element-citation publication-type="journal" id="CITATION332"><person-group person-group-type="author"><name name-style="western"><surname>Rojas</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>DL</given-names></name><name name-style="western"><surname>Romero</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>DT</given-names></name><name name-style="western"><surname>Al-Shabrawey</surname><given-names>M</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>NT</given-names></name><etal>et al.</etal></person-group><article-title>Role of IL-6 in angiotensin II&#8211;induced retinal vascular inflammation</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.09-3375">Invest Ophthalmol Vis Sci</uri></source><year>2009</year><volume>51</volume><fpage>1709</fpage><lpage>1718</lpage><pub-id pub-id-type="doi">10.1167/iovs.09-3375</pub-id><pub-id pub-id-type="pmid">19834028</pub-id><pub-id pub-id-type="pmcid">PMC2868419</pub-id></element-citation></ref><ref id="REF333"><label>333</label><element-citation publication-type="journal" id="CITATION333"><person-group person-group-type="author"><name name-style="western"><surname>Sim&#243;-Servat</surname><given-names>O</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C</given-names></name><name name-style="western"><surname>Sim&#243;</surname><given-names>R</given-names></name></person-group><article-title>Genetics in diabetic retinopathy: current concepts and new insights</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2174/13892029113149990008">Curr Genom</uri></source><year>2013</year><volume>14</volume><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.2174/13892029113149990008</pub-id><pub-id pub-id-type="pmid">24403848</pub-id><pub-id pub-id-type="pmcid">PMC3763680</pub-id></element-citation></ref><ref id="REF334"><label>334</label><element-citation publication-type="journal" id="CITATION334"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>MC</given-names></name><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name><name name-style="western"><surname>Susztak</surname><given-names>K</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>K</given-names></name><name name-style="western"><surname>Jandeleit-Dahm</surname><given-names>KA</given-names></name><name name-style="western"><surname>Zoungas</surname><given-names>S</given-names></name><name name-style="western"><surname>Rossing</surname><given-names>P</given-names></name><etal>et al.</etal></person-group><article-title>Diabetic kidney disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.42.1.80">Nat Rev Dis Primers</uri></source><year>2015</year><volume>1</volume><fpage>15018</fpage><pub-id pub-id-type="doi">10.2337/diab.42.1.80</pub-id><pub-id pub-id-type="pmid">27188921</pub-id><pub-id pub-id-type="pmcid">PMC7724636</pub-id></element-citation></ref><ref id="REF335"><label>335</label><element-citation publication-type="journal" id="CITATION335"><person-group person-group-type="author"><name name-style="western"><surname>Kador</surname><given-names>PF</given-names></name><name name-style="western"><surname>Wyman</surname><given-names>M</given-names></name><name name-style="western"><surname>Oates</surname><given-names>PJ</given-names></name></person-group><article-title>Aldose reductase, ocular diabetic complications and the development of topical Kinostat
<sup>&#174;</sup>
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.preteyeres.2016.04.006">Prog Retinal Eye Res</uri></source><year>2016</year><volume>54</volume><fpage>1</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2016.04.006</pub-id><pub-id pub-id-type="pmcid">PMC11844803</pub-id><pub-id pub-id-type="pmid">27102270</pub-id></element-citation></ref><ref id="REF336"><label>336</label><element-citation publication-type="journal" id="CITATION336"><person-group person-group-type="author"><name name-style="western"><surname>Aiello</surname><given-names>LP</given-names></name><name name-style="western"><surname>Bursell</surname><given-names>SE</given-names></name><name name-style="western"><surname>Clermont</surname><given-names>A</given-names></name><name name-style="western"><surname>Duh</surname><given-names>E</given-names></name><name name-style="western"><surname>Ishii</surname><given-names>H</given-names></name><name name-style="western"><surname>Takagi</surname><given-names>C</given-names></name><name name-style="western"><surname>Mori</surname><given-names>F</given-names></name><etal>et al.</etal></person-group><article-title>Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C
<italic toggle="yes">in vivo</italic> and suppressed by an orally effective &#946;-isoform&#8211;selective inhibitor
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.46.9.1473">Diabetes</uri></source><year>1997</year><volume>46</volume><fpage>1473</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.2337/diab.46.9.1473</pub-id><pub-id pub-id-type="pmid">9287049</pub-id></element-citation></ref><ref id="REF337"><label>337</label><element-citation publication-type="other" id="CITATION337"><article-title>PKC-DRS Study Group. The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C Beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15046548/">Diabetes</uri> 2005, 54: 2188&#8211;2197
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diabetes.54.7.2188</pub-id><pub-id pub-id-type="pmid">15983221</pub-id></element-citation></ref><ref id="REF338"><label>338</label><element-citation publication-type="other" id="CITATION338"><article-title>Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15046548/">Physiol Res</uri>2004, 53: 131&#8211;142
</article-title><pub-id pub-id-type="pmid">15046548</pub-id></element-citation></ref><ref id="REF339"><label>339</label><element-citation publication-type="journal" id="CITATION339"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>AKW</given-names></name><name name-style="western"><surname>Lo</surname><given-names>ACY</given-names></name></person-group><article-title>Animal models of diabetic retinopathy: summary and comparison</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1155/2013/106594">J Diabetes Res</uri></source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1155/2013/106594</pub-id><pub-id pub-id-type="pmid">24286086</pub-id><pub-id pub-id-type="pmcid">PMC3826427</pub-id></element-citation></ref><ref id="REF340"><label>340</label><element-citation publication-type="other" id="CITATION340"><article-title>Tso M, Kurosawa A, Benhamou E, Bauman A, Jeffrey J, Jonasson O. Microangiopathic retinopathy in experimental diabetic monkeys.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/2980946/">Transactions Am Ophthalmol Soc</uri> 1988, 86: 389
</article-title><pub-id pub-id-type="pmcid">PMC1298817</pub-id><pub-id pub-id-type="pmid">2980946</pub-id></element-citation></ref><ref id="REF341"><label>341</label><element-citation publication-type="journal" id="CITATION341"><person-group person-group-type="author"><name name-style="western"><surname>Olivares</surname><given-names>AM</given-names></name><name name-style="western"><surname>Althoff</surname><given-names>K</given-names></name><name name-style="western"><surname>Chen</surname><given-names>GF</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name><name name-style="western"><surname>Morrisson</surname><given-names>MA</given-names></name><name name-style="western"><surname>DeAngelis</surname><given-names>MM</given-names></name><name name-style="western"><surname>Haider</surname><given-names>N</given-names></name></person-group><article-title>Animal models of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s11892-017-0913-0">Curr Diab Rep</uri></source><year>2017</year><volume>17</volume><fpage>93</fpage><pub-id pub-id-type="doi">10.1007/s11892-017-0913-0</pub-id><pub-id pub-id-type="pmid">28836097</pub-id><pub-id pub-id-type="pmcid">PMC5569142</pub-id></element-citation></ref><ref id="REF342"><label>342</label><element-citation publication-type="journal" id="CITATION342"><person-group person-group-type="author"><name name-style="western"><surname>Barber</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Antonetti</surname><given-names>DA</given-names></name><name name-style="western"><surname>Kern</surname><given-names>TS</given-names></name><name name-style="western"><surname>Reiter</surname><given-names>CEN</given-names></name><name name-style="western"><surname>Soans</surname><given-names>RS</given-names></name><name name-style="western"><surname>Krady</surname><given-names>JK</given-names></name><name name-style="western"><surname>Levison</surname><given-names>SW</given-names></name><etal>et al.</etal></person-group><article-title>The Ins2
<sup>Akita</sup> Mouse as a Model of Early Retinal Complications in Diabetes
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.04-1340">Invest Ophthalmol Vis Sci</uri></source><year>2005</year><volume>46</volume><fpage>2210</fpage><lpage>2218</lpage><pub-id pub-id-type="doi">10.1167/iovs.04-1340</pub-id><pub-id pub-id-type="pmid">15914643</pub-id></element-citation></ref><ref id="REF343"><label>343</label><element-citation publication-type="journal" id="CITATION343"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ji</surname><given-names>F</given-names></name><name name-style="western"><surname>Sinclair</surname><given-names>SH</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>G</given-names></name><etal>et al.</etal></person-group><article-title>Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.07-0721">Invest Ophthalmol Vis Sci</uri></source><year>2008</year><volume>49</volume><fpage>732</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-0721</pub-id><pub-id pub-id-type="pmid">18235022</pub-id></element-citation></ref><ref id="REF344"><label>344</label><element-citation publication-type="journal" id="CITATION344"><person-group person-group-type="author"><name name-style="western"><surname>Kern</surname><given-names>TS</given-names></name><name name-style="western"><surname>Engerman</surname><given-names>RL</given-names></name></person-group><article-title>Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/02713689409015087">Curr Eye Res</uri></source><year>1994</year><volume>13</volume><fpage>863</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.3109/02713689409015087</pub-id><pub-id pub-id-type="pmid">7720392</pub-id></element-citation></ref><ref id="REF345"><label>345</label><element-citation publication-type="other" id="CITATION345"><article-title>Joussen AM, Doehmen S, Le ML, Koizumi K, Radetzky S, Krohne TU, Poulaki V, Semkova I, Kociok N. TNF-&#945;-mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19641635/">Mol Vis</uri> 2009, 15: 1418&#8211;1428
</article-title><pub-id pub-id-type="pmcid">PMC2716944</pub-id><pub-id pub-id-type="pmid">19641635</pub-id></element-citation></ref><ref id="REF346"><label>346</label><element-citation publication-type="journal" id="CITATION346"><person-group person-group-type="author"><name name-style="western"><surname>Kern</surname><given-names>TS</given-names></name></person-group><article-title>A mouse model of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/archopht.1996.01100140194013">Arch Ophthalmol</uri></source><year>1996</year><volume>114</volume><fpage>986</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1001/archopht.1996.01100140194013</pub-id><pub-id pub-id-type="pmid">8694735</pub-id></element-citation></ref><ref id="REF347"><label>347</label><element-citation publication-type="journal" id="CITATION347"><person-group person-group-type="author"><name name-style="western"><surname>Joussen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Poulaki</surname><given-names>V</given-names></name><name name-style="western"><surname>Le</surname><given-names>ML</given-names></name><name name-style="western"><surname>Koizumi</surname><given-names>K</given-names></name><name name-style="western"><surname>Esser</surname><given-names>C</given-names></name><name name-style="western"><surname>Janicki</surname><given-names>H</given-names></name><name name-style="western"><surname>Schraermeyer</surname><given-names>U</given-names></name><etal>et al.</etal></person-group><article-title>A central role for inflammation in the pathogenesis of diabetic retinopathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1096/fj.03-1476fje">FASEB J</uri></source><year>2004</year><volume>18</volume><fpage>1450</fpage><lpage>1452</lpage><pub-id pub-id-type="doi">10.1096/fj.03-1476fje</pub-id><pub-id pub-id-type="pmid">15231732</pub-id></element-citation></ref><ref id="REF348"><label>348</label><element-citation publication-type="journal" id="CITATION348"><person-group person-group-type="author"><name name-style="western"><surname>Bola&#241;os</surname><given-names>JP</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>A</given-names></name><name name-style="western"><surname>Moncada</surname><given-names>S</given-names></name></person-group><article-title>Glycolysis: a bioenergetic or a survival pathway?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.tibs.2009.10.006">Trends Biochem Sci</uri></source><year>2010</year><volume>35</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2009.10.006</pub-id><pub-id pub-id-type="pmid">20006513</pub-id></element-citation></ref><ref id="REF349"><label>349</label><element-citation publication-type="journal" id="CITATION349"><person-group person-group-type="author"><name name-style="western"><surname>Boyd</surname><given-names>RB</given-names></name><name name-style="western"><surname>Burke</surname><given-names>JP</given-names></name><name name-style="western"><surname>Atkin</surname><given-names>J</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>VW</given-names></name><name name-style="western"><surname>Nugent</surname><given-names>JF</given-names></name></person-group><article-title>Significance of capillary basement membrane changes in diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.7547/87507315-80-6-307">J Am Podiatr Med Assoc</uri></source><year>1990</year><volume>80</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.7547/87507315-80-6-307</pub-id><pub-id pub-id-type="pmid">2189988</pub-id></element-citation></ref><ref id="REF350"><label>350</label><element-citation publication-type="other" id="CITATION350"><article-title>Williamson JR, Kilo C. Basement-membrane thickening and diabetic microangiopathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/786763/">Diabetes</uri> 1976, 25(2 Suppl): 925&#8211;927
</article-title><pub-id pub-id-type="pmid">786763</pub-id></element-citation></ref><ref id="REF351"><label>351</label><element-citation publication-type="journal" id="CITATION351"><person-group person-group-type="author"><name name-style="western"><surname>Huo</surname><given-names>L</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>JE</given-names></name><name name-style="western"><surname>Wong</surname><given-names>E</given-names></name><name name-style="western"><surname>Harding</surname><given-names>JL</given-names></name><name name-style="western"><surname>Peeters</surname><given-names>A</given-names></name><name name-style="western"><surname>Magliano</surname><given-names>DJ</given-names></name></person-group><article-title>Burden of diabetes in Australia: life expectancy and disability-free life expectancy in adults with diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-016-3948-x">Diabetologia</uri></source><year>2016</year><volume>59</volume><fpage>1437</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.1007/s00125-016-3948-x</pub-id><pub-id pub-id-type="pmid">27075450</pub-id></element-citation></ref><ref id="REF352"><label>352</label><element-citation publication-type="journal" id="CITATION352"><person-group person-group-type="author"><name name-style="western"><surname>Livingstone</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Levin</surname><given-names>D</given-names></name><name name-style="western"><surname>Looker</surname><given-names>HC</given-names></name><name name-style="western"><surname>Lindsay</surname><given-names>RS</given-names></name><name name-style="western"><surname>Wild</surname><given-names>SH</given-names></name><name name-style="western"><surname>Joss</surname><given-names>N</given-names></name><name name-style="western"><surname>Leese</surname><given-names>G</given-names></name><etal>et al.</etal></person-group><article-title>Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/jama.2014.16425">JAMA</uri></source><year>2015</year><volume>313</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1001/jama.2014.16425</pub-id><pub-id pub-id-type="pmid">25562264</pub-id><pub-id pub-id-type="pmcid">PMC4426486</pub-id></element-citation></ref><ref id="REF353"><label>353</label><element-citation publication-type="journal" id="CITATION353"><person-group person-group-type="author"><name name-style="western"><surname>Heilig</surname><given-names>CW</given-names></name><name name-style="western"><surname>Concepcion</surname><given-names>LA</given-names></name><name name-style="western"><surname>Riser</surname><given-names>BL</given-names></name><name name-style="western"><surname>Freytag</surname><given-names>SO</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Cortes</surname><given-names>P</given-names></name></person-group><article-title>Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI118226">J Clin Invest</uri></source><year>1995</year><volume>96</volume><fpage>1802</fpage><lpage>1814</lpage><pub-id pub-id-type="doi">10.1172/JCI118226</pub-id><pub-id pub-id-type="pmid">7560072</pub-id><pub-id pub-id-type="pmcid">PMC185817</pub-id></element-citation></ref><ref id="REF354"><label>354</label><element-citation publication-type="journal" id="CITATION354"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>K</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Shi</surname><given-names>S</given-names></name><name name-style="western"><surname>Fu</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>The correlation between transcutaneous oxygen tension and microvascular complications in type 2 diabetic patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.jdiacomp.2017.02.006">J Diabetes Complications</uri></source><year>2017</year><volume>31</volume><fpage>886</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2017.02.006</pub-id><pub-id pub-id-type="pmid">28242269</pub-id></element-citation></ref><ref id="REF355"><label>355</label><element-citation publication-type="journal" id="CITATION355"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>CA</given-names></name><name name-style="western"><surname>Malik</surname><given-names>RA</given-names></name><name name-style="western"><surname>van Ross</surname><given-names>ERE</given-names></name><name name-style="western"><surname>Kulkarni</surname><given-names>J</given-names></name><name name-style="western"><surname>Boulton</surname><given-names>AJM</given-names></name></person-group><article-title>Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc11-1108">Diabetes Care</uri></source><year>2011</year><volume>34</volume><fpage>2220</fpage><lpage>2224</lpage><pub-id pub-id-type="doi">10.2337/dc11-1108</pub-id><pub-id pub-id-type="pmid">21852677</pub-id><pub-id pub-id-type="pmcid">PMC3177727</pub-id></element-citation></ref><ref id="REF356"><label>356</label><element-citation publication-type="journal" id="CITATION356"><person-group person-group-type="author"><name name-style="western"><surname>Selvarajah</surname><given-names>D</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>ID</given-names></name><name name-style="western"><surname>Emery</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Harris</surname><given-names>ND</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Witte</surname><given-names>DR</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>PD</given-names></name><etal>et al.</etal></person-group><article-title>Early involvement of the spinal cord in diabetic peripheral neuropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc06-0650">Diabetes Care</uri></source><year>2006</year><volume>29</volume><fpage>2664</fpage><lpage>2669</lpage><pub-id pub-id-type="doi">10.2337/dc06-0650</pub-id><pub-id pub-id-type="pmid">17130202</pub-id></element-citation></ref><ref id="REF357"><label>357</label><element-citation publication-type="journal" id="CITATION357"><person-group person-group-type="author"><name name-style="western"><surname>Wessels</surname><given-names>AM</given-names></name><name name-style="western"><surname>Rombouts</surname><given-names>SARB</given-names></name><name name-style="western"><surname>Simsek</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuijer</surname><given-names>JPA</given-names></name><name name-style="western"><surname>Kostense</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Barkhof</surname><given-names>F</given-names></name><name name-style="western"><surname>Scheltens</surname><given-names>P</given-names></name><etal>et al.</etal></person-group><article-title>Microvascular disease in type 1 diabetes alters brain activation</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.55.02.06.db05-0680">Diabetes</uri></source><year>2006</year><volume>55</volume><fpage>334</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.2337/diabetes.55.02.06.db05-0680</pub-id><pub-id pub-id-type="pmid">16443765</pub-id></element-citation></ref><ref id="REF358"><label>358</label><element-citation publication-type="journal" id="CITATION358"><person-group person-group-type="author"><name name-style="western"><surname>Gaudieri</surname><given-names>PA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><name name-style="western"><surname>Greer</surname><given-names>TF</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>CS</given-names></name></person-group><article-title>Cognitive function in children with type 1 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc07-2132">Diabetes Care</uri></source><year>2008</year><volume>31</volume><fpage>1892</fpage><lpage>1897</lpage><pub-id pub-id-type="doi">10.2337/dc07-2132</pub-id><pub-id pub-id-type="pmid">18753668</pub-id><pub-id pub-id-type="pmcid">PMC2518367</pub-id></element-citation></ref><ref id="REF359"><label>359</label><element-citation publication-type="journal" id="CITATION359"><person-group person-group-type="author"><name name-style="western"><surname>Tonoli</surname><given-names>C</given-names></name><name name-style="western"><surname>Heyman</surname><given-names>E</given-names></name><name name-style="western"><surname>Roelands</surname><given-names>B</given-names></name><name name-style="western"><surname>Pattyn</surname><given-names>N</given-names></name><name name-style="western"><surname>Buyse</surname><given-names>L</given-names></name><name name-style="western"><surname>Piacentini</surname><given-names>MF</given-names></name><name name-style="western"><surname>Berthoin</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Type 1 diabetes-associated cognitive decline: a meta-analysis and update of the current literature</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/1753-0407.12193">J Diabetes</uri></source><year>2014</year><volume>6</volume><fpage>499</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1111/1753-0407.12193</pub-id><pub-id pub-id-type="pmid">25042689</pub-id></element-citation></ref><ref id="REF360"><label>360</label><element-citation publication-type="journal" id="CITATION360"><person-group person-group-type="author"><name name-style="western"><surname>Hirabayashi</surname><given-names>N</given-names></name><name name-style="western"><surname>Hata</surname><given-names>J</given-names></name><name name-style="western"><surname>Ohara</surname><given-names>T</given-names></name><name name-style="western"><surname>Mukai</surname><given-names>N</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>M</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>M</given-names></name><name name-style="western"><surname>Gotoh</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Association between diabetes and hippocampal atrophy in elderly Japanese: The Hisayama Study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc15-2800">Diabetes Care</uri></source><year>2016</year><volume>39</volume><fpage>1543</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.2337/dc15-2800</pub-id><pub-id pub-id-type="pmid">27385328</pub-id></element-citation></ref><ref id="REF361"><label>361</label><element-citation publication-type="journal" id="CITATION361"><person-group person-group-type="author"><name name-style="western"><surname>Wisse</surname><given-names>LEM</given-names></name><name name-style="western"><surname>de Bresser</surname><given-names>J</given-names></name><name name-style="western"><surname>Geerlings</surname><given-names>MI</given-names></name><name name-style="western"><surname>Reijmer</surname><given-names>YD</given-names></name><name name-style="western"><surname>Portegies</surname><given-names>MLP</given-names></name><name name-style="western"><surname>Brundel</surname><given-names>M</given-names></name><name name-style="western"><surname>Kappelle</surname><given-names>LJ</given-names></name><etal>et al.</etal></person-group><article-title>Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.jns.2014.06.008">J Neurol Sci</uri></source><year>2014</year><volume>344</volume><fpage>32</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2014.06.008</pub-id><pub-id pub-id-type="pmid">24958596</pub-id></element-citation></ref><ref id="REF362"><label>362</label><element-citation publication-type="journal" id="CITATION362"><person-group person-group-type="author"><name name-style="western"><surname>den Heijer</surname><given-names>T</given-names></name><name name-style="western"><surname>Vermeer</surname><given-names>SE</given-names></name><name name-style="western"><surname>van Dijk</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Prins</surname><given-names>ND</given-names></name><name name-style="western"><surname>Koudstaal</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Hofman</surname><given-names>A</given-names></name><name name-style="western"><surname>Breteler</surname><given-names>MMB</given-names></name></person-group><article-title>Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-003-1235-0">Diabetologia</uri></source><year>2003</year><volume>46</volume><fpage>1604</fpage><lpage>1610</lpage><pub-id pub-id-type="doi">10.1007/s00125-003-1235-0</pub-id><pub-id pub-id-type="pmid">14595538</pub-id></element-citation></ref><ref id="REF363"><label>363</label><element-citation publication-type="journal" id="CITATION363"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>C</given-names></name><name name-style="western"><surname>Phan</surname><given-names>TG</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Blizzard</surname><given-names>L</given-names></name><name name-style="western"><surname>Beare</surname><given-names>R</given-names></name><name name-style="western"><surname>Venn</surname><given-names>A</given-names></name><name name-style="western"><surname>Munch</surname><given-names>G</given-names></name><etal>et al.</etal></person-group><article-title>Brain atrophy in type 2 diabetes: regional distribution and influence on cognition</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc13-0143">Diabetes Care</uri></source><year>2013</year><volume>36</volume><fpage>4036</fpage><lpage>4042</lpage><pub-id pub-id-type="doi">10.2337/dc13-0143</pub-id><pub-id pub-id-type="pmid">23939539</pub-id><pub-id pub-id-type="pmcid">PMC3836136</pub-id></element-citation></ref><ref id="REF364"><label>364</label><element-citation publication-type="journal" id="CITATION364"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.neulet.2014.01.006">Neurosci Lett</uri></source><year>2014</year><volume>562</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2014.01.006</pub-id><pub-id pub-id-type="pmid">24434688</pub-id></element-citation></ref><ref id="REF365"><label>365</label><element-citation publication-type="journal" id="CITATION365"><person-group person-group-type="author"><name name-style="western"><surname>Espeland</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bryan</surname><given-names>RN</given-names></name><name name-style="western"><surname>Goveas</surname><given-names>JS</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>JG</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>MS</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>PE</given-names></name><etal>et al.</etal></person-group><article-title>Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women&#8217;s Health Initiative Magnetic Resonance Imaging studies</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc12-0555">Diabetes Care</uri></source><year>2013</year><volume>36</volume><fpage>90</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.2337/dc12-0555</pub-id><pub-id pub-id-type="pmid">22933440</pub-id><pub-id pub-id-type="pmcid">PMC3526228</pub-id></element-citation></ref><ref id="REF366"><label>366</label><element-citation publication-type="journal" id="CITATION366"><person-group person-group-type="author"><name name-style="western"><surname>Antonetti</surname><given-names>DA</given-names></name><name name-style="western"><surname>Barber</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Bronson</surname><given-names>SK</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>WM</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>TW</given-names></name><name name-style="western"><surname>Jefferson</surname><given-names>LS</given-names></name><name name-style="western"><surname>Kester</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Diabetic retinopathy: seeing beyond glucose-induced microvascular disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db05-1635">Diabetes</uri></source><year>2006</year><volume>55</volume><fpage>2401</fpage><lpage>2411</lpage><pub-id pub-id-type="doi">10.2337/db05-1635</pub-id><pub-id pub-id-type="pmid">16936187</pub-id></element-citation></ref><ref id="REF367"><label>367</label><element-citation publication-type="journal" id="CITATION367"><person-group person-group-type="author"><name name-style="western"><surname>Pittenger</surname><given-names>GL</given-names></name><name name-style="western"><surname>Ray</surname><given-names>M</given-names></name><name name-style="western"><surname>Burcus</surname><given-names>NI</given-names></name><name name-style="western"><surname>McNulty</surname><given-names>P</given-names></name><name name-style="western"><surname>Basta</surname><given-names>B</given-names></name><name name-style="western"><surname>Vinik</surname><given-names>AI</given-names></name></person-group><article-title>Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diacare.27.8.1974">Diabetes Care</uri></source><year>2004</year><volume>27</volume><fpage>1974</fpage><lpage>1979</lpage><pub-id pub-id-type="doi">10.2337/diacare.27.8.1974</pub-id><pub-id pub-id-type="pmid">15277426</pub-id></element-citation></ref><ref id="REF368"><label>368</label><element-citation publication-type="journal" id="CITATION368"><person-group person-group-type="author"><name name-style="western"><surname>Shun</surname><given-names>CT</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>HP</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>SC</given-names></name><name name-style="western"><surname>Lin</surname><given-names>WM</given-names></name><name name-style="western"><surname>Lin</surname><given-names>YH</given-names></name><name name-style="western"><surname>Tai</surname><given-names>TY</given-names></name><etal>et al.</etal></person-group><article-title>Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/brain/awh180">Brain</uri></source><year>2004</year><volume>127</volume><fpage>1593</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1093/brain/awh180</pub-id><pub-id pub-id-type="pmid">15128619</pub-id></element-citation></ref><ref id="REF369"><label>369</label><element-citation publication-type="journal" id="CITATION369"><person-group person-group-type="author"><name name-style="western"><surname>Malik</surname><given-names>RA</given-names></name><name name-style="western"><surname>Kallinikos</surname><given-names>P</given-names></name><name name-style="western"><surname>Abbott</surname><given-names>CA</given-names></name><name name-style="western"><surname>van Schie</surname><given-names>CHM</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>P</given-names></name><name name-style="western"><surname>Efron</surname><given-names>N</given-names></name><name name-style="western"><surname>Boulton</surname><given-names>AJM</given-names></name></person-group><article-title>Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-003-1086-8">Diabetologia</uri></source><year>2003</year><volume>46</volume><fpage>683</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1007/s00125-003-1086-8</pub-id><pub-id pub-id-type="pmid">12739016</pub-id></element-citation></ref><ref id="REF370"><label>370</label><element-citation publication-type="journal" id="CITATION370"><person-group person-group-type="author"><name name-style="western"><surname>Quattrini</surname><given-names>C</given-names></name><name name-style="western"><surname>Tavakoli</surname><given-names>M</given-names></name><name name-style="western"><surname>Jeziorska</surname><given-names>M</given-names></name><name name-style="western"><surname>Kallinikos</surname><given-names>P</given-names></name><name name-style="western"><surname>Tesfaye</surname><given-names>S</given-names></name><name name-style="western"><surname>Finnigan</surname><given-names>J</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Surrogate markers of small fiber damage in human diabetic neuropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db07-0285">Diabetes</uri></source><year>2007</year><volume>56</volume><fpage>2148</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.2337/db07-0285</pub-id><pub-id pub-id-type="pmid">17513704</pub-id></element-citation></ref><ref id="REF371"><label>371</label><element-citation publication-type="journal" id="CITATION371"><person-group person-group-type="author"><name name-style="western"><surname>Yagihashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Mizukami</surname><given-names>H</given-names></name><name name-style="western"><surname>Sugimoto</surname><given-names>K</given-names></name></person-group><article-title>Mechanism of diabetic neuropathy: where are we now and where to go?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.2040-1124.2010.00070.x">J Diabetes Invest</uri></source><year>2011</year><volume>2</volume><fpage>18</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1111/j.2040-1124.2010.00070.x</pub-id><pub-id pub-id-type="pmid">24843457</pub-id><pub-id pub-id-type="pmcid">PMC4008011</pub-id></element-citation></ref><ref id="REF372"><label>372</label><element-citation publication-type="journal" id="CITATION372"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>JL</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>HT</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>EL</given-names></name></person-group><article-title>Diabetic neuropathy: mechanisms to management</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.pharmthera.2008.05.005">Pharmacol Ther</uri></source><year>2008</year><volume>120</volume><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.05.005</pub-id><pub-id pub-id-type="pmid">18616962</pub-id><pub-id pub-id-type="pmcid">PMC4007052</pub-id></element-citation></ref><ref id="REF373"><label>373</label><element-citation publication-type="journal" id="CITATION373"><person-group person-group-type="author"><name name-style="western"><surname>Leinninger</surname><given-names>GM</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>JL</given-names></name><name name-style="western"><surname>Lipshaw</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>EL</given-names></name></person-group><article-title>Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/ncpneuro0320">Nat Rev Neurol</uri></source><year>2006</year><volume>2</volume><fpage>620</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1038/ncpneuro0320</pub-id><pub-id pub-id-type="pmid">17057749</pub-id></element-citation></ref><ref id="REF374"><label>374</label><element-citation publication-type="journal" id="CITATION374"><person-group person-group-type="author"><name name-style="western"><surname>Calkins</surname><given-names>DJ</given-names></name></person-group><article-title>Critical pathogenic events underlying progression of neurodegeneration in glaucoma</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.preteyeres.2012.07.001">Prog Retinal Eye Res</uri></source><year>2012</year><volume>31</volume><fpage>702</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2012.07.001</pub-id><pub-id pub-id-type="pmid">22871543</pub-id><pub-id pub-id-type="pmcid">PMC3472111</pub-id></element-citation></ref><ref id="REF375"><label>375</label><element-citation publication-type="journal" id="CITATION375"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>KA</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>EL</given-names></name></person-group><article-title>New developments in diabetic neuropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/01.wco.0000178825.56414.52">Curr Opin Neurol</uri></source><year>2005</year><volume>18</volume><fpage>586</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1097/01.wco.0000178825.56414.52</pub-id><pub-id pub-id-type="pmid">16155445</pub-id></element-citation></ref><ref id="REF376"><label>376</label><element-citation publication-type="journal" id="CITATION376"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>AK</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>PK</given-names></name></person-group><article-title>Peripheral nerve structure and function in experimental diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0022-510X(74)90136-1">J Neurol Sci</uri></source><year>1974</year><volume>23</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/0022-510X(74)90136-1</pub-id><pub-id pub-id-type="pmid">4277605</pub-id></element-citation></ref><ref id="REF377"><label>377</label><element-citation publication-type="journal" id="CITATION377"><person-group person-group-type="author"><name name-style="western"><surname>Kamiya</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Sima</surname><given-names>AAF</given-names></name></person-group><article-title>Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-006-0379-0">Diabetologia</uri></source><year>2006</year><volume>49</volume><fpage>2763</fpage><lpage>2774</lpage><pub-id pub-id-type="doi">10.1007/s00125-006-0379-0</pub-id><pub-id pub-id-type="pmid">17047923</pub-id></element-citation></ref><ref id="REF378"><label>378</label><element-citation publication-type="journal" id="CITATION378"><person-group person-group-type="author"><name name-style="western"><surname>Brussee</surname><given-names>V</given-names></name><name name-style="western"><surname>Guo</surname><given-names>GF</given-names></name><name name-style="western"><surname>Dong</surname><given-names>YY</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>C</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>J&#769;A</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D</given-names></name><name name-style="western"><surname>Glazner</surname><given-names>GW</given-names></name><etal>et al.</etal></person-group><article-title>Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db07-1737">Diabetes</uri></source><year>2008</year><volume>57</volume><fpage>1664</fpage><lpage>1673</lpage><pub-id pub-id-type="doi">10.2337/db07-1737</pub-id><pub-id pub-id-type="pmid">18332094</pub-id></element-citation></ref><ref id="REF379"><label>379</label><element-citation publication-type="journal" id="CITATION379"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>YS</given-names></name><name name-style="western"><surname>Chung</surname><given-names>SSM</given-names></name><name name-style="western"><surname>Chung</surname><given-names>SK</given-names></name></person-group><article-title>Noninvasive monitoring of diabetes-induced cutaneous nerve fiber loss and hypoalgesia in
<italic toggle="yes">thy1</italic>-YFP transgenic mice
</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diabetes.54.11.3112">Diabetes</uri></source><year>2005</year><volume>54</volume><fpage>3112</fpage><lpage>3118</lpage><pub-id pub-id-type="doi">10.2337/diabetes.54.11.3112</pub-id><pub-id pub-id-type="pmid">16249433</pub-id></element-citation></ref><ref id="REF380"><label>380</label><element-citation publication-type="journal" id="CITATION380"><person-group person-group-type="author"><name name-style="western"><surname>Drel</surname><given-names>VR</given-names></name><name name-style="western"><surname>Mashtalir</surname><given-names>N</given-names></name><name name-style="western"><surname>Ilnytska</surname><given-names>O</given-names></name><name name-style="western"><surname>Shin</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Lyzogubov</surname><given-names>VV</given-names></name><name name-style="western"><surname>Obrosova</surname><given-names>IG</given-names></name></person-group><article-title>The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-011-2393-0">Diabetes</uri></source><year>2006</year><volume>55</volume><fpage>3335</fpage><lpage>3343</lpage><pub-id pub-id-type="doi">10.1007/s00125-011-2393-0</pub-id><pub-id pub-id-type="pmid">17130477</pub-id></element-citation></ref><ref id="REF381"><label>381</label><element-citation publication-type="journal" id="CITATION381"><person-group person-group-type="author"><name name-style="western"><surname>Kar&#225;di</surname><given-names>I</given-names></name><name name-style="western"><surname>M&#233;sz&#225;ros</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cs&#225;nyi</surname><given-names>A</given-names></name><name name-style="western"><surname>Szombathy</surname><given-names>T</given-names></name><name name-style="western"><surname>Hossz&#250;falusi</surname><given-names>N</given-names></name><name name-style="western"><surname>Romics</surname><given-names>L</given-names></name><name name-style="western"><surname>Magyar</surname><given-names>K</given-names></name></person-group><article-title>Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0009-8981(02)00189-4">Clin Chim Acta</uri></source><year>2002</year><volume>323</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/S0009-8981(02)00189-4</pub-id><pub-id pub-id-type="pmid">12135815</pub-id></element-citation></ref><ref id="REF382"><label>382</label><element-citation publication-type="other" id="CITATION382"><article-title>Boomsma F, Hut H, Bagghoe U, van der Houwen A, van den Meiracker A. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15795708/">Med Sci Monit</uri> 2005, 11: RA122&#8211;RA126
</article-title><pub-id pub-id-type="pmid">15795708</pub-id></element-citation></ref><ref id="REF383"><label>383</label><element-citation publication-type="journal" id="CITATION383"><person-group person-group-type="author"><name name-style="western"><surname>Mogensen</surname><given-names>CE</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>CK</given-names></name><name name-style="western"><surname>Vittinghus</surname><given-names>E</given-names></name></person-group><article-title>The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.32.2.S64">Diabetes</uri></source><year>1983</year><volume>32</volume><fpage>64</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.2337/diab.32.2.S64</pub-id><pub-id pub-id-type="pmid">6400670</pub-id></element-citation></ref><ref id="REF384"><label>384</label><element-citation publication-type="other" id="CITATION384"><article-title>Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0140-6736(10)60674-5">Lancet</uri> 2010, 375: 2073&#8211;2081
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(10)60674-5</pub-id><pub-id pub-id-type="pmcid">PMC3993088</pub-id><pub-id pub-id-type="pmid">20483451</pub-id></element-citation></ref><ref id="REF385"><label>385</label><element-citation publication-type="journal" id="CITATION385"><person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>RG</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C&#8208;</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>JP</given-names></name><name name-style="western"><surname>Gardiner</surname><given-names>BS</given-names></name></person-group><article-title>What makes the kidney susceptible to hypoxia?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/ar.24260">Anat Rec</uri></source><year>2020</year><volume>303</volume><fpage>2544</fpage><lpage>2552</lpage><pub-id pub-id-type="doi">10.1002/ar.24260</pub-id><pub-id pub-id-type="pmid">31566903</pub-id></element-citation></ref><ref id="REF386"><label>386</label><element-citation publication-type="journal" id="CITATION386"><person-group person-group-type="author"><name name-style="western"><surname>Forbes</surname><given-names>JM</given-names></name><name name-style="western"><surname>Thorburn</surname><given-names>DR</given-names></name></person-group><article-title>Mitochondrial dysfunction in diabetic kidney disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/nrneph.2018.9">Nat Rev Nephrol</uri></source><year>2018</year><volume>14</volume><fpage>291</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2018.9</pub-id><pub-id pub-id-type="pmid">29456246</pub-id></element-citation></ref><ref id="REF387"><label>387</label><element-citation publication-type="journal" id="CITATION387"><person-group person-group-type="author"><name name-style="western"><surname>Miner</surname><given-names>JH</given-names></name></person-group><article-title>The glomerular basement membrane</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.yexcr.2012.02.031">Exp Cell Res</uri></source><year>2012</year><volume>318</volume><fpage>973</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2012.02.031</pub-id><pub-id pub-id-type="pmid">22410250</pub-id><pub-id pub-id-type="pmcid">PMC3334451</pub-id></element-citation></ref><ref id="REF388"><label>388</label><element-citation publication-type="journal" id="CITATION388"><person-group person-group-type="author"><name name-style="western"><surname>St. John</surname><given-names>PL</given-names></name><name name-style="western"><surname>Abrahamson</surname><given-names>DR</given-names></name></person-group><article-title>Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1046/j.1523-1755.2001.0600031037.x">Kidney Int</uri></source><year>2001</year><volume>60</volume><fpage>1037</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.2001.0600031037.x</pub-id><pub-id pub-id-type="pmid">11532098</pub-id></element-citation></ref><ref id="REF389"><label>389</label><element-citation publication-type="journal" id="CITATION389"><person-group person-group-type="author"><name name-style="western"><surname>Miner</surname><given-names>JH</given-names></name></person-group><article-title>Organogenesis of the kidney glomerulus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.4161/org.7.2.15275">Organogenesis</uri></source><year>2011</year><volume>7</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.4161/org.7.2.15275</pub-id><pub-id pub-id-type="pmid">21519194</pub-id><pub-id pub-id-type="pmcid">PMC3142441</pub-id></element-citation></ref><ref id="REF390"><label>390</label><element-citation publication-type="journal" id="CITATION390"><person-group person-group-type="author"><name name-style="western"><surname>Farquhar</surname><given-names>MG</given-names></name><name name-style="western"><surname>Wissig</surname><given-names>SL</given-names></name><name name-style="western"><surname>Palade</surname><given-names>GE</given-names></name></person-group><article-title>Glomerular permeability. I Ferritin transfer across the normal glomerular capillary wall</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1084/jem.113.1.47">J Exp Med</uri></source><year>1961</year><volume>113</volume><fpage>47</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1084/jem.113.1.47</pub-id><pub-id pub-id-type="pmid">13698249</pub-id><pub-id pub-id-type="pmcid">PMC2137334</pub-id></element-citation></ref><ref id="REF391"><label>391</label><element-citation publication-type="journal" id="CITATION391"><person-group person-group-type="author"><name name-style="western"><surname>Farquhar</surname><given-names>MG</given-names></name><name name-style="western"><surname>Palade</surname><given-names>GE</given-names></name></person-group><article-title>Glomerular permeability. II Ferritin transfer across the glomerular capillary wall in nephrotic rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1084/jem.114.5.699">J Exp Med</uri></source><year>1961</year><volume>114</volume><fpage>699</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1084/jem.114.5.699</pub-id><pub-id pub-id-type="pmid">13891678</pub-id><pub-id pub-id-type="pmcid">PMC2180376</pub-id></element-citation></ref><ref id="REF392"><label>392</label><element-citation publication-type="journal" id="CITATION392"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>BM</given-names></name><name name-style="western"><surname>Hostetter</surname><given-names>TH</given-names></name><name name-style="western"><surname>Humes</surname><given-names>HD</given-names></name></person-group><article-title>Glomerular permselectivity: barrier function based on discrimination of molecular size and charge</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajprenal.1978.234.6.F455">Am J Physiol</uri></source><year>1978</year><volume>234</volume><fpage>F455</fpage><lpage>F460</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.1978.234.6.F455</pub-id><pub-id pub-id-type="pmid">665772</pub-id></element-citation></ref><ref id="REF393"><label>393</label><element-citation publication-type="journal" id="CITATION393"><person-group person-group-type="author"><name name-style="western"><surname>Harindhanavudhi</surname><given-names>T</given-names></name><name name-style="western"><surname>Parks</surname><given-names>A</given-names></name><name name-style="western"><surname>Mauer</surname><given-names>M</given-names></name><name name-style="western"><surname>Caramori</surname><given-names>ML</given-names></name></person-group><article-title>Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1159/000381992">Am J Nephrol</uri></source><year>2015</year><volume>41</volume><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1159/000381992</pub-id><pub-id pub-id-type="pmid">26021523</pub-id><pub-id pub-id-type="pmcid">PMC4514533</pub-id></element-citation></ref><ref id="REF394"><label>394</label><element-citation publication-type="journal" id="CITATION394"><person-group person-group-type="author"><name name-style="western"><surname>Ponchiardi</surname><given-names>C</given-names></name><name name-style="western"><surname>Mauer</surname><given-names>M</given-names></name><name name-style="western"><surname>Najafian</surname><given-names>B</given-names></name></person-group><article-title>Temporal profile of diabetic nephropathy pathologic changes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s11892-013-0395-7">Curr Diab Rep</uri></source><year>2013</year><volume>13</volume><fpage>592</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1007/s11892-013-0395-7</pub-id><pub-id pub-id-type="pmid">23712652</pub-id></element-citation></ref><ref id="REF395"><label>395</label><element-citation publication-type="other" id="CITATION395"><article-title>Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P. Structural involvement in type 1 and type 2 diabetic nephropathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10922968/">Diabetes Metab</uri> 2000, 26(Suppl 4): 8&#8211;14
</article-title><pub-id pub-id-type="pmid">10922968</pub-id></element-citation></ref><ref id="REF396"><label>396</label><element-citation publication-type="journal" id="CITATION396"><person-group person-group-type="author"><name name-style="western"><surname>Lewko</surname><given-names>B</given-names></name><name name-style="western"><surname>Stepinski</surname><given-names>J</given-names></name></person-group><article-title>Hyperglycemia and mechanical stress: targeting the renal podocyte</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/jcp.21856">J Cell Physiol</uri></source><year>2009</year><volume>221</volume><fpage>288</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1002/jcp.21856</pub-id><pub-id pub-id-type="pmid">19562677</pub-id></element-citation></ref><ref id="REF397"><label>397</label><element-citation publication-type="journal" id="CITATION397"><person-group person-group-type="author"><name name-style="western"><surname>Eremina</surname><given-names>V</given-names></name><name name-style="western"><surname>Sood</surname><given-names>M</given-names></name><name name-style="western"><surname>Haigh</surname><given-names>J</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>A</given-names></name><name name-style="western"><surname>Lajoie</surname><given-names>G</given-names></name><name name-style="western"><surname>Ferrara</surname><given-names>N</given-names></name><name name-style="western"><surname>Gerber</surname><given-names>HP</given-names></name><etal>et al.</etal></person-group><article-title>Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI17423">J Clin Invest</uri></source><year>2003</year><volume>111</volume><fpage>707</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1172/JCI17423</pub-id><pub-id pub-id-type="pmid">12618525</pub-id><pub-id pub-id-type="pmcid">PMC151905</pub-id></element-citation></ref><ref id="REF398"><label>398</label><element-citation publication-type="journal" id="CITATION398"><person-group person-group-type="author"><name name-style="western"><surname>Reidy</surname><given-names>K</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HM</given-names></name><name name-style="western"><surname>Hostetter</surname><given-names>T</given-names></name><name name-style="western"><surname>Susztak</surname><given-names>K</given-names></name></person-group><article-title>Molecular mechanisms of diabetic kidney disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI72271">J Clin Invest</uri></source><year>2014</year><volume>124</volume><fpage>2333</fpage><lpage>2340</lpage><pub-id pub-id-type="doi">10.1172/JCI72271</pub-id><pub-id pub-id-type="pmid">24892707</pub-id><pub-id pub-id-type="pmcid">PMC4089448</pub-id></element-citation></ref><ref id="REF399"><label>399</label><element-citation publication-type="journal" id="CITATION399"><person-group person-group-type="author"><name name-style="western"><surname>Hartleben</surname><given-names>B</given-names></name><name name-style="western"><surname>G&#246;del</surname><given-names>M</given-names></name><name name-style="western"><surname>Meyer-Schwesinger</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Ulrich</surname><given-names>T</given-names></name><name name-style="western"><surname>K&#246;bler</surname><given-names>S</given-names></name><name name-style="western"><surname>Wiech</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI39492">J Clin Invest</uri></source><year>2010</year><volume>120</volume><fpage>1084</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1172/JCI39492</pub-id><pub-id pub-id-type="pmid">20200449</pub-id><pub-id pub-id-type="pmcid">PMC2846040</pub-id></element-citation></ref><ref id="REF400"><label>400</label><element-citation publication-type="journal" id="CITATION400"><person-group person-group-type="author"><name name-style="western"><surname>Herman-Edelstein</surname><given-names>M</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>MC</given-names></name><name name-style="western"><surname>Thallas-Bonke</surname><given-names>V</given-names></name><name name-style="western"><surname>Saleem</surname><given-names>M</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>ME</given-names></name><name name-style="western"><surname>Kantharidis</surname><given-names>P</given-names></name></person-group><article-title>Dedifferentiation of immortalized human podocytes in response to transforming growth factor-&#946;</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db10-1110">Diabetes</uri></source><year>2011</year><volume>60</volume><fpage>1779</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.2337/db10-1110</pub-id><pub-id pub-id-type="pmid">21521871</pub-id><pub-id pub-id-type="pmcid">PMC3114395</pub-id></element-citation></ref><ref id="REF401"><label>401</label><element-citation publication-type="journal" id="CITATION401"><person-group person-group-type="author"><name name-style="western"><surname>Kato</surname><given-names>H</given-names></name><name name-style="western"><surname>Gruenwald</surname><given-names>A</given-names></name><name name-style="western"><surname>Suh</surname><given-names>JH</given-names></name><name name-style="western"><surname>Miner</surname><given-names>JH</given-names></name><name name-style="western"><surname>Barisoni-Thomas</surname><given-names>L</given-names></name><name name-style="western"><surname>Taketo</surname><given-names>MM</given-names></name><name name-style="western"><surname>Faul</surname><given-names>C</given-names></name><etal>et al.</etal></person-group><article-title>Wnt/&#946;-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1074/jbc.M111.223164">J Biol Chem</uri></source><year>2011</year><volume>286</volume><fpage>26003</fpage><lpage>26015</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.223164</pub-id><pub-id pub-id-type="pmid">21613219</pub-id><pub-id pub-id-type="pmcid">PMC3138306</pub-id></element-citation></ref><ref id="REF402"><label>402</label><element-citation publication-type="journal" id="CITATION402"><person-group person-group-type="author"><name name-style="western"><surname>Coward</surname><given-names>R</given-names></name><name name-style="western"><surname>Fornoni</surname><given-names>A</given-names></name></person-group><article-title>Insulin signaling</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/MNH.0000000000000078">Curr Opin Nephrol Hypertens</uri></source><year>2015</year><volume>24</volume><fpage>104</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1097/MNH.0000000000000078</pub-id><pub-id pub-id-type="pmid">25415617</pub-id><pub-id pub-id-type="pmcid">PMC4386894</pub-id></element-citation></ref><ref id="REF403"><label>403</label><element-citation publication-type="journal" id="CITATION403"><person-group person-group-type="author"><name name-style="western"><surname>Kurihara</surname><given-names>H</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>T</given-names></name></person-group><article-title>Cell biology of mesangial cells: the third cell that maintains the glomerular capillary</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s12565-016-0334-1">Anat Sci Int</uri></source><year>2017</year><volume>92</volume><fpage>173</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1007/s12565-016-0334-1</pub-id><pub-id pub-id-type="pmid">26910209</pub-id></element-citation></ref><ref id="REF404"><label>404</label><element-citation publication-type="journal" id="CITATION404"><person-group person-group-type="author"><name name-style="western"><surname>Morita</surname><given-names>T</given-names></name><name name-style="western"><surname>Churg</surname><given-names>J</given-names></name></person-group><article-title>Mesangiolysis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/ki.1983.119">Kidney Int</uri></source><year>1983</year><volume>24</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/ki.1983.119</pub-id><pub-id pub-id-type="pmid">6353041</pub-id></element-citation></ref><ref id="REF405"><label>405</label><element-citation publication-type="journal" id="CITATION405"><person-group person-group-type="author"><name name-style="western"><surname>Schnaper</surname><given-names>HW</given-names></name></person-group><article-title>Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF00858986">Pediatr Nephrol</uri></source><year>1995</year><volume>9</volume><fpage>104</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1007/BF00858986</pub-id><pub-id pub-id-type="pmid">7742207</pub-id></element-citation></ref><ref id="REF406"><label>406</label><element-citation publication-type="journal" id="CITATION406"><person-group person-group-type="author"><name name-style="western"><surname>Lenz</surname><given-names>O</given-names></name><name name-style="western"><surname>Elliot</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Stetler-stevenson</surname><given-names>WG</given-names></name></person-group><article-title>Matrix metalloproteinases in renal development and disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1681/ASN.V113574">J Am Soc Nephrol</uri></source><year>2000</year><volume>11</volume><fpage>574</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1681/ASN.V113574</pub-id><pub-id pub-id-type="pmid">10703682</pub-id></element-citation></ref><ref id="REF407"><label>407</label><element-citation publication-type="journal" id="CITATION407"><person-group person-group-type="author"><name name-style="western"><surname>Rasch</surname><given-names>R</given-names></name><name name-style="western"><surname>Norgaard</surname><given-names>JOR</given-names></name></person-group><article-title>Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF00279944">Diabetologia</uri></source><year>1983</year><volume>25</volume><fpage>280</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1007/BF00279944</pub-id><pub-id pub-id-type="pmid">6642092</pub-id></element-citation></ref><ref id="REF408"><label>408</label><element-citation publication-type="other" id="CITATION408"><article-title>Zhao JH. Mesangial cells and renal bibrosis.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/978-981-13-8871-2_9">Adv Exp Med Biol</uri> 2019, 1165: 165&#8211;194
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-981-13-8871-2_9</pub-id><pub-id pub-id-type="pmid">31399966</pub-id></element-citation></ref><ref id="REF409"><label>409</label><element-citation publication-type="journal" id="CITATION409"><person-group person-group-type="author"><name name-style="western"><surname>Wada</surname><given-names>T</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>M</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>H</given-names></name><name name-style="western"><surname>Iwata</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kaneko</surname><given-names>S</given-names></name><name name-style="western"><surname>Furuichi</surname><given-names>K</given-names></name></person-group><article-title>Nodular lesions and mesangiolysis in diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s10157-012-0711-6">Clin Exp Nephrol</uri></source><year>2013</year><volume>17</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s10157-012-0711-6</pub-id><pub-id pub-id-type="pmid">23100177</pub-id></element-citation></ref><ref id="REF410"><label>410</label><element-citation publication-type="journal" id="CITATION410"><person-group person-group-type="author"><name name-style="western"><surname>Lemley</surname><given-names>KV</given-names></name><name name-style="western"><surname>Abdullah</surname><given-names>I</given-names></name><name name-style="western"><surname>Myers</surname><given-names>BD</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>TW</given-names></name><name name-style="western"><surname>Blouch</surname><given-names>K</given-names></name><name name-style="western"><surname>Smith</surname><given-names>WE</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>PH</given-names></name><etal>et al.</etal></person-group><article-title>Evolution of incipient nephropathy in type 2 diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1046/j.1523-1755.2000.00223.x">Kidney Int</uri></source><year>2000</year><volume>58</volume><fpage>1228</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1755.2000.00223.x</pub-id><pub-id pub-id-type="pmid">10972685</pub-id></element-citation></ref><ref id="REF411"><label>411</label><element-citation publication-type="journal" id="CITATION411"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>E</given-names></name><name name-style="western"><surname>Pennathur</surname><given-names>S</given-names></name><name name-style="western"><surname>Kretzler</surname><given-names>M</given-names></name><name name-style="western"><surname>Brosius Iii</surname><given-names>FC</given-names></name></person-group><article-title>From fibrosis to sclerosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db08-0061">Diabetes</uri></source><year>2008</year><volume>57</volume><fpage>1439</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.2337/db08-0061</pub-id><pub-id pub-id-type="pmid">18511444</pub-id><pub-id pub-id-type="pmcid">PMC4239998</pub-id></element-citation></ref><ref id="REF412"><label>412</label><element-citation publication-type="journal" id="CITATION412"><person-group person-group-type="author"><name name-style="western"><surname>Mauer</surname><given-names>SM</given-names></name><name name-style="western"><surname>Steffes</surname><given-names>MW</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>EN</given-names></name><name name-style="western"><surname>Sutherland</surname><given-names>DE</given-names></name><name name-style="western"><surname>Brown</surname><given-names>DM</given-names></name><name name-style="western"><surname>Goetz</surname><given-names>FC</given-names></name></person-group><article-title>Structural-functional relationships in diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI111523">J Clin Invest</uri></source><year>1984</year><volume>74</volume><fpage>1143</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1172/JCI111523</pub-id><pub-id pub-id-type="pmid">6480821</pub-id><pub-id pub-id-type="pmcid">PMC425280</pub-id></element-citation></ref><ref id="REF413"><label>413</label><element-citation publication-type="other" id="CITATION413"><article-title>Dorup J, Morsing P, Rasch R. Tubule-tubule and tubule-arteriole contacts in rat kidney distal nephrons. A morphologic study based on computer-assisted three-dimensional reconstructions.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/1460867/">Lab Invest</uri> 1992, 67: 761&#8211;769.
</article-title><pub-id pub-id-type="pmid">1460867</pub-id></element-citation></ref><ref id="REF414"><label>414</label><element-citation publication-type="journal" id="CITATION414"><person-group person-group-type="author"><name name-style="western"><surname>Seyer-Hansen</surname><given-names>K</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>J</given-names></name><name name-style="western"><surname>Gundersen</surname><given-names>HJG</given-names></name></person-group><article-title>Renal hypertrophy in experimental diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF00261707">Diabetologia</uri></source><year>1980</year><volume>18</volume><fpage>501</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1007/BF00261707</pub-id><pub-id pub-id-type="pmid">7418959</pub-id></element-citation></ref><ref id="REF415"><label>415</label><element-citation publication-type="journal" id="CITATION415"><person-group person-group-type="author"><name name-style="western"><surname>Vallon</surname><given-names>V</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>SC</given-names></name></person-group><article-title>Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1146/annurev-physiol-020911-153333">Annu Rev Physiol</uri></source><year>2012</year><volume>74</volume><fpage>351</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-020911-153333</pub-id><pub-id pub-id-type="pmid">22335797</pub-id><pub-id pub-id-type="pmcid">PMC3807782</pub-id></element-citation></ref><ref id="REF416"><label>416</label><element-citation publication-type="journal" id="CITATION416"><person-group person-group-type="author"><name name-style="western"><surname>Najafian</surname><given-names>B</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Crosson</surname><given-names>JT</given-names></name><name name-style="western"><surname>Mauer</surname><given-names>M</given-names></name></person-group><article-title>Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/01.ASN.0000057854.32413.81">J Am Soc Nephrol</uri></source><year>2003</year><volume>14</volume><fpage>908</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1097/01.ASN.0000057854.32413.81</pub-id><pub-id pub-id-type="pmid">12660325</pub-id></element-citation></ref><ref id="REF417"><label>417</label><element-citation publication-type="journal" id="CITATION417"><person-group person-group-type="author"><name name-style="western"><surname>Russo</surname><given-names>LM</given-names></name><name name-style="western"><surname>Sandoval</surname><given-names>RM</given-names></name><name name-style="western"><surname>Campos</surname><given-names>SB</given-names></name><name name-style="western"><surname>Molitoris</surname><given-names>BA</given-names></name><name name-style="western"><surname>Comper</surname><given-names>WD</given-names></name><name name-style="western"><surname>Brown</surname><given-names>D</given-names></name></person-group><article-title>Impaired tubular uptake explains albuminuria in early diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1681/ASN.2008050503">J Am Soc Nephrol</uri></source><year>2009</year><volume>20</volume><fpage>489</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1681/ASN.2008050503</pub-id><pub-id pub-id-type="pmid">19118149</pub-id><pub-id pub-id-type="pmcid">PMC2653682</pub-id></element-citation></ref><ref id="REF418"><label>418</label><element-citation publication-type="journal" id="CITATION418"><person-group person-group-type="author"><name name-style="western"><surname>Bohle</surname><given-names>A</given-names></name><name name-style="western"><surname>Mackensen-Haen</surname><given-names>S</given-names></name><name name-style="western"><surname>von Gise</surname><given-names>H</given-names></name><name name-style="western"><surname>Grund</surname><given-names>KE</given-names></name><name name-style="western"><surname>Wehrmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Batz</surname><given-names>C</given-names></name><name name-style="western"><surname>Bogensch&#252;tz</surname><given-names>O</given-names></name><etal>et al.</etal></person-group><article-title>The consequences of tubulo-interstitial changes for renal function in glomerulopathies</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0344-0338(11)81021-6">Pathol Res Pract</uri></source><year>1990</year><volume>186</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/S0344-0338(11)81021-6</pub-id><pub-id pub-id-type="pmid">2315207</pub-id></element-citation></ref><ref id="REF419"><label>419</label><element-citation publication-type="journal" id="CITATION419"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>T</given-names></name><name name-style="western"><surname>Dow</surname><given-names>J</given-names></name><name name-style="western"><surname>Foster</surname><given-names>J</given-names></name></person-group><article-title>Increased formic acid excretion and the development of kidney toxicity in rats following chronic dosing with trichloroethanol, a major metabolite of trichloroethylene</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0300-483X(03)00206-3">Toxicology</uri></source><year>2003</year><volume>191</volume><fpage>109</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/S0300-483X(03)00206-3</pub-id><pub-id pub-id-type="pmid">12965114</pub-id></element-citation></ref><ref id="REF420"><label>420</label><element-citation publication-type="other" id="CITATION420"><article-title>O&#8217;Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9148381/">Semin Nephrol</uri>1997, 17: 93&#8211;100
</article-title><pub-id pub-id-type="pmid">9148381</pub-id></element-citation></ref><ref id="REF421"><label>421</label><element-citation publication-type="journal" id="CITATION421"><person-group person-group-type="author"><name name-style="western"><surname>Groop</surname><given-names>PH</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>MC</given-names></name><name name-style="western"><surname>Moran</surname><given-names>JL</given-names></name><name name-style="western"><surname>Wad&#232;n</surname><given-names>J</given-names></name><name name-style="western"><surname>Thorn</surname><given-names>LM</given-names></name><name name-style="western"><surname>M&#228;kinen</surname><given-names>VP</given-names></name><name name-style="western"><surname>Roseng&#229;rd-B&#228;rlund</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db08-1543">Diabetes</uri></source><year>2009</year><volume>58</volume><fpage>1651</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.2337/db08-1543</pub-id><pub-id pub-id-type="pmid">19401416</pub-id><pub-id pub-id-type="pmcid">PMC2699848</pub-id></element-citation></ref><ref id="REF422"><label>422</label><element-citation publication-type="journal" id="CITATION422"><person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>FY</given-names></name><name name-style="western"><surname>Nikolic-Paterson</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Ozols</surname><given-names>E</given-names></name><name name-style="western"><surname>Atkins</surname><given-names>RC</given-names></name><name name-style="western"><surname>Rollin</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Tesch</surname><given-names>GH</given-names></name></person-group><article-title>Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/sj.ki.5000014">Kidney Int</uri></source><year>2006</year><volume>69</volume><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5000014</pub-id><pub-id pub-id-type="pmid">16374426</pub-id></element-citation></ref><ref id="REF423"><label>423</label><element-citation publication-type="journal" id="CITATION423"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>AKH</given-names></name><name name-style="western"><surname>Tesch</surname><given-names>GH</given-names></name></person-group><article-title>Inflammation in diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1155/2012/146154">Mediators Inflamm</uri></source><year>2012</year><volume>2012</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2012/146154</pub-id><pub-id pub-id-type="pmid">22969168</pub-id><pub-id pub-id-type="pmcid">PMC3432398</pub-id></element-citation></ref><ref id="REF424"><label>424</label><element-citation publication-type="journal" id="CITATION424"><person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>FY</given-names></name><name name-style="western"><surname>Nikolic-Paterson</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Ozols</surname><given-names>E</given-names></name><name name-style="western"><surname>Atkins</surname><given-names>RC</given-names></name><name name-style="western"><surname>Tesch</surname><given-names>GH</given-names></name></person-group><article-title>Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1681/ASN.2004070612">J Am Soc Nephrol</uri></source><year>2005</year><volume>16</volume><fpage>1711</fpage><lpage>1722</lpage><pub-id pub-id-type="doi">10.1681/ASN.2004070612</pub-id><pub-id pub-id-type="pmid">15857924</pub-id></element-citation></ref><ref id="REF425"><label>425</label><element-citation publication-type="journal" id="CITATION425"><person-group person-group-type="author"><name name-style="western"><surname>Kanamori</surname><given-names>H</given-names></name><name name-style="western"><surname>Matsubara</surname><given-names>T</given-names></name><name name-style="western"><surname>Mima</surname><given-names>A</given-names></name><name name-style="western"><surname>Sumi</surname><given-names>E</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>K</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Abe</surname><given-names>H</given-names></name><etal>et al.</etal></person-group><article-title>Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.bbrc.2007.06.148">Biochem Biophys Res Commun</uri></source><year>2007</year><volume>360</volume><fpage>772</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.06.148</pub-id><pub-id pub-id-type="pmid">17631861</pub-id></element-citation></ref><ref id="REF426"><label>426</label><element-citation publication-type="journal" id="CITATION426"><person-group person-group-type="author"><name name-style="western"><surname>Alpers</surname><given-names>CE</given-names></name><name name-style="western"><surname>Hudkins</surname><given-names>KL</given-names></name></person-group><article-title>Mouse models of diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/MNH.0b013e3283451901">Curr Opin Nephrol Hypertens</uri></source><year>2011</year><volume>20</volume><fpage>278</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1097/MNH.0b013e3283451901</pub-id><pub-id pub-id-type="pmid">21422926</pub-id><pub-id pub-id-type="pmcid">PMC3658822</pub-id></element-citation></ref><ref id="REF427"><label>427</label><element-citation publication-type="journal" id="CITATION427"><person-group person-group-type="author"><name name-style="western"><surname>Breyer</surname><given-names>MD</given-names></name><name name-style="western"><surname>B&#246;ttinger</surname><given-names>E</given-names></name><name name-style="western"><surname>Brosius Iii</surname><given-names>FC</given-names></name><name name-style="western"><surname>Coffman</surname><given-names>TM</given-names></name><name name-style="western"><surname>Harris</surname><given-names>RC</given-names></name><name name-style="western"><surname>Heilig</surname><given-names>CW</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>K</given-names></name></person-group><article-title>Mouse models of diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1681/ASN.2004080648">J Am Soc Nephrol</uri></source><year>2005</year><volume>16</volume><fpage>27</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1681/ASN.2004080648</pub-id><pub-id pub-id-type="pmid">15563560</pub-id></element-citation></ref><ref id="REF428"><label>428</label><element-citation publication-type="journal" id="CITATION428"><person-group person-group-type="author"><name name-style="western"><surname>Blantz</surname><given-names>RC</given-names></name></person-group><article-title>Phenotypic characteristics of diabetic kidney involvement</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/ki.2013.552">Kidney Int</uri></source><year>2014</year><volume>86</volume><fpage>7</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/ki.2013.552</pub-id><pub-id pub-id-type="pmid">24978373</pub-id><pub-id pub-id-type="pmcid">PMC4076684</pub-id></element-citation></ref><ref id="REF429"><label>429</label><element-citation publication-type="journal" id="CITATION429"><person-group person-group-type="author"><name name-style="western"><surname>Takiyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Haneda</surname><given-names>M</given-names></name></person-group><article-title>Hypoxia in diabetic kidneys</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1155/2014/837421">Biomed Res Int</uri></source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2014/837421</pub-id><pub-id pub-id-type="pmid">25054148</pub-id><pub-id pub-id-type="pmcid">PMC4094876</pub-id></element-citation></ref><ref id="REF430"><label>430</label><element-citation publication-type="journal" id="CITATION430"><person-group person-group-type="author"><name name-style="western"><surname>Advani</surname><given-names>A</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>RE</given-names></name></person-group><article-title>The endothelium in diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.semnephrol.2012.02.006">Semin Nephrol</uri></source><year>2012</year><volume>32</volume><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.semnephrol.2012.02.006</pub-id><pub-id pub-id-type="pmid">22617769</pub-id></element-citation></ref><ref id="REF431"><label>431</label><element-citation publication-type="journal" id="CITATION431"><person-group person-group-type="author"><name name-style="western"><surname>Karniski</surname><given-names>LP</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>PS</given-names></name></person-group><article-title>Chloride/formate exchange with formic acid recycling: a mechanism of active chloride transport across epithelial membranes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1073/pnas.82.18.6362">Proc Natl Acad Sci U S A</uri></source><year>1985</year><volume>82</volume><fpage>6362</fpage><lpage>6365</lpage><pub-id pub-id-type="doi">10.1073/pnas.82.18.6362</pub-id><pub-id pub-id-type="other">1985PNAS...82.6362K</pub-id><pub-id pub-id-type="pmid">3862136</pub-id><pub-id pub-id-type="pmcid">PMC391054</pub-id></element-citation></ref><ref id="REF432"><label>432</label><element-citation publication-type="journal" id="CITATION432"><person-group person-group-type="author"><name name-style="western"><surname>Schild</surname><given-names>L</given-names></name><name name-style="western"><surname>Giebisch</surname><given-names>G</given-names></name><name name-style="western"><surname>Karniski</surname><given-names>LP</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>PS</given-names></name></person-group><article-title>Effect of formate on volume reabsorption in the rabbit proximal tubule</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI112803">J Clin Invest</uri></source><year>1987</year><volume>79</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1172/JCI112803</pub-id><pub-id pub-id-type="pmid">3793930</pub-id><pub-id pub-id-type="pmcid">PMC423979</pub-id></element-citation></ref><ref id="REF433"><label>433</label><element-citation publication-type="other" id="CITATION433"><article-title>UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://europepmc.org/article/MED/9742976">Lancet</uri> 1998, 352: 837&#8211;853.
</article-title><pub-id pub-id-type="pmid">9742976</pub-id></element-citation></ref><ref id="REF434"><label>434</label><element-citation publication-type="journal" id="CITATION434"><article-title>Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bmj.317.7160.703">BMJ</uri></source><year>1998</year><volume>317</volume><fpage>703</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1136/bmj.317.7160.703</pub-id><pub-id pub-id-type="pmid">9732337</pub-id><pub-id pub-id-type="pmcid">PMC28659</pub-id></element-citation></ref><ref id="REF435"><label>435</label><element-citation publication-type="other" id="CITATION435"><article-title>Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulindependent diabetes mellitus.
<italic toggle="yes">N Engl J Med</italic> 1993, 329: 977&#8211;986
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199309303291401</pub-id><pub-id pub-id-type="pmid">8366922</pub-id></element-citation></ref><ref id="REF436"><label>436</label><element-citation publication-type="journal" id="CITATION436"><person-group person-group-type="author"><name name-style="western"><surname>Boudina</surname><given-names>S</given-names></name><name name-style="western"><surname>Abel</surname><given-names>ED</given-names></name></person-group><article-title>Diabetic cardiomyopathy revisited</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.106.679597">Circulation</uri></source><year>2007</year><volume>115</volume><fpage>3213</fpage><lpage>3223</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.679597</pub-id><pub-id pub-id-type="pmid">17592090</pub-id></element-citation></ref><ref id="REF437"><label>437</label><element-citation publication-type="journal" id="CITATION437"><person-group person-group-type="author"><name name-style="western"><surname>Rubler</surname><given-names>S</given-names></name><name name-style="western"><surname>Dlugash</surname><given-names>J</given-names></name><name name-style="western"><surname>Yuceoglu</surname><given-names>YZ</given-names></name><name name-style="western"><surname>Kumral</surname><given-names>T</given-names></name><name name-style="western"><surname>Branwood</surname><given-names>AW</given-names></name><name name-style="western"><surname>Grishman</surname><given-names>A</given-names></name></person-group><article-title>New type of cardiomyopathy associated with diabetic glomerulosclerosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9149(72)90595-4">Am J Cardiol</uri></source><year>1972</year><volume>30</volume><fpage>595</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/0002-9149(72)90595-4</pub-id><pub-id pub-id-type="pmid">4263660</pub-id></element-citation></ref><ref id="REF438"><label>438</label><element-citation publication-type="other" id="CITATION438"><article-title>Cohen A. Myocardiopathie diab&#233;tique [Diabetic cardiomyopathy].
<italic toggle="yes">Arch Mal Coeur Vaiss</italic> 1995, 88: 479&#8211;486
</article-title><pub-id pub-id-type="pmid">7646266</pub-id></element-citation></ref><ref id="REF439"><label>439</label><element-citation publication-type="other" id="CITATION439"><article-title>Spector KS. Diabetic cardiomyopathy.
<italic toggle="yes">Clin Cardiol</italic> 1998, 21: 885&#8211;887
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/clc.4960211205</pub-id><pub-id pub-id-type="pmcid">PMC6655683</pub-id><pub-id pub-id-type="pmid">9853179</pub-id></element-citation></ref><ref id="REF440"><label>440</label><element-citation publication-type="journal" id="CITATION440"><person-group person-group-type="author"><name name-style="western"><surname>Kannel</surname><given-names>WB</given-names></name><name name-style="western"><surname>Hjortland</surname><given-names>M</given-names></name><name name-style="western"><surname>Castelli</surname><given-names>WP</given-names></name></person-group><article-title>Role of diabetes in congestive heart failure: The Framingham study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9149(74)90089-7">Am J Cardiol</uri></source><year>1974</year><volume>34</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/0002-9149(74)90089-7</pub-id><pub-id pub-id-type="pmid">4835750</pub-id></element-citation></ref><ref id="REF441"><label>441</label><element-citation publication-type="journal" id="CITATION441"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>P</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>T</given-names></name><name name-style="western"><surname>Khand</surname><given-names>A</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AL</given-names></name><name name-style="western"><surname>Cleland</surname><given-names>JGF</given-names></name></person-group><article-title>Diastolic heart failure: neglected or misdiagnosed?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/s0735-1097(01)01704-1">J Am College Cardiol</uri></source><year>2002</year><volume>39</volume><fpage>138</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(01)01704-1</pub-id><pub-id pub-id-type="pmid">11755299</pub-id></element-citation></ref><ref id="REF442"><label>442</label><element-citation publication-type="journal" id="CITATION442"><person-group person-group-type="author"><name name-style="western"><surname>Zile</surname><given-names>MR</given-names></name><name name-style="western"><surname>Brutsaert</surname><given-names>DL</given-names></name></person-group><article-title>New concepts in diastolic dysfunction and diastolic heart failure: Part I</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1161/hc1102.105289">Circulation</uri></source><year>2002</year><volume>105</volume><fpage>1387</fpage><lpage>1393</lpage><pub-id pub-id-type="doi">10.1161/hc1102.105289</pub-id><pub-id pub-id-type="pmid">11901053</pub-id></element-citation></ref><ref id="REF443"><label>443</label><element-citation publication-type="journal" id="CITATION443"><person-group person-group-type="author"><name name-style="western"><surname>Zile</surname><given-names>MR</given-names></name><name name-style="western"><surname>Brutsaert</surname><given-names>DL</given-names></name></person-group><article-title>New concepts in diastolic dysfunction and diastolic heart failure: Part II</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1161/hc1202.105290">Circulation</uri></source><year>2002</year><volume>105</volume><fpage>1503</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1161/hc1202.105290</pub-id><pub-id pub-id-type="pmid">11914262</pub-id></element-citation></ref><ref id="REF444"><label>444</label><element-citation publication-type="journal" id="CITATION444"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>JE</given-names></name><name name-style="western"><surname>Palmieri</surname><given-names>V</given-names></name><name name-style="western"><surname>Roman</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bella</surname><given-names>JN</given-names></name><name name-style="western"><surname>Fabsitz</surname><given-names>R</given-names></name><name name-style="western"><surname>Howard</surname><given-names>BV</given-names></name><name name-style="western"><surname>Welty</surname><given-names>TK</given-names></name><etal>et al.</etal></person-group><article-title>The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: The strong heart study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0735-1097(01)01230-X">J Am College Cardiol</uri></source><year>2001</year><volume>37</volume><fpage>1943</fpage><lpage>1949</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(01)01230-X</pub-id><pub-id pub-id-type="pmid">11401136</pub-id></element-citation></ref><ref id="REF445"><label>445</label><element-citation publication-type="journal" id="CITATION445"><person-group person-group-type="author"><name name-style="western"><surname>Baynes</surname><given-names>JW</given-names></name></person-group><article-title>Role of oxidative stress in development of complications in diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diab.40.4.405">Diabetes</uri></source><year>1991</year><volume>40</volume><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.2337/diab.40.4.405</pub-id><pub-id pub-id-type="pmid">2010041</pub-id></element-citation></ref><ref id="REF446"><label>446</label><element-citation publication-type="journal" id="CITATION446"><person-group person-group-type="author"><name name-style="western"><surname>Lopaschuk</surname><given-names>GD</given-names></name><name name-style="western"><surname>Ussher</surname><given-names>JR</given-names></name><name name-style="western"><surname>Folmes</surname><given-names>CDL</given-names></name><name name-style="western"><surname>Jaswal</surname><given-names>JS</given-names></name><name name-style="western"><surname>Stanley</surname><given-names>WC</given-names></name></person-group><article-title>Myocardial fatty acid metabolism in health and disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/physrev.00015.2009">Physiol Rev</uri></source><year>2010</year><volume>90</volume><fpage>207</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1152/physrev.00015.2009</pub-id><pub-id pub-id-type="pmid">20086077</pub-id></element-citation></ref><ref id="REF447"><label>447</label><element-citation publication-type="journal" id="CITATION447"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Fan</surname><given-names>F</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Shen</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><etal>et al.</etal></person-group><article-title>Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00109-016-1449-5">J Mol Med</uri></source><year>2016</year><volume>94</volume><fpage>1229</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1007/s00109-016-1449-5</pub-id><pub-id pub-id-type="pmid">27488451</pub-id></element-citation></ref><ref id="REF448"><label>448</label><element-citation publication-type="other" id="CITATION448"><article-title>Chen CH, Ferreira JCB, Mochly-Rosen D. ALDH2 and cardiovascular disease.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/978-981-13-6260-6_3">Adv Exp Med Biol</uri> 2019, 1193: 53&#8211;67
</article-title><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-981-13-6260-6_3</pub-id><pub-id pub-id-type="pmid">31368097</pub-id></element-citation></ref><ref id="REF449"><label>449</label><element-citation publication-type="journal" id="CITATION449"><person-group person-group-type="author"><name name-style="western"><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>Pathophysiology of insulin resistance in human disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/physrev.1995.75.3.473">Physiol Rev</uri></source><year>1995</year><volume>75</volume><fpage>473</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1152/physrev.1995.75.3.473</pub-id><pub-id pub-id-type="pmid">7624391</pub-id></element-citation></ref><ref id="REF450"><label>450</label><element-citation publication-type="journal" id="CITATION450"><person-group person-group-type="author"><name name-style="western"><surname>Eknoyan</surname><given-names>G</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>J</given-names></name></person-group><article-title>A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1053/j.ackd.2005.01.002">Adv Chronic Kidney Dis</uri></source><year>2005</year><volume>12</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1053/j.ackd.2005.01.002</pub-id><pub-id pub-id-type="pmid">15822058</pub-id></element-citation></ref><ref id="REF451"><label>451</label><element-citation publication-type="journal" id="CITATION451"><person-group person-group-type="author"><name name-style="western"><surname>Montanya</surname><given-names>E</given-names></name></person-group><article-title>Insulin resistance compensation: not just a matter of &#946;-Cells?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db13-1843">Diabetes</uri></source><year>2014</year><volume>63</volume><fpage>832</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.2337/db13-1843</pub-id><pub-id pub-id-type="pmid">24556860</pub-id></element-citation></ref><ref id="REF452"><label>452</label><element-citation publication-type="journal" id="CITATION452"><person-group person-group-type="author"><name name-style="western"><surname>Katagiri</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name><name name-style="western"><surname>Oka</surname><given-names>Y</given-names></name></person-group><article-title>Adiposity and cardiovascular disorders</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1161/CIRCRESAHA.107.151621">Circ Res</uri></source><year>2007</year><volume>101</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.151621</pub-id><pub-id pub-id-type="pmid">17615379</pub-id></element-citation></ref><ref id="REF453"><label>453</label><element-citation publication-type="journal" id="CITATION453"><person-group person-group-type="author"><name name-style="western"><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1210/jc.2003-030087">J Clin Endocrinol Metab</uri></source><year>2003</year><volume>88</volume><fpage>2399</fpage><lpage>2403</lpage><pub-id pub-id-type="doi">10.1210/jc.2003-030087</pub-id><pub-id pub-id-type="pmid">12788834</pub-id></element-citation></ref><ref id="REF454"><label>454</label><element-citation publication-type="journal" id="CITATION454"><person-group person-group-type="author"><name name-style="western"><surname>Tchernof</surname><given-names>A</given-names></name><name name-style="western"><surname>Despr&#233;s</surname><given-names>JP</given-names></name></person-group><article-title>Pathophysiology of human visceral obesity: an update</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/physrev.00033.2011">Physiol Rev</uri></source><year>2013</year><volume>93</volume><fpage>359</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1152/physrev.00033.2011</pub-id><pub-id pub-id-type="pmid">23303913</pub-id></element-citation></ref><ref id="REF455"><label>455</label><element-citation publication-type="journal" id="CITATION455"><person-group person-group-type="author"><name name-style="western"><surname>Olefsky</surname><given-names>JM</given-names></name><name name-style="western"><surname>Farquhar</surname><given-names>JW</given-names></name><name name-style="western"><surname>Reaven</surname><given-names>GM</given-names></name></person-group><article-title>Reappraisal of the role of insulin in hypertriglyceridemia</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/0002-9343(74)90006-0">Am J Med</uri></source><year>1974</year><volume>57</volume><fpage>551</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(74)90006-0</pub-id><pub-id pub-id-type="pmid">4372881</pub-id></element-citation></ref><ref id="REF456"><label>456</label><element-citation publication-type="journal" id="CITATION456"><person-group person-group-type="author"><name name-style="western"><surname>Reaven</surname><given-names>G</given-names></name></person-group><article-title>Insulin resistance and coronary heart disease in nondiabetic individuals</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1161/ATVBAHA.111.241885">Arterioscler Thromb Vasc Biol</uri></source><year>2012</year><volume>32</volume><fpage>1754</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.111.241885</pub-id><pub-id pub-id-type="pmid">22815340</pub-id></element-citation></ref><ref id="REF457"><label>457</label><element-citation publication-type="journal" id="CITATION457"><person-group person-group-type="author"><name name-style="western"><surname>Kuk</surname><given-names>JL</given-names></name><name name-style="western"><surname>Brown</surname><given-names>RE</given-names></name></person-group><article-title>Aspartame intake is associated with greater glucose intolerance in individuals with obesity</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1139/apnm-2015-0675">Appl Physiol Nutr Metab</uri></source><year>2016</year><volume>41</volume><fpage>795</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1139/apnm-2015-0675</pub-id><pub-id pub-id-type="pmid">27216413</pub-id></element-citation></ref><ref id="REF458"><label>458</label><element-citation publication-type="journal" id="CITATION458"><person-group person-group-type="author"><name name-style="western"><surname>Choudhary</surname><given-names>AK</given-names></name></person-group><article-title>Aspartame: Should individuals with type II diabetes be taking it?</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2174/1573399813666170601093336">Curr Diabetes Rev</uri></source><year>2018</year><volume>14</volume><fpage>350</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.2174/1573399813666170601093336</pub-id><pub-id pub-id-type="pmid">28571543</pub-id></element-citation></ref><ref id="REF459"><label>459</label><element-citation publication-type="journal" id="CITATION459"><person-group person-group-type="author"><name name-style="western"><surname>Butchko</surname><given-names>HH</given-names></name><name name-style="western"><surname>Stargel</surname><given-names>WW</given-names></name><name name-style="western"><surname>Comer</surname><given-names>CP</given-names></name><name name-style="western"><surname>Mayhew</surname><given-names>DA</given-names></name><name name-style="western"><surname>Benninger</surname><given-names>C</given-names></name><name name-style="western"><surname>Blackburn</surname><given-names>GL</given-names></name><name name-style="western"><surname>de Sonneville</surname><given-names>LMJ</given-names></name><etal>et al.</etal></person-group><article-title>Aspartame: review of safety</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1006/rtph.2002.1542">Regul Toxicol Pharmacol</uri></source><year>2002</year><volume>35</volume><fpage>S1</fpage><lpage>S93</lpage><pub-id pub-id-type="doi">10.1006/rtph.2002.1542</pub-id><pub-id pub-id-type="pmid">12180494</pub-id></element-citation></ref><ref id="REF460"><label>460</label><element-citation publication-type="journal" id="CITATION460"><person-group person-group-type="author"><name name-style="western"><surname>&#352;pan&#283;l</surname><given-names>P</given-names></name><name name-style="western"><surname>Dryahina</surname><given-names>K</given-names></name><name name-style="western"><surname>Vicherkov&#225;</surname><given-names>P</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D</given-names></name></person-group><article-title>Increase of methanol in exhaled breath quantified by SIFT-MS following aspartame ingestion</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1088/1752-7155/9/4/047104">J Breath Res</uri></source><year>2015</year><volume>9</volume><fpage>047104</fpage><pub-id pub-id-type="doi">10.1088/1752-7155/9/4/047104</pub-id><pub-id pub-id-type="other">2015JBR.....9d7104S</pub-id><pub-id pub-id-type="pmid">26582819</pub-id></element-citation></ref><ref id="REF461"><label>461</label><element-citation publication-type="journal" id="CITATION461"><person-group person-group-type="author"><name name-style="western"><surname>Flory</surname><given-names>J</given-names></name><name name-style="western"><surname>Lipska</surname><given-names>K</given-names></name></person-group><article-title>Metformin in 2019</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/jama.2019.3805">JAMA</uri></source><year>2019</year><volume>321</volume><fpage>1926</fpage><pub-id pub-id-type="doi">10.1001/jama.2019.3805</pub-id><pub-id pub-id-type="pmid">31009043</pub-id><pub-id pub-id-type="pmcid">PMC7552083</pub-id></element-citation></ref><ref id="REF462"><label>462</label><element-citation publication-type="journal" id="CITATION462"><person-group person-group-type="author"><name name-style="western"><surname>Balasse</surname><given-names>EO</given-names></name><name name-style="western"><surname>F&#233;ry</surname><given-names>F</given-names></name></person-group><article-title>Ketone body production and disposal: effects of fasting, diabetes, and exercise</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/dmr.5610050304">RevDiabetes Metab</uri></source><year>1989</year><volume>5</volume><fpage>247</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1002/dmr.5610050304</pub-id><pub-id pub-id-type="pmid">2656155</pub-id></element-citation></ref><ref id="REF463"><label>463</label><element-citation publication-type="journal" id="CITATION463"><person-group person-group-type="author"><name name-style="western"><surname>Bentourkia</surname><given-names>M</given-names></name><name name-style="western"><surname>Tremblay</surname><given-names>S</given-names></name><name name-style="western"><surname>Pifferi</surname><given-names>F</given-names></name><name name-style="western"><surname>Rousseau</surname><given-names>J</given-names></name><name name-style="western"><surname>Lecomte</surname><given-names>R</given-names></name><name name-style="western"><surname>Cunnane</surname><given-names>S</given-names></name></person-group><article-title>PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajpendo.90644.2008">Am J Physiol Endocrinol Metab</uri></source><year>2009</year><volume>296</volume><fpage>E796</fpage><lpage>E801</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.90644.2008</pub-id><pub-id pub-id-type="pmid">19176356</pub-id></element-citation></ref><ref id="REF464"><label>464</label><element-citation publication-type="journal" id="CITATION464"><person-group person-group-type="author"><name name-style="western"><surname>Owen</surname><given-names>OE</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>AP</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>HG</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Herrera</surname><given-names>MG</given-names></name><name name-style="western"><surname>Cahill Jr</surname><given-names>GF</given-names></name></person-group><article-title>Brain metabolism during fasting</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI105650">J Clin Invest</uri></source><year>1967</year><volume>46</volume><fpage>1589</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1172/JCI105650</pub-id><pub-id pub-id-type="pmid">6061736</pub-id><pub-id pub-id-type="pmcid">PMC292907</pub-id></element-citation></ref><ref id="REF465"><label>465</label><element-citation publication-type="journal" id="CITATION465"><person-group person-group-type="author"><name name-style="western"><surname>Reichard Jr</surname><given-names>GA</given-names></name><name name-style="western"><surname>Owen</surname><given-names>OE</given-names></name><name name-style="western"><surname>Haff</surname><given-names>AC</given-names></name><name name-style="western"><surname>Paul</surname><given-names>P</given-names></name><name name-style="western"><surname>Bortz</surname><given-names>WM</given-names></name></person-group><article-title>Ketone-body production and oxidation in fasting obese humans</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI107584">J Clin Invest</uri></source><year>1974</year><volume>53</volume><fpage>508</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1172/JCI107584</pub-id><pub-id pub-id-type="pmid">11344564</pub-id><pub-id pub-id-type="pmcid">PMC301493</pub-id></element-citation></ref><ref id="REF466"><label>466</label><element-citation publication-type="journal" id="CITATION466"><person-group person-group-type="author"><name name-style="western"><surname>Kitabchi</surname><given-names>AE</given-names></name><name name-style="western"><surname>Wall</surname><given-names>BM</given-names></name></person-group><article-title>Diabetic ketoacidosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0025-7125(16)30082-7">Med Clin North Am</uri></source><year>1995</year><volume>79</volume><fpage>9</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/S0025-7125(16)30082-7</pub-id><pub-id pub-id-type="pmid">7808097</pub-id></element-citation></ref><ref id="REF467"><label>467</label><element-citation publication-type="journal" id="CITATION467"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>AM</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>DH</given-names></name></person-group><article-title>Physiological roles of ketone bodies as substrates and signals in mammalian tissues</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/physrev.1980.60.1.143">Physiol Rev</uri></source><year>1980</year><volume>60</volume><fpage>143</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1152/physrev.1980.60.1.143</pub-id><pub-id pub-id-type="pmid">6986618</pub-id></element-citation></ref><ref id="REF468"><label>468</label><element-citation publication-type="journal" id="CITATION468"><person-group person-group-type="author"><name name-style="western"><surname>Fukao</surname><given-names>T</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>G</given-names></name><name name-style="western"><surname>Sass</surname><given-names>JO</given-names></name><name name-style="western"><surname>Hori</surname><given-names>T</given-names></name><name name-style="western"><surname>Orii</surname><given-names>K</given-names></name><name name-style="western"><surname>Aoyama</surname><given-names>Y</given-names></name></person-group><article-title>Ketone body metabolism and its defects</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s10545-014-9704-9">J Inherit Metab Dis</uri></source><year>2014</year><volume>37</volume><fpage>541</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1007/s10545-014-9704-9</pub-id><pub-id pub-id-type="pmid">24706027</pub-id></element-citation></ref><ref id="REF469"><label>469</label><element-citation publication-type="journal" id="CITATION469"><person-group person-group-type="author"><name name-style="western"><surname>Celik</surname><given-names>U</given-names></name><name name-style="western"><surname>Celik</surname><given-names>T</given-names></name><name name-style="western"><surname>Avci</surname><given-names>A</given-names></name><name name-style="western"><surname>Annagur</surname><given-names>A</given-names></name><name name-style="western"><surname>Yilmaz</surname><given-names>HL</given-names></name><name name-style="western"><surname>Kucukosmanoglu</surname><given-names>O</given-names></name><name name-style="western"><surname>Topaloglu</surname><given-names>AK</given-names></name><etal>et al.</etal></person-group><article-title>Metabolic acidosis in a patient with type 1 diabetes mellitus complicated by methanol and amitriptyline intoxication</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/MEJ.0b013e3283034245">Eur J Emerg Med</uri></source><year>2009</year><volume>16</volume><fpage>45</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1097/MEJ.0b013e3283034245</pub-id><pub-id pub-id-type="pmid">19106720</pub-id></element-citation></ref><ref id="REF470"><label>470</label><element-citation publication-type="journal" id="CITATION470"><person-group person-group-type="author"><name name-style="western"><surname>Laffel</surname><given-names>L</given-names></name></person-group><article-title>Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/(SICI)1520-7560(199911/12)15:6&lt;412::AID-DMRR72&gt;3.0.CO;2-8">Diabetes Metab Res Rev</uri></source><year>1999</year><volume>15</volume><fpage>412</fpage><lpage>426</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1520-7560(199911/12)15:6&amp;#x0003c;412::AID-DMRR72&amp;#x0003e;3.0.CO;2-8</pub-id><pub-id pub-id-type="pmid">10634967</pub-id></element-citation></ref><ref id="REF471"><label>471</label><element-citation publication-type="journal" id="CITATION471"><person-group person-group-type="author"><name name-style="western"><surname>Barski</surname><given-names>L</given-names></name><name name-style="western"><surname>Eshkoli</surname><given-names>T</given-names></name><name name-style="western"><surname>Brandstaetter</surname><given-names>E</given-names></name><name name-style="western"><surname>Jotkowitz</surname><given-names>A</given-names></name></person-group><article-title>Euglycemic diabetic ketoacidosis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.ejim.2019.03.014">Eur J Internal Med</uri></source><year>2019</year><volume>63</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.ejim.2019.03.014</pub-id><pub-id pub-id-type="pmid">30910328</pub-id></element-citation></ref><ref id="REF472"><label>472</label><element-citation publication-type="journal" id="CITATION472"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>AL</given-names></name><name name-style="western"><surname>Buschur</surname><given-names>EO</given-names></name><name name-style="western"><surname>Buse</surname><given-names>JB</given-names></name><name name-style="western"><surname>Cohan</surname><given-names>P</given-names></name><name name-style="western"><surname>Diner</surname><given-names>JC</given-names></name><name name-style="western"><surname>Hirsch</surname><given-names>IB</given-names></name></person-group><article-title>Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium&#8211;glucose cotransporter 2 inhibition</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc15-0843">Diabetes Care</uri></source><year>2015</year><volume>38</volume><fpage>1687</fpage><lpage>1693</lpage><pub-id pub-id-type="doi">10.2337/dc15-0843</pub-id><pub-id pub-id-type="pmid">26078479</pub-id><pub-id pub-id-type="pmcid">PMC4542270</pub-id></element-citation></ref><ref id="REF473"><label>473</label><element-citation publication-type="journal" id="CITATION473"><person-group person-group-type="author"><name name-style="western"><surname>Modi</surname><given-names>A</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>A</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>F</given-names></name></person-group><article-title>Euglycemic diabetic ketoacidosis: a review</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2174/1573399812666160421121307">Curr Diabetes Rev</uri></source><year>2017</year><volume>13</volume><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.2174/1573399812666160421121307</pub-id><pub-id pub-id-type="pmid">27097605</pub-id></element-citation></ref><ref id="REF474"><label>474</label><element-citation publication-type="journal" id="CITATION474"><person-group person-group-type="author"><name name-style="western"><surname>Pascolini</surname><given-names>D</given-names></name><name name-style="western"><surname>Mariotti</surname><given-names>SP</given-names></name></person-group><article-title>Global estimates of visual impairment: 2010</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1136/bjophthalmol-2011-300539">Br J Ophthalmol</uri></source><year>2012</year><volume>96</volume><fpage>614</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2011-300539</pub-id><pub-id pub-id-type="pmid">22133988</pub-id></element-citation></ref><ref id="REF475"><label>475</label><element-citation publication-type="journal" id="CITATION475"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Wan</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name></person-group><article-title>Meta-analysis of the risk of cataract in type 2 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1186/1471-2415-14-94">BMC Ophthalmol</uri></source><year>2014</year><volume>14</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1186/1471-2415-14-94</pub-id><pub-id pub-id-type="pmid">25060855</pub-id><pub-id pub-id-type="pmcid">PMC4113025</pub-id></element-citation></ref><ref id="REF476"><label>476</label><element-citation publication-type="journal" id="CITATION476"><person-group person-group-type="author"><name name-style="western"><surname>Drinkwater</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Davis</surname><given-names>WA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>TME</given-names></name></person-group><article-title>A systematic review of risk factors for cataract in type 2 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/dmrr.3073">Diabetes Metab Res Rev</uri></source><year>2019</year><volume>35</volume><fpage>e3073</fpage><pub-id pub-id-type="doi">10.1002/dmrr.3073</pub-id><pub-id pub-id-type="pmid">30209868</pub-id></element-citation></ref><ref id="REF477"><label>477</label><element-citation publication-type="journal" id="CITATION477"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>BEK</given-names></name><name name-style="western"><surname>Klein</surname><given-names>R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KE</given-names></name></person-group><article-title>Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the beaver dam eye study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0002-9394(98)00280-3">Am J Ophthalmol</uri></source><year>1998</year><volume>126</volume><fpage>782</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1016/S0002-9394(98)00280-3</pub-id><pub-id pub-id-type="pmid">9860001</pub-id></element-citation></ref><ref id="REF478"><label>478</label><element-citation publication-type="journal" id="CITATION478"><person-group person-group-type="author"><name name-style="western"><surname>Srinivasan</surname><given-names>S</given-names></name><name name-style="western"><surname>Raman</surname><given-names>R</given-names></name><name name-style="western"><surname>Swaminathan</surname><given-names>G</given-names></name><name name-style="western"><surname>Ganesan</surname><given-names>S</given-names></name><name name-style="western"><surname>Kulothungan</surname><given-names>V</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>T</given-names></name></person-group><article-title>Incidence, progression, and risk factors for cataract in type 2 diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.17-22264">SciInvest Ophthalmol Vis</uri></source><year>2017</year><volume>58</volume><fpage>5921</fpage><lpage>5929</lpage><pub-id pub-id-type="doi">10.1167/iovs.17-22264</pub-id><pub-id pub-id-type="pmid">29164235</pub-id></element-citation></ref><ref id="REF479"><label>479</label><element-citation publication-type="journal" id="CITATION479"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>C</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>C</given-names></name><name name-style="western"><surname>Aball&#233;a</surname><given-names>S</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>C</given-names></name><name name-style="western"><surname>Bourne</surname><given-names>R</given-names></name><name name-style="western"><surname>Jick</surname><given-names>S</given-names></name><name name-style="western"><surname>Meier</surname><given-names>C</given-names></name></person-group><article-title>Cataract in patients with diabetes mellitus&#8212;incidence rates in the UK and risk factors</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/s41433-017-0003-1">Eye</uri></source><year>2018</year><volume>32</volume><fpage>1028</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1038/s41433-017-0003-1</pub-id><pub-id pub-id-type="pmid">29386666</pub-id><pub-id pub-id-type="pmcid">PMC5997651</pub-id></element-citation></ref><ref id="REF480"><label>480</label><element-citation publication-type="journal" id="CITATION480"><person-group person-group-type="author"><name name-style="western"><surname>Olafsdottir</surname><given-names>E</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>DKG</given-names></name><name name-style="western"><surname>Stef&#225;nsson</surname><given-names>E</given-names></name></person-group><article-title>The prevalence of cataract in a population with and without type 2 diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1755-3768.2011.02326.x">Acta Ophthalmol</uri></source><year>2012</year><volume>90</volume><fpage>334</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1111/j.1755-3768.2011.02326.x</pub-id><pub-id pub-id-type="pmid">22176834</pub-id></element-citation></ref><ref id="REF481"><label>481</label><element-citation publication-type="journal" id="CITATION481"><person-group person-group-type="author"><name name-style="western"><surname>Janghorbani</surname><given-names>M</given-names></name><name name-style="western"><surname>Jones</surname><given-names>RB</given-names></name><name name-style="western"><surname>Allison</surname><given-names>SP</given-names></name></person-group><article-title>Incidence of and risk factors for cataract among diabetes clinic attenders</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1076/0928-6586(200003)711-2FT013">Ophthalmic Epidemiol</uri></source><year>2000</year><volume>7</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1076/0928-6586(200003)711-2FT013</pub-id><pub-id pub-id-type="pmid">10652168</pub-id></element-citation></ref><ref id="REF482"><label>482</label><element-citation publication-type="journal" id="CITATION482"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>AYW</given-names></name><name name-style="western"><surname>Chung</surname><given-names>SSM</given-names></name></person-group><article-title>Contributions of polyol pathway to oxidative stress in diabetic cataract</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1096/fasebj.13.1.23">FASEB J</uri></source><year>1999</year><volume>13</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1096/fasebj.13.1.23</pub-id><pub-id pub-id-type="pmid">9872926</pub-id></element-citation></ref><ref id="REF483"><label>483</label><element-citation publication-type="journal" id="CITATION483"><person-group person-group-type="author"><name name-style="western"><surname>Vinson</surname><given-names>JA</given-names></name></person-group><article-title>Oxidative stress in cataracts</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.pathophys.2006.05.006">Pathophysiology</uri></source><year>2006</year><volume>13</volume><fpage>151</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.pathophys.2006.05.006</pub-id><pub-id pub-id-type="pmid">16765571</pub-id></element-citation></ref><ref id="REF484"><label>484</label><element-citation publication-type="journal" id="CITATION484"><person-group person-group-type="author"><name name-style="western"><surname>Babizhayev</surname><given-names>MA</given-names></name><name name-style="western"><surname>Yegorov</surname><given-names>YE</given-names></name></person-group><article-title>Reactive oxygen species and the aging eye</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/MJT.0b013e3181ea31ff">Am J Ther</uri></source><year>2006</year><volume>23</volume><fpage>e98</fpage><lpage>e117</lpage><pub-id pub-id-type="doi">10.1097/MJT.0b013e3181ea31ff</pub-id><pub-id pub-id-type="pmid">21048433</pub-id></element-citation></ref><ref id="REF485"><label>485</label><element-citation publication-type="journal" id="CITATION485"><person-group person-group-type="author"><name name-style="western"><surname>Elanchezhian</surname><given-names>R</given-names></name><name name-style="western"><surname>Palsamy</surname><given-names>P</given-names></name><name name-style="western"><surname>Madson</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Mulhern</surname><given-names>ML</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>DW</given-names></name><name name-style="western"><surname>Troia</surname><given-names>AM</given-names></name><name name-style="western"><surname>Usukura</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>Low glucose under hypoxic conditions induces unfolded protein response and produces reactive oxygen species in lens epithelial cells</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/cddis.2012.40">Cell Death Dis</uri></source><year>2012</year><volume>3</volume><fpage>e301</fpage><pub-id pub-id-type="doi">10.1038/cddis.2012.40</pub-id><pub-id pub-id-type="pmid">22513875</pub-id><pub-id pub-id-type="pmcid">PMC3358018</pub-id></element-citation></ref><ref id="REF486"><label>486</label><element-citation publication-type="journal" id="CITATION486"><person-group person-group-type="author"><name name-style="western"><surname>Gallagher</surname><given-names>EJ</given-names></name><name name-style="western"><surname>LeRoith</surname><given-names>D</given-names></name></person-group><article-title>Obesity and diabetes: the increased risk of cancer and cancer-related mortality</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/physrev.00030.2014">Physiol Rev</uri></source><year>2015</year><volume>95</volume><fpage>727</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1152/physrev.00030.2014</pub-id><pub-id pub-id-type="pmid">26084689</pub-id><pub-id pub-id-type="pmcid">PMC4491542</pub-id></element-citation></ref><ref id="REF487"><label>487</label><element-citation publication-type="journal" id="CITATION487"><person-group person-group-type="author"><name name-style="western"><surname>Michels</surname><given-names>KB</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>CG</given-names></name><name name-style="western"><surname>Hu</surname><given-names>FB</given-names></name><name name-style="western"><surname>Rosner</surname><given-names>BA</given-names></name><name name-style="western"><surname>Hankinson</surname><given-names>SE</given-names></name><name name-style="western"><surname>Colditz</surname><given-names>GA</given-names></name><name name-style="western"><surname>Manson</surname><given-names>JAE</given-names></name></person-group><article-title>Type 2 diabetes and subsequent incidence of breast cancer in the nurses&#8217; health study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/diacare.26.6.1752">Diabetes Care</uri></source><year>2003</year><volume>26</volume><fpage>1752</fpage><lpage>1758</lpage><pub-id pub-id-type="doi">10.2337/diacare.26.6.1752</pub-id><pub-id pub-id-type="pmid">12766105</pub-id></element-citation></ref><ref id="REF488"><label>488</label><element-citation publication-type="journal" id="CITATION488"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><name name-style="western"><surname>Ren</surname><given-names>H</given-names></name><name name-style="western"><surname>Ben</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name></person-group><article-title>Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s10552-011-9874-9">Cancer Causes Control</uri></source><year>2012</year><volume>23</volume><fpage>263</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1007/s10552-011-9874-9</pub-id><pub-id pub-id-type="pmid">22094992</pub-id></element-citation></ref><ref id="REF489"><label>489</label><element-citation publication-type="journal" id="CITATION489"><person-group person-group-type="author"><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Orsini</surname><given-names>N</given-names></name><name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name></person-group><article-title>Diabetes mellitus and risk of colorectal cancer: a meta-analysis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/jnci/dji375">J Natl Cancer Inst</uri></source><year>2005</year><volume>97</volume><fpage>1679</fpage><lpage>1687</lpage><pub-id pub-id-type="doi">10.1093/jnci/dji375</pub-id><pub-id pub-id-type="pmid">16288121</pub-id></element-citation></ref><ref id="REF490"><label>490</label><element-citation publication-type="journal" id="CITATION490"><person-group person-group-type="author"><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name></person-group><article-title>Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/s00125-011-2051-6">Diabetologia</uri></source><year>2011</year><volume>54</volume><fpage>1013</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1007/s00125-011-2051-6</pub-id><pub-id pub-id-type="pmid">21274512</pub-id></element-citation></ref><ref id="REF491"><label>491</label><element-citation publication-type="journal" id="CITATION491"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>PT</given-names></name><name name-style="western"><surname>Newton</surname><given-names>CC</given-names></name><name name-style="western"><surname>Patel</surname><given-names>AV</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Gapstur</surname><given-names>SM</given-names></name></person-group><article-title>Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc12-0002">Diabetes Care</uri></source><year>2012</year><volume>35</volume><fpage>1835</fpage><lpage>1844</lpage><pub-id pub-id-type="doi">10.2337/dc12-0002</pub-id><pub-id pub-id-type="pmid">22699290</pub-id><pub-id pub-id-type="pmcid">PMC3425000</pub-id></element-citation></ref><ref id="REF492"><label>492</label><element-citation publication-type="journal" id="CITATION492"><person-group person-group-type="author"><name name-style="western"><surname>Barone</surname><given-names>BB</given-names></name></person-group><article-title>Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/jama.2008.824">JAMA</uri></source><year>2008</year><volume>300</volume><fpage>2754</fpage><lpage>2764</lpage><pub-id pub-id-type="doi">10.1001/jama.2008.824</pub-id><pub-id pub-id-type="pmid">19088353</pub-id><pub-id pub-id-type="pmcid">PMC3093051</pub-id></element-citation></ref><ref id="REF493"><label>493</label><element-citation publication-type="other" id="CITATION493"><article-title>Mansour S, Hatchell D, Chandler D, Saloupis P, Hatchell M. Reduction of basement membrane thickening in diabetic cat retina by sulindac.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/2318584/">Invest Ophthalmol Vis Sci</uri> 1990, 31: 457&#8211;463.
</article-title><pub-id pub-id-type="pmid">2318584</pub-id></element-citation></ref><ref id="REF494"><label>494</label><element-citation publication-type="journal" id="CITATION494"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>CS</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>SM</given-names></name></person-group><article-title>Forgoing the folate?&#8212;contemporary recommendations for methanol poisoning and evidence review</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1097/MJT.0000000000000059">Am J Ther</uri></source><year>2016</year><volume>23</volume><fpage>e850</fpage><lpage>e854</lpage><pub-id pub-id-type="doi">10.1097/MJT.0000000000000059</pub-id><pub-id pub-id-type="pmid">24531405</pub-id></element-citation></ref><ref id="REF495"><label>495</label><element-citation publication-type="journal" id="CITATION495"><person-group person-group-type="author"><name name-style="western"><surname>Theobald</surname><given-names>J</given-names></name><name name-style="western"><surname>Lim</surname><given-names>C</given-names></name></person-group><article-title>Folate as an adjuvant therapy in methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/ncp.10329">Nutr Clin Pract</uri></source><year>2019</year><volume>34</volume><fpage>521</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1002/ncp.10329</pub-id><pub-id pub-id-type="pmid">31172585</pub-id></element-citation></ref><ref id="REF496"><label>496</label><element-citation publication-type="journal" id="CITATION496"><person-group person-group-type="author"><name name-style="western"><surname>Sanaei-Zadeh</surname><given-names>H</given-names></name><name name-style="western"><surname>Zamani</surname><given-names>N</given-names></name><name name-style="western"><surname>Shadnia</surname><given-names>S</given-names></name></person-group><article-title>Outcomes of visual disturbances after methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/15563650.2011.556642">Clin Toxicol</uri></source><year>2011</year><volume>49</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.3109/15563650.2011.556642</pub-id><pub-id pub-id-type="pmid">21370946</pub-id></element-citation></ref><ref id="REF497"><label>497</label><element-citation publication-type="journal" id="CITATION497"><person-group person-group-type="author"><name name-style="western"><surname>Jacobsen</surname><given-names>D</given-names></name><name name-style="western"><surname>McMartin</surname><given-names>KE</given-names></name></person-group><article-title>Methanol and ethylene glycol poisonings</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1007/BF03259846">Med Toxicol</uri></source><year>1986</year><volume>1</volume><fpage>309</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1007/BF03259846</pub-id><pub-id pub-id-type="pmid">3537623</pub-id></element-citation></ref><ref id="REF498"><label>498</label><element-citation publication-type="journal" id="CITATION498"><person-group person-group-type="author"><name name-style="western"><surname>Zakharov</surname><given-names>S</given-names></name><name name-style="western"><surname>Pelclova</surname><given-names>D</given-names></name><name name-style="western"><surname>Diblik</surname><given-names>P</given-names></name><name name-style="western"><surname>Urban</surname><given-names>P</given-names></name><name name-style="western"><surname>Kuthan</surname><given-names>P</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>O</given-names></name><name name-style="western"><surname>Kotikova</surname><given-names>K</given-names></name><etal>et al.</etal></person-group><article-title>Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/15563650.2015.1086488">Clin Toxicol</uri></source><year>2015</year><volume>53</volume><fpage>884</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.3109/15563650.2015.1086488</pub-id><pub-id pub-id-type="pmid">26364866</pub-id></element-citation></ref><ref id="REF499"><label>499</label><element-citation publication-type="journal" id="CITATION499"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>DF</given-names></name><name name-style="western"><surname>Bentley</surname><given-names>AM</given-names></name><name name-style="western"><surname>Dawling</surname><given-names>S</given-names></name><name name-style="western"><surname>Hoare</surname><given-names>AM</given-names></name><name name-style="western"><surname>Henry</surname><given-names>JA</given-names></name></person-group><article-title>Folinic acid and enhanced renal elimination in formic acid intoxication</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3109/15563659409000451">J Toxicol Clin Toxicol</uri></source><year>1994</year><volume>32</volume><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.3109/15563659409000451</pub-id><pub-id pub-id-type="pmid">8145360</pub-id></element-citation></ref><ref id="REF500"><label>500</label><element-citation publication-type="journal" id="CITATION500"><person-group person-group-type="author"><name name-style="western"><surname>Smolek</surname><given-names>M</given-names></name><name name-style="western"><surname>Notaroberto</surname><given-names>M</given-names></name><name name-style="western"><surname>Jaramillo</surname><given-names>M</given-names></name><name name-style="western"><surname>Pradillo</surname><given-names>M</given-names></name></person-group><article-title>Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2147/OPTH.S46718">Clin Ophthalmol</uri></source><year>2013</year><volume>7</volume><fpage>1451</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S46718</pub-id><pub-id pub-id-type="pmid">23898220</pub-id><pub-id pub-id-type="pmcid">PMC3718838</pub-id></element-citation></ref><ref id="REF501"><label>501</label><element-citation publication-type="journal" id="CITATION501"><person-group person-group-type="author"><name name-style="western"><surname>Vald&#233;s-Ramos</surname><given-names>R</given-names></name><name name-style="western"><surname>Guadarrama-L&#243;pez</surname><given-names>AL</given-names></name><name name-style="western"><surname>Mart&#237;nez-Carrillo</surname><given-names>BE</given-names></name><name name-style="western"><surname>Ben&#237;tez-Arciniega</surname><given-names>AD</given-names></name></person-group><article-title>Vitamins and type 2 diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2174/1871530314666141111103217">Endocr Metab Immune Disord Drug Targets</uri></source><year>2015</year><volume>15</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.2174/1871530314666141111103217</pub-id><pub-id pub-id-type="pmid">25388747</pub-id><pub-id pub-id-type="pmcid">PMC4435229</pub-id></element-citation></ref><ref id="REF502"><label>502</label><element-citation publication-type="journal" id="CITATION502"><person-group person-group-type="author"><name name-style="western"><surname>House</surname><given-names>AA</given-names></name><name name-style="western"><surname>Eliasziw</surname><given-names>M</given-names></name><name name-style="western"><surname>Cattran</surname><given-names>DC</given-names></name><name name-style="western"><surname>Churchill</surname><given-names>DN</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Fine</surname><given-names>A</given-names></name><name name-style="western"><surname>Dresser</surname><given-names>GK</given-names></name><etal>et al.</etal></person-group><article-title>Effect of B-vitamin therapy on progression of diabetic nephropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1001/jama.2010.490">JAMA</uri></source><year>2010</year><volume>303</volume><fpage>1603</fpage><lpage>1609</lpage><pub-id pub-id-type="doi">10.1001/jama.2010.490</pub-id><pub-id pub-id-type="pmid">20424250</pub-id></element-citation></ref><ref id="REF503"><label>503</label><element-citation publication-type="journal" id="CITATION503"><person-group person-group-type="author"><name name-style="western"><surname>Lonn</surname><given-names>E</given-names></name><name name-style="western"><surname>Yusuf</surname><given-names>S</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Sheridan</surname><given-names>P</given-names></name><name name-style="western"><surname>Pogue</surname><given-names>J</given-names></name><name name-style="western"><surname>Micks</surname><given-names>M</given-names></name><name name-style="western"><surname>McQueen</surname><given-names>MJ</given-names></name><etal>et al.</etal></person-group><article-title>Homocysteine lowering with folic acid and B vitamins in vascular disease</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1056/NEJMoa060900">N Engl J Med</uri></source><year>2006</year><volume>354</volume><fpage>1567</fpage><lpage>1577</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa060900</pub-id><pub-id pub-id-type="pmid">16531613</pub-id></element-citation></ref><ref id="REF504"><label>504</label><element-citation publication-type="journal" id="CITATION504"><person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>CD</given-names></name></person-group><article-title>Oral ethanol doses in patients with methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1093/ajhp/38.7.1024">Am J Hosp Pharm</uri></source><year>1981</year><volume>38</volume><fpage>1024</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1093/ajhp/38.7.1024</pub-id><pub-id pub-id-type="pmid">7258202</pub-id></element-citation></ref><ref id="REF505"><label>505</label><element-citation publication-type="journal" id="CITATION505"><person-group person-group-type="author"><name name-style="western"><surname>Barceloux</surname><given-names>DG</given-names></name><name name-style="western"><surname>Randall Bond</surname><given-names>G</given-names></name><name name-style="western"><surname>Krenzelok</surname><given-names>EP</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>H</given-names></name><name name-style="western"><surname>Allister Vale</surname><given-names>J</given-names></name></person-group><collab>American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning.</collab><article-title>American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1081/CLT-120006745">J Toxicol Clin Toxicol</uri></source><year>2002</year><volume>40</volume><fpage>415</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1081/CLT-120006745</pub-id><pub-id pub-id-type="pmid">12216995</pub-id></element-citation></ref><ref id="REF506"><label>506</label><element-citation publication-type="journal" id="CITATION506"><person-group person-group-type="author"><name name-style="western"><surname>Hovda</surname><given-names>KE</given-names></name><name name-style="western"><surname>Hunderi</surname><given-names>OH</given-names></name><name name-style="western"><surname>Tafjord</surname><given-names>AB</given-names></name><name name-style="western"><surname>Dunlop</surname><given-names>O</given-names></name><name name-style="western"><surname>Rudberg</surname><given-names>N</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>D</given-names></name></person-group><article-title>Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1365-2796.2005.01521.x">J Intern Med</uri></source><year>2005</year><volume>258</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2005.01521.x</pub-id><pub-id pub-id-type="pmid">16018795</pub-id></element-citation></ref><ref id="REF507"><label>507</label><element-citation publication-type="journal" id="CITATION507"><person-group person-group-type="author"><name name-style="western"><surname>Knott</surname><given-names>C</given-names></name><name name-style="western"><surname>Bell</surname><given-names>S</given-names></name><name name-style="western"><surname>Britton</surname><given-names>A</given-names></name></person-group><article-title>Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/dc15-0710">Diabetes Care</uri></source><year>2015</year><volume>38</volume><fpage>1804</fpage><lpage>1812</lpage><pub-id pub-id-type="doi">10.2337/dc15-0710</pub-id><pub-id pub-id-type="pmid">26294775</pub-id></element-citation></ref><ref id="REF508"><label>508</label><element-citation publication-type="journal" id="CITATION508"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>XH</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>YH</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3945/ajcn.115.114389">Am J Clin Nutr</uri></source><year>2016</year><volume>103</volume><fpage>818</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.3945/ajcn.115.114389</pub-id><pub-id pub-id-type="pmid">26843157</pub-id></element-citation></ref><ref id="REF509"><label>509</label><element-citation publication-type="journal" id="CITATION509"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>FM</given-names></name><name name-style="western"><surname>Palmeira</surname><given-names>CM</given-names></name><name name-style="western"><surname>Sei&#231;a</surname><given-names>R</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Santos</surname><given-names>MS</given-names></name></person-group><article-title>Diabetes and mitochondrial bioenergetics: alterations with age</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1002/jbt.10081">J Biochem Mol Toxicol</uri></source><year>2003</year><volume>17</volume><fpage>214</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1002/jbt.10081</pub-id><pub-id pub-id-type="pmid">12898645</pub-id></element-citation></ref><ref id="REF510"><label>510</label><element-citation publication-type="journal" id="CITATION510"><person-group person-group-type="author"><name name-style="western"><surname>Fitzl</surname><given-names>G</given-names></name><name name-style="western"><surname>Welt</surname><given-names>K</given-names></name><name name-style="western"><surname>Martin</surname><given-names>R</given-names></name><name name-style="western"><surname>Dettmer</surname><given-names>D</given-names></name><name name-style="western"><surname>Hermsdorf</surname><given-names>T</given-names></name><name name-style="western"><surname>Clemens</surname><given-names>N</given-names></name><name name-style="western"><surname>K&#246;nig</surname><given-names>S</given-names></name></person-group><article-title>The influence of hypoxia on the myocardium of experimentally diabetic rats with and without protection by Ginkgo biloba extract. I. Ultrastructural and biochemical investigations on cardiomyocytes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/S0940-2993(00)80075-5">Exp Toxicologic Pathol</uri></source><year>2000</year><volume>52</volume><fpage>419</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/S0940-2993(00)80075-5</pub-id><pub-id pub-id-type="pmid">11089893</pub-id></element-citation></ref><ref id="REF511"><label>511</label><element-citation publication-type="other" id="CITATION511"><article-title>Pierce G, Dhalla N. Heart mitochondrial function in chronic experimental diabetes in rats.
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/2996724/">Canadian J Cardiol</uri> 1985,1: 48&#8211;54.
</article-title><pub-id pub-id-type="pmid">2996724</pub-id></element-citation></ref><ref id="REF512"><label>512</label><element-citation publication-type="journal" id="CITATION512"><person-group person-group-type="author"><name name-style="western"><surname>Bugger</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Riehle</surname><given-names>C</given-names></name><name name-style="western"><surname>Soto</surname><given-names>J</given-names></name><name name-style="western"><surname>Theobald</surname><given-names>HA</given-names></name><name name-style="western"><surname>Hu</surname><given-names>XX</given-names></name><name name-style="western"><surname>Ganesan</surname><given-names>B</given-names></name><etal>et al.</etal></person-group><article-title>Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db09-0259">Diabetes</uri></source><year>2009</year><volume>58</volume><fpage>1986</fpage><lpage>1997</lpage><pub-id pub-id-type="doi">10.2337/db09-0259</pub-id><pub-id pub-id-type="pmid">19542201</pub-id><pub-id pub-id-type="pmcid">PMC2731527</pub-id></element-citation></ref><ref id="REF513"><label>513</label><element-citation publication-type="journal" id="CITATION513"><person-group person-group-type="author"><name name-style="western"><surname>Chowdhury</surname><given-names>SKR</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DR</given-names></name><name name-style="western"><surname>Fernyhough</surname><given-names>P</given-names></name></person-group><article-title>The role of aberrant mitochondrial bioenergetics in diabetic neuropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1016/j.nbd.2012.03.016">Neurobiol Dis</uri></source><year>2013</year><volume>51</volume><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2012.03.016</pub-id><pub-id pub-id-type="pmid">22446165</pub-id></element-citation></ref><ref id="REF514"><label>514</label><element-citation publication-type="journal" id="CITATION514"><person-group person-group-type="author"><name name-style="western"><surname>Shenouda</surname><given-names>SM</given-names></name><name name-style="western"><surname>Widlansky</surname><given-names>ME</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Xu</surname><given-names>G</given-names></name><name name-style="western"><surname>Holbrook</surname><given-names>M</given-names></name><name name-style="western"><surname>Tabit</surname><given-names>CE</given-names></name><name name-style="western"><surname>Hamburg</surname><given-names>NM</given-names></name><etal>et al.</etal></person-group><article-title>Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.110.014506">Circulation</uri></source><year>2011</year><volume>124</volume><fpage>444</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.014506</pub-id><pub-id pub-id-type="pmid">21747057</pub-id><pub-id pub-id-type="pmcid">PMC3149100</pub-id></element-citation></ref><ref id="REF515"><label>515</label><element-citation publication-type="journal" id="CITATION515"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kowluru</surname><given-names>RA</given-names></name></person-group><article-title>Diabetic retinopathy and damage to mitochondrial structure and transport machinery</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1167/iovs.11-8045">Invest Ophthalmol Vis Sci</uri></source><year>2011</year><volume>52</volume><fpage>8739</fpage><lpage>8746</lpage><pub-id pub-id-type="doi">10.1167/iovs.11-8045</pub-id><pub-id pub-id-type="pmid">22003103</pub-id><pub-id pub-id-type="pmcid">PMC3263781</pub-id></element-citation></ref><ref id="REF516"><label>516</label><element-citation publication-type="journal" id="CITATION516"><person-group person-group-type="author"><name name-style="western"><surname>Piconi</surname><given-names>L</given-names></name><name name-style="western"><surname>Quagliaro</surname><given-names>L</given-names></name><name name-style="western"><surname>Ceriello</surname><given-names>A</given-names></name></person-group><article-title>Oxidative stress in diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1515/CCLM.2003.177">Clin Chem Lab Med</uri></source><year>2003</year><volume>41</volume><fpage>1144</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1515/CCLM.2003.177</pub-id><pub-id pub-id-type="pmid">14598863</pub-id></element-citation></ref><ref id="REF517"><label>517</label><element-citation publication-type="journal" id="CITATION517"><person-group person-group-type="author"><name name-style="western"><surname>Vincent</surname><given-names>AM</given-names></name><name name-style="western"><surname>Brownlee</surname><given-names>M</given-names></name><name name-style="western"><surname>Russell</surname><given-names>JW</given-names></name></person-group><article-title>Oxidative stress and programmed cell death in diabetic neuropathy</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1111/j.1749-6632.2002.tb02108.x">Ann NY Acad Sci</uri></source><year>2002</year><volume>959</volume><fpage>368</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb02108.x</pub-id><pub-id pub-id-type="other">2002NYASA.959..368V</pub-id><pub-id pub-id-type="pmid">11976211</pub-id></element-citation></ref><ref id="REF518"><label>518</label><element-citation publication-type="journal" id="CITATION518"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>XL</given-names></name><name name-style="western"><surname>Edelstein</surname><given-names>D</given-names></name><name name-style="western"><surname>Rossetti</surname><given-names>L</given-names></name><name name-style="western"><surname>Fantus</surname><given-names>IG</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Ziyadeh</surname><given-names>F</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1073/pnas.97.22.12222">Proc Natl Acad Sci U S A</uri></source><year>2000</year><volume>97</volume><fpage>12222</fpage><lpage>12226</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.22.12222</pub-id><pub-id pub-id-type="other">2000PNAS...9712222D</pub-id><pub-id pub-id-type="pmid">11050244</pub-id><pub-id pub-id-type="pmcid">PMC17322</pub-id></element-citation></ref><ref id="REF519"><label>519</label><element-citation publication-type="journal" id="CITATION519"><person-group person-group-type="author"><name name-style="western"><surname>Abe</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sakairi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kajiyama</surname><given-names>H</given-names></name><name name-style="western"><surname>Shrivastav</surname><given-names>S</given-names></name><name name-style="western"><surname>Beeson</surname><given-names>C</given-names></name><name name-style="western"><surname>Kopp</surname><given-names>JB</given-names></name></person-group><article-title>Bioenergetic characterization of mouse podocytes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajpcell.00563.2009">Am J Physiol Cell Physiol</uri></source><year>2010</year><volume>299</volume><fpage>C464</fpage><lpage>C476</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00563.2009</pub-id><pub-id pub-id-type="pmid">20445170</pub-id><pub-id pub-id-type="pmcid">PMC2928644</pub-id></element-citation></ref><ref id="REF520"><label>520</label><element-citation publication-type="journal" id="CITATION520"><person-group person-group-type="author"><name name-style="western"><surname>Akude</surname><given-names>E</given-names></name><name name-style="western"><surname>Zherebitskaya</surname><given-names>E</given-names></name><name name-style="western"><surname>Chowdhury</surname><given-names>SKR</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DR</given-names></name><name name-style="western"><surname>Dobrowsky</surname><given-names>RT</given-names></name><name name-style="western"><surname>Fernyhough</surname><given-names>P</given-names></name></person-group><article-title>Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.2337/db10-0818">Diabetes</uri></source><year>2011</year><volume>60</volume><fpage>288</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.2337/db10-0818</pub-id><pub-id pub-id-type="pmid">20876714</pub-id><pub-id pub-id-type="pmcid">PMC3012184</pub-id></element-citation></ref><ref id="REF521"><label>521</label><element-citation publication-type="journal" id="CITATION521"><person-group person-group-type="author"><name name-style="western"><surname>Coughlan</surname><given-names>MT</given-names></name><name name-style="western"><surname>Thorburn</surname><given-names>DR</given-names></name><name name-style="western"><surname>Penfold</surname><given-names>SA</given-names></name><name name-style="western"><surname>Laskowski</surname><given-names>A</given-names></name><name name-style="western"><surname>Harcourt</surname><given-names>BE</given-names></name><name name-style="western"><surname>Sourris</surname><given-names>KC</given-names></name><name name-style="western"><surname>Tan</surname><given-names>ALY</given-names></name><etal>et al.</etal></person-group><article-title>RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1681/ASN.2008050514">J Am Soc Nephrol</uri></source><year>2009</year><volume>20</volume><fpage>742</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1681/ASN.2008050514</pub-id><pub-id pub-id-type="pmid">19158353</pub-id><pub-id pub-id-type="pmcid">PMC2663823</pub-id></element-citation></ref><ref id="REF522"><label>522</label><element-citation publication-type="journal" id="CITATION522"><person-group person-group-type="author"><name name-style="western"><surname>Flarsheim</surname><given-names>CE</given-names></name><name name-style="western"><surname>Grupp</surname><given-names>IL</given-names></name><name name-style="western"><surname>Matlib</surname><given-names>MA</given-names></name></person-group><article-title>Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajpheart.1996.271.1.H192">Am J Physiol Heart Circ Physiol</uri></source><year>1996</year><volume>271</volume><fpage>H192</fpage><lpage>H202</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.1996.271.1.H192</pub-id><pub-id pub-id-type="pmid">8760175</pub-id></element-citation></ref><ref id="REF523"><label>523</label><element-citation publication-type="journal" id="CITATION523"><person-group person-group-type="author"><name name-style="western"><surname>Rosca</surname><given-names>MG</given-names></name><name name-style="western"><surname>Monnier</surname><given-names>VM</given-names></name><name name-style="western"><surname>Szweda</surname><given-names>LI</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>MF</given-names></name></person-group><article-title>Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1152/ajprenal.00302.2001">Am J Physiol Renal Physiol</uri></source><year>2002</year><volume>283</volume><fpage>F52</fpage><lpage>F59</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00302.2001</pub-id><pub-id pub-id-type="pmid">12060586</pub-id></element-citation></ref><ref id="REF524"><label>524</label><element-citation publication-type="journal" id="CITATION524"><person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>C</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cho</surname><given-names>SG</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Z</given-names></name></person-group><article-title>Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models</article-title><source><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1172/JCI37829">J Clin Invest</uri></source><year>2009</year><volume>119</volume><fpage>1275</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1172/JCI37829</pub-id><pub-id pub-id-type="pmid">19349686</pub-id><pub-id pub-id-type="pmcid">PMC2673870</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>